data_2m0t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m0t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 CA--C 1.513 -0.542 0 CA-C-O 121.256 0.44 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.446 ' HZ ' HG12 ' A' ' 104' ' ' VAL . 9.0 m-85 -148.04 151.94 36.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.241 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 t -170.38 126.37 0.77 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.994 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt 47.86 60.98 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.714 0.634 . . . . 0.0 110.572 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.783 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.55 164.61 59.67 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.29 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 11' ' ' LEU . 18.1 Cg_endo -56.63 161.48 9.84 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.754 2.97 . . . . 0.0 113.099 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -144.27 127.27 16.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.127 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 tp -84.08 106.34 15.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 30.7 m -96.47 114.7 26.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.54 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.8 m -98.97 111.78 24.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -121.38 153.49 37.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.467 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.59 147.45 30.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.139 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.82 117.92 20.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.382 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.41 -151.43 20.29 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.041 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.08 -17.3 36.21 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.987 2.458 . . . . 0.0 113.238 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -119.88 30.21 7.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.202 0.525 . . . . 0.0 110.626 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.89 -122.0 5.73 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.493 ' HB3' HD13 ' A' ' 17' ' ' LEU . 97.5 m-85 -110.73 -13.79 14.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.431 0.616 . . . . 0.0 111.18 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 80.32 32.89 33.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.438 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.52 152.05 46.63 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.419 -0.46 . . . . 0.0 109.976 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.8 m-70 -112.18 125.36 54.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.77 131.52 54.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.45 151.19 47.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.015 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.21 6.16 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.17 133.14 44.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.873 0.368 . . . . 0.0 111.523 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.96 138.51 55.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.511 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.31 -44.23 2.48 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.638 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.76 173.15 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -129.9 35.81 4.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.299 0.571 . . . . 0.0 110.456 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.94 167.51 25.62 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.844 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG3' HG21 ' A' ' 75' ' ' VAL . 36.4 mm-40 -103.66 146.03 29.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.705 0.288 . . . . 0.0 110.379 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.43 152.35 51.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.6 mm -70.76 113.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 3.6 tmm_? -86.94 -39.91 15.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 110.086 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 46.2 tp -153.39 143.97 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.69 116.23 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.32 111.13 10.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 51.7 Cg_exo -55.66 119.46 6.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 112.346 -177.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.71 30.32 Favored Glycine 0 C--N 1.316 -0.561 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.165 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 79.9 p -95.76 160.22 30.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.985 0.421 . . . . 0.0 111.281 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.27 -17.56 58.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.841 2.361 . . . . 0.0 112.138 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -63.19 -38.34 90.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 36.8 mt-10 -64.75 -38.97 92.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.046 0.45 . . . . 0.0 110.007 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -64.36 -32.51 74.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.652 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.21 -18.16 53.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.97 37.8 4.82 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.989 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 48' ' ' ALA . 98.3 mt -91.04 130.14 36.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.89 0.345 . . . . 0.0 110.162 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 tt -126.84 141.63 51.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.06 95.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 111.225 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.12 -26.65 1.13 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.485 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 70.2 m-20 -63.71 139.07 58.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.714 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -85.1 132.23 34.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.303 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 54.9 tp -76.26 117.12 17.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.541 ' HB ' HD12 ' A' ' 89' ' ' LEU . 57.9 t -103.47 -36.2 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.274 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 8.7 tt0 -152.01 151.49 31.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 111.142 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.66 116.85 44.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.453 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 60.6 m-80 68.61 -60.9 0.42 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.281 1.033 . . . . 0.0 111.059 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.26 26.89 0.07 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -125.79 129.01 48.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -68.34 125.25 25.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.272 0.358 . . . . 0.0 111.044 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 75' ' ' VAL . 29.8 m -127.7 24.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.461 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.478 ' HG2' HG11 ' A' ' 60' ' ' VAL . 53.5 mt-10 -53.08 -47.52 68.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.951 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -111.0 9.47 22.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.223 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.27 157.73 19.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.457 0.646 . . . . 0.0 112.088 -171.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -85.56 169.06 13.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.909 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.566 ' O ' HG22 ' A' ' 76' ' ' VAL . 64.3 t60 -56.74 -45.55 81.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.928 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.85 -38.61 89.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 111.057 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.07 -38.79 86.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.489 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.501 HG21 ' HG3' ' A' ' 37' ' ' GLN . 29.3 m -70.26 -43.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.442 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 72' ' ' HIS . 77.9 t -54.69 -42.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.4 m -60.07 -40.65 90.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -68.52 -35.85 78.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.458 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 75' ' ' VAL . 83.7 mt -62.77 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.7 mmt180 -61.53 -23.22 65.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.86 -6.99 53.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.16 117.16 17.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.96 -60.13 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -129.61 -20.04 3.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.75 145.96 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.042 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.433 HG12 ' CE1' ' A' ' 24' ' ' TYR . 14.5 p -116.82 141.81 33.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.128 0.49 . . . . 0.0 110.407 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 95.8 mtt180 -101.92 117.02 33.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.807 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD13 ' A' ' 53' ' ' LEU . 92.6 mt -112.75 118.96 36.43 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 1.6 tm? -93.48 116.55 29.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 35.4 m -134.02 154.15 37.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.158 0.504 . . . . 0.0 111.338 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.73 150.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.181 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.08 125.46 74.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 109.973 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.67 -38.36 94.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.921 3.081 . . . . 0.0 113.905 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.75 -39.15 80.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.098 0.475 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 17.4 m -71.33 -36.52 71.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.303 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 8.9 t70 -56.97 -45.87 82.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 57.2 mt-10 -65.85 -39.36 90.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 95' ' ' THR . 21.0 pt20 -72.38 -39.85 67.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.522 HD13 HD11 ' A' ' 110' ' ' LEU . 53.4 mt -70.43 -34.04 72.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.72 0.295 . . . . 0.0 110.746 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 49.0 mt-30 -66.05 -34.46 78.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.619 0.247 . . . . 0.0 110.825 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.5 mttp -61.92 -19.07 62.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.01 -9.81 57.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.71 11.48 63.77 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.175 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG12 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -92.91 138.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 0.0 111.102 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.791 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -77.95 98.45 5.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.407 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 12' ' ' PRO . 67.0 t -66.18 -22.38 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.08 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.633 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -59.89 -35.36 74.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -173.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HA ' HD11 ' A' ' 111' ' ' LEU . 65.4 tt0 -165.86 -40.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.94 0.4 . . . . 0.0 110.989 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.791 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 30.4 mm-40 -55.74 -30.83 61.87 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.522 HD11 HD13 ' A' ' 99' ' ' LEU . 2.1 tt -65.44 -40.26 93.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.137 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 108' ' ' GLU . 6.0 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 110.387 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 CA-C-O 120.955 0.315 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.453 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 38.0 m-85 -152.59 149.21 28.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.475 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.401 HG21 HG21 ' A' ' 95' ' ' THR . 2.7 t -160.37 -43.51 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.201 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.404 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.0 tpt -139.82 90.89 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.753 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.69 157.84 83.61 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.819 -177.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 1.039 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 57.9 Cg_endo -67.72 149.56 78.85 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.067 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.93 128.25 48.33 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.187 178.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.78 107.27 16.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 67.5 m -94.02 111.47 23.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' HH11 ' A' ' 87' ' ' ARG . 4.3 p -98.62 110.79 23.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.069 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -121.4 156.37 32.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.393 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.74 138.7 49.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 35.2 ttpt -71.55 124.64 25.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.914 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.15 -162.2 35.41 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.31 -28.84 87.62 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.989 2.459 . . . . 0.0 112.711 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -122.41 40.89 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.902 0.382 . . . . 0.0 110.681 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.501 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 84.21 -144.2 21.56 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.363 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' HB3' HD11 ' A' ' 17' ' ' LEU . 84.8 m-85 -101.66 -25.62 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.84 32.82 12.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.739 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -127.46 141.26 51.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.457 0.629 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.46 ' C ' ' HB3' ' A' ' 40' ' ' ARG . 30.4 m-70 -100.94 144.69 29.58 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.82 137.25 54.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.118 0.261 . . . . 0.0 110.541 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -138.47 149.35 45.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.65 117.31 3.47 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.9 137.61 43.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.03 100.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.827 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.11 -38.27 1.62 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.5 -179.24 7.11 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.509 -0.845 . . . . 0.0 109.043 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.58 21.27 2.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 110.449 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.1 176.38 18.44 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -104.14 143.51 32.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.076 0.465 . . . . 0.0 110.89 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.91 156.72 41.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.884 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 55' ' ' ALA . 31.7 mm -70.39 120.51 18.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.979 0.418 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HB3' ' C ' ' A' ' 27' ' ' HIS . 0.5 OUTLIER -93.52 -47.96 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -173.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.5 tm? -158.57 140.12 13.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.517 ' N ' HD13 ' A' ' 41' ' ' LEU . 48.2 t -117.63 115.74 49.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.21 130.99 89.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.2 127.46 18.4 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.008 1.806 . . . . 0.0 111.892 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.92 28.69 40.96 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.58 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.8 p -102.36 162.3 20.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 122.674 -0.31 . . . . 0.0 110.811 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 18.6 Cg_endo -62.31 -23.5 75.28 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.467 2.112 . . . . 0.0 112.23 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -62.45 -41.73 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.305 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -59.92 -43.58 94.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.756 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 95.7 mttt -59.6 -37.35 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . . . -79.7 -11.79 59.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.056 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.11 31.89 15.87 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.146 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.34 104.54 11.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.0 140.97 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.366 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . . . -70.79 106.88 3.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.806 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.43 -16.5 3.83 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.553 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -73.73 146.39 44.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 0.0 110.859 176.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -91.26 127.39 36.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.488 ' HA ' HG13 ' A' ' 90' ' ' VAL . 38.8 tp -77.8 109.84 12.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.727 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.11 -32.87 3.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.468 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -147.71 149.72 32.96 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.407 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 75' ' ' VAL . 96.8 t -136.67 116.55 16.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.325 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 64.53 26.28 13.32 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.649 0.738 . . . . 0.0 110.683 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.36 16.03 59.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.366 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 8.9 tp10 -124.74 133.08 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.16 128.45 36.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.675 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.493 ' HB ' HG23 ' A' ' 75' ' ' VAL . 35.7 m -123.63 26.83 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.56 -27.31 64.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.661 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -118.12 14.0 13.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.386 0.612 . . . . 0.0 109.583 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -96.47 146.51 24.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.19 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.1 p -81.28 178.04 8.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 76' ' ' VAL . 57.3 t60 -58.02 -46.35 85.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.148 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.61 -42.88 91.1 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.553 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 57.9 mt-30 -61.49 -41.14 96.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 67' ' ' VAL . 94.5 t -71.42 -44.61 71.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 25.4 t -54.57 -45.26 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.66 0.267 . . . . 0.0 111.611 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -59.93 -37.02 78.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.944 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.2 mtt-85 -68.3 -37.03 80.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.598 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 75' ' ' VAL . 68.7 mt -64.77 -35.47 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mpt_? -73.34 -20.57 60.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.28 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 134.79 40.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.286 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.63 -70.74 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.579 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -112.57 -19.73 11.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.847 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.16 145.08 26.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.44 149.41 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.955 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.433 HH11 ' HB2' ' A' ' 16' ' ' CYS . 22.1 mmt180 -108.88 113.19 25.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.458 HD12 HD22 ' A' ' 17' ' ' LEU . 74.9 mt -109.38 118.62 37.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.683 0.278 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.1 tp -93.82 122.22 36.07 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.6 m -133.34 154.6 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.416 0.627 . . . . 0.0 111.431 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.09 145.14 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.327 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.01 122.06 45.03 Favored Pre-proline 0 C--O 1.225 -0.237 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.2 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.579 -172.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.97 -38.97 66.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HG ' ' A' ' 99' ' ' LEU . 19.4 m -70.03 -37.87 75.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.27 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.76 -39.29 77.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.33 -49.2 78.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.445 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.654 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 pt20 -72.97 -46.69 50.92 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.653 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 95' ' ' THR . 29.6 mt -62.33 -43.77 98.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 111.537 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -67.75 -36.6 80.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.874 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -70.24 -23.04 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 96.3 mt -71.79 -22.28 61.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.38 19.94 8.11 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -107.07 134.76 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.82 102.66 13.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.827 0.822 . . . . 0.0 110.925 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 1.039 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 14.8 m -65.2 -13.33 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.608 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -58.36 -31.36 67.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -167.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -171.14 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.415 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -54.4 -42.07 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 110' ' ' LEU . 1.8 tm? -60.09 -29.18 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.545 -177.305 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.46 -0.47 0 CA-C-O 121.075 0.365 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.54 ' HB3' HD12 ' A' ' 11' ' ' LEU . 29.3 m-85 -148.61 154.04 39.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.326 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -172.52 123.58 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.687 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.57 61.09 2.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.828 HD21 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.0 140.43 96.05 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.578 -169.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 19.4 Cg_endo -61.62 159.28 33.06 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.024 2.483 . . . . 0.0 111.524 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -143.07 156.64 44.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.133 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -84.21 114.17 21.62 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.9 m -93.55 107.76 19.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.09 111.71 23.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.971 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -115.7 148.68 39.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 85' ' ' ALA . 32.8 mt-10 -122.92 129.31 51.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.161 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.9 ttmt -54.94 126.42 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.625 -170.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.7 12.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.378 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.32 -19.56 13.24 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.545 2.163 . . . . 0.0 112.701 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.23 27.15 7.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.261 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 89.72 -114.6 4.38 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.562 -175.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' HA ' ' HG2' ' A' ' 47' ' ' PRO . 97.7 m-85 -123.89 -22.9 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.238 0.519 . . . . 0.0 111.642 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.73 33.83 23.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.966 171.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -132.66 142.63 49.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.396 0.598 . . . . 0.0 110.086 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' HD11 ' A' ' 41' ' ' LEU . 29.3 m-70 -111.32 131.69 54.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.5 tp -101.96 144.4 30.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.299 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.421 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 3.1 p80 -141.69 153.05 44.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.916 0.388 . . . . 0.0 111.259 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.74 125.87 4.9 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.522 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.21 -175.77 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.896 0.379 . . . . 0.0 110.431 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -109.5 135.62 50.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.987 0.422 . . . . 0.0 110.133 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.83 15.49 57.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.5 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 -174.38 2.51 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.741 0.305 . . . . 0.0 110.365 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.1 pt? -125.4 -33.53 2.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.621 172.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.9 177.8 21.24 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.587 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -104.99 155.13 19.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -130.73 153.21 49.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 0.0 110.577 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 mm -71.58 123.54 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.633 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HG2' ' CG ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.6 -45.91 8.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 42' ' ' VAL . 3.0 tm? -150.67 140.88 22.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.527 ' N ' HD12 ' A' ' 41' ' ' LEU . 96.6 t -122.14 116.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.487 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -58.8 126.78 81.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -63.4 115.44 3.02 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.035 1.824 . . . . 0.0 111.972 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 41.76 7.55 Favored Glycine 0 C--N 1.317 -0.517 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.536 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 77.3 p -112.23 168.06 8.23 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.514 ' HG2' ' HA ' ' A' ' 24' ' ' TYR . 10.2 Cg_endo -56.07 -30.38 78.5 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.241 1.961 . . . . 0.0 112.313 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -61.7 -38.66 88.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 0.0 110.332 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.03 -39.35 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.462 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.2 mttm -64.61 -29.39 70.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.044 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -88.24 -17.88 29.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.32 35.79 5.37 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.926 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 42' ' ' VAL . 90.1 mt -92.67 138.95 31.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.6 tp -145.87 153.2 40.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.874 0.369 . . . . 0.0 110.716 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.54 104.58 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.035 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.31 -30.01 2.46 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.902 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 14.1 m-20 -63.23 136.15 57.54 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.004 0.43 . . . . 0.0 110.664 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -87.79 128.71 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.361 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HA ' HG13 ' A' ' 90' ' ' VAL . 58.5 tp -80.23 121.31 25.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.123 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.53 -42.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.585 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.1 tt0 -144.75 151.63 39.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.836 0.35 . . . . 0.0 111.181 -177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.689 HG21 HG11 ' A' ' 75' ' ' VAL . 66.0 t -132.31 114.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.323 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.08 36.29 27.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.418 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.09 1.83 59.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.134 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 8.6 tp10 -125.52 136.61 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.855 0.828 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -68.17 125.71 27.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.064 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 62' ' ' VAL . 34.3 m -122.78 31.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.895 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -66.51 -21.0 66.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 34.8 mtmm -127.5 5.43 6.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.464 . . . . 0.0 111.046 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.8 mp0 -79.01 164.97 23.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -175.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.2 p -99.87 170.39 8.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -54.51 -47.93 72.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.53 -45.24 93.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.294 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -64.62 -39.2 93.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.77 -40.18 76.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.019 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.435 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 19.1 t -58.39 -39.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.4 m -57.74 -40.66 80.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 0.0 110.596 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -68.83 -37.19 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.699 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -65.12 -36.23 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 6.3 mpt_? -73.7 -22.82 59.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.267 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.16 59.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 110.19 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 113.58 12.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -84.71 -66.01 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.38 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -97.39 -33.12 11.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.023 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.439 ' HB2' ' HG2' ' A' ' 18' ' ' GLU . . . -151.77 156.56 40.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.403 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.24 141.36 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.453 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -105.98 112.95 26.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.81 122.55 45.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 16.9 tp -94.88 118.77 32.34 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.5 m -129.89 161.08 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.991 0.424 . . . . 0.0 110.707 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 96' ' ' ASP . 7.5 p -131.93 138.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.163 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.65 125.63 54.34 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.567 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -44.83 45.82 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.966 2.444 . . . . 0.0 115.117 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.53 -31.18 63.53 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.258 0.551 . . . . 0.0 110.584 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.467 HG22 ' HG ' ' A' ' 99' ' ' LEU . 40.4 m -71.95 -36.28 69.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.63 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.453 ' HB2' HG12 ' A' ' 91' ' ' VAL . 11.3 t70 -56.16 -43.73 78.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.3 -41.13 88.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 29.8 mm-40 -73.07 -50.01 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 102' ' ' LEU . 23.6 mt -68.56 -31.64 71.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.185 -170.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.597 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 pt20 -57.93 -41.9 83.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 28.5 mtpp -77.47 -37.12 52.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.258 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.544 HD11 HD23 ' A' ' 99' ' ' LEU . 70.5 mt -69.43 -39.92 77.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.3 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.31 90.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 6.1 p -80.64 80.62 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.271 1.034 . . . . 0.0 112.087 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -112.61 34.79 4.15 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 170.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.433 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 13.3 m -67.23 -14.65 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.753 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 78.8 ttt180 -58.91 -45.31 90.64 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -167.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 34.5 tt0 -167.26 -24.1 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.414 . . . . 0.0 110.474 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.18 -47.07 79.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.32 0.581 . . . . 0.0 110.281 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 11' ' ' LEU . 57.5 tp -67.46 -19.98 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.349 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 10.9 mp . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 N--CA 1.471 0.197 0 N-CA-C 113.534 0.552 . . . . 0.0 113.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.582 ' CZ ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -156.15 163.16 39.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.933 0.397 . . . . 0.0 110.956 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 95' ' ' THR . 4.5 t -173.13 128.42 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.092 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.69 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 22.2 ttt 73.54 -51.51 0.7 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.672 0.789 . . . . 0.0 112.313 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER 55.8 133.53 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.801 1.241 . . . . 0.0 113.131 -174.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 75.7 Cg_endo -75.22 167.99 25.65 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.465 2.777 . . . . 0.0 113.24 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.52 144.63 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.652 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.18 109.04 19.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 167.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 51.0 m -94.17 116.45 28.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.852 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -104.12 112.3 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.01 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -120.72 154.48 35.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.2 142.49 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 38.4 ttmt -74.07 115.83 14.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.735 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.63 -150.95 18.17 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.727 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.83 -29.25 42.25 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.732 2.288 . . . . 0.0 112.556 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -130.69 43.99 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.164 0.507 . . . . 0.0 111.351 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 93.59 -108.76 3.71 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.992 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.516 ' HB3' HD11 ' A' ' 17' ' ' LEU . 99.5 m-85 -135.88 -21.98 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 112.774 -172.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 27.61 20.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.378 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -123.96 142.93 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.468 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 10.2 m170 -101.27 119.71 39.16 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.8 tp -102.46 133.15 47.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.769 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.445 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.5 p80 -123.57 143.69 50.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.469 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.9 93.95 0.52 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.483 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 45.2 mt-10 -55.99 130.36 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.853 0.384 . . . . 0.0 111.45 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -66.52 119.1 11.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.68 -37.31 3.34 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 37.2 mmtm -77.57 160.38 28.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.8 0.333 . . . . 0.0 110.163 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.4 pp -113.1 19.87 16.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.724 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.67 167.01 28.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.913 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.479 ' HG3' HG23 ' A' ' 75' ' ' VAL . 25.6 mm-40 -105.93 151.84 24.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.445 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 m-85 -138.54 153.77 48.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.58 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.427 HG12 ' OD1' ' A' ' 57' ' ' ASP . 9.7 mm -71.07 121.87 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -98.27 -25.69 14.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 42' ' ' VAL . 9.9 tt -164.85 147.1 8.22 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.67 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.454 ' N ' HD23 ' A' ' 41' ' ' LEU . 1.8 p -131.96 122.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.044 0.449 . . . . 0.0 109.806 173.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 37.2 mm-40 -60.22 130.1 89.15 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.987 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 18.1 Cg_exo -65.27 119.4 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.429 2.086 . . . . 0.0 111.451 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 13.92 52.41 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.334 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 98.4 p -91.82 160.4 36.2 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.809 0.338 . . . . 0.0 110.287 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 32.1 Cg_endo -65.23 -17.41 58.41 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 111.39 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -65.74 -43.04 90.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -65.61 -37.01 85.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.108 0.48 . . . . 0.0 109.961 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -67.76 -26.04 65.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.045 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -81.8 -18.8 42.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.145 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.29 29.59 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.939 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 48' ' ' ALA . 85.1 mt -86.38 147.94 25.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.95 0.375 . . . . 0.0 110.262 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 tt -146.13 140.3 26.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.24 81.18 1.0 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.463 0.649 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HD3' ' A' ' 93' ' ' PRO . . . 157.06 39.03 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 8.6 p-10 -105.76 -169.97 1.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.47 0.652 . . . . 0.0 111.165 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.413 ' HE ' ' CG ' ' A' ' 96' ' ' ASP . 25.1 ttm-85 -132.76 124.1 27.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 156.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD13 HD22 ' A' ' 88' ' ' LEU . 34.6 tp -71.39 102.33 2.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.092 0.472 . . . . 0.0 109.775 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.27 -41.11 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.491 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.0 tt0 -148.55 151.06 34.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.705 0.288 . . . . 0.0 111.188 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.453 HG21 HG21 ' A' ' 67' ' ' VAL . 69.9 t -132.16 117.23 32.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.311 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.46 21.73 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.532 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.29 7.38 46.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.923 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.8 tp10 -124.41 133.03 53.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 110.696 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.78 126.97 30.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.098 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 33.6 m -126.52 27.73 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.431 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.19 -28.18 66.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.33 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 13.7 ptmm? -128.64 39.32 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.289 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 50.9 mm-40 -103.67 168.85 8.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 0.0 112.086 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.565 ' O ' HG21 ' A' ' 75' ' ' VAL . 66.9 p -97.78 178.61 5.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.366 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -65.45 -46.6 79.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.437 ' HA ' HG11 ' A' ' 76' ' ' VAL . 30.4 tt0 -66.46 -32.83 74.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.439 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 16.3 mm100 -70.42 -46.1 64.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.976 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 71' ' ' THR . 14.5 m -72.51 -41.2 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.6 p -57.74 -36.36 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.072 0.463 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -64.11 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.937 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.6 mtt-85 -66.52 -36.05 81.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.567 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -63.01 -38.12 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.262 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 22.2 mmt85 -73.36 -25.01 60.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.323 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.73 55.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB2' ' HH ' ' A' ' 24' ' ' TYR . . . -71.64 122.65 20.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.145 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.17 -83.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.515 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.01 -11.96 13.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.96 25.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.82 144.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -109.9 112.88 25.18 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 59' ' ' LEU . 78.9 mt -115.61 122.75 46.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.618 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 18.6 tp -95.27 116.41 28.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 35.5 m -129.97 154.65 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.692 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.9 p -144.73 145.93 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' HE1' ' A' ' 10' ' ' MET . 1.0 OUTLIER -65.95 133.16 94.8 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.676 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 38.8 Cg_exo -59.87 -28.24 86.75 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.7 2.934 . . . . 0.0 113.736 -171.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.5 -48.25 67.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 109.86 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 9' ' ' THR . 15.0 m -71.78 -37.32 70.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.269 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.541 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 2.6 t70 -57.21 -47.13 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.607 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.738 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 28.5 tt0 -72.48 -39.37 67.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.041 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 95' ' ' THR . 20.0 pt20 -69.47 -38.72 77.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.572 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 95' ' ' THR . 43.7 mt -68.83 -39.13 80.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 97' ' ' GLU . 10.6 pt20 -66.32 -33.16 75.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.16 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 34.4 mmtp -57.22 -35.33 69.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.414 0.626 . . . . 0.0 109.34 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.39 -55.57 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.707 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.22 -108.09 0.48 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.1 t 68.74 125.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.532 0.682 . . . . 0.0 112.572 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.82 71.86 10.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.66 . . . . 0.0 109.924 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -56.12 -24.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.421 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.618 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 14.7 ptm180 -60.6 -26.71 67.18 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -165.62 -26.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -44.3 67.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.762 0.315 . . . . 0.0 111.406 -167.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.582 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 3.0 mm? -68.66 -31.09 69.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.105 -177.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.722 0.239 . . . . 0.0 112.722 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -154.0 137.65 16.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.516 0.674 . . . . 0.0 111.272 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -141.33 111.71 6.9 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.859 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.4 mtm 48.93 54.98 9.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.071 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.905 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.04 144.56 82.29 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.878 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.903 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 28.9 Cg_endo -63.85 159.93 39.52 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.447 2.765 . . . . 0.0 112.762 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -143.16 155.1 44.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.971 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 87' ' ' ARG . 45.9 tp -84.9 109.55 18.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.54 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -93.79 108.09 19.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -96.92 114.84 26.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.509 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -121.81 154.13 37.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.471 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.24 146.7 28.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.226 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -74.99 118.16 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.946 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -149.12 17.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.477 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 -20.06 20.03 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.98 2.454 . . . . 0.0 112.78 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -124.48 39.07 4.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.076 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.65 -122.99 7.96 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.41 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' HB3' HD11 ' A' ' 17' ' ' LEU . 98.3 m-85 -112.26 -30.18 7.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.17 0.485 . . . . 0.0 110.658 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.96 27.83 8.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.243 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.9 142.26 51.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.238 0.519 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -107.3 144.36 34.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 tp -119.49 129.84 54.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.497 0.189 . . . . 0.0 110.967 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -127.19 150.42 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 110.56 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.71 129.09 9.37 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.4 mm-40 -70.37 128.26 35.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.01 110.24 5.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.341 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.51 -12.18 33.11 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.466 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 4.2 mptp? -96.17 178.96 5.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.5 pp -122.27 16.46 10.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.608 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.67 168.58 25.19 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.909 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -104.54 146.35 29.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 110.204 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -133.11 157.12 46.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.244 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.75 122.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.034 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -85.15 -47.65 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.171 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -164.05 140.88 6.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.509 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -110.7 124.42 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.737 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.07 124.15 87.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.46 126.64 18.08 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.845 1.697 . . . . 0.0 112.074 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.81 17.69 37.37 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.254 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -97.89 158.94 32.04 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.9 -20.03 67.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.651 2.234 . . . . 0.0 111.994 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -62.26 -45.7 92.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.09 -37.24 86.42 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.148 0.499 . . . . 0.0 110.011 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -70.23 -23.51 62.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.923 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -84.06 -17.84 38.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.21 22.65 10.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.26 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -93.46 113.06 25.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 54' ' ' LEU . 2.7 mm? -117.83 166.55 12.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.344 0.592 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.56 122.16 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.133 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.59 -20.44 12.13 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.022 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 6.0 m-20 -59.47 141.86 53.75 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.288 0.566 . . . . 0.0 111.597 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.464 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 30.1 ttt180 -85.73 121.78 28.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.822 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HA ' HG12 ' A' ' 90' ' ' VAL . 27.1 tp -78.95 109.43 13.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.118 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.29 -37.86 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.409 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.716 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 25.6 tt0 -144.95 151.76 39.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 67' ' ' VAL . 74.0 t -134.5 119.75 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.694 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.59 -43.65 0.56 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.86 3.86 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.125 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -126.69 146.97 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.193 0.996 . . . . 0.0 111.251 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -63.48 123.16 18.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.843 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.594 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 32.6 m -118.39 17.98 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.214 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.19 -22.54 63.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.834 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.6 ptpp? -131.42 28.88 4.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.594 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 7.5 mm-40 -103.5 -174.55 2.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 75' ' ' VAL . 28.4 p -112.71 169.79 8.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.072 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.434 ' O ' HG22 ' A' ' 76' ' ' VAL . 16.3 t60 -58.58 -48.68 80.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.511 0.196 . . . . 0.0 110.914 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.97 -38.66 86.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.794 0.807 . . . . 0.0 110.334 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 5.3 tp-100 -61.18 -44.64 96.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.133 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 71' ' ' THR . 15.6 m -72.77 -42.69 61.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 43.5 t -54.88 -40.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.402 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 m -58.24 -38.06 76.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 0.0 110.655 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 74' ' ' GLN . 61.2 mtt85 -68.62 -35.89 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.852 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 76' ' ' VAL . 69.0 mt -62.61 -33.65 60.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.492 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 4.3 mpt_? -66.92 -21.79 65.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.1 -2.11 57.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.23 128.53 36.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.242 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.55 -73.39 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.546 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -131.83 -4.88 3.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.19 158.5 44.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.856 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 24' ' ' TYR . 12.7 p -127.83 146.4 33.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.488 ' HB3' HD13 ' A' ' 14' ' ' LEU . 14.8 mtm180 -97.7 122.84 41.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD23 ' A' ' 17' ' ' LEU . 89.4 mt -121.46 113.63 20.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.962 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 26.9 tp -94.1 116.08 28.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.2 m -133.01 157.41 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.221 0.534 . . . . 0.0 111.765 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.903 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 11.7 p -147.98 148.43 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.866 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.82 118.26 33.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 58' ' ' ARG . 34.6 Cg_endo -63.53 -31.88 70.77 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.239 2.626 . . . . 0.0 113.169 -172.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.26 -37.04 69.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.025 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.5 m -71.79 -40.3 69.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.99 -30.84 66.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.194 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.31 -50.77 70.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.85 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.63 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 11.4 pt20 -74.87 -39.48 61.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.021 0.439 . . . . 0.0 110.839 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.548 HD12 HD11 ' A' ' 102' ' ' LEU . 27.6 tp -66.13 -43.07 88.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.981 -164.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -68.19 -36.23 79.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.309 0.576 . . . . 0.0 110.245 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.27 -18.29 62.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.277 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 92.9 mt -70.15 -15.06 62.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.36 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 62.15 0.93 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.537 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.28 131.66 41.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.548 0.213 . . . . 0.0 110.773 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 10.7 mt-30 -83.15 85.89 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.572 0.701 . . . . 0.0 109.754 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.455 HG13 ' HG3' ' A' ' 12' ' ' PRO . 3.8 t -59.99 -27.82 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.734 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.71 -25.52 66.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -175.18 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.122 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 33.7 tt0 -55.79 -41.02 73.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.108 0.48 . . . . 0.0 110.961 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 11' ' ' LEU . 49.0 tp -64.39 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.396 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 -177.397 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 CA--C 1.519 -0.253 0 N-CA-C 113.012 0.351 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -157.03 120.09 4.07 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.407 0.622 . . . . 0.0 110.557 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -159.4 126.53 4.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.79 -168.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.447 ' HE2' ' OG1' ' A' ' 95' ' ' THR . 69.7 mtm 54.21 30.92 13.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.856 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -58.31 139.77 84.17 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.024 -176.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 40.5 Cg_endo -65.66 158.39 53.61 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.598 2.865 . . . . 0.0 113.588 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -143.69 169.96 16.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HG ' ' CD2' ' A' ' 111' ' ' LEU . 17.5 mt -84.34 122.5 29.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.756 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 64.1 m -94.37 108.28 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.357 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -95.62 111.82 23.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.115 0.483 . . . . 0.0 110.585 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.49 147.8 40.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.516 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -112.59 135.32 53.45 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.376 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 33.2 ttpt -71.05 120.53 16.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.284 -173.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.35 -170.13 44.64 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.52 -29.91 91.15 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.651 2.234 . . . . 0.0 112.747 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -99.36 -0.56 40.8 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.166 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.37 -141.82 16.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.134 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.596 ' O ' ' HB2' ' A' ' 46' ' ' SER . 84.4 m-85 -105.72 -36.34 7.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.0 111.33 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 40.59 4.81 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.928 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -135.56 152.96 51.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.504 0.652 . . . . 0.0 110.405 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -124.36 144.51 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.467 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.4 mt -120.96 154.59 35.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 0.0 111.17 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 2.1 p80 -144.13 151.65 39.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.44 141.42 15.27 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.0 mt-10 -107.69 152.14 24.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.799 0.333 . . . . 0.0 111.169 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.81 141.78 38.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.25 -43.6 2.81 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 27.0 mmtp -78.07 175.32 10.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.1 pt? -144.0 29.05 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.38 -163.79 9.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.96 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HG3' HG22 ' A' ' 75' ' ' VAL . 31.1 mm-40 -112.27 148.03 35.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -134.39 160.83 36.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.426 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.464 HG12 ' CG ' ' A' ' 57' ' ' ASP . 31.8 mm -68.59 119.59 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.203 0.525 . . . . 0.0 110.86 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.25 -36.95 13.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 tp -161.94 143.31 10.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.8 117.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.823 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.4 mm-40 -68.8 129.54 92.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.835 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.5 Cg_exo -70.02 121.38 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 111.355 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.94 17.24 21.39 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.549 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 91.4 p -105.41 154.97 38.66 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 -15.24 49.22 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.747 2.298 . . . . 0.0 111.813 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HB1' HD23 ' A' ' 53' ' ' LEU . . . -66.38 -35.88 81.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.602 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.23 -38.65 91.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.0 110.091 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.42 -20.12 62.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.165 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . . . -85.92 -18.0 33.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.21 28.11 7.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.172 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 48' ' ' ALA . 11.2 mp -79.2 136.36 37.06 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.582 -0.363 . . . . 0.0 110.489 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 tt -146.46 142.2 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.2 109.09 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.122 0.487 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.71 6.85 2.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.88 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' CG ' HG12 ' A' ' 39' ' ' ILE . 6.8 p-10 -72.16 -173.11 1.0 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.923 0.868 . . . . 0.0 111.787 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -135.96 115.37 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.661 165.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.2 tp -78.31 106.65 10.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 109.809 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -97.5 -38.06 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.873 -175.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 25.2 tt0 -149.77 151.8 34.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.709 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 67' ' ' VAL . 90.4 t -134.62 117.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.217 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 56.46 29.82 15.99 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.22 5.73 57.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.563 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 9.2 tp10 -124.41 130.32 52.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.432 0.616 . . . . 0.0 110.656 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.97 127.08 31.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 35.3 m -123.79 24.21 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 52.1 mt-10 -68.26 -25.35 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.633 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 1.3 ptpt -126.44 29.93 5.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -177.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 44.4 mm-40 -93.17 -171.36 2.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 74' ' ' GLN . 33.6 p -113.16 -179.79 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.683 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.557 ' O ' HG21 ' A' ' 76' ' ' VAL . 75.1 t60 -64.38 -47.0 80.9 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -67.55 -37.83 83.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.764 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.438 ' HG2' ' OG1' ' A' ' 71' ' ' THR . 14.5 mm100 -60.51 -43.23 97.32 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.735 0.303 . . . . 0.0 110.908 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 37' ' ' GLN . 13.4 m -71.58 -40.21 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.835 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 72' ' ' HIS . 72.5 t -54.09 -37.91 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.451 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -57.14 -44.51 83.47 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.284 0.564 . . . . 0.0 110.122 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -69.23 -36.19 76.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.121 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 75' ' ' VAL . 72.6 mt -64.21 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.486 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 41.6 mmt180 -69.78 -22.55 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.98 55.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.896 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.8 116.83 15.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.92 -66.5 0.78 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.55 -172.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.75 -17.84 10.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.002 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.65 150.07 29.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.0 111.19 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -123.79 141.09 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.594 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -105.84 111.16 23.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 109.969 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.56 129.87 53.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.028 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 14.7 tp -102.01 118.81 37.69 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.4 154.92 40.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.114 0.483 . . . . 0.0 110.686 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.6 p -140.64 145.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.3 138.18 68.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.1 -25.63 64.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.701 2.934 . . . . 0.0 113.995 -172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.96 -50.39 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.532 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.447 ' OG1' ' HE2' ' A' ' 10' ' ' MET . 85.3 m -67.38 -42.6 83.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.658 0.742 . . . . 0.0 110.158 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -58.14 -45.71 86.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.66 -43.25 89.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.559 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.2 pt20 -72.21 -44.35 63.08 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.038 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 102' ' ' LEU . 12.7 mt -67.16 -40.17 86.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.415 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -64.67 -36.08 83.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.757 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -70.58 -19.7 62.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.367 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 74.5 mt -81.76 -8.24 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.266 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.97 24.19 30.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.08 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG13 HD22 ' A' ' 110' ' ' LEU . 98.6 t -89.55 128.42 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.815 0.34 . . . . 0.0 111.141 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 37.0 mt-30 -96.51 83.85 3.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.032 0.444 . . . . 0.0 109.884 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 19.7 m -59.23 -14.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.593 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.97 -25.75 63.83 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.19 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.809 0.337 . . . . 0.0 110.938 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 105' ' ' GLN . 44.9 tt0 -54.98 -38.03 67.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 104' ' ' VAL . 57.3 mt -79.21 -40.26 31.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.455 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 7.3 mp . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.464 -0.238 0 N-CA-C 113.285 0.456 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.483 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 7.2 m-85 -156.61 118.36 3.87 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.216 1.008 . . . . 0.0 112.172 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 95' ' ' THR . 4.6 t -153.49 125.66 7.96 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.434 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.6 mtt 53.77 48.79 20.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.039 0.447 . . . . 0.0 110.434 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.735 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -74.04 152.92 88.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.641 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.929 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.0 Cg_endo -68.79 151.45 74.31 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.943 2.429 . . . . 0.0 112.694 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HA ' HD13 ' A' ' 111' ' ' LEU . 69.6 mtp180 -126.05 153.72 44.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.618 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.623 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 40.9 tp -89.64 106.07 18.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 68.8 m -93.22 108.03 19.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 p -95.31 120.78 36.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.96 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.559 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -125.51 151.52 46.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.37 135.14 42.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.479 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 ttmt -68.47 119.33 12.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.06 -144.03 14.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.069 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.36 -14.2 25.35 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.072 2.514 . . . . 0.0 113.398 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -137.85 35.94 2.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.945 0.402 . . . . 0.0 111.015 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 84.1 -104.72 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.544 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.486 ' HB3' HD13 ' A' ' 17' ' ' LEU . 92.2 m-85 -132.53 -22.13 2.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.411 0.605 . . . . 0.0 112.255 -175.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.47 28.38 24.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.497 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.94 155.72 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' CD2' HD23 ' A' ' 41' ' ' LEU . 91.1 m-70 -122.06 134.19 54.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.404 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.3 tp -108.45 135.66 49.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.8 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -128.85 152.1 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.77 119.92 3.15 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.811 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.46 118.85 11.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.657 0.265 . . . . 0.0 110.448 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -63.36 125.36 23.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.045 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.3 -36.33 3.66 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -106.3 165.95 10.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -112.22 10.06 20.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.681 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.9 143.1 16.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.564 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -105.04 143.88 32.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.02 151.5 49.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 0.0 110.794 -175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.11 121.89 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.879 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 -26.25 14.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.68 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 8.1 tp -162.45 151.56 15.35 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 111.311 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.52 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.6 t -128.8 119.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.614 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.07 125.75 90.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.64 111.63 2.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.038 1.825 . . . . 0.0 111.386 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.59 10.97 20.59 Favored Glycine 0 C--N 1.311 -0.852 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.948 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.405 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.3 p -99.1 159.75 29.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.231 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 36.1 Cg_endo -65.91 -14.41 44.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.99 2.46 . . . . 0.0 112.409 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -65.05 -40.43 94.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.779 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -62.64 -33.09 74.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 110.242 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -71.69 -13.27 61.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.067 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . . . -100.24 -17.66 17.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.24 7.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.863 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 42' ' ' VAL . 10.5 mp -84.83 134.15 34.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.715 0.258 . . . . 0.0 110.324 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -137.84 152.22 48.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 110.577 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.7 107.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.533 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.27 3.75 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.944 -176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 42.8 m-20 -66.68 142.58 57.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 111.443 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 71.1 ttt180 -91.43 121.66 33.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 90' ' ' VAL . 53.6 tp -79.03 104.76 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 0.0 110.22 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.416 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 41.5 t -91.39 -40.93 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 10.7 tt0 -144.74 150.98 38.18 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.51 HG22 HG11 ' A' ' 75' ' ' VAL . 90.0 t -130.24 117.57 40.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 9.9 t-20 70.92 -61.2 0.49 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.151 0.98 . . . . 0.0 110.631 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.0 20.65 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -125.85 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.715 0.257 . . . . 0.0 110.506 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -71.9 99.65 2.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.452 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.485 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 27.0 m -82.75 0.93 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.233 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 24.2 mm-40 -70.79 -3.99 21.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 171.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -113.53 6.89 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.025 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.485 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 13.5 mm-40 -110.75 -165.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.298 -172.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 75' ' ' VAL . 65.3 p -132.29 176.34 8.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.119 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.444 ' O ' HG22 ' A' ' 76' ' ' VAL . 13.4 t60 -54.16 -48.05 71.31 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 176.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -65.34 -43.01 92.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.185 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 54.9 mt-30 -66.88 -44.07 81.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.51 HG11 HG22 ' A' ' 62' ' ' VAL . 91.4 t -62.29 -42.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.963 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 72' ' ' HIS . 52.3 t -57.95 -45.03 87.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 110.27 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 m -58.4 -39.33 79.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 84.0 mtt-85 -65.92 -34.53 78.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 75' ' ' VAL . 67.6 mt -62.5 -33.92 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.686 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.32 60.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.77 115.03 10.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.851 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.95 -74.49 0.24 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.304 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -101.32 -28.84 12.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.417 0.627 . . . . 0.0 109.902 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.77 159.01 44.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.761 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.48 142.27 41.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.857 0.36 . . . . 0.0 110.37 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' HD3' HD23 ' A' ' 14' ' ' LEU . 96.2 mtt180 -98.74 112.87 24.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.888 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 17' ' ' LEU . 91.9 mt -114.06 113.67 25.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 28.2 tp -94.11 116.78 29.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.4 m -130.84 153.67 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.053 0.454 . . . . 0.0 111.459 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.743 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.1 p -142.54 142.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.8 114.63 10.85 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.571 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 32.4 Cg_exo -57.75 -29.39 85.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.095 2.53 . . . . 0.0 112.767 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.7 -47.58 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.955 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 7.5 m -72.46 -35.23 68.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.898 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -39.79 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.741 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 10.2 tp10 -58.73 -48.35 81.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.9 pt20 -72.92 -40.13 65.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.361 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 99' ' ' LEU . 31.4 mt -67.79 -43.18 80.33 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HA ' HG22 ' A' ' 104' ' ' VAL . 29.6 pt20 -60.44 -34.38 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.318 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 55.7 mttm -67.56 -18.94 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 111.077 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.34 -3.73 58.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.19 42.86 8.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.815 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 100' ' ' GLN . 19.7 m -90.72 171.75 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 111.666 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.46 ' HB2' ' CB ' ' A' ' 109' ' ' GLU . 57.6 mt-30 -133.97 83.4 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.929 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.7 m -66.34 -16.47 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.29 -43.96 92.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.556 ' HA ' HD22 ' A' ' 111' ' ' LEU . 35.3 tt0 -169.77 -11.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.975 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.46 ' CB ' ' HB2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -55.48 -39.91 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.058 0.456 . . . . 0.0 110.141 -177.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.483 HD23 ' CZ ' ' A' ' 8' ' ' PHE . 46.8 mt -73.61 -39.48 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.485 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 14' ' ' LEU . 3.0 mm? . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.087 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 CA-C-O 121.279 0.449 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' HD22 ' A' ' 110' ' ' LEU . 2.6 m-85 -148.77 146.79 28.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.791 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -171.03 134.72 0.96 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.425 ' HB3' HG22 ' A' ' 95' ' ' THR . 13.7 tpt 53.36 63.98 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.843 0.83 . . . . 0.0 109.538 -174.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 HD21 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -65.56 140.47 97.55 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.624 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 1.01 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 77.0 Cg_endo -72.76 169.23 22.5 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.298 2.665 . . . . 0.0 112.147 -176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -130.02 136.1 49.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.838 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 87' ' ' ARG . 57.2 tp -83.9 104.83 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -94.87 115.78 27.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.697 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.0 110.37 22.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.826 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -110.21 152.69 25.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.434 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -103.69 143.03 33.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.553 -170.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -72.83 104.95 4.17 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.8 -151.01 21.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.543 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 -22.57 23.61 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.876 2.384 . . . . 0.0 112.478 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -124.38 39.02 4.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.473 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.2 -125.61 8.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.44 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.531 ' HB3' HD12 ' A' ' 17' ' ' LEU . 88.3 m-85 -111.29 -28.04 8.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.145 0.472 . . . . 0.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.51 36.58 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.28 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -123.9 146.41 48.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.472 0.636 . . . . 0.0 110.458 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.5 m-70 -106.8 125.16 50.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.247 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.31 127.29 54.95 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.494 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.594 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -113.18 132.12 55.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.341 0.591 . . . . 0.0 109.983 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.63 112.23 2.95 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 11.8 mm-40 -57.1 132.02 51.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.189 0.518 . . . . 0.0 111.126 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.41 119.7 14.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.564 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.65 -36.41 3.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.652 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 58.4 mmtt -76.01 160.8 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.893 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -100.77 16.14 26.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.017 0.436 . . . . 0.0 111.615 -177.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.41 132.06 10.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.53 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.06 137.88 40.65 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.0 m-85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.618 0.247 . . . . 0.0 110.424 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.79 119.61 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -25.79 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 -175.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.568 HD11 ' N ' ' A' ' 42' ' ' VAL . 2.2 tm? -164.62 145.91 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.529 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.568 ' N ' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -132.6 132.98 59.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -78.73 98.39 0.32 Allowed Pre-proline 0 N--CA 1.465 0.325 0 O-C-N 123.355 0.409 . . . . 0.0 110.734 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 42' ' ' VAL . 14.5 Cg_exo -34.67 94.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.469 3.446 . . . . 0.0 114.301 -168.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.04 25.16 1.91 Allowed Glycine 0 C--N 1.314 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.742 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -96.03 163.01 21.99 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 117.228 0.514 . . . . 0.0 110.193 178.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.522 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 29.7 Cg_endo -64.22 -17.38 59.51 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.324 2.016 . . . . 0.0 111.686 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.51 -48.73 76.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.197 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' OE1' ' HB2' ' A' ' 46' ' ' SER . 1.9 mp0 -66.12 -38.74 88.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 29.5 mtpp -62.41 -32.16 72.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.35 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -79.19 -19.19 51.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.03 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.27 39.94 1.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.823 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.56 134.3 47.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 tt -137.4 138.08 39.49 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.19 99.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.418 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.06 -24.88 1.91 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.119 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 68.0 m-20 -70.73 141.68 51.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.653 0.263 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -88.47 134.56 33.82 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.225 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.512 ' HA ' HG11 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -75.49 124.83 27.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.785 177.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.4 -43.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -145.14 150.32 36.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.864 0.364 . . . . 0.0 110.802 -178.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 75' ' ' VAL . 63.6 t -133.65 111.67 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.051 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 60.71 38.64 18.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.868 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.0 9.73 80.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.952 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.487 ' HG2' ' NE ' ' A' ' 78' ' ' ARG . 7.2 tp10 -120.81 127.05 51.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -69.7 129.14 38.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.75 -0.204 . . . . 0.0 110.751 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG13 ' NH1' ' A' ' 78' ' ' ARG . 20.4 m -120.94 31.21 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.262 0.553 . . . . 0.0 111.418 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.462 ' O ' HD11 ' A' ' 35' ' ' LEU . 58.0 mt-10 -71.33 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.398 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.893 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.3 mtmp? -130.02 16.76 5.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.451 0.644 . . . . 0.0 110.106 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -174.45 3.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.302 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 74' ' ' GLN . 32.5 p -119.68 166.98 12.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.863 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.582 ' O ' HG23 ' A' ' 76' ' ' VAL . 49.5 t60 -58.11 -48.4 80.31 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.899 0.124 . . . . 0.0 110.684 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.08 -41.35 99.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.801 0.81 . . . . 0.0 110.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 6.6 tp60 -60.87 -39.25 88.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.811 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 62' ' ' VAL . 74.4 t -71.69 -41.34 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.406 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 72' ' ' HIS . 69.6 t -55.69 -41.15 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.673 0.273 . . . . 0.0 111.729 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -57.86 -40.0 79.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.208 0.527 . . . . 0.0 110.442 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.551 ' NH1' HG13 ' A' ' 67' ' ' VAL . 59.6 mtt180 -69.98 -36.05 74.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.123 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.57 -36.33 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.057 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -72.94 -22.59 60.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.842 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.25 -15.52 59.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.981 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.72 128.55 36.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.747 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.48 -67.66 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.36 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -111.18 -26.93 8.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.349 0.595 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.2 155.42 38.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.09 144.56 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HD3' HD23 ' A' ' 14' ' ' LEU . 84.9 mtt180 -98.82 118.49 35.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.94 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.458 HD13 HD22 ' A' ' 17' ' ' LEU . 88.9 mt -121.86 115.51 22.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.245 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 18.4 tp -95.09 123.34 38.53 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 59' ' ' LEU . 29.8 m -133.3 155.74 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.291 0.567 . . . . 0.0 112.349 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.7 p -146.7 146.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.486 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 p30 -73.23 134.29 80.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.93 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 58.3 Cg_exo -53.4 -34.1 69.69 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.064 3.176 . . . . 0.0 114.301 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.58 -46.7 78.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.835 0.35 . . . . 0.0 110.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 10' ' ' MET . 24.9 m -69.78 -37.18 76.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.486 ' HB2' HG11 ' A' ' 91' ' ' VAL . 3.9 t70 -57.51 -45.1 85.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.429 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.927 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.441 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 9.5 pt20 -74.8 -42.53 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.079 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.601 HD21 HD13 ' A' ' 102' ' ' LEU . 25.7 mt -62.43 -34.15 76.21 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.7 -35.6 81.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.383 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -74.56 -24.98 59.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.072 0.463 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.601 HD13 HD21 ' A' ' 99' ' ' LEU . 37.1 mt -84.8 -46.47 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.422 0.629 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.99 96.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.01 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -76.67 86.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 122.309 1.052 . . . . 0.0 111.85 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 77.9 mt-30 -104.7 17.49 24.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.43 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 1.01 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m -66.66 -16.33 20.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.441 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 96.3 mtt180 -60.73 -43.77 97.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.9 -172.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HA ' HD13 ' A' ' 111' ' ' LEU . 30.0 tt0 -172.66 -21.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 110.348 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 2.5 mp0 -55.15 -46.33 75.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.322 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 8' ' ' PHE . 52.0 tp -65.39 -35.54 81.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 108' ' ' GLU . 7.0 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.307 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.778 0.241 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.442 ' CD1' HD21 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -159.81 138.73 10.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.406 176.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -136.95 113.64 10.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.491 -167.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.3 mtp 54.32 57.04 6.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.566 0.698 . . . . 0.0 109.663 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -64.26 161.59 39.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.392 -173.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.685 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 22.1 Cg_endo -59.52 164.24 11.52 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.546 2.831 . . . . 0.0 112.419 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HA ' HD11 ' A' ' 111' ' ' LEU . 28.2 mmm180 -136.96 139.72 41.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.945 -172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 89' ' ' LEU . 48.6 tp -84.63 105.02 15.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 29.9 m -95.17 108.35 20.47 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.09 -173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.9 110.9 22.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -114.67 148.98 37.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.765 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -119.54 128.08 53.6 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.008 -168.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 30.9 ttpt -65.4 114.75 5.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.291 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.04 -166.24 37.01 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.27 -12.54 33.32 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.578 2.185 . . . . 0.0 112.39 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -103.78 1.6 31.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.97 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.36 -133.75 11.89 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.132 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.486 ' HB3' HD13 ' A' ' 17' ' ' LEU . 98.9 m-85 -106.71 -28.83 9.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.263 0.532 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.85 39.59 9.37 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 114.267 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -138.4 157.83 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 109.999 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.52 ' CD2' HD23 ' A' ' 41' ' ' LEU . 52.9 m-70 -125.55 139.07 53.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -110.35 141.86 42.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.721 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 1.4 p80 -136.2 151.85 50.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.47 112.12 1.01 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.978 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 46.0 mt-10 -65.8 176.81 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 0.0 110.881 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -103.29 137.82 40.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.85 15.22 63.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.177 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.37 -171.33 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CD ' ' A' ' 69' ' ' LYS . 1.8 pt? -124.38 -34.29 2.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.172 172.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.0 -177.94 15.32 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.247 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -104.66 150.24 24.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.589 0.356 . . . . 0.0 110.106 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.423 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 15.8 m-85 -126.69 151.43 48.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.66 0.266 . . . . 0.0 110.422 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.93 122.59 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.054 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 5.6 tmm_? -92.43 -42.14 9.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.989 0.423 . . . . 0.0 110.051 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.52 HD23 ' CD2' ' A' ' 27' ' ' HIS . 23.7 tp -149.22 150.22 32.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -125.7 118.84 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.22 121.53 76.98 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.985 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.64 121.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.222 1.948 . . . . 0.0 111.808 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.04 43.81 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.368 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.501 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 99.3 p -83.28 164.81 44.0 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.561 -0.376 . . . . 0.0 111.054 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.2 Cg_endo -67.81 -18.38 47.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.48 2.12 . . . . 0.0 112.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -62.65 -43.15 99.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.625 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.05 -38.7 89.73 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.338 0.59 . . . . 0.0 110.035 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 60.1 mttp -68.88 -25.05 64.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.86 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -84.61 -18.55 35.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.87 10.46 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 88' ' ' LEU . 10.2 mp -81.48 131.7 35.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.999 0.4 . . . . 0.0 110.45 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.64 152.65 51.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.05 92.87 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.32 -26.73 0.78 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.649 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 9.7 m-20 -64.26 140.78 58.9 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 111.12 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -90.47 132.33 35.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 90' ' ' VAL . 33.5 tp -80.73 112.7 18.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.833 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.04 -38.6 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.296 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' HD2' ' A' ' 107' ' ' ARG . 3.0 tt0 -148.88 150.59 33.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.275 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.484 HG23 HG23 ' A' ' 67' ' ' VAL . 86.5 t -132.21 111.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.176 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 53.44 37.06 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.798 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.06 9.6 58.11 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.674 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.498 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.6 tp10 -120.23 130.83 54.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.439 0.619 . . . . 0.0 111.039 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -72.53 101.44 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.7 m -102.74 5.96 10.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.253 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -8.92 41.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' CD ' HD11 ' A' ' 35' ' ' LEU . 30.4 mmtp -125.0 17.02 8.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.799 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.553 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 39.9 mt-10 -107.12 -172.2 2.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 112.483 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 p -107.63 170.47 7.96 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.049 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.45 ' O ' HG21 ' A' ' 76' ' ' VAL . 10.0 t60 -57.36 -47.55 81.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.023 177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -63.8 -47.59 80.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 28.1 mt-30 -61.71 -43.6 98.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.567 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 79' ' ' ILE . 70.3 t -66.73 -44.02 89.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.572 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 72' ' ' HIS . 50.1 t -57.8 -37.49 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.777 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 t -62.79 -39.34 93.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mtt-85 -68.91 -36.39 77.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 75' ' ' VAL . 78.3 mt -63.26 -42.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.76 -23.29 63.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -12.71 61.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.212 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.57 123.26 30.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.952 0.406 . . . . 0.0 109.942 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.47 -64.54 1.14 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.319 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -104.0 -28.81 11.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.57 32.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.777 0.322 . . . . 0.0 111.488 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.98 146.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.627 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.29 114.25 26.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 53' ' ' LEU . 84.1 mt -114.63 126.02 54.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -95.15 119.57 33.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.9 m -132.8 160.03 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.685 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.9 p -147.77 143.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.372 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.3 t70 -67.26 126.78 93.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.298 175.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 31.6 Cg_exo -59.46 -32.82 97.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.625 2.883 . . . . 0.0 113.971 -174.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -72.1 -41.31 67.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.647 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 30.5 m -69.52 -39.59 77.45 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.272 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.48 -33.41 69.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.93 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.49 -40.56 78.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.76 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.65 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 96.8 mt-30 -72.78 -49.15 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 173.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 95' ' ' THR . 30.1 mt -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.401 -166.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.15 -35.73 81.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -71.46 -36.04 71.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 66.7 mt -63.32 -59.53 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.193 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 146.11 -154.45 25.96 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.602 HG12 ' HG ' ' A' ' 110' ' ' LEU . 91.7 t 67.0 146.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.861 0.864 . . . . 0.0 112.491 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 14.6 mm100 -81.3 91.69 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 0.0 109.857 175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.559 HG12 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -55.35 -25.07 16.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.643 -1.162 . . . . 0.0 114.013 -171.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.647 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 17.8 ptt180 -66.4 -17.67 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -170.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.542 ' HA ' HD22 ' A' ' 111' ' ' LEU . 33.2 tt0 179.99 -13.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.2 tt0 -55.56 -37.42 67.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 110.976 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.602 ' HG ' HG12 ' A' ' 104' ' ' VAL . 52.4 mt -73.09 -39.68 65.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 108' ' ' GLU . 3.5 mm? . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.928 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.709 0.212 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -150.58 149.54 30.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.251 0.548 . . . . 0.0 111.733 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' THR . 5.1 t -170.63 123.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.603 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.5 ttt 53.54 54.21 10.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.571 0.7 . . . . 0.0 110.338 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.839 HD21 ' H ' ' A' ' 11' ' ' LEU . 1.3 pt? -80.36 162.25 61.91 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' CG ' HG11 ' A' ' 106' ' ' VAL . 81.1 Cg_endo -88.52 172.66 4.77 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.718 2.279 . . . . 0.0 113.833 -166.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -138.11 154.09 49.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.853 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.9 111.5 19.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 64.0 m -92.55 109.72 21.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.472 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -95.48 110.7 22.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.381 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -113.98 149.57 35.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.956 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -112.9 134.89 54.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.472 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 33.1 ttpt -68.99 112.66 5.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.007 -174.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.27 -156.02 30.19 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.129 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.18 -8.95 24.58 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.014 2.476 . . . . 0.0 113.81 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -126.45 10.77 7.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 104.22 -139.14 14.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.311 -173.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.519 ' HB3' HD11 ' A' ' 17' ' ' LEU . 98.5 m-85 -103.17 -32.43 9.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.551 0.675 . . . . 0.0 112.072 -174.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.25 32.17 7.18 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.069 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -138.85 150.69 46.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -123.11 130.28 52.57 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.71 139.23 36.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.703 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -142.18 152.74 43.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.89 19.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.376 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HG3' ' CE2' ' A' ' 38' ' ' TYR . 51.3 mt-10 -78.22 -172.37 2.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -75.45 92.42 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.117 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.33 -83.98 0.75 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 37.83 -154.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.288 -0.956 . . . . 0.0 112.378 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 68' ' ' GLU . 1.8 pp -145.0 5.0 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.008 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.52 154.05 21.29 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.041 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -105.38 148.59 26.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.0 110.191 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 31' ' ' GLU . 8.4 m-85 -126.93 153.29 45.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 110.538 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.69 121.35 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.187 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 tmm_? -88.99 -46.69 8.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.7 tp -147.39 144.29 28.59 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.083 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 49' ' ' GLU . 2.2 p -129.97 113.72 27.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CA ' ' A' ' 25' ' ' GLY . 1.7 mt-10 -70.34 132.76 87.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.195 -166.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.19 118.14 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.407 2.071 . . . . 0.0 111.89 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.85 -1.43 33.85 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.382 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.47 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 99.3 p -85.45 158.95 56.83 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.181 -177.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -17.86 49.02 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 111.339 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -63.53 -43.39 97.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.721 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 42' ' ' VAL . 44.6 mt-10 -60.15 -44.16 95.18 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.279 0.561 . . . . 0.0 110.004 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.41 -17.67 63.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.511 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . . . -83.27 -18.83 37.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 0.0 110.286 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.41 26.41 6.56 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.07 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.68 136.23 33.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.76 0.315 . . . . 0.0 110.634 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 55' ' ' ALA . 3.8 tt -137.41 143.37 41.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.55 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -58.03 117.65 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.305 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.55 -26.51 6.27 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.126 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 94.3 m-20 -58.17 141.73 49.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.025 0.441 . . . . 0.0 111.792 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 46.8 ttt180 -85.31 122.68 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.436 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.74 118.8 21.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.908 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.55 -41.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.576 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 11.6 tt0 -149.96 150.94 32.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.729 0.3 . . . . 0.0 110.731 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.699 HG23 HG12 ' A' ' 75' ' ' VAL . 48.8 t -128.81 116.11 39.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.585 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 62.8 m-80 68.39 -58.25 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.427 1.091 . . . . 0.0 111.171 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.11 28.21 0.06 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.189 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.7 tp10 -125.54 127.26 46.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -69.92 115.72 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.32 . . . . 0.0 110.489 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 31.4 m -111.52 29.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.13 0.49 . . . . 0.0 111.486 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 35' ' ' LEU . 4.4 mm-40 -73.14 -8.72 57.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.732 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -138.43 32.45 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 111.169 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.458 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 61.4 mm-40 -107.11 -172.17 2.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.363 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -123.48 174.1 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.56 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.424 ' O ' HG22 ' A' ' 76' ' ' VAL . 9.5 t60 -55.3 -47.9 74.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.001 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -65.73 -43.36 89.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.151 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 14.0 mm-40 -60.76 -42.9 98.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.571 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.699 HG12 HG23 ' A' ' 62' ' ' VAL . 90.1 t -70.79 -38.9 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.504 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 72' ' ' HIS . 25.4 t -58.88 -39.85 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -59.13 -41.78 89.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.277 0.561 . . . . 0.0 109.856 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' NE ' ' HG2' ' A' ' 65' ' ' GLU . 53.1 mtt180 -69.34 -35.88 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.9 mt -65.18 -32.59 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.202 0.525 . . . . 0.0 109.898 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.91 -17.3 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 109.997 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.53 114.29 20.83 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.562 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.53 -63.7 1.01 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.575 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -135.38 -0.12 2.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.149 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.98 141.65 20.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -126.62 144.15 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.839 0.352 . . . . 0.0 110.246 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 59.6 mtm-85 -103.31 113.23 26.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.152 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 17' ' ' LEU . 99.0 mt -112.37 118.47 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.014 0.435 . . . . 0.0 110.968 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.462 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 32.8 tp -95.1 116.32 28.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 31.8 m -130.02 154.08 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.842 0.353 . . . . 0.0 110.6 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.83 147.57 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.154 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.54 121.75 69.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.604 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.43 -31.1 92.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.526 2.817 . . . . 0.0 113.508 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.84 -44.74 63.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.003 0.43 . . . . 0.0 110.241 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 9' ' ' THR . 23.7 m -71.13 -36.74 72.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.735 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 9.1 t70 -56.92 -33.28 66.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.872 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 8.7 mm-40 -59.03 -49.66 77.04 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -72.74 -39.77 66.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.931 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.84 -33.9 76.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.988 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.592 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 1.3 tt0 -57.23 -49.14 76.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.495 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 14.0 mptt -68.94 -18.32 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.515 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.06 -10.81 59.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.84 46.3 38.43 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.614 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.591 HG23 HG23 ' A' ' 106' ' ' VAL . 24.0 m -91.72 160.86 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.278 0.561 . . . . 0.0 111.96 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -104.32 69.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.9 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.591 HG23 HG23 ' A' ' 104' ' ' VAL . 16.8 t -56.72 -27.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.466 ' HB2' ' OE1' ' A' ' 61' ' ' GLU . 7.6 ptm180 -59.9 -29.22 68.2 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -165.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -174.59 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.177 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.22 -32.28 70.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.81 -19.73 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.197 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.426 -174.047 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.461 -0.436 0 CA-C-O 120.697 0.207 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.543 ' CE1' HD11 ' A' ' 110' ' ' LEU . 17.4 m-85 -146.78 147.32 30.79 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.519 0.676 . . . . 0.0 112.255 -174.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 10' ' ' MET . 4.0 t -172.0 133.74 0.73 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.794 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.55 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 16.4 tpt 75.2 -60.58 0.51 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.708 0.803 . . . . 0.0 110.493 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 51.91 132.91 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.296 1.438 . . . . 0.0 114.178 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.984 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 84.9 Cg_endo -76.8 173.43 14.49 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.577 2.851 . . . . 0.0 113.514 -176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -143.04 157.69 44.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.124 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 89' ' ' LEU . 29.6 mt -84.54 115.98 22.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.2 m -94.49 108.31 20.25 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.517 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -94.62 111.62 23.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -121.88 150.31 42.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 36.3 mt-10 -112.97 134.76 54.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.786 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.87 117.58 4.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -172.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.63 -161.67 32.16 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.489 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.74 -33.15 93.35 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.42 2.747 . . . . 0.0 113.046 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -136.98 24.01 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 111.544 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.43 -153.26 18.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.758 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.513 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.4 m-85 -104.08 -29.91 10.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.967 0.383 . . . . 0.0 111.985 -173.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.14 29.65 6.69 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.79 172.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -134.0 141.07 47.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.429 -0.454 . . . . 0.0 110.32 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -101.6 144.17 30.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.53 128.32 49.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.493 0.187 . . . . 0.0 111.311 -172.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.4 p80 -123.94 140.27 53.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -118.1 6.48 15.17 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 64.16 -173.7 0.17 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.978 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -107.61 122.09 45.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.46 61.98 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.68 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 4.2 mptp? -96.44 167.71 11.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.855 HD13 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -130.51 20.48 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.061 175.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 144.05 15.8 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HB2' HD23 ' A' ' 59' ' ' LEU . 12.5 mm100 -103.86 146.22 28.97 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 117.007 0.404 . . . . 0.0 110.299 -173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -128.22 152.69 47.77 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 55' ' ' ALA . 28.5 mm -70.09 118.3 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 109.952 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.493 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 1.2 tpt180 -93.96 -49.67 5.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.521 -173.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.7 tm? -152.5 141.37 21.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 41' ' ' LEU . 25.0 t -118.82 127.29 75.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -80.88 120.05 77.79 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.92 101.94 1.14 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.511 2.14 . . . . 0.0 112.386 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.2 22.11 1.26 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.99 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.49 173.84 3.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.77 0.319 . . . . 0.0 110.196 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.545 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 56.1 Cg_endo -70.34 -13.46 33.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.405 2.07 . . . . 0.0 112.922 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -47.9 81.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.402 . . . . 0.0 110.891 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' CG1' ' A' ' 42' ' ' VAL . 1.7 mp0 -67.34 -32.97 74.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.406 0.622 . . . . 0.0 109.791 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 27.3 mtpp -69.56 -21.02 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.908 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 17' ' ' LEU . . . -91.67 -17.81 24.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.37 38.11 4.1 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.52 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 48' ' ' ALA . 94.6 mt -92.9 130.86 38.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.432 HD21 ' N ' ' A' ' 55' ' ' ALA . 6.9 tt -129.09 138.74 52.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 39' ' ' ILE . . . -63.4 103.89 0.56 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.183 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.99 -26.89 2.58 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.654 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.7 m-20 -65.25 149.39 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.33 0.586 . . . . 0.0 111.549 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 58.8 ttt180 -92.13 125.51 36.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 37' ' ' GLN . 48.2 tp -80.42 100.71 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.032 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 106' ' ' VAL . 41.9 t -86.32 -39.51 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.161 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -146.73 151.42 37.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 111.534 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 75' ' ' VAL . 83.9 t -131.3 111.3 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.617 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.99 -24.0 0.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.844 0.858 . . . . 0.0 112.03 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 148.0 13.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.454 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -126.0 135.39 51.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.393 0.597 . . . . 0.0 110.185 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.22 102.49 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.916 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 62' ' ' VAL . 29.9 m -92.61 12.7 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -170.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.5 -3.22 19.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.185 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.855 ' HA ' HD13 ' A' ' 35' ' ' LEU . 97.9 mttt -132.64 31.16 4.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.172 0.51 . . . . 0.0 110.086 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -116.9 -164.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.261 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 75' ' ' VAL . 59.6 p -133.29 167.1 21.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.102 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.556 ' O ' HG22 ' A' ' 76' ' ' VAL . 20.4 t60 -53.88 -47.34 71.18 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.16 -46.81 88.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.2 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 48.6 mt-30 -65.32 -38.12 89.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 62' ' ' VAL . 75.7 t -66.05 -39.55 84.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.924 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 72' ' ' HIS . 62.0 t -57.54 -46.1 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.614 0.245 . . . . 0.0 111.069 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -37.33 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.674 0.273 . . . . 0.0 110.989 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 85.9 mtt-85 -66.57 -36.38 82.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.974 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.2 mt -65.52 -39.87 86.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.0 110.173 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.4 mmt180 -71.21 -20.87 62.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.687 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.63 62.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.963 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' HH ' ' A' ' 24' ' ' TYR . . . -65.2 131.01 45.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.77 -52.27 10.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.216 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.87 -22.19 2.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.3 153.28 34.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.705 0.288 . . . . 0.0 110.937 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.0 141.71 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.12 114.51 27.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.438 HD13 HD12 ' A' ' 53' ' ' LEU . 94.3 mt -109.62 119.46 39.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 14' ' ' LEU . 26.8 tp -94.33 116.01 28.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 29.3 m -127.89 153.09 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.12 0.486 . . . . 0.0 111.041 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.984 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 10.6 p -148.26 153.51 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.326 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.89 118.69 16.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.41 -40.96 77.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.542 2.828 . . . . 0.0 113.597 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.34 -37.47 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -66.21 -38.28 87.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.913 0.387 . . . . 0.0 110.271 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.7 t70 -61.68 -36.7 81.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.88 -48.33 80.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.296 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.537 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 17.0 pt20 -72.43 -42.87 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.998 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 mt -59.44 -43.98 93.02 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.639 0.257 . . . . 0.0 111.203 -177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' ASP . 77.5 mm-40 -61.9 -38.16 87.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.796 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 98' ' ' GLN . 12.5 pttp -75.55 -19.79 59.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.366 . . . . 0.0 110.453 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 86.4 mt -76.89 -3.65 39.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.488 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.82 30.48 26.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.737 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 39.8 t -89.35 131.28 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.869 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -95.18 85.29 4.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.336 174.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -65.47 -17.47 22.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.222 -175.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -59.39 -45.91 90.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HA ' HD13 ' A' ' 111' ' ' LEU . 21.3 tt0 -166.79 -10.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.137 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.52 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 42.1 mm-40 -55.69 -40.79 72.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 110.6 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.543 HD11 ' CE1' ' A' ' 8' ' ' PHE . 45.1 mt -65.23 -40.22 93.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.392 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 108' ' ' GLU . 4.9 mp . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.052 -170.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 CA--C 1.513 -0.56 0 CA-C-O 121.443 0.518 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -149.53 139.67 22.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.317 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -148.56 -45.52 0.15 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.974 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.515 ' HB3' HG23 ' A' ' 95' ' ' THR . 51.0 tpp -138.9 78.57 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.887 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.54 155.8 85.35 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 -179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.686 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 55.3 Cg_endo -93.75 160.01 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.166 2.578 . . . . 0.0 112.775 -173.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -136.38 150.01 48.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.377 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.508 HD22 ' HD3' ' A' ' 87' ' ' ARG . 33.1 tp -82.21 106.79 14.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -92.49 111.66 23.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.051 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.616 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 42.6 m -97.31 110.9 23.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.256 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -110.97 154.98 23.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.339 176.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.96 130.41 55.69 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 -167.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -65.19 126.34 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.18 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.6 -169.18 21.82 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.24 -16.73 56.64 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.443 2.095 . . . . 0.0 112.135 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -97.81 0.74 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.132 0.492 . . . . 0.0 110.087 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.49 -119.76 5.81 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.526 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 91.7 m-85 -119.26 -24.55 6.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.114 0.457 . . . . 0.0 110.661 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.0 31.18 29.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.576 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -128.7 156.6 43.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.361 0.581 . . . . 0.0 110.056 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -126.16 144.61 50.69 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -120.15 143.18 48.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -139.48 147.35 41.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.706 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.36 108.81 2.29 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.736 ' O ' ' HD2' ' A' ' 34' ' ' LYS . 9.1 mm-40 -70.53 147.01 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -67.4 116.93 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 50.81 2.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.784 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.736 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -134.76 -171.87 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 110.55 -177.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 pt? -129.4 -29.27 2.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.752 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.06 -163.95 12.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.04 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -111.93 155.69 23.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.892 0.377 . . . . 0.0 110.622 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.516 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 83.2 m-85 -131.16 151.9 50.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.534 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.1 mm -72.53 124.91 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.806 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 2.4 tmm_? -89.06 -40.73 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 7.7 tp -161.9 150.07 14.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.478 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 65.0 t -129.29 129.9 67.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -76.94 115.97 53.04 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.31 114.2 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.207 1.938 . . . . 0.0 111.051 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 40.81 2.75 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.842 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.754 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 34.3 p -119.64 -164.16 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 74.5 Cg_endo -90.31 -13.36 2.42 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.245 1.296 . . . . 0.0 112.919 163.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -73.81 -41.62 62.1 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -74.73 -35.14 62.66 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.392 1.091 . . . . 0.0 108.14 -174.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -57.29 -34.66 68.9 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.938 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -78.87 -17.32 55.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.24 24.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.618 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.69 130.44 37.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.765 0.317 . . . . 0.0 110.495 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.3 tp -137.31 150.83 48.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.999 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 94.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.272 0.558 . . . . 0.0 111.179 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.71 -25.25 1.05 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.1 m-20 -62.26 140.81 58.48 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.137 0.494 . . . . 0.0 111.231 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.516 ' HE ' ' HE1' ' A' ' 38' ' ' TYR . 42.1 ttm180 -88.9 126.7 35.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.907 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.471 ' HA ' HG12 ' A' ' 90' ' ' VAL . 46.3 tp -80.46 117.36 21.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.02 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 89' ' ' LEU . 52.6 t -102.21 -37.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.463 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.65 149.73 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.632 -178.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 HG13 ' A' ' 75' ' ' VAL . 86.8 t -137.05 117.68 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.617 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 60.44 37.42 19.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.386 0.613 . . . . 0.0 110.147 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.52 16.24 76.25 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.705 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 7.3 tp10 -125.16 135.15 52.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.519 -0.401 . . . . 0.0 110.957 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.711 HD21 ' HD3' ' A' ' 107' ' ' ARG . 23.1 t-20 -70.02 113.96 7.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.375 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.545 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.9 m -111.99 26.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.327 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.444 ' CD ' HD22 ' A' ' 66' ' ' ASN . 81.2 mt-10 -61.24 -25.4 67.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.424 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 5.7 ptpp? -141.94 34.98 1.56 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.037 0.446 . . . . 0.0 111.543 -170.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mt-10 -110.56 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.019 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.3 p -113.48 167.62 10.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.535 ' O ' HG21 ' A' ' 76' ' ' VAL . 16.6 t60 -56.71 -44.52 81.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.853 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.62 -46.01 90.24 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.607 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.598 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 56.8 mt-30 -61.38 -42.4 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.806 HG13 HG22 ' A' ' 62' ' ' VAL . 74.3 t -64.97 -41.14 91.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.506 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 72' ' ' HIS . 73.1 t -58.01 -44.21 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.625 0.25 . . . . 0.0 111.425 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 p -64.0 -36.48 84.11 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.534 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 44.6 mtt-85 -64.94 -37.67 88.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 75' ' ' VAL . 77.2 mt -63.22 -32.8 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 110.268 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.6 mmt180 -70.34 -21.06 62.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -6.69 51.02 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' ALA . . . -90.14 125.23 35.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.707 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.55 -75.86 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.144 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -118.64 -1.92 11.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.506 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -151.98 149.58 29.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 174.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.23 142.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.616 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 94.1 mtt180 -98.68 117.37 33.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.98 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 17' ' ' LEU . 89.3 mt -121.75 125.92 47.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 10.4 tp -100.25 115.94 31.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.3 m -127.93 155.79 39.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.067 0.461 . . . . 0.0 110.375 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.3 p -148.0 154.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.039 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.62 123.37 56.93 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.95 -35.34 98.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.55 2.833 . . . . 0.0 113.246 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -72.22 -43.58 64.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 10' ' ' MET . 27.6 m -66.38 -37.43 85.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.689 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HB2' HG13 ' A' ' 91' ' ' VAL . 30.5 t70 -57.92 -39.74 78.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.347 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -58.51 -49.05 78.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.281 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.3 pt20 -72.64 -39.59 67.08 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.765 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.439 ' HG ' HG21 ' A' ' 95' ' ' THR . 38.8 mt -70.48 -42.78 70.93 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -47.93 82.49 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.7 -18.92 65.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.685 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 95.8 mt -69.49 -20.84 63.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.54 33.09 4.59 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.058 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.26 132.1 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.049 0.452 . . . . 0.0 111.139 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.82 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -87.08 88.58 7.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.91 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.463 HG12 ' CG ' ' A' ' 12' ' ' PRO . 2.3 t -65.64 -29.62 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.121 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.711 ' HD3' HD21 ' A' ' 66' ' ' ASN . 15.1 ttp85 -60.69 -44.02 97.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -168.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -158.81 -34.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.965 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.82 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 8.4 tp10 -55.52 -39.51 70.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.6 tp -68.86 -20.86 64.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 mp . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 120.968 0.414 . . . . 0.0 110.857 -178.536 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 CA-C-O 121.458 0.524 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.412 ' HB3' HD21 ' A' ' 11' ' ' LEU . 37.2 m-85 -153.97 145.11 22.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.74 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 10' ' ' MET . 1.5 t -142.68 -98.49 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.135 -169.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.453 ' H ' HG21 ' A' ' 9' ' ' THR . 82.6 mtp -97.41 -28.05 14.18 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 28.1 mt 76.36 160.09 0.15 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.083 167.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 58.5 Cg_endo -69.03 157.32 62.27 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.103 2.536 . . . . 0.0 112.732 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -129.75 126.27 37.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 87' ' ' ARG . 58.8 tp -90.9 106.62 18.64 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.511 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.74 107.96 20.16 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.27 111.62 23.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.26 0.552 . . . . 0.0 110.126 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -114.89 165.43 12.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.386 -178.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.1 147.38 44.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.859 -170.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -72.03 107.52 4.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.41 -163.76 39.28 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.55 -26.72 81.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.74 2.293 . . . . 0.0 112.71 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -112.63 25.67 11.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.475 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -105.05 2.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.958 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 46' ' ' SER . 90.3 m-85 -131.7 -42.07 1.04 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.488 -0.419 . . . . 0.0 111.662 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 42.72 4.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.397 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.82 158.3 43.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.491 0.646 . . . . 0.0 110.171 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.432 ' CD2' HD22 ' A' ' 41' ' ' LEU . 60.8 m-70 -128.27 143.83 51.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.166 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.68 155.91 38.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.212 0.529 . . . . 0.0 111.748 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -140.17 139.1 35.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.43 117.57 5.57 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -74.75 134.87 41.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 111.38 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -59.82 108.33 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.945 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.6 -31.46 3.96 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 12.0 mptt -110.25 159.51 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 109.864 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.618 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 1.5 pp -106.51 -4.05 20.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.076 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.06 147.99 24.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HG3' HG22 ' A' ' 75' ' ' VAL . 33.8 mm-40 -103.33 152.4 21.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.953 0.406 . . . . 0.0 110.061 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -126.39 144.75 50.72 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.1 120.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.27 -47.2 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.9 tp -146.66 149.41 33.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -123.67 120.04 58.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.163 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 53.0 mm-40 -64.29 131.91 95.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.5 Cg_exo -70.89 123.85 10.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.887 1.725 . . . . 0.0 111.786 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.7 22.07 24.67 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.055 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 89.9 p -104.24 158.08 32.69 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.746 0.308 . . . . 0.0 110.564 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.75 -14.82 46.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.601 2.201 . . . . 0.0 111.7 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -66.47 -40.69 89.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.347 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 28.8 mt-10 -64.94 -37.68 88.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.874 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.67 -29.11 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.006 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -79.16 -18.89 52.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.34 33.66 5.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 48' ' ' ALA . 83.4 mt -86.89 134.74 33.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.281 . . . . 0.0 110.444 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.71 153.33 51.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 128.1 34.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.468 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.71 -15.73 21.61 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.149 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 1.7 m-20 -78.29 147.18 34.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.925 0.393 . . . . 0.0 110.761 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 61.0 ttt180 -92.48 126.9 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.4 tp -77.58 112.79 14.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.163 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.503 ' HB ' HD21 ' A' ' 89' ' ' LEU . 40.8 t -104.88 -31.37 2.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.428 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -143.13 149.96 38.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.055 -0.403 . . . . 0.0 110.78 -178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.59 113.59 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.315 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.82 35.28 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.837 0.827 . . . . 0.0 110.844 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.66 10.96 69.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.147 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.7 tp10 -124.79 132.05 53.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.112 0.456 . . . . 0.0 110.868 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.26 108.95 3.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.7 16.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.698 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -76.39 7.54 4.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.46 23.48 2.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.668 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -109.25 -172.61 2.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.811 -174.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 75' ' ' VAL . 69.5 p -128.19 175.22 8.61 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.579 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 t60 -61.57 -46.56 89.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -66.51 -41.46 88.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.846 0.355 . . . . 0.0 110.716 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 15.8 mt-30 -67.17 -38.71 85.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 37' ' ' GLN . 17.8 m -68.64 -41.18 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.08 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 72' ' ' HIS . 76.3 t -56.31 -39.13 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 m -61.94 -38.64 89.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.387 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -67.37 -36.57 81.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.625 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 75' ' ' VAL . 71.7 mt -63.17 -37.71 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.208 0.528 . . . . 0.0 110.004 175.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -68.96 -24.52 64.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.074 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.82 58.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.8 130.89 46.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.203 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.05 -67.05 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.858 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.37 -24.58 9.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.09 157.93 43.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.793 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 ' CE1' ' A' ' 24' ' ' TYR . 11.5 p -130.05 143.36 41.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.479 ' HB3' HD12 ' A' ' 14' ' ' LEU . 9.9 mtm180 -98.74 128.51 45.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 53' ' ' LEU . 94.4 mt -122.12 110.57 15.92 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 11.9 tp -93.62 126.46 38.79 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.3 m -130.97 165.36 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 96' ' ' ASP . 8.7 p -148.14 140.1 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.569 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.5 p30 -75.1 145.12 80.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 50.4 Cg_exo -55.21 -31.52 76.47 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.017 3.145 . . . . 0.0 114.512 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.93 -47.89 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.777 0.323 . . . . 0.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.426 HG23 HG21 ' A' ' 9' ' ' THR . 99.1 m -64.19 -44.78 90.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.622 0.725 . . . . 0.0 109.879 174.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.443 ' HB2' HG13 ' A' ' 91' ' ' VAL . 17.6 t70 -59.24 -39.64 83.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.507 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 1.9 tm-20 -57.41 -49.81 75.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.136 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.583 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 6.0 pt20 -73.96 -47.34 38.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.416 HD13 HG23 ' A' ' 104' ' ' VAL . 2.7 mm? -58.76 -38.9 79.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 7.4 pt20 -64.53 -40.64 95.98 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.212 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 97' ' ' GLU . 44.1 mtmt -75.52 -34.98 60.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.878 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 90.6 mt -63.16 -27.3 69.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.606 -177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.61 73.92 0.9 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG23 HD13 ' A' ' 99' ' ' LEU . 57.4 t -121.37 153.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.566 0.222 . . . . 0.0 110.605 -173.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.81 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 11.5 pt20 -71.22 57.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.36 0.6 . . . . 0.0 111.171 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 ' HG3' ' A' ' 12' ' ' PRO . 47.8 t -63.66 -27.57 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.775 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 39.4 ptt180 -60.61 -23.04 64.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -169.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 17.8 tt0 171.18 -41.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.418 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.81 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.0 mt-10 -54.47 -32.5 57.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.206 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 61.7 tp -70.28 -41.97 72.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 0.0 111.245 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.257 0.551 . . . . 0.0 111.135 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 CA-C-O 121.528 0.554 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -144.75 142.83 30.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.609 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 179.7 132.11 0.09 Allowed 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.496 0.498 . . . . 0.0 110.39 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.8 mtt 44.06 47.06 7.31 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.74 0.65 . . . . 0.0 111.622 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.75 135.74 96.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.363 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.1 155.43 69.54 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.132 2.555 . . . . 0.0 113.518 -174.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -116.81 154.09 31.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.315 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' A' ' 87' ' ' ARG . 58.4 tp -82.06 115.48 21.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.8 m -93.41 115.85 28.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -104.38 112.21 25.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.727 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.66 155.68 34.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.182 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -104.34 145.77 29.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.512 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 26.0 ttpt -77.74 119.53 21.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.373 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.16 -158.36 25.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.701 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.12 -27.45 65.12 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.77 2.313 . . . . 0.0 112.457 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -110.25 26.1 11.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.274 0.559 . . . . 0.0 110.208 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 80.91 -100.58 1.99 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.5 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . 87.1 m-85 -133.72 -22.63 1.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.302 0.551 . . . . 0.0 111.804 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.05 28.96 24.23 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.76 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -127.31 140.6 52.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.85 138.77 45.75 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.54 132.18 56.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.739 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -122.78 146.74 47.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.977 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.89 113.0 1.95 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 8.8 mm-40 -61.57 133.71 55.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.612 0.244 . . . . 0.0 110.833 -175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.12 98.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.276 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.01 -13.16 9.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.229 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 27.8 mmmt -91.54 155.66 18.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.2 pp -102.57 19.28 19.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.31 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.39 152.47 20.64 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.666 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -103.71 137.52 41.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.907 0.384 . . . . 0.0 110.578 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -125.08 155.41 39.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.013 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.33 127.83 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -101.14 -45.15 5.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.807 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -146.68 141.22 26.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.53 -172.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.578 ' N ' HD12 ' A' ' 41' ' ' LEU . 55.1 t -121.67 113.79 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.9 mm-40 -73.59 130.14 84.28 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.16 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.3 Cg_exo -70.13 124.04 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.367 2.044 . . . . 0.0 111.815 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.9 16.93 29.34 Favored Glycine 0 C--N 1.317 -0.496 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.899 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 95.9 p -101.71 159.54 29.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 0.0 110.829 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.96 -20.25 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.83 172.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -64.19 -42.13 96.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.21 -42.0 89.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.307 0.575 . . . . 0.0 110.362 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.65 -22.93 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.11 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -87.28 -17.83 31.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.901 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.67 29.96 5.71 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.202 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.13 133.51 36.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 tt -139.97 141.06 36.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.86 100.03 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.382 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.04 -31.23 1.74 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.9 m-20 -60.28 140.9 56.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.519 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -89.04 132.35 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.861 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HA ' HG11 ' A' ' 90' ' ' VAL . 32.7 tp -75.2 114.06 13.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.758 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 106' ' ' VAL . 46.3 t -101.7 -36.45 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.07 150.25 35.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.003 -178.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 67' ' ' VAL . 93.0 t -136.17 107.24 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.123 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.5 m120 62.99 22.4 13.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.346 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.401 ' H ' ' CD ' ' A' ' 61' ' ' GLU . . . 106.67 4.22 36.94 Favored Glycine 0 C--N 1.321 -0.285 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.218 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.626 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.1 tp10 -109.09 128.7 55.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.725 0.298 . . . . 0.0 110.356 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.36 93.29 1.91 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.422 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 35.7 m -95.41 35.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -173.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.48 -18.69 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.1 19.2 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.673 -177.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mp0 -93.93 141.12 28.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.99 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 75' ' ' VAL . 82.2 p -81.01 175.14 10.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.908 -174.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.435 ' O ' HG21 ' A' ' 76' ' ' VAL . 21.9 t60 -53.84 -47.04 71.34 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.029 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.95 -40.97 91.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 84.1 mm-40 -62.86 -44.03 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.958 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 71' ' ' THR . 12.6 m -71.71 -44.96 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 72' ' ' HIS . 77.7 t -59.22 -35.88 60.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.027 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 t -57.53 -40.95 79.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.317 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.626 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 68.2 mtt-85 -70.0 -37.68 75.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.44 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.8 mt -64.61 -37.92 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.353 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.776 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.48 -22.33 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 127.68 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 83' ' ' LEU . 6.8 mp -78.06 -62.29 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.755 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -128.33 -12.58 5.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.379 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.55 31.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.628 0.251 . . . . 0.0 110.81 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 24' ' ' TYR . 12.1 p -126.21 146.99 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 8.4 mtm180 -98.61 120.83 39.71 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 17' ' ' LEU . 92.6 mt -122.33 116.07 23.41 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.65 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 29.3 tp -101.54 117.37 34.77 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.663 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 25.8 m -131.04 153.77 39.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.943 0.402 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 96' ' ' ASP . 11.3 p -142.65 149.04 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.185 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.39 129.35 68.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.31 -34.11 88.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.61 2.873 . . . . 0.0 113.576 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.35 -43.34 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 17.3 m -66.39 -41.4 89.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 91' ' ' VAL . 14.0 t70 -58.84 -42.75 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.75 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.22 -47.03 84.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.019 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 13.6 pt20 -73.27 -38.67 65.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.0 111.001 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.97 -40.3 91.12 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -175.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.81 -37.18 85.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -71.67 -17.9 62.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.526 . . . . 0.0 110.655 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 77.0 mt -79.51 -3.85 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.906 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.84 41.71 72.26 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.104 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.91 137.64 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.859 0.361 . . . . 0.0 111.668 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 109' ' ' GLU . 17.3 mm-40 -79.33 54.64 1.73 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.483 HG12 HG13 ' A' ' 60' ' ' VAL . 1.5 t -60.57 -26.61 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.946 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.678 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -65.72 -5.44 8.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 33.3 tt0 168.55 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.934 0.397 . . . . 0.0 110.634 171.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 31.7 tt0 -55.54 -37.68 68.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.412 -172.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 110' ' ' LEU . 2.2 tm? -65.73 -26.79 67.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.97 -177.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.555 -177.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.856 0.274 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HD2' HD12 ' A' ' 11' ' ' LEU . 16.2 m-85 -144.81 151.87 39.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 -174.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 95' ' ' THR . 10.1 t 175.96 142.74 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -169.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.431 ' HB2' HG21 ' A' ' 95' ' ' THR . 86.1 mtp 48.44 47.4 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.807 0.692 . . . . 0.0 111.651 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 2.0 mm? -72.8 157.61 88.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.515 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 37.7 Cg_endo -64.45 178.88 1.44 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.438 2.759 . . . . 0.0 113.709 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -143.3 149.37 37.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.626 -178.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.461 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 13.4 mt -84.22 108.01 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.6 m -94.38 108.41 20.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.044 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -95.1 111.85 23.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.915 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -122.04 150.79 41.61 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.42 147.83 29.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.558 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -69.43 97.53 1.0 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.653 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 -167.09 14.56 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.836 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.23 -34.2 98.15 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.928 2.418 . . . . 0.0 112.261 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -102.34 24.37 10.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.547 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.63 64.27 3.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.37 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' HB3' HD11 ' A' ' 17' ' ' LEU . 98.7 m-85 78.74 -38.57 0.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.215 1.006 . . . . 0.0 111.374 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.51 12.45 53.83 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -123.35 149.76 44.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.126 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 41' ' ' LEU . 39.6 m-70 -124.3 131.94 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.806 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -104.71 142.05 35.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.42 -172.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -133.42 134.93 44.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.149 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.39 104.04 2.15 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.5 mt-10 -60.39 146.37 44.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.095 0.474 . . . . 0.0 111.635 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.78 117.98 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.636 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.0 -38.3 3.36 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.851 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.568 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 70.7 mmtt -66.85 157.18 33.71 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -113.0 5.08 17.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.88 165.69 16.65 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.676 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.433 ' HG2' HG23 ' A' ' 75' ' ' VAL . 3.1 mp0 -103.66 148.56 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.804 0.335 . . . . 0.0 110.411 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.451 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 32.6 m-85 -131.44 154.47 48.65 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.91 113.41 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 ttp180 -85.48 -47.51 9.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.491 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 27' ' ' HIS . 26.7 tp -145.7 142.49 29.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.704 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 54' ' ' LEU . 1.7 p -135.66 112.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -78.87 135.43 59.25 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.68 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -61.67 129.17 26.82 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.609 2.206 . . . . 0.0 112.057 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.79 1.38 45.99 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.942 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.596 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 96.0 p -93.76 152.14 40.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.156 0.503 . . . . 0.0 110.947 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.24 -13.7 41.04 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.86 2.373 . . . . 0.0 112.17 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -63.98 -39.96 95.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.001 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' CD ' ' HA ' ' A' ' 44' ' ' PRO . 30.1 mt-10 -62.92 -39.46 94.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.963 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -65.6 -29.84 70.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.934 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.12 -19.42 51.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.331 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.63 49.98 1.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -124.68 121.13 33.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.526 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.17 171.24 10.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.729 173.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.55 78.62 6.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.39 0.614 . . . . 0.0 111.191 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.33 -21.2 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.957 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 67.3 m-20 -63.97 141.75 58.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.686 0.279 . . . . 0.0 111.114 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.18 124.92 34.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.78 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.534 ' HA ' HG12 ' A' ' 90' ' ' VAL . 51.8 tp -78.4 119.48 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 HG22 ' A' ' 106' ' ' VAL . 60.2 t -103.78 -34.97 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.388 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 16.6 tt0 -150.55 151.18 32.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.761 0.315 . . . . 0.0 111.17 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 64' ' ' GLY . 65.6 t -132.4 119.92 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.469 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 72.9 -26.1 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.027 0.931 . . . . 0.0 111.729 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 145.16 10.68 0.28 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.604 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.3 tp10 -125.81 128.97 48.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.44 132.41 53.64 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.456 0.472 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 33.0 m -128.16 29.55 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.8 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.72 -24.28 66.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 35' ' ' LEU . 98.3 mttt -129.95 29.83 4.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.813 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 15.9 mm-40 -95.19 179.93 5.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.934 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 74' ' ' GLN . 25.1 p -107.63 167.62 9.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.695 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.417 ' O ' HG21 ' A' ' 76' ' ' VAL . 27.2 t60 -62.69 -44.13 97.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -64.83 -36.75 85.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 0.0 109.973 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.655 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -62.96 -45.4 92.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.819 -177.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 67' ' ' VAL . 4.7 m -71.32 -40.14 73.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.348 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 72' ' ' HIS . 45.1 t -57.55 -36.92 55.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.6 t -57.96 -41.53 83.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -69.09 -36.69 77.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -64.22 -32.8 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 109.906 176.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -21.34 62.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.847 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.09 -18.35 46.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.424 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.18 119.07 26.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.832 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.96 -62.85 1.43 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.295 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -107.15 -27.52 10.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.306 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.63 155.06 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.994 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.457 HG11 ' CE1' ' A' ' 24' ' ' TYR . 9.8 p -131.5 153.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.802 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -106.7 125.19 50.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 99.5 mt -120.37 127.68 52.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.2 tp -103.37 116.73 32.98 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.7 m -130.54 153.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -131.9 148.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.296 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.0 m-20 -68.24 123.14 86.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 33.0 Cg_exo -57.62 -31.74 92.61 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.541 2.827 . . . . 0.0 113.318 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.77 -48.46 81.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 109.897 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 9' ' ' THR . 2.6 m -73.67 -36.04 65.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.261 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.07 -40.42 76.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 43.7 mt-10 -61.04 -43.51 98.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.775 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -74.41 -39.89 62.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.076 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' A' ' 102' ' ' LEU . 52.2 mt -64.94 -34.18 77.8 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 18.1 pt20 -60.17 -34.33 73.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.42 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 7.5 mtpm? -71.71 -37.77 70.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.321 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 99' ' ' LEU . 27.2 mt -76.89 -44.51 31.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.458 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.58 94.19 0.16 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.05 95.54 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.14 0.971 . . . . 0.0 112.072 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -113.08 28.33 8.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.418 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.776 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 21.8 m -66.35 -14.19 17.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.29 -37.76 75.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -166.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.556 ' HA ' HD22 ' A' ' 111' ' ' LEU . 39.0 tt0 -162.13 -19.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.175 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.26 -36.2 65.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.722 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.69 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 3.9 mm? -77.92 -28.64 49.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.087 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 108' ' ' GLU . 3.6 mm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.235 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' HD13 ' A' ' 102' ' ' LEU . 30.0 Cg_endo . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 113.298 0.461 . . . . 0.0 113.298 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -146.01 150.05 35.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.066 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -173.71 126.58 0.39 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.453 -171.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt 72.8 -71.0 0.14 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.884 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 HD13 HG13 ' A' ' 106' ' ' VAL . 2.8 mm? 65.74 156.89 0.13 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 72.4 Cg_endo -74.01 158.99 45.35 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.774 2.316 . . . . 0.0 112.553 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -115.33 143.98 44.45 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.737 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -83.19 106.3 14.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.3 m -96.24 108.52 21.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.671 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 22.0 m -91.82 111.75 23.4 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 48' ' ' ALA . 21.1 mt -88.27 163.65 15.99 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 41.6 mt-10 -115.34 121.85 44.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.19 101.75 2.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.932 0.396 . . . . 0.0 110.666 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.59 -157.87 33.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.709 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 -26.82 73.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.59 14.8 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 -124.44 6.47 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.155 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.47 -22.55 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.896 0.379 . . . . 0.0 110.932 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.06 33.94 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.112 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.17 149.9 52.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.458 0.629 . . . . 0.0 110.182 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -105.78 134.53 48.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.3 tp -119.87 124.25 45.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.572 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.1 p80 -123.88 146.0 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.074 -175.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.62 105.01 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.941 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.615 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 41.8 mt-10 -74.78 -178.33 3.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.655 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -99.2 138.68 35.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.64 -1.46 60.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.957 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HE2' ' O ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -104.65 -173.95 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.612 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.99 -12.67 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.588 174.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.12 -173.41 13.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.898 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.66 149.78 26.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.661 0.267 . . . . 0.0 110.658 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -125.91 152.17 45.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.532 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.3 mm -70.57 122.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.691 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -91.7 -48.52 6.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.973 -177.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.534 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 2.8 tp -154.93 152.09 29.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.534 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 54.8 t -119.52 115.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.19 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 69.4 mm-40 -62.94 127.66 91.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 7.6 Cg_exo -69.77 109.72 2.38 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.215 1.943 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.91 28.76 4.88 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.507 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.436 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 96.7 p -115.18 161.38 29.85 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.712 0.291 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.541 ' HA ' ' HG2' ' A' ' 50' ' ' LYS . 38.6 Cg_endo -66.86 -13.41 39.83 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.132 2.555 . . . . 0.0 112.501 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . . . -65.67 -39.94 91.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.359 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.41 -46.98 74.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 47' ' ' PRO . 21.2 ptmt -61.12 -34.77 75.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.951 -174.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.04 -17.68 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 58.92 0.71 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.494 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.51 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.7 mp -120.11 126.31 50.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -127.84 166.6 17.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.3 0.571 . . . . 0.0 110.826 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.9 105.48 6.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.263 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.92 -24.73 2.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.175 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 27.8 m-20 -63.87 144.4 57.09 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -95.75 133.05 40.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HA ' HG11 ' A' ' 90' ' ' VAL . 28.9 tp -73.33 110.37 7.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.004 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -95.33 -45.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.073 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -143.59 149.78 37.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.602 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 67' ' ' VAL . 82.3 t -137.04 119.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.965 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.29 37.79 13.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.2 5.86 82.3 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.526 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' HG11 ' A' ' 67' ' ' VAL . 32.9 tt0 -126.09 128.75 47.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.17 0.485 . . . . 0.0 111.07 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -58.86 119.95 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.702 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 36.0 m -116.96 21.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.411 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.0 -14.89 61.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.86 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -122.69 19.01 10.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.964 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 21.6 mm-40 -92.0 -176.82 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.039 0.447 . . . . 0.0 111.202 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.557 ' O ' HG23 ' A' ' 75' ' ' VAL . 55.5 p -115.19 169.34 9.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.853 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.514 ' O ' HG21 ' A' ' 76' ' ' VAL . 29.4 t60 -55.1 -47.0 75.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.741 0.305 . . . . 0.0 110.263 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -65.6 -46.35 79.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.444 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -62.57 -40.64 97.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.45 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 71' ' ' THR . 15.9 m -70.18 -42.98 79.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.668 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 72' ' ' HIS . 71.3 t -58.64 -36.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.731 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.8 m -59.52 -40.15 86.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 110.184 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.21 -36.85 82.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.34 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 76' ' ' VAL . 74.0 mt -63.53 -38.04 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.659 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.2 mmt180 -71.82 -22.71 61.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.666 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.23 -19.28 63.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.374 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -82.06 127.89 33.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.85 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.62 -71.15 0.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.465 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -108.45 -17.66 13.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.353 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.501 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.276 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.4 146.64 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.604 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 98.6 mtt180 -98.68 119.88 38.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.205 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.7 mt -121.67 121.96 38.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.396 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.9 tp -102.42 118.27 36.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.231 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 23.8 m -128.59 153.49 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.612 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 150.17 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.483 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.8 116.16 45.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.446 174.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -58.07 -24.89 68.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.897 2.398 . . . . 0.0 112.277 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.31 -47.79 75.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.059 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 m -73.75 -38.83 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.488 . . . . 0.0 110.909 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 11.8 t70 -58.48 -32.16 68.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.78 -48.28 80.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.397 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -74.28 -40.14 62.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.015 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.84 -38.3 85.04 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 46.8 mt-30 -58.07 -35.9 72.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.417 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -72.66 -19.43 61.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 7' ' ' PRO . 16.2 mt -101.55 -35.09 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.3 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.79 86.21 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.956 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 106' ' ' VAL . 3.0 p -85.45 102.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.772 0.796 . . . . 0.0 111.942 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -126.71 49.18 2.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.109 0.957 . . . . 0.0 108.504 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.746 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 30.7 m -67.17 -13.42 16.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.063 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.629 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.59 -35.43 72.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -163.081 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 111' ' ' LEU . 22.5 tt0 -164.66 -22.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.191 0.52 . . . . 0.0 110.986 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -55.39 -45.57 76.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.526 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.16 -18.54 55.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 111.408 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 89' ' ' LEU . 73.3 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.228 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 CA--C 1.522 -0.095 0 CA-C-O 120.776 0.24 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.33 156.2 36.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.897 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.485 HG23 ' NE2' ' A' ' 98' ' ' GLN . 5.1 t -170.42 127.52 0.8 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.151 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.469 ' HB3' HG23 ' A' ' 95' ' ' THR . 26.1 ttt 43.9 64.03 1.41 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.902 0.751 . . . . 0.0 111.302 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -75.81 146.85 80.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 -176.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 1.074 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 55.2 Cg_endo -67.15 140.14 52.91 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 123.342 2.695 . . . . 0.0 112.274 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -113.71 140.68 48.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.967 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.53 105.01 12.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.514 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 56.3 m -96.09 113.07 24.65 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.891 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.32 115.98 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.151 0.501 . . . . 0.0 109.851 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 24' ' ' TYR . 15.1 mt -98.59 147.55 24.69 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.396 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -100.17 122.43 42.99 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -65.75 111.31 3.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.85 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.44 -160.5 36.54 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.889 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.44 -29.65 71.63 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.777 2.318 . . . . 0.0 112.417 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -113.19 31.99 6.05 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -116.0 4.13 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.215 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.464 ' HB3' HD13 ' A' ' 17' ' ' LEU . 45.8 m-85 -125.16 -25.67 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.985 0.393 . . . . 0.0 111.274 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.58 30.44 11.85 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.562 -0.828 . . . . 0.0 114.026 172.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -125.46 152.2 45.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.577 0.688 . . . . 0.0 110.051 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 51.1 m-70 -117.52 139.3 51.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.391 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.35 127.84 49.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.064 -169.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.54 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.0 p80 -116.55 133.54 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.34 6.79 42.66 Favored Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.989 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.797 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 11.7 mm-40 64.16 172.3 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.816 0.817 . . . . 0.0 112.708 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -125.14 101.26 6.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.296 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.69 -19.19 10.53 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.797 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -98.44 -177.24 3.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' N ' HD21 ' A' ' 35' ' ' LEU . 2.0 pt? -141.22 35.72 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.858 0.361 . . . . 0.0 110.952 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.94 155.72 24.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.833 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HG3' HG21 ' A' ' 75' ' ' VAL . 68.2 mm-40 -104.0 137.22 42.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.54 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 7.2 m-85 -134.07 152.9 52.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.729 0.3 . . . . 0.0 110.633 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.46 120.37 18.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -99.12 -26.81 14.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.598 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.6 tp -163.93 150.15 11.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.468 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.7 t -125.24 118.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.395 173.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 40.5 mm-40 -64.17 129.87 94.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.0 Cg_exo -69.3 123.11 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.075 1.85 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.44 20.58 26.85 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.593 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 90.7 p -104.17 159.3 29.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.87 -21.31 56.73 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.695 2.263 . . . . 0.0 111.887 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HA ' HD23 ' A' ' 17' ' ' LEU . . . -61.73 -38.78 89.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.151 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 21.3 mt-10 -71.08 -33.1 69.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.31 -36.69 77.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.41 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -80.44 -17.98 50.14 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.115 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 38.32 4.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.525 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.62 127.79 34.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 tp -121.02 141.48 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.67 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.62 102.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.331 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.9 -28.3 2.01 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.394 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.623 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 31.7 m-20 -62.23 139.41 58.5 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.57 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 42.7 ttp180 -89.75 132.68 35.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.53 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.2 tp -74.72 112.5 10.99 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.729 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.437 HG11 ' CD ' ' A' ' 68' ' ' GLU . 57.3 t -95.7 -44.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.24 -175.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.84 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -145.58 150.04 35.66 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.619 -175.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.605 HG21 HG13 ' A' ' 75' ' ' VAL . 92.3 t -137.13 116.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m120 62.2 30.38 17.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.471 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.52 7.01 58.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.553 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.5 tp10 -125.53 135.4 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.603 0.701 . . . . 0.0 111.684 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -67.25 117.16 8.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.822 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 75' ' ' VAL . 29.6 m -117.9 26.38 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.437 ' CD ' HG11 ' A' ' 60' ' ' VAL . 53.8 mt-10 -73.53 -19.7 60.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.836 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -122.06 21.48 10.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.599 0.714 . . . . 0.0 109.84 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -101.54 153.82 19.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.472 -177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.8 p -77.1 162.32 27.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.354 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -56.38 -42.31 77.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.85 0.357 . . . . 0.0 110.166 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.515 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.1 tt0 -66.66 -40.79 88.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.053 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 88.7 mt-30 -62.01 -39.97 94.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 0.0 110.669 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 62' ' ' VAL . 93.5 t -67.24 -50.44 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.324 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 73' ' ' GLN . 26.8 m -61.08 -35.34 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 111.631 -177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 t -57.99 -43.12 86.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 83.7 mtt-85 -64.55 -39.9 94.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.999 0.428 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.7 -33.13 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -73.13 -20.99 60.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.123 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.8 -17.57 55.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.809 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.76 30.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.9 -66.98 0.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.645 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -116.23 -19.43 10.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.452 . . . . 0.0 110.351 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 153.66 35.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.317 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -127.55 145.23 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -107.83 117.56 34.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.06 123.35 45.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.487 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HD23 ' A' ' 111' ' ' LEU . 37.8 tp -97.12 120.01 36.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 21.4 m -132.09 154.96 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.727 0.298 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.2 p -147.15 140.96 19.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.963 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.93 119.26 43.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.797 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 35.9 Cg_exo -59.33 -32.36 96.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.52 2.813 . . . . 0.0 113.018 -172.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.94 -37.46 69.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.848 0.356 . . . . 0.0 110.189 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 10' ' ' MET . 27.8 m -72.14 -38.61 69.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 173.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.92 -35.66 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.245 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 43.9 tt0 -58.23 -37.6 75.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.661 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 27.6 mt-30 -72.07 -48.82 41.35 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.3 mt -62.69 -35.79 80.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.511 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.71 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -64.1 -36.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.604 178.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 65.0 mmtt -71.04 -25.1 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.518 . . . . 0.0 109.837 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 14.8 mt -82.61 -10.25 59.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.747 -177.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.7 19.88 42.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.256 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -92.51 142.54 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.654 -0.321 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -116.91 98.16 6.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 1.074 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.3 m -65.7 -13.96 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.668 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 60.3 mtp180 -58.41 -29.53 66.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -167.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 9.2 tm-20 175.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -54.06 -38.36 65.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.244 0.545 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 11' ' ' LEU . 66.8 tp -77.38 -27.32 52.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.46 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.872 HD23 HD11 ' A' ' 89' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.465 0.316 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.706 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.471 0.192 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.64 146.19 6.86 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -163.29 136.59 5.67 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.687 ' HB2' HG21 ' A' ' 95' ' ' THR . 61.8 mtt 57.18 45.82 19.93 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.873 0.733 . . . . 0.0 109.676 176.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.25 145.62 89.93 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.643 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.991 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.6 Cg_endo -70.97 149.06 58.56 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.297 2.665 . . . . 0.0 112.647 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -119.2 142.58 47.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 89' ' ' LEU . 58.9 tp -82.64 108.6 16.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.9 m -108.75 118.86 37.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.217 -169.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -95.04 133.86 38.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.016 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -133.91 153.46 51.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.721 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -100.34 151.4 21.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 0.0 110.349 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' CG ' ' HA2' ' A' ' 23' ' ' GLY . 34.6 ttpt -87.85 115.11 25.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.834 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.45 -154.12 29.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.303 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.9 -29.58 58.07 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.278 2.652 . . . . 0.0 111.96 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.67 28.47 8.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.294 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 19' ' ' LYS . . . 82.1 -146.38 25.19 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.708 -177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 17' ' ' LEU . 85.0 m-85 -93.29 -22.88 18.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.959 0.38 . . . . 0.0 111.234 -176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 30.1 22.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.216 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -131.03 157.45 42.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.212 0.506 . . . . 0.0 109.959 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.429 ' CD2' HD22 ' A' ' 41' ' ' LEU . 84.8 m-70 -127.26 145.11 50.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.4 tp -122.92 137.18 55.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.773 0.321 . . . . 0.0 111.776 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.432 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 2.9 p80 -133.25 140.29 47.42 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.06 2.42 20.98 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 58.25 -169.3 0.12 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.709 0.403 . . . . 0.0 111.094 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -131.56 133.2 44.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.2 -21.13 46.96 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -86.32 173.61 9.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.4 pt? -130.98 16.52 5.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.24 161.94 25.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.711 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 34.9 mm-40 -103.3 145.36 30.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.404 . . . . 0.0 110.304 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.9 m-85 -128.73 150.94 50.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.722 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -70.7 125.16 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -91.7 -36.33 13.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 14.6 tp -164.08 148.33 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -125.01 118.72 53.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.169 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -63.9 128.34 92.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.462 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.78 127.73 22.37 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.302 2.001 . . . . 0.0 112.557 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.04 75.13 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.192 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.498 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 87.7 p -84.6 164.47 42.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.814 0.307 . . . . 0.0 110.583 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 12.3 Cg_endo -57.71 -26.32 72.48 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.555 2.17 . . . . 0.0 112.176 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -65.29 -31.8 73.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.74 -28.55 65.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.12 -37.07 84.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 110.119 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -78.96 -17.31 55.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.235 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.7 29.67 7.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.0 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 51' ' ' ALA . 11.1 mp -84.56 138.0 32.99 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.682 -0.305 . . . . 0.0 110.514 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.3 tt -145.59 143.13 29.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -59.56 103.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.293 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -31.63 1.57 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.717 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 14.7 m-20 -61.54 141.49 57.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -89.36 124.99 34.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.394 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.54 ' HA ' HG12 ' A' ' 90' ' ' VAL . 48.2 tp -78.39 112.46 15.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.893 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 ' HG ' ' A' ' 89' ' ' LEU . 5.0 m -105.94 -26.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.792 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -146.41 150.64 36.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.778 0.323 . . . . 0.0 111.21 175.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 75' ' ' VAL . 62.1 t -136.39 113.81 13.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 57.0 41.3 27.86 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.528 0.517 . . . . 0.0 112.344 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.85 -8.38 59.6 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.359 171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.413 ' CD ' HH12 ' A' ' 78' ' ' ARG . 44.2 tt0 -126.36 128.62 47.35 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.127 0.963 . . . . 0.0 109.613 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 27.0 m120 -69.53 135.13 49.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.235 -174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 23.1 m -118.91 24.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.922 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 8.0 mt-10 -54.84 -33.15 61.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.508 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -131.48 21.06 4.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.71 -175.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 1.4 mp0 -98.15 161.56 13.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.118 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.1 p -89.54 165.13 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.728 -172.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.444 ' O ' HG22 ' A' ' 76' ' ' VAL . 65.3 t60 -58.62 -46.62 86.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.95 -41.48 96.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.843 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 98.2 mt-30 -63.57 -43.78 96.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 62' ' ' VAL . 94.1 t -63.7 -46.2 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.419 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 72' ' ' HIS . 95.5 t -59.94 -39.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 0.0 110.991 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 m -58.45 -38.13 76.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 86.6 mtt-85 -61.73 -34.61 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.331 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.91 -31.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 -177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -69.88 -22.67 63.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 110.731 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.76 62.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.109 0.481 . . . . 0.0 110.07 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -72.32 121.09 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.837 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.78 -61.27 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.703 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.48 -7.26 4.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.23 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.41 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.78 154.48 36.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.513 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.499 HG13 ' CE1' ' A' ' 24' ' ' TYR . 11.2 p -130.65 144.59 37.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -101.55 117.63 35.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 17' ' ' LEU . 98.5 mt -119.9 123.23 43.09 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.792 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 45.0 tp -101.9 118.32 36.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.587 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 59' ' ' LEU . 28.5 m -131.36 158.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.0 p -135.11 144.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.703 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.16 126.71 61.87 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.624 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 57' ' ' ASP . 19.9 Cg_endo -58.7 -40.18 75.52 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.714 2.942 . . . . 0.0 113.929 -170.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 95' ' ' THR . 8.3 pt-20 -72.35 -39.86 67.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 10' ' ' MET . 1.8 m -71.76 -36.51 70.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' HG13 ' A' ' 91' ' ' VAL . 6.7 t70 -56.88 -43.89 81.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.707 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 32.5 mt-10 -67.92 -36.42 80.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.686 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.22 -39.17 60.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.443 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 102' ' ' LEU . 53.6 mt -67.41 -31.95 72.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 23.6 pt20 -56.62 -36.71 69.77 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -172.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.44 -20.08 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.691 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.456 HD11 HD22 ' A' ' 99' ' ' LEU . 55.7 mt -84.02 -40.11 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.242 0.544 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.56 0.52 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.412 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.578 HG21 HH21 ' A' ' 107' ' ' ARG . 18.6 m -85.09 41.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.825 0.821 . . . . 0.0 110.427 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -83.44 5.31 24.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.197 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.991 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 2.5 m -65.12 -15.71 18.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.197 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.578 HH21 HG21 ' A' ' 104' ' ' VAL . 27.7 mtt180 -59.65 -32.19 70.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.027 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 51.0 tt0 171.65 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.703 0.627 . . . . 0.0 109.363 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -55.67 -51.84 65.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.629 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.8 tp -60.19 -30.14 69.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.773 0.321 . . . . 0.0 110.602 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.382 -176.478 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.464 -0.222 0 CA-C-O 121.262 0.442 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.95 147.0 26.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.544 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -157.26 122.67 4.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.981 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt 62.74 65.54 0.82 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.708 0.766 . . . . 0.0 109.991 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.59 138.09 47.7 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.807 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.988 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 66.5 Cg_endo -72.83 171.15 17.98 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.171 2.58 . . . . 0.0 113.653 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 156.56 46.82 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.694 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' ' 111' ' ' LEU . 32.8 tp -83.99 117.91 23.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 m -94.53 111.22 22.98 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.8 p -100.69 111.09 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 110.195 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -116.6 146.61 42.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.408 -177.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.14 141.6 44.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.1 -170.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.0 ttmt -68.07 119.57 12.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.926 0.393 . . . . 0.0 111.201 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.1 -149.32 25.34 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.267 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.62 -27.27 45.67 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.947 2.432 . . . . 0.0 112.468 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -132.86 53.03 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 0.0 110.497 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 79.14 -121.6 5.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.441 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' HD11 ' A' ' 17' ' ' LEU . 97.6 m-85 -123.15 -27.74 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.38 29.31 9.6 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.322 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -141.1 143.2 34.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.308 0.554 . . . . 0.0 110.328 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -129.68 143.46 50.83 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.91 150.05 32.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.978 -173.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.489 ' HD2' ' O ' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -134.73 144.01 47.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.325 176.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.43 114.94 3.93 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.77 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.625 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 38.5 mt-10 -55.58 125.45 21.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -67.42 133.95 50.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.34 -15.41 63.02 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.722 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -100.91 178.33 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -129.93 25.29 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.46 166.61 25.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.857 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -104.24 136.91 42.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 0.0 110.594 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.489 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 89.3 m-85 -121.43 157.36 30.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.544 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.0 mm -71.35 114.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -85.19 -43.14 14.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.2 tp -149.37 141.95 24.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.415 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.84 114.51 46.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -70.73 112.93 14.84 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 14.0 Cg_endo -58.32 121.55 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 112.232 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.96 13.78 26.43 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.082 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.489 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 89.8 p -103.91 160.22 26.8 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 37.1 Cg_endo -66.46 -16.19 50.29 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.803 2.335 . . . . 0.0 112.106 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 53' ' ' LEU . . . -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.117 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 42.2 mt-10 -63.06 -43.64 98.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.6 mttm -62.72 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.31 -19.66 31.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.269 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 44.36 1.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' A' ' 48' ' ' ALA . 85.0 mt -102.67 146.95 27.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 174.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tt -145.96 143.62 29.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.77 101.48 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.4 -25.41 1.85 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.97 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 71.0 m-20 -75.28 148.56 39.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -92.74 133.57 35.9 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.445 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.503 ' HA ' HG13 ' A' ' 90' ' ' VAL . 40.7 tp -75.91 107.12 7.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.648 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.873 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 47.2 t -95.31 -33.96 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -175.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -147.09 150.55 35.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 0.0 111.008 -178.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG22 HG21 ' A' ' 67' ' ' VAL . 81.3 t -136.58 113.83 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.096 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.46 33.27 20.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.077 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.65 16.13 60.55 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.859 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -123.87 135.23 53.61 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.591 -0.358 . . . . 0.0 110.617 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.55 114.75 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.663 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.601 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 17.4 m -128.47 11.53 2.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -172.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.873 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -72.34 -21.7 61.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.768 -174.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 33.8 mtmm -110.23 18.21 20.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.215 174.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.601 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 36.9 mm-40 -97.3 175.57 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.314 0.578 . . . . 0.0 111.97 -176.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.4 p -89.58 173.98 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.073 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.499 ' O ' HG22 ' A' ' 76' ' ' VAL . 61.8 t60 -65.31 -44.43 87.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 175.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.79 -39.29 90.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.703 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 11.1 mm-40 -61.39 -45.82 92.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.05 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 79' ' ' ILE . 18.6 m -68.68 -45.15 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.369 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 72' ' ' HIS . 80.2 t -54.7 -43.77 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.994 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -60.27 -41.26 92.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 75.1 mtt-85 -69.18 -36.23 77.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.189 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.1 mt -62.26 -42.19 94.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 7.8 mpt_? -64.89 -20.79 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.16 64.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.65 0.262 . . . . 0.0 111.507 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.48 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.27 142.29 54.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.308 0.575 . . . . 0.0 110.746 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 -56.55 4.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.884 -175.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.87 -28.75 3.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.8 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -146.18 143.42 29.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.359 -172.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG11 ' CB ' ' A' ' 82' ' ' ALA . 3.2 m -109.56 158.4 9.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.142 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.26 119.21 38.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 86' ' ' VAL . 88.2 mt -119.7 128.54 53.9 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.902 0.382 . . . . 0.0 110.831 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 15.6 tp -106.46 121.8 45.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.978 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.503 HG13 ' HA ' ' A' ' 59' ' ' LEU . 26.7 m -131.69 155.29 41.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.05 0.452 . . . . 0.0 110.983 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.79 150.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.074 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 18.3 t70 -64.5 120.51 66.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 32.9 Cg_exo -60.89 -29.46 88.15 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.448 2.765 . . . . 0.0 113.208 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.8 -47.87 50.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 20.3 m -66.24 -37.18 84.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 22.0 t70 -58.5 -36.14 73.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.61 -48.16 81.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.8 pt20 -71.63 -38.79 70.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.47 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.83 -33.87 73.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.749 0.309 . . . . 0.0 110.926 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 67.3 mt-30 -57.86 -41.61 82.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.927 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -71.12 -21.26 62.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.982 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.38 -43.03 8.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.369 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.2 84.69 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -66.85 90.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 122.228 1.013 . . . . 0.0 111.834 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 23.7 mt-30 -103.14 22.1 14.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.16 177.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.988 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.9 m -66.0 -18.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.582 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.38 -33.73 76.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -170.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -179.68 -27.83 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.104 0.478 . . . . 0.0 109.995 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 5.0 mm-40 -55.74 -40.95 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.312 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 52.8 mt -78.72 -17.48 55.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 111.898 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 89' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.32 -0.709 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 121.346 0.477 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 104' ' ' VAL . 7.3 m-85 -149.01 150.88 33.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 t -172.16 101.98 0.17 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.875 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.1 tpt 69.42 64.06 0.27 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -172.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.579 HD22 ' H ' ' A' ' 11' ' ' LEU . 2.7 pt? -80.15 160.1 69.03 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.933 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.865 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 73.7 Cg_endo -73.35 165.76 31.71 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.768 2.312 . . . . 0.0 113.049 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.415 ' HA ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -143.16 146.19 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 111' ' ' LEU . 47.0 tp -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -93.66 115.89 28.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.45 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 m -103.97 111.24 23.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.808 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -117.21 154.63 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.845 -177.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -111.59 136.51 50.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 38.9 ttmt -67.27 131.09 45.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.341 0.591 . . . . 0.0 111.928 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.86 -148.74 10.45 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.618 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.27 -2.67 12.72 Favored 'Trans proline' 0 N--CA 1.472 0.209 0 C-N-CA 123.157 2.572 . . . . 0.0 112.444 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -128.08 22.22 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.235 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 77.28 -106.11 2.17 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 -172.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CZ ' HG13 ' A' ' 86' ' ' VAL . 84.0 m-85 -127.79 -15.93 4.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.1 0.45 . . . . 0.0 111.332 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.19 32.57 43.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.102 -0.57 . . . . 0.0 114.078 173.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.26 151.79 50.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.618 0.709 . . . . 0.0 110.225 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.468 ' CD2' HD21 ' A' ' 41' ' ' LEU . 26.1 m-70 -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 37' ' ' GLN . 14.1 mt -118.45 151.36 37.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.106 0.479 . . . . 0.0 111.809 -177.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.557 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.6 p80 -130.86 144.84 51.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.67 108.65 3.04 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 33.4 mm-40 -71.51 125.0 25.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.073 0.464 . . . . 0.0 110.176 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.05 133.75 52.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.107 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.6 -28.22 11.82 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.819 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 12.1 mptt -93.13 -32.75 14.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.837 0.351 . . . . 0.0 111.383 -177.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt 74.65 -50.32 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.578 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.61 157.95 8.14 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.683 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HB3' HD21 ' A' ' 28' ' ' LEU . 35.8 mm-40 -102.09 144.64 30.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.033 0.445 . . . . 0.0 110.11 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.557 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 19.5 m-85 -122.53 152.15 40.65 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mm -70.83 108.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -81.12 -42.9 20.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 27' ' ' HIS . 22.9 tp -147.31 145.27 29.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.162 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -135.76 120.96 28.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -63.99 126.07 89.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.59 -172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.52 109.06 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.316 2.011 . . . . 0.0 111.721 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.84 12.91 21.46 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.987 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 88.1 p -91.57 159.4 38.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.7 Cg_endo -69.07 -13.66 36.83 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.555 2.17 . . . . 0.0 112.355 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -67.51 -45.45 75.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.726 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.71 -39.14 83.64 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.39 0.614 . . . . 0.0 110.207 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -75.96 -11.17 59.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.399 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -91.07 -17.61 25.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.105 0.479 . . . . 0.0 110.237 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.75 53.05 0.72 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.2 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.31 114.74 16.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.466 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.8 tp -118.0 162.12 18.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.06 43.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.961 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.22 5.6 0.32 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.416 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.9 m-20 -91.1 146.6 23.71 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.597 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 41.0 ttp180 -99.78 130.33 45.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.554 ' HA ' HG12 ' A' ' 90' ' ' VAL . 41.7 tp -77.71 109.16 11.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.216 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.68 -42.84 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.11 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -144.21 150.84 38.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 0.0 110.427 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.612 HG23 HG13 ' A' ' 75' ' ' VAL . 61.3 t -135.78 107.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.238 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 58.74 39.06 24.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.129 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.68 35.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.718 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.89 136.68 54.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.298 1.049 . . . . 0.0 111.826 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -67.95 115.72 7.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.535 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.536 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 29.0 m -102.57 18.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -67.3 -16.7 64.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.336 0.588 . . . . 0.0 111.211 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -122.5 22.29 9.98 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.947 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 33.9 mm-40 -105.07 -173.62 2.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.1 p -117.16 173.93 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.1 t60 -60.49 -47.06 87.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.872 0.368 . . . . 0.0 110.153 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.71 -44.76 89.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.823 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 51.3 mt-30 -63.89 -41.32 97.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG13 HG23 ' A' ' 62' ' ' VAL . 55.1 t -62.79 -44.99 99.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.133 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 72' ' ' HIS . 96.9 t -61.15 -38.68 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -60.13 -38.21 82.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 110.402 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 77.0 mtt-85 -68.48 -36.04 78.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.697 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.6 -35.82 75.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.163 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 40.0 mmt180 -68.6 -21.96 64.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.98 95.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.619 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -77.2 132.79 38.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.299 0.571 . . . . 0.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.47 -68.05 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.41 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -110.87 -16.66 13.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.43 134.98 17.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.542 HG13 ' CZ ' ' A' ' 24' ' ' TYR . 3.2 m -110.68 158.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.5 ' HD3' HD21 ' A' ' 14' ' ' LEU . 62.5 mtt180 -112.58 114.63 27.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.561 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HG ' HG23 ' A' ' 86' ' ' VAL . 71.2 mt -118.72 119.33 34.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.831 0.348 . . . . 0.0 110.773 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 111' ' ' LEU . 21.7 tp -94.53 124.11 38.36 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.2 m -132.58 155.16 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.928 0.394 . . . . 0.0 111.412 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.0 p -139.24 144.32 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.345 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.11 116.97 28.67 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.597 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 34.5 Cg_exo -58.17 -24.95 69.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.959 2.44 . . . . 0.0 112.243 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.21 -47.06 68.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.01 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.49 HG21 ' HG ' ' A' ' 99' ' ' LEU . 90.3 m -72.02 -38.39 69.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.87 -31.19 66.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.187 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -57.38 -45.68 84.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.699 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 1.9 mp0 -72.42 -48.1 43.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 110.394 175.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.596 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 mt -59.72 -40.87 89.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.482 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -59.5 -38.64 81.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -75.13 -19.91 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.124 0.488 . . . . 0.0 110.337 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 50.0 mt -83.48 -6.57 59.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.72 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.14 41.45 39.3 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.662 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 99' ' ' LEU . 14.9 m -90.23 169.16 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 111.504 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -125.17 83.23 2.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.077 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.865 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 8.5 m -67.5 -17.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.9 ttm180 -60.63 -44.68 96.06 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -168.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.505 ' HA ' HD13 ' A' ' 111' ' ' LEU . 31.2 tt0 -161.25 -18.75 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.985 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.84 -47.37 74.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 111.603 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.79 -18.18 56.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 89' ' ' LEU . 38.0 mt . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 121.802 0.81 . . . . 0.0 108.969 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.5 mm -97.97 139.71 19.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -91.04 117.8 68.13 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.63 -22.05 38.43 Favored 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 123.039 2.492 . . . . 0.0 112.065 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.446 ' HZ ' HG12 ' A' ' 104' ' ' VAL . 9.0 m-85 -148.04 151.94 36.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.241 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 t -170.38 126.37 0.77 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.994 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt 47.86 60.98 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.714 0.634 . . . . 0.0 110.572 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.783 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.55 164.61 59.67 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.29 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 11' ' ' LEU . 18.1 Cg_endo -56.63 161.48 9.84 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.754 2.97 . . . . 0.0 113.099 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -144.27 127.27 16.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.127 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 tp -84.08 106.34 15.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 30.7 m -96.47 114.7 26.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.54 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.8 m -98.97 111.78 24.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -121.38 153.49 37.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.467 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.59 147.45 30.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.139 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.82 117.92 20.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.382 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.41 -151.43 20.29 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.041 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.08 -17.3 36.21 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.987 2.458 . . . . 0.0 113.238 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -119.88 30.21 7.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.202 0.525 . . . . 0.0 110.626 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.89 -122.0 5.73 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.493 ' HB3' HD13 ' A' ' 17' ' ' LEU . 97.5 m-85 -110.73 -13.79 14.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.431 0.616 . . . . 0.0 111.18 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 80.32 32.89 33.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.438 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.52 152.05 46.63 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.419 -0.46 . . . . 0.0 109.976 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.8 m-70 -112.18 125.36 54.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.77 131.52 54.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.45 151.19 47.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.015 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.21 6.16 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.17 133.14 44.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.873 0.368 . . . . 0.0 111.523 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.96 138.51 55.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.511 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.31 -44.23 2.48 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.638 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.76 173.15 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -129.9 35.81 4.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.299 0.571 . . . . 0.0 110.456 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.94 167.51 25.62 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.844 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG3' HG21 ' A' ' 75' ' ' VAL . 36.4 mm-40 -103.66 146.03 29.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.705 0.288 . . . . 0.0 110.379 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.43 152.35 51.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.6 mm -70.76 113.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 3.6 tmm_? -86.94 -39.91 15.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 110.086 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 46.2 tp -153.39 143.97 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.69 116.23 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.32 111.13 10.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.401 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 51.7 Cg_exo -55.66 119.46 6.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 112.346 -177.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.71 30.32 Favored Glycine 0 C--N 1.316 -0.561 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.165 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 79.9 p -95.76 160.22 30.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.985 0.421 . . . . 0.0 111.281 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.27 -17.56 58.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.841 2.361 . . . . 0.0 112.138 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.518 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -63.19 -38.34 90.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 36.8 mt-10 -64.75 -38.97 92.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.046 0.45 . . . . 0.0 110.007 177.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -64.36 -32.51 74.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.652 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.21 -18.16 53.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.97 37.8 4.82 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.989 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 48' ' ' ALA . 98.3 mt -91.04 130.14 36.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.89 0.345 . . . . 0.0 110.162 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 tt -126.84 141.63 51.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.06 95.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 111.225 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.12 -26.65 1.13 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.485 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 70.2 m-20 -63.71 139.07 58.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.714 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -85.1 132.23 34.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.303 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 54.9 tp -76.26 117.12 17.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.541 ' HB ' HD12 ' A' ' 89' ' ' LEU . 57.9 t -103.47 -36.2 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.274 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 8.7 tt0 -152.01 151.49 31.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 111.142 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.66 116.85 44.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.453 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 60.6 m-80 68.61 -60.9 0.42 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.281 1.033 . . . . 0.0 111.059 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.26 26.89 0.07 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -125.79 129.01 48.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -68.34 125.25 25.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.272 0.358 . . . . 0.0 111.044 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 75' ' ' VAL . 29.8 m -127.7 24.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.461 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.478 ' HG2' HG11 ' A' ' 60' ' ' VAL . 53.5 mt-10 -53.08 -47.52 68.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.951 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -111.0 9.47 22.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.223 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.27 157.73 19.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.457 0.646 . . . . 0.0 112.088 -171.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -85.56 169.06 13.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.909 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.566 ' O ' HG22 ' A' ' 76' ' ' VAL . 64.3 t60 -56.74 -45.55 81.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.928 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.85 -38.61 89.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 111.057 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.07 -38.79 86.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.489 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.501 HG21 ' HG3' ' A' ' 37' ' ' GLN . 29.3 m -70.26 -43.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.442 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 72' ' ' HIS . 77.9 t -54.69 -42.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.4 m -60.07 -40.65 90.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -68.52 -35.85 78.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.458 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 75' ' ' VAL . 83.7 mt -62.77 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.7 mmt180 -61.53 -23.22 65.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.86 -6.99 53.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.16 117.16 17.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.96 -60.13 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -129.61 -20.04 3.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.75 145.96 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.042 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.433 HG12 ' CE1' ' A' ' 24' ' ' TYR . 14.5 p -116.82 141.81 33.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.128 0.49 . . . . 0.0 110.407 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 95.8 mtt180 -101.92 117.02 33.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.807 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD13 ' A' ' 53' ' ' LEU . 92.6 mt -112.75 118.96 36.43 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 1.6 tm? -93.48 116.55 29.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 35.4 m -134.02 154.15 37.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.158 0.504 . . . . 0.0 111.338 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.73 150.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.181 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.08 125.46 74.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 109.973 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.67 -38.36 94.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.921 3.081 . . . . 0.0 113.905 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.75 -39.15 80.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.098 0.475 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 17.4 m -71.33 -36.52 71.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.303 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 8.9 t70 -56.97 -45.87 82.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 57.2 mt-10 -65.85 -39.36 90.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 95' ' ' THR . 21.0 pt20 -72.38 -39.85 67.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.522 HD13 HD11 ' A' ' 110' ' ' LEU . 53.4 mt -70.43 -34.04 72.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.72 0.295 . . . . 0.0 110.746 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 49.0 mt-30 -66.05 -34.46 78.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.619 0.247 . . . . 0.0 110.825 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.5 mttp -61.92 -19.07 62.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.01 -9.81 57.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.71 11.48 63.77 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.175 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG12 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -92.91 138.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 0.0 111.102 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.791 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -77.95 98.45 5.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.407 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 12' ' ' PRO . 67.0 t -66.18 -22.38 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.08 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.633 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -59.89 -35.36 74.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -173.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HA ' HD11 ' A' ' 111' ' ' LEU . 65.4 tt0 -165.86 -40.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.94 0.4 . . . . 0.0 110.989 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.791 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 30.4 mm-40 -55.74 -30.83 61.87 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.522 HD11 HD13 ' A' ' 99' ' ' LEU . 2.1 tt -65.44 -40.26 93.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.137 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 108' ' ' GLU . 6.0 mp -69.41 -31.21 69.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 110.387 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.4 -54.63 6.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.422 ' HB3' ' H ' ' A' ' 118' ' ' GLY . . . -74.27 46.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.749 -175.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -85.72 -7.85 58.53 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 170.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.13 104.63 13.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.587 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 62.1 94.56 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.669 0.605 . . . . 0.0 110.429 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -51.67 101.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.589 2.86 . . . . 0.0 113.654 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 113' ' ' ALA . . . 144.39 -174.26 24.7 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.07 -19.18 58.81 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.076 179.605 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.07 144.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.6 118.16 70.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.988 0.423 . . . . 0.0 110.172 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -66.51 -29.08 45.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.848 2.365 . . . . 0.0 111.825 -176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.453 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 38.0 m-85 -152.59 149.21 28.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.475 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.401 HG21 HG21 ' A' ' 95' ' ' THR . 2.7 t -160.37 -43.51 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.201 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.404 ' HB3' HG22 ' A' ' 95' ' ' THR . 15.0 tpt -139.82 90.89 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.753 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.69 157.84 83.61 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.819 -177.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 1.039 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 57.9 Cg_endo -67.72 149.56 78.85 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.067 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.93 128.25 48.33 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.187 178.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.78 107.27 16.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 67.5 m -94.02 111.47 23.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' HH11 ' A' ' 87' ' ' ARG . 4.3 p -98.62 110.79 23.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.069 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -121.4 156.37 32.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.393 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.74 138.7 49.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 35.2 ttpt -71.55 124.64 25.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.914 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.15 -162.2 35.41 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.31 -28.84 87.62 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.989 2.459 . . . . 0.0 112.711 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -122.41 40.89 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.902 0.382 . . . . 0.0 110.681 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.501 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 84.21 -144.2 21.56 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.363 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' HB3' HD11 ' A' ' 17' ' ' LEU . 84.8 m-85 -101.66 -25.62 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.84 32.82 12.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.739 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -127.46 141.26 51.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.457 0.629 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.46 ' C ' ' HB3' ' A' ' 40' ' ' ARG . 30.4 m-70 -100.94 144.69 29.58 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.82 137.25 54.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.118 0.261 . . . . 0.0 110.541 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -138.47 149.35 45.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.65 117.31 3.47 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.9 137.61 43.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.03 100.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.827 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.11 -38.27 1.62 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.5 -179.24 7.11 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.509 -0.845 . . . . 0.0 109.043 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.58 21.27 2.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 110.449 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.1 176.38 18.44 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -104.14 143.51 32.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.076 0.465 . . . . 0.0 110.89 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.91 156.72 41.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.884 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 55' ' ' ALA . 31.7 mm -70.39 120.51 18.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.979 0.418 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HB3' ' C ' ' A' ' 27' ' ' HIS . 0.5 OUTLIER -93.52 -47.96 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -173.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.5 tm? -158.57 140.12 13.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' N ' HD13 ' A' ' 41' ' ' LEU . 48.2 t -117.63 115.74 49.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.21 130.99 89.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.2 127.46 18.4 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.008 1.806 . . . . 0.0 111.892 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.92 28.69 40.96 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.58 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.8 p -102.36 162.3 20.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 122.674 -0.31 . . . . 0.0 110.811 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 18.6 Cg_endo -62.31 -23.5 75.28 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.467 2.112 . . . . 0.0 112.23 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -62.45 -41.73 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.305 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -59.92 -43.58 94.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.756 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 95.7 mttt -59.6 -37.35 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . . . -79.7 -11.79 59.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.056 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.11 31.89 15.87 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.146 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.34 104.54 11.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.0 140.97 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.366 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . . . -70.79 106.88 3.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.806 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.43 -16.5 3.83 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.553 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -73.73 146.39 44.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 0.0 110.859 176.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -91.26 127.39 36.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.488 ' HA ' HG13 ' A' ' 90' ' ' VAL . 38.8 tp -77.8 109.84 12.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.727 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.11 -32.87 3.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.468 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -147.71 149.72 32.96 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.407 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 75' ' ' VAL . 96.8 t -136.67 116.55 16.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.325 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 64.53 26.28 13.32 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.649 0.738 . . . . 0.0 110.683 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.36 16.03 59.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.366 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 8.9 tp10 -124.74 133.08 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.16 128.45 36.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.675 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.493 ' HB ' HG23 ' A' ' 75' ' ' VAL . 35.7 m -123.63 26.83 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.56 -27.31 64.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.661 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -118.12 14.0 13.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.386 0.612 . . . . 0.0 109.583 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -96.47 146.51 24.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.19 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.1 p -81.28 178.04 8.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 76' ' ' VAL . 57.3 t60 -58.02 -46.35 85.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.148 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.61 -42.88 91.1 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.553 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 57.9 mt-30 -61.49 -41.14 96.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 67' ' ' VAL . 94.5 t -71.42 -44.61 71.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 25.4 t -54.57 -45.26 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.66 0.267 . . . . 0.0 111.611 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -59.93 -37.02 78.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.944 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.2 mtt-85 -68.3 -37.03 80.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.598 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 75' ' ' VAL . 68.7 mt -64.77 -35.47 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mpt_? -73.34 -20.57 60.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.28 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 134.79 40.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.286 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.63 -70.74 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.579 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -112.57 -19.73 11.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.847 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.16 145.08 26.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.44 149.41 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.955 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.433 HH11 ' HB2' ' A' ' 16' ' ' CYS . 22.1 mmt180 -108.88 113.19 25.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.458 HD12 HD22 ' A' ' 17' ' ' LEU . 74.9 mt -109.38 118.62 37.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.683 0.278 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.1 tp -93.82 122.22 36.07 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.6 m -133.34 154.6 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.416 0.627 . . . . 0.0 111.431 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.09 145.14 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.327 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.01 122.06 45.03 Favored Pre-proline 0 C--O 1.225 -0.237 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.2 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.579 -172.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.97 -38.97 66.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HG ' ' A' ' 99' ' ' LEU . 19.4 m -70.03 -37.87 75.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.27 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.76 -39.29 77.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.33 -49.2 78.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.445 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.654 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 pt20 -72.97 -46.69 50.92 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.653 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.515 ' HG ' HG23 ' A' ' 95' ' ' THR . 29.6 mt -62.33 -43.77 98.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 111.537 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -67.75 -36.6 80.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.874 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -70.24 -23.04 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 96.3 mt -71.79 -22.28 61.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.38 19.94 8.11 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -107.07 134.76 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.82 102.66 13.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.827 0.822 . . . . 0.0 110.925 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 1.039 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 14.8 m -65.2 -13.33 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.608 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -58.36 -31.36 67.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -167.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -171.14 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.415 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -54.4 -42.07 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.866 HD22 ' HG2' ' A' ' 114' ' ' GLN . 1.8 tm? -60.09 -29.18 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.49 -12.28 59.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.545 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -83.78 -81.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.311 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.96 109.88 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.648 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.866 ' HG2' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -97.06 76.33 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.92 0.39 . . . . 0.0 110.057 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -107.41 133.75 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.029 0.442 . . . . 0.0 110.929 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.38 130.84 10.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.878 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.73 76.89 1.47 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.27 73.9 1.08 Allowed Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.94 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -95.09 126.32 40.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.237 -179.36 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.04 132.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.51 125.61 53.25 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.961 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -71.05 -25.64 22.47 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.861 2.374 . . . . 0.0 111.758 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.54 ' HB3' HD12 ' A' ' 11' ' ' LEU . 29.3 m-85 -148.61 154.04 39.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.326 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -172.52 123.58 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.687 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.57 61.09 2.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.828 HD21 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.0 140.43 96.05 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.578 -169.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 19.4 Cg_endo -61.62 159.28 33.06 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.024 2.483 . . . . 0.0 111.524 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -143.07 156.64 44.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.133 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -84.21 114.17 21.62 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.9 m -93.55 107.76 19.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.09 111.71 23.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.971 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -115.7 148.68 39.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 85' ' ' ALA . 32.8 mt-10 -122.92 129.31 51.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.161 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.9 ttmt -54.94 126.42 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.625 -170.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.7 12.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.378 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.32 -19.56 13.24 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.545 2.163 . . . . 0.0 112.701 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.23 27.15 7.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.261 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 89.72 -114.6 4.38 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.562 -175.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' HA ' ' HG2' ' A' ' 47' ' ' PRO . 97.7 m-85 -123.89 -22.9 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.238 0.519 . . . . 0.0 111.642 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.73 33.83 23.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.966 171.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -132.66 142.63 49.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.396 0.598 . . . . 0.0 110.086 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' HD11 ' A' ' 41' ' ' LEU . 29.3 m-70 -111.32 131.69 54.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.5 tp -101.96 144.4 30.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.299 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.421 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 3.1 p80 -141.69 153.05 44.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.916 0.388 . . . . 0.0 111.259 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.74 125.87 4.9 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.522 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.21 -175.77 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.896 0.379 . . . . 0.0 110.431 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -109.5 135.62 50.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.987 0.422 . . . . 0.0 110.133 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.83 15.49 57.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.5 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 -174.38 2.51 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.741 0.305 . . . . 0.0 110.365 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.1 pt? -125.4 -33.53 2.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.621 172.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.9 177.8 21.24 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.587 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -104.99 155.13 19.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -130.73 153.21 49.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 0.0 110.577 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 mm -71.58 123.54 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.633 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HG2' ' CG ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.6 -45.91 8.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 42' ' ' VAL . 3.0 tm? -150.67 140.88 22.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' N ' HD12 ' A' ' 41' ' ' LEU . 96.6 t -122.14 116.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.487 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -58.8 126.78 81.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -63.4 115.44 3.02 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.035 1.824 . . . . 0.0 111.972 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.76 41.76 7.55 Favored Glycine 0 C--N 1.317 -0.517 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.536 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 77.3 p -112.23 168.06 8.23 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.514 ' HG2' ' HA ' ' A' ' 24' ' ' TYR . 10.2 Cg_endo -56.07 -30.38 78.5 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.241 1.961 . . . . 0.0 112.313 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -61.7 -38.66 88.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 0.0 110.332 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -62.03 -39.35 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.462 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.2 mttm -64.61 -29.39 70.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.044 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -88.24 -17.88 29.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.32 35.79 5.37 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.926 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 42' ' ' VAL . 90.1 mt -92.67 138.95 31.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.6 tp -145.87 153.2 40.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.874 0.369 . . . . 0.0 110.716 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.54 104.58 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.035 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.31 -30.01 2.46 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.902 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 14.1 m-20 -63.23 136.15 57.54 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.004 0.43 . . . . 0.0 110.664 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -87.79 128.71 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.361 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HA ' HG13 ' A' ' 90' ' ' VAL . 58.5 tp -80.23 121.31 25.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.123 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.53 -42.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.585 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.1 tt0 -144.75 151.63 39.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.836 0.35 . . . . 0.0 111.181 -177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG21 HG11 ' A' ' 75' ' ' VAL . 66.0 t -132.31 114.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.323 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.08 36.29 27.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.418 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.09 1.83 59.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.134 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 8.6 tp10 -125.52 136.61 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.855 0.828 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -68.17 125.71 27.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.064 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 62' ' ' VAL . 34.3 m -122.78 31.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.895 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -66.51 -21.0 66.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 34.8 mtmm -127.5 5.43 6.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.464 . . . . 0.0 111.046 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.8 mp0 -79.01 164.97 23.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -175.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.2 p -99.87 170.39 8.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -54.51 -47.93 72.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.53 -45.24 93.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.294 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -64.62 -39.2 93.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.77 -40.18 76.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.019 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.435 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 19.1 t -58.39 -39.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.4 m -57.74 -40.66 80.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 0.0 110.596 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -68.83 -37.19 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.699 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -65.12 -36.23 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 6.3 mpt_? -73.7 -22.82 59.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.267 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.16 59.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 110.19 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 113.58 12.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -84.71 -66.01 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.38 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -97.39 -33.12 11.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.023 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.439 ' HB2' ' HG2' ' A' ' 18' ' ' GLU . . . -151.77 156.56 40.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.403 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.24 141.36 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.453 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -105.98 112.95 26.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.81 122.55 45.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 16.9 tp -94.88 118.77 32.34 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.5 m -129.89 161.08 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.991 0.424 . . . . 0.0 110.707 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 96' ' ' ASP . 7.5 p -131.93 138.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.163 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.65 125.63 54.34 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.567 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -44.83 45.82 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.966 2.444 . . . . 0.0 115.117 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.53 -31.18 63.53 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.258 0.551 . . . . 0.0 110.584 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.467 HG22 ' HG ' ' A' ' 99' ' ' LEU . 40.4 m -71.95 -36.28 69.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.63 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.453 ' HB2' HG12 ' A' ' 91' ' ' VAL . 11.3 t70 -56.16 -43.73 78.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.3 -41.13 88.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 29.8 mm-40 -73.07 -50.01 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 102' ' ' LEU . 23.6 mt -68.56 -31.64 71.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.185 -170.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.597 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 pt20 -57.93 -41.9 83.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 28.5 mtpp -77.47 -37.12 52.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.258 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.544 HD11 HD23 ' A' ' 99' ' ' LEU . 70.5 mt -69.43 -39.92 77.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.3 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.31 90.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 6.1 p -80.64 80.62 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.271 1.034 . . . . 0.0 112.087 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -112.61 34.79 4.15 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 170.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.433 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 13.3 m -67.23 -14.65 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.753 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 78.8 ttt180 -58.91 -45.31 90.64 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -167.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 34.5 tt0 -167.26 -24.1 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.414 . . . . 0.0 110.474 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.18 -47.07 79.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.32 0.581 . . . . 0.0 110.281 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 11' ' ' LEU . 57.5 tp -67.46 -19.98 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.349 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.52 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 10.9 mp -71.92 -36.92 70.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.497 ' N ' ' HD3' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -81.32 -20.5 40.58 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 109.682 176.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.53 -22.04 51.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.905 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 2.3 pt20 -96.55 3.3 52.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.891 0.376 . . . . 0.0 110.828 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -135.14 174.88 10.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.68 107.05 5.46 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.458 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.17 64.43 5.25 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.153 2.568 . . . . 0.0 112.351 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.37 103.94 0.2 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.226 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -158.42 97.03 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.01 0.433 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.256 -179.259 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 HG21 HD21 ' A' ' 102' ' ' LEU . 60.3 mt -101.45 143.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.09 134.45 30.02 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.8 -28.2 75.81 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.465 2.777 . . . . 0.0 113.534 -170.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.582 ' CZ ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -156.15 163.16 39.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.933 0.397 . . . . 0.0 110.956 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 95' ' ' THR . 4.5 t -173.13 128.42 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.092 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.69 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 22.2 ttt 73.54 -51.51 0.7 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.672 0.789 . . . . 0.0 112.313 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER 55.8 133.53 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.801 1.241 . . . . 0.0 113.131 -174.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 75.7 Cg_endo -75.22 167.99 25.65 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.465 2.777 . . . . 0.0 113.24 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.52 144.63 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.652 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.18 109.04 19.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 167.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 51.0 m -94.17 116.45 28.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.852 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -104.12 112.3 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.01 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -120.72 154.48 35.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.2 142.49 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 38.4 ttmt -74.07 115.83 14.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.735 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.63 -150.95 18.17 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.727 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.83 -29.25 42.25 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.732 2.288 . . . . 0.0 112.556 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -130.69 43.99 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.164 0.507 . . . . 0.0 111.351 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 93.59 -108.76 3.71 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.992 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.516 ' HB3' HD11 ' A' ' 17' ' ' LEU . 99.5 m-85 -135.88 -21.98 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 112.774 -172.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 27.61 20.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.378 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -123.96 142.93 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.468 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 10.2 m170 -101.27 119.71 39.16 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.8 tp -102.46 133.15 47.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.769 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.445 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.5 p80 -123.57 143.69 50.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.469 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.9 93.95 0.52 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 45.2 mt-10 -55.99 130.36 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.853 0.384 . . . . 0.0 111.45 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -66.52 119.1 11.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.68 -37.31 3.34 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 37.2 mmtm -77.57 160.38 28.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.8 0.333 . . . . 0.0 110.163 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.4 pp -113.1 19.87 16.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.724 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.67 167.01 28.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.913 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.479 ' HG3' HG23 ' A' ' 75' ' ' VAL . 25.6 mm-40 -105.93 151.84 24.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.445 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 m-85 -138.54 153.77 48.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.58 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.427 HG12 ' OD1' ' A' ' 57' ' ' ASP . 9.7 mm -71.07 121.87 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -98.27 -25.69 14.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 42' ' ' VAL . 9.9 tt -164.85 147.1 8.22 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.67 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' N ' HD23 ' A' ' 41' ' ' LEU . 1.8 p -131.96 122.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.044 0.449 . . . . 0.0 109.806 173.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 37.2 mm-40 -60.22 130.1 89.15 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.987 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 18.1 Cg_exo -65.27 119.4 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.429 2.086 . . . . 0.0 111.451 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 13.92 52.41 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.334 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 98.4 p -91.82 160.4 36.2 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.809 0.338 . . . . 0.0 110.287 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 32.1 Cg_endo -65.23 -17.41 58.41 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 111.39 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -65.74 -43.04 90.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -65.61 -37.01 85.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.108 0.48 . . . . 0.0 109.961 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -67.76 -26.04 65.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.045 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -81.8 -18.8 42.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.145 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.29 29.59 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.939 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 48' ' ' ALA . 85.1 mt -86.38 147.94 25.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.95 0.375 . . . . 0.0 110.262 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 tt -146.13 140.3 26.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.24 81.18 1.0 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.463 0.649 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HD3' ' A' ' 93' ' ' PRO . . . 157.06 39.03 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 8.6 p-10 -105.76 -169.97 1.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.47 0.652 . . . . 0.0 111.165 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.413 ' HE ' ' CG ' ' A' ' 96' ' ' ASP . 25.1 ttm-85 -132.76 124.1 27.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 156.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD13 HD22 ' A' ' 88' ' ' LEU . 34.6 tp -71.39 102.33 2.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.092 0.472 . . . . 0.0 109.775 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.27 -41.11 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.491 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.0 tt0 -148.55 151.06 34.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.705 0.288 . . . . 0.0 111.188 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.453 HG21 HG21 ' A' ' 67' ' ' VAL . 69.9 t -132.16 117.23 32.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.311 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.46 21.73 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.532 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.29 7.38 46.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.923 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.8 tp10 -124.41 133.03 53.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 110.696 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.78 126.97 30.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.098 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 33.6 m -126.52 27.73 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.431 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.19 -28.18 66.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.33 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 13.7 ptmm? -128.64 39.32 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.289 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 50.9 mm-40 -103.67 168.85 8.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 0.0 112.086 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.565 ' O ' HG21 ' A' ' 75' ' ' VAL . 66.9 p -97.78 178.61 5.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.366 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -65.45 -46.6 79.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.437 ' HA ' HG11 ' A' ' 76' ' ' VAL . 30.4 tt0 -66.46 -32.83 74.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.439 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 16.3 mm100 -70.42 -46.1 64.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.976 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 71' ' ' THR . 14.5 m -72.51 -41.2 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.6 p -57.74 -36.36 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.072 0.463 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -64.11 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.937 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.6 mtt-85 -66.52 -36.05 81.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.567 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -63.01 -38.12 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.262 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 22.2 mmt85 -73.36 -25.01 60.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.323 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.73 55.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB2' ' HH ' ' A' ' 24' ' ' TYR . . . -71.64 122.65 20.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.145 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.17 -83.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.515 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.01 -11.96 13.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.96 25.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.82 144.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -109.9 112.88 25.18 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 59' ' ' LEU . 78.9 mt -115.61 122.75 46.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.618 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 18.6 tp -95.27 116.41 28.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 35.5 m -129.97 154.65 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.692 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.9 p -144.73 145.93 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' HE1' ' A' ' 10' ' ' MET . 1.0 OUTLIER -65.95 133.16 94.8 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.676 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 38.8 Cg_exo -59.87 -28.24 86.75 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.7 2.934 . . . . 0.0 113.736 -171.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.5 -48.25 67.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 109.86 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.704 HG23 HG23 ' A' ' 9' ' ' THR . 15.0 m -71.78 -37.32 70.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.269 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.541 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 2.6 t70 -57.21 -47.13 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.607 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.738 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 28.5 tt0 -72.48 -39.37 67.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.041 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 95' ' ' THR . 20.0 pt20 -69.47 -38.72 77.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.572 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 95' ' ' THR . 43.7 mt -68.83 -39.13 80.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 97' ' ' GLU . 10.6 pt20 -66.32 -33.16 75.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.16 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 34.4 mmtp -57.22 -35.33 69.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.414 0.626 . . . . 0.0 109.34 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.471 HD21 HG21 ' A' ' 5' ' ' ILE . 15.8 mt -80.39 -55.57 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.22 -108.09 0.48 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.1 t 68.74 125.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.532 0.682 . . . . 0.0 112.572 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.82 71.86 10.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.66 . . . . 0.0 109.924 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -56.12 -24.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.421 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.618 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 14.7 ptm180 -60.6 -26.71 67.18 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -165.62 -26.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -44.3 67.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.762 0.315 . . . . 0.0 111.406 -167.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.582 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 3.0 mm? -68.66 -31.09 69.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mp -85.62 -31.46 22.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.105 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 2.9 tpm_? -58.1 -60.96 2.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.771 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.8 -4.63 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -100.88 12.74 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 112' ' ' ARG . 8.0 pt-20 -87.04 57.73 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 110.481 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.25 100.22 1.13 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.804 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -84.54 172.71 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.739 2.292 . . . . 0.0 112.077 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 119' ' ' GLN . . . 130.09 -17.16 5.43 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.784 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 118' ' ' GLY . 27.6 tt0 74.26 -42.14 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 111.604 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.327 177.299 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.73 136.99 46.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.88 0.371 . . . . 0.0 110.085 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -98.05 129.16 31.6 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.33 -25.08 79.78 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.975 2.45 . . . . 0.0 112.722 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -154.0 137.65 16.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.516 0.674 . . . . 0.0 111.272 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -141.33 111.71 6.9 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.859 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.4 mtm 48.93 54.98 9.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.071 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.905 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.04 144.56 82.29 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.878 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.903 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 28.9 Cg_endo -63.85 159.93 39.52 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.447 2.765 . . . . 0.0 112.762 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -143.16 155.1 44.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.971 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 87' ' ' ARG . 45.9 tp -84.9 109.55 18.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.54 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -93.79 108.09 19.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -96.92 114.84 26.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.509 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -121.81 154.13 37.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.471 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.24 146.7 28.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.226 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -74.99 118.16 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.946 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -149.12 17.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.477 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 -20.06 20.03 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.98 2.454 . . . . 0.0 112.78 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -124.48 39.07 4.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.076 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.65 -122.99 7.96 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.41 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' HB3' HD11 ' A' ' 17' ' ' LEU . 98.3 m-85 -112.26 -30.18 7.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.17 0.485 . . . . 0.0 110.658 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.96 27.83 8.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.243 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.9 142.26 51.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.238 0.519 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -107.3 144.36 34.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 tp -119.49 129.84 54.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.497 0.189 . . . . 0.0 110.967 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -127.19 150.42 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 110.56 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.71 129.09 9.37 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.4 mm-40 -70.37 128.26 35.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.01 110.24 5.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.341 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.51 -12.18 33.11 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.466 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 4.2 mptp? -96.17 178.96 5.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.5 pp -122.27 16.46 10.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.608 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.67 168.58 25.19 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.909 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -104.54 146.35 29.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 110.204 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -133.11 157.12 46.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.244 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.75 122.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.034 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -85.15 -47.65 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.171 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -164.05 140.88 6.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.509 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.3 t -110.7 124.42 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.737 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.07 124.15 87.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.46 126.64 18.08 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.845 1.697 . . . . 0.0 112.074 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.81 17.69 37.37 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.254 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -97.89 158.94 32.04 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.9 -20.03 67.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.651 2.234 . . . . 0.0 111.994 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -62.26 -45.7 92.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.09 -37.24 86.42 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.148 0.499 . . . . 0.0 110.011 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -70.23 -23.51 62.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.923 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -84.06 -17.84 38.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.21 22.65 10.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.26 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -93.46 113.06 25.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 54' ' ' LEU . 2.7 mm? -117.83 166.55 12.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.344 0.592 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.56 122.16 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.133 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.59 -20.44 12.13 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.022 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 6.0 m-20 -59.47 141.86 53.75 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.288 0.566 . . . . 0.0 111.597 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.464 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 30.1 ttt180 -85.73 121.78 28.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.822 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HA ' HG12 ' A' ' 90' ' ' VAL . 27.1 tp -78.95 109.43 13.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.118 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.29 -37.86 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.409 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.716 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 25.6 tt0 -144.95 151.76 39.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 67' ' ' VAL . 74.0 t -134.5 119.75 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.694 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.59 -43.65 0.56 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.86 3.86 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.125 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -126.69 146.97 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.193 0.996 . . . . 0.0 111.251 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -63.48 123.16 18.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.843 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.594 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 32.6 m -118.39 17.98 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.214 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.19 -22.54 63.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.834 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.6 ptpp? -131.42 28.88 4.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.594 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 7.5 mm-40 -103.5 -174.55 2.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 75' ' ' VAL . 28.4 p -112.71 169.79 8.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.072 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.434 ' O ' HG22 ' A' ' 76' ' ' VAL . 16.3 t60 -58.58 -48.68 80.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.511 0.196 . . . . 0.0 110.914 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.97 -38.66 86.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.794 0.807 . . . . 0.0 110.334 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 5.3 tp-100 -61.18 -44.64 96.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.133 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 71' ' ' THR . 15.6 m -72.77 -42.69 61.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 43.5 t -54.88 -40.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.402 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 m -58.24 -38.06 76.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 0.0 110.655 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.461 ' NH1' ' HG3' ' A' ' 74' ' ' GLN . 61.2 mtt85 -68.62 -35.89 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.852 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 76' ' ' VAL . 69.0 mt -62.61 -33.65 60.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.492 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 4.3 mpt_? -66.92 -21.79 65.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.1 -2.11 57.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.23 128.53 36.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.242 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.55 -73.39 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.546 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -131.83 -4.88 3.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.19 158.5 44.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.856 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 24' ' ' TYR . 12.7 p -127.83 146.4 33.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.488 ' HB3' HD13 ' A' ' 14' ' ' LEU . 14.8 mtm180 -97.7 122.84 41.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD23 ' A' ' 17' ' ' LEU . 89.4 mt -121.46 113.63 20.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.962 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 26.9 tp -94.1 116.08 28.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.2 m -133.01 157.41 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.221 0.534 . . . . 0.0 111.765 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.903 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 11.7 p -147.98 148.43 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.866 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.82 118.26 33.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 58' ' ' ARG . 34.6 Cg_endo -63.53 -31.88 70.77 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.239 2.626 . . . . 0.0 113.169 -172.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.26 -37.04 69.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.025 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.5 m -71.79 -40.3 69.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.99 -30.84 66.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.194 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.31 -50.77 70.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.85 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.63 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 11.4 pt20 -74.87 -39.48 61.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.021 0.439 . . . . 0.0 110.839 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.548 HD12 HD11 ' A' ' 102' ' ' LEU . 27.6 tp -66.13 -43.07 88.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.981 -164.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -68.19 -36.23 79.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.309 0.576 . . . . 0.0 110.245 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.27 -18.29 62.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.277 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 92.9 mt -70.15 -15.06 62.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.36 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 62.15 0.93 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.537 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.28 131.66 41.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.548 0.213 . . . . 0.0 110.773 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 10.7 mt-30 -83.15 85.89 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.572 0.701 . . . . 0.0 109.754 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.455 HG13 ' HG3' ' A' ' 12' ' ' PRO . 3.8 t -59.99 -27.82 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.734 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.71 -25.52 66.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -175.18 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.122 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 33.7 tt0 -55.79 -41.02 73.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.108 0.48 . . . . 0.0 110.961 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 11' ' ' LEU . 49.0 tp -64.39 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.396 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.687 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 9.8 mp -73.99 -26.24 60.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -63.06 -25.99 68.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.743 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.31 55.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.687 ' HG2' ' HA ' ' A' ' 111' ' ' LEU . 12.2 pt20 -118.99 24.89 10.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -134.6 138.52 44.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.13 0.49 . . . . 0.0 111.307 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.78 82.64 55.3 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.76 176.07 8.77 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.584 2.189 . . . . 0.0 113.653 -171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 179.5 -98.23 0.11 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -159.03 104.83 1.73 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.228 -178.62 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 5' ' ' ILE . 4.2 mp -99.61 132.47 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 109.924 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.514 ' OD2' ' HB ' ' A' ' 9' ' ' THR . 21.5 t70 -81.2 129.43 66.85 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.91 -34.69 95.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.254 2.636 . . . . 0.0 113.012 -171.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -157.03 120.09 4.07 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.407 0.622 . . . . 0.0 110.557 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 ' HB ' ' OD2' ' A' ' 6' ' ' ASP . 10.2 t -159.4 126.53 4.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.79 -168.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.447 ' HE2' ' OG1' ' A' ' 95' ' ' THR . 69.7 mtm 54.21 30.92 13.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.856 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -58.31 139.77 84.17 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.024 -176.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 40.5 Cg_endo -65.66 158.39 53.61 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.598 2.865 . . . . 0.0 113.588 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -143.69 169.96 16.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HG ' ' CD2' ' A' ' 111' ' ' LEU . 17.5 mt -84.34 122.5 29.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.756 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 64.1 m -94.37 108.28 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.357 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -95.62 111.82 23.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.115 0.483 . . . . 0.0 110.585 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.49 147.8 40.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.516 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -112.59 135.32 53.45 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.376 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 33.2 ttpt -71.05 120.53 16.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.284 -173.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.35 -170.13 44.64 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.52 -29.91 91.15 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.651 2.234 . . . . 0.0 112.747 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -99.36 -0.56 40.8 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.166 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.37 -141.82 16.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.134 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.596 ' O ' ' HB2' ' A' ' 46' ' ' SER . 84.4 m-85 -105.72 -36.34 7.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.0 111.33 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 40.59 4.81 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.928 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -135.56 152.96 51.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.504 0.652 . . . . 0.0 110.405 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -124.36 144.51 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.467 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.4 mt -120.96 154.59 35.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 0.0 111.17 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 2.1 p80 -144.13 151.65 39.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.44 141.42 15.27 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.0 mt-10 -107.69 152.14 24.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.799 0.333 . . . . 0.0 111.169 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.81 141.78 38.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.25 -43.6 2.81 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 27.0 mmtp -78.07 175.32 10.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.1 pt? -144.0 29.05 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.38 -163.79 9.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.96 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HG3' HG22 ' A' ' 75' ' ' VAL . 31.1 mm-40 -112.27 148.03 35.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -134.39 160.83 36.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.426 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.464 HG12 ' CG ' ' A' ' 57' ' ' ASP . 31.8 mm -68.59 119.59 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.203 0.525 . . . . 0.0 110.86 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.25 -36.95 13.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 tp -161.94 143.31 10.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.8 117.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.823 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.4 mm-40 -68.8 129.54 92.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.835 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.5 Cg_exo -70.02 121.38 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 111.355 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.94 17.24 21.39 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.549 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 91.4 p -105.41 154.97 38.66 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 -15.24 49.22 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.747 2.298 . . . . 0.0 111.813 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HB1' HD23 ' A' ' 53' ' ' LEU . . . -66.38 -35.88 81.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.602 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.23 -38.65 91.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.0 110.091 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.42 -20.12 62.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.165 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . . . -85.92 -18.0 33.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.21 28.11 7.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.172 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 48' ' ' ALA . 11.2 mp -79.2 136.36 37.06 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.582 -0.363 . . . . 0.0 110.489 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 tt -146.46 142.2 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.2 109.09 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.122 0.487 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.71 6.85 2.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.88 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' CG ' HG12 ' A' ' 39' ' ' ILE . 6.8 p-10 -72.16 -173.11 1.0 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.923 0.868 . . . . 0.0 111.787 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -135.96 115.37 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.661 165.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.2 tp -78.31 106.65 10.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 109.809 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -97.5 -38.06 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.873 -175.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 25.2 tt0 -149.77 151.8 34.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.709 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 67' ' ' VAL . 90.4 t -134.62 117.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.217 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 56.46 29.82 15.99 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.22 5.73 57.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.563 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 9.2 tp10 -124.41 130.32 52.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.432 0.616 . . . . 0.0 110.656 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.97 127.08 31.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 35.3 m -123.79 24.21 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 52.1 mt-10 -68.26 -25.35 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.633 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 1.3 ptpt -126.44 29.93 5.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -177.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 44.4 mm-40 -93.17 -171.36 2.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 74' ' ' GLN . 33.6 p -113.16 -179.79 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.683 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.557 ' O ' HG21 ' A' ' 76' ' ' VAL . 75.1 t60 -64.38 -47.0 80.9 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -67.55 -37.83 83.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.764 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.438 ' HG2' ' OG1' ' A' ' 71' ' ' THR . 14.5 mm100 -60.51 -43.23 97.32 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.735 0.303 . . . . 0.0 110.908 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 37' ' ' GLN . 13.4 m -71.58 -40.21 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.835 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 72' ' ' HIS . 72.5 t -54.09 -37.91 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.451 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -57.14 -44.51 83.47 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.284 0.564 . . . . 0.0 110.122 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -69.23 -36.19 76.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.121 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 75' ' ' VAL . 72.6 mt -64.21 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.486 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 41.6 mmt180 -69.78 -22.55 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.98 55.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.896 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.8 116.83 15.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.92 -66.5 0.78 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.55 -172.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.75 -17.84 10.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.002 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.65 150.07 29.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.0 111.19 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -123.79 141.09 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.594 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -105.84 111.16 23.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 109.969 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.56 129.87 53.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.028 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 14.7 tp -102.01 118.81 37.69 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.4 154.92 40.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.114 0.483 . . . . 0.0 110.686 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.6 p -140.64 145.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.3 138.18 68.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.1 -25.63 64.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.701 2.934 . . . . 0.0 113.995 -172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.96 -50.39 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.532 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.447 ' OG1' ' HE2' ' A' ' 10' ' ' MET . 85.3 m -67.38 -42.6 83.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.658 0.742 . . . . 0.0 110.158 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -58.14 -45.71 86.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.66 -43.25 89.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.559 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.2 pt20 -72.21 -44.35 63.08 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.038 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 102' ' ' LEU . 12.7 mt -67.16 -40.17 86.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.415 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -64.67 -36.08 83.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.757 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -70.58 -19.7 62.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.367 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 74.5 mt -81.76 -8.24 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.266 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.97 24.19 30.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.08 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG13 HD22 ' A' ' 110' ' ' LEU . 98.6 t -89.55 128.42 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.815 0.34 . . . . 0.0 111.141 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 37.0 mt-30 -96.51 83.85 3.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.032 0.444 . . . . 0.0 109.884 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 19.7 m -59.23 -14.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.593 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.97 -25.75 63.83 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.19 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.809 0.337 . . . . 0.0 110.938 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 105' ' ' GLN . 44.9 tt0 -54.98 -38.03 67.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.59 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 57.3 mt -79.21 -40.26 31.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.455 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 7.3 mp -66.54 -26.76 67.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.23 -49.49 60.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.136 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.73 -31.94 68.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.561 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 63.4 mt-30 -77.99 62.46 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.133 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.34 159.84 38.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.965 0.412 . . . . 0.0 111.242 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.54 121.88 3.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.041 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 99.13 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.119 2.546 . . . . 0.0 112.481 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 120' ' ' ALA . . . 57.86 -128.55 47.78 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.587 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 71.11 -11.38 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.384 0.674 . . . . 0.0 112.183 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 118' ' ' GLY . . . . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.993 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.9 mt -122.32 143.56 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.1 126.72 90.18 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 -28.92 69.91 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.075 2.517 . . . . 0.0 113.285 -172.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.483 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 7.2 m-85 -156.61 118.36 3.87 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.216 1.008 . . . . 0.0 112.172 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 95' ' ' THR . 4.6 t -153.49 125.66 7.96 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.434 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.6 mtt 53.77 48.79 20.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.039 0.447 . . . . 0.0 110.434 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.735 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -74.04 152.92 88.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.641 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.929 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.0 Cg_endo -68.79 151.45 74.31 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.943 2.429 . . . . 0.0 112.694 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HA ' HD13 ' A' ' 111' ' ' LEU . 69.6 mtp180 -126.05 153.72 44.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.618 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.623 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 40.9 tp -89.64 106.07 18.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 68.8 m -93.22 108.03 19.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 p -95.31 120.78 36.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.96 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.559 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -125.51 151.52 46.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.37 135.14 42.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.479 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 ttmt -68.47 119.33 12.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.06 -144.03 14.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.069 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.36 -14.2 25.35 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.072 2.514 . . . . 0.0 113.398 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -137.85 35.94 2.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.945 0.402 . . . . 0.0 111.015 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 84.1 -104.72 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.544 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.486 ' HB3' HD13 ' A' ' 17' ' ' LEU . 92.2 m-85 -132.53 -22.13 2.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.411 0.605 . . . . 0.0 112.255 -175.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.47 28.38 24.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.497 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.94 155.72 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' CD2' HD23 ' A' ' 41' ' ' LEU . 91.1 m-70 -122.06 134.19 54.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.404 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.3 tp -108.45 135.66 49.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.8 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -128.85 152.1 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.77 119.92 3.15 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.811 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.46 118.85 11.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.657 0.265 . . . . 0.0 110.448 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -63.36 125.36 23.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.045 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.3 -36.33 3.66 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -106.3 165.95 10.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -112.22 10.06 20.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.681 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.9 143.1 16.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.564 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -105.04 143.88 32.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.02 151.5 49.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 0.0 110.794 -175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.11 121.89 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.879 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 -26.25 14.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.68 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 8.1 tp -162.45 151.56 15.35 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 111.311 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.6 t -128.8 119.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.614 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.07 125.75 90.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.64 111.63 2.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.038 1.825 . . . . 0.0 111.386 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.59 10.97 20.59 Favored Glycine 0 C--N 1.311 -0.852 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.948 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.405 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.3 p -99.1 159.75 29.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.231 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 36.1 Cg_endo -65.91 -14.41 44.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.99 2.46 . . . . 0.0 112.409 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -65.05 -40.43 94.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.779 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -62.64 -33.09 74.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 110.242 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -71.69 -13.27 61.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.067 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . . . -100.24 -17.66 17.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.24 7.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.863 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 42' ' ' VAL . 10.5 mp -84.83 134.15 34.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.715 0.258 . . . . 0.0 110.324 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -137.84 152.22 48.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 110.577 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.7 107.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.533 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.27 3.75 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.944 -176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 42.8 m-20 -66.68 142.58 57.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 111.443 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 71.1 ttt180 -91.43 121.66 33.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 90' ' ' VAL . 53.6 tp -79.03 104.76 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 0.0 110.22 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.416 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 41.5 t -91.39 -40.93 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 10.7 tt0 -144.74 150.98 38.18 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.51 HG22 HG11 ' A' ' 75' ' ' VAL . 90.0 t -130.24 117.57 40.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 9.9 t-20 70.92 -61.2 0.49 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.151 0.98 . . . . 0.0 110.631 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.0 20.65 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -125.85 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.715 0.257 . . . . 0.0 110.506 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -71.9 99.65 2.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.452 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.485 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 27.0 m -82.75 0.93 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.233 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 24.2 mm-40 -70.79 -3.99 21.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 171.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -113.53 6.89 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.025 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.485 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 13.5 mm-40 -110.75 -165.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.298 -172.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 75' ' ' VAL . 65.3 p -132.29 176.34 8.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.119 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.444 ' O ' HG22 ' A' ' 76' ' ' VAL . 13.4 t60 -54.16 -48.05 71.31 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 176.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -65.34 -43.01 92.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.185 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.584 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 54.9 mt-30 -66.88 -44.07 81.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.51 HG11 HG22 ' A' ' 62' ' ' VAL . 91.4 t -62.29 -42.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.963 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 72' ' ' HIS . 52.3 t -57.95 -45.03 87.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 110.27 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 m -58.4 -39.33 79.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 84.0 mtt-85 -65.92 -34.53 78.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 75' ' ' VAL . 67.6 mt -62.5 -33.92 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.686 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.32 60.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.77 115.03 10.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.851 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.95 -74.49 0.24 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.304 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -101.32 -28.84 12.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.417 0.627 . . . . 0.0 109.902 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.77 159.01 44.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.761 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.48 142.27 41.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.857 0.36 . . . . 0.0 110.37 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' HD3' HD23 ' A' ' 14' ' ' LEU . 96.2 mtt180 -98.74 112.87 24.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.888 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 17' ' ' LEU . 91.9 mt -114.06 113.67 25.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 28.2 tp -94.11 116.78 29.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.4 m -130.84 153.67 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.053 0.454 . . . . 0.0 111.459 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.743 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.1 p -142.54 142.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.8 114.63 10.85 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.571 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 32.4 Cg_exo -57.75 -29.39 85.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.095 2.53 . . . . 0.0 112.767 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.7 -47.58 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.955 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 7.5 m -72.46 -35.23 68.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.898 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -39.79 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.741 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 10.2 tp10 -58.73 -48.35 81.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.9 pt20 -72.92 -40.13 65.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.361 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 99' ' ' LEU . 31.4 mt -67.79 -43.18 80.33 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HA ' HG22 ' A' ' 104' ' ' VAL . 29.6 pt20 -60.44 -34.38 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.318 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 55.7 mttm -67.56 -18.94 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 111.077 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.34 -3.73 58.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.19 42.86 8.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.815 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 100' ' ' GLN . 19.7 m -90.72 171.75 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 111.666 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.46 ' HB2' ' CB ' ' A' ' 109' ' ' GLU . 57.6 mt-30 -133.97 83.4 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.929 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.7 m -66.34 -16.47 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.29 -43.96 92.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.556 ' HA ' HD22 ' A' ' 111' ' ' LEU . 35.3 tt0 -169.77 -11.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.975 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.46 ' CB ' ' HB2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -55.48 -39.91 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.058 0.456 . . . . 0.0 110.141 -177.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.558 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 46.8 mt -73.61 -39.48 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.485 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 14' ' ' LEU . 3.0 mm? -70.09 -34.24 72.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.087 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 112' ' ' ARG . 11.4 ptm180 -76.91 -17.78 58.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 110.686 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.5 -10.54 31.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.871 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 78.6 mt-30 -87.5 85.98 7.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.036 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -76.64 163.3 26.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.674 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.8 99.3 15.42 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.35 -166.32 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.337 2.691 . . . . 0.0 111.829 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.5 67.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.977 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.977 0.418 . . . . 0.0 111.311 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.934 178.481 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.8 mt -75.26 140.12 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -84.99 130.71 51.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.023 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.68 -24.23 48.02 Favored 'Trans proline' 0 CA--C 1.518 -0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 111.656 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' HD22 ' A' ' 110' ' ' LEU . 2.6 m-85 -148.77 146.79 28.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.791 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -171.03 134.72 0.96 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.425 ' HB3' HG22 ' A' ' 95' ' ' THR . 13.7 tpt 53.36 63.98 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.843 0.83 . . . . 0.0 109.538 -174.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 HD21 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -65.56 140.47 97.55 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.624 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 1.01 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 77.0 Cg_endo -72.76 169.23 22.5 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.298 2.665 . . . . 0.0 112.147 -176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -130.02 136.1 49.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.838 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 87' ' ' ARG . 57.2 tp -83.9 104.83 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -94.87 115.78 27.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.697 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.0 110.37 22.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.826 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -110.21 152.69 25.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.434 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -103.69 143.03 33.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.553 -170.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -72.83 104.95 4.17 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.8 -151.01 21.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.543 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 -22.57 23.61 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.876 2.384 . . . . 0.0 112.478 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -124.38 39.02 4.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.473 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.2 -125.61 8.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.44 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.531 ' HB3' HD12 ' A' ' 17' ' ' LEU . 88.3 m-85 -111.29 -28.04 8.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.145 0.472 . . . . 0.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.51 36.58 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.28 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -123.9 146.41 48.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.472 0.636 . . . . 0.0 110.458 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.5 m-70 -106.8 125.16 50.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.247 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.31 127.29 54.95 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.494 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.594 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -113.18 132.12 55.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.341 0.591 . . . . 0.0 109.983 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.63 112.23 2.95 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 11.8 mm-40 -57.1 132.02 51.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.189 0.518 . . . . 0.0 111.126 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.41 119.7 14.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.564 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.65 -36.41 3.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.652 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 58.4 mmtt -76.01 160.8 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.893 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -100.77 16.14 26.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.017 0.436 . . . . 0.0 111.615 -177.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.41 132.06 10.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.53 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.06 137.88 40.65 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.0 m-85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.618 0.247 . . . . 0.0 110.424 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.79 119.61 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -25.79 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 -175.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.568 HD11 ' N ' ' A' ' 42' ' ' VAL . 2.2 tm? -164.62 145.91 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.529 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.568 ' N ' HD11 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -132.6 132.98 59.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -78.73 98.39 0.32 Allowed Pre-proline 0 N--CA 1.465 0.325 0 O-C-N 123.355 0.409 . . . . 0.0 110.734 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 42' ' ' VAL . 14.5 Cg_exo -34.67 94.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.469 3.446 . . . . 0.0 114.301 -168.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.04 25.16 1.91 Allowed Glycine 0 C--N 1.314 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.742 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -96.03 163.01 21.99 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 117.228 0.514 . . . . 0.0 110.193 178.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.522 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 29.7 Cg_endo -64.22 -17.38 59.51 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.324 2.016 . . . . 0.0 111.686 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.51 -48.73 76.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.197 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' OE1' ' HB2' ' A' ' 46' ' ' SER . 1.9 mp0 -66.12 -38.74 88.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 29.5 mtpp -62.41 -32.16 72.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.35 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -79.19 -19.19 51.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.03 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.27 39.94 1.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.823 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.56 134.3 47.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 tt -137.4 138.08 39.49 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.19 99.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.418 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.06 -24.88 1.91 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.119 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 68.0 m-20 -70.73 141.68 51.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.653 0.263 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -88.47 134.56 33.82 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.225 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.512 ' HA ' HG11 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -75.49 124.83 27.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.785 177.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.4 -43.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -145.14 150.32 36.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.864 0.364 . . . . 0.0 110.802 -178.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 75' ' ' VAL . 63.6 t -133.65 111.67 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.051 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 60.71 38.64 18.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.868 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.0 9.73 80.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.952 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.487 ' HG2' ' NE ' ' A' ' 78' ' ' ARG . 7.2 tp10 -120.81 127.05 51.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -69.7 129.14 38.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.75 -0.204 . . . . 0.0 110.751 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG13 ' NH1' ' A' ' 78' ' ' ARG . 20.4 m -120.94 31.21 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.262 0.553 . . . . 0.0 111.418 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.462 ' O ' HD11 ' A' ' 35' ' ' LEU . 58.0 mt-10 -71.33 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.398 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.893 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.3 mtmp? -130.02 16.76 5.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.451 0.644 . . . . 0.0 110.106 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.78 -174.45 3.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.302 -169.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 74' ' ' GLN . 32.5 p -119.68 166.98 12.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.863 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.582 ' O ' HG23 ' A' ' 76' ' ' VAL . 49.5 t60 -58.11 -48.4 80.31 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.899 0.124 . . . . 0.0 110.684 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.08 -41.35 99.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.801 0.81 . . . . 0.0 110.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 6.6 tp60 -60.87 -39.25 88.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.811 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 62' ' ' VAL . 74.4 t -71.69 -41.34 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.406 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 72' ' ' HIS . 69.6 t -55.69 -41.15 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.673 0.273 . . . . 0.0 111.729 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -57.86 -40.0 79.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.208 0.527 . . . . 0.0 110.442 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.551 ' NH1' HG13 ' A' ' 67' ' ' VAL . 59.6 mtt180 -69.98 -36.05 74.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.123 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.57 -36.33 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.057 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -72.94 -22.59 60.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.842 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.25 -15.52 59.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.981 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.72 128.55 36.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.747 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.48 -67.66 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.36 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -111.18 -26.93 8.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.349 0.595 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.2 155.42 38.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.09 144.56 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HD3' HD23 ' A' ' 14' ' ' LEU . 84.9 mtt180 -98.82 118.49 35.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.94 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.458 HD13 HD22 ' A' ' 17' ' ' LEU . 88.9 mt -121.86 115.51 22.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.245 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 18.4 tp -95.09 123.34 38.53 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 59' ' ' LEU . 29.8 m -133.3 155.74 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.291 0.567 . . . . 0.0 112.349 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.7 p -146.7 146.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.486 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 p30 -73.23 134.29 80.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.93 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 58.3 Cg_exo -53.4 -34.1 69.69 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.064 3.176 . . . . 0.0 114.301 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.58 -46.7 78.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.835 0.35 . . . . 0.0 110.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 10' ' ' MET . 24.9 m -69.78 -37.18 76.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.486 ' HB2' HG11 ' A' ' 91' ' ' VAL . 3.9 t70 -57.51 -45.1 85.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.429 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.927 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.441 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 9.5 pt20 -74.8 -42.53 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.079 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.601 HD21 HD13 ' A' ' 102' ' ' LEU . 25.7 mt -62.43 -34.15 76.21 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.7 -35.6 81.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.383 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -74.56 -24.98 59.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.072 0.463 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.601 HD13 HD21 ' A' ' 99' ' ' LEU . 37.1 mt -84.8 -46.47 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.422 0.629 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.99 96.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.01 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -76.67 86.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 122.309 1.052 . . . . 0.0 111.85 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 77.9 mt-30 -104.7 17.49 24.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.43 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 1.01 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m -66.66 -16.33 20.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.441 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 96.3 mtt180 -60.73 -43.77 97.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.9 -172.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HA ' HD13 ' A' ' 111' ' ' LEU . 30.0 tt0 -172.66 -21.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 110.348 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 2.5 mp0 -55.15 -46.33 75.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.322 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 8' ' ' PHE . 52.0 tp -65.39 -35.54 81.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 108' ' ' GLU . 7.0 mp -68.6 -18.0 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.307 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -73.24 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.01 102.81 11.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.669 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.894 ' HA ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -88.23 8.32 27.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.62 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.93 -81.63 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.681 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.4 108.85 2.41 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.715 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.7 156.56 63.18 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.575 2.183 . . . . 0.0 112.474 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 112.73 173.93 19.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.019 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.3 37.86 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.071 0.462 . . . . 0.0 110.833 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.985 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.4 mt -123.16 143.19 37.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' OD1' ' HD2' ' A' ' 7' ' ' PRO . 35.2 t0 -87.22 118.9 70.58 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD2' ' OD1' ' A' ' 6' ' ' ASP . 24.6 Cg_endo -63.69 -27.97 68.83 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 123.014 2.476 . . . . 0.0 112.283 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.442 ' CD1' HD21 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -159.81 138.73 10.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.406 176.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -136.95 113.64 10.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.491 -167.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.3 mtp 54.32 57.04 6.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.566 0.698 . . . . 0.0 109.663 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -64.26 161.59 39.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.392 -173.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.685 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 22.1 Cg_endo -59.52 164.24 11.52 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.546 2.831 . . . . 0.0 112.419 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HA ' HD11 ' A' ' 111' ' ' LEU . 28.2 mmm180 -136.96 139.72 41.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.945 -172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 89' ' ' LEU . 48.6 tp -84.63 105.02 15.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 29.9 m -95.17 108.35 20.47 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.09 -173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.9 110.9 22.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -114.67 148.98 37.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.765 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -119.54 128.08 53.6 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.008 -168.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 30.9 ttpt -65.4 114.75 5.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.291 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.04 -166.24 37.01 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.27 -12.54 33.32 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.578 2.185 . . . . 0.0 112.39 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -103.78 1.6 31.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.97 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.36 -133.75 11.89 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.132 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.486 ' HB3' HD13 ' A' ' 17' ' ' LEU . 98.9 m-85 -106.71 -28.83 9.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.263 0.532 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.85 39.59 9.37 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 114.267 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -138.4 157.83 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 109.999 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.52 ' CD2' HD23 ' A' ' 41' ' ' LEU . 52.9 m-70 -125.55 139.07 53.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -110.35 141.86 42.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.721 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 1.4 p80 -136.2 151.85 50.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.47 112.12 1.01 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.978 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 46.0 mt-10 -65.8 176.81 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 0.0 110.881 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -103.29 137.82 40.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.85 15.22 63.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.177 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.37 -171.33 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CD ' ' A' ' 69' ' ' LYS . 1.8 pt? -124.38 -34.29 2.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.172 172.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.0 -177.94 15.32 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.247 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -104.66 150.24 24.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.589 0.356 . . . . 0.0 110.106 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.423 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 15.8 m-85 -126.69 151.43 48.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.66 0.266 . . . . 0.0 110.422 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.93 122.59 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.054 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 5.6 tmm_? -92.43 -42.14 9.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.989 0.423 . . . . 0.0 110.051 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.52 HD23 ' CD2' ' A' ' 27' ' ' HIS . 23.7 tp -149.22 150.22 32.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -125.7 118.84 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.22 121.53 76.98 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.985 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.64 121.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.222 1.948 . . . . 0.0 111.808 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.04 43.81 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.368 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.501 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 99.3 p -83.28 164.81 44.0 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.561 -0.376 . . . . 0.0 111.054 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.2 Cg_endo -67.81 -18.38 47.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.48 2.12 . . . . 0.0 112.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -62.65 -43.15 99.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.625 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.05 -38.7 89.73 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.338 0.59 . . . . 0.0 110.035 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 60.1 mttp -68.88 -25.05 64.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.86 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -84.61 -18.55 35.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.87 10.46 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 88' ' ' LEU . 10.2 mp -81.48 131.7 35.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.999 0.4 . . . . 0.0 110.45 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.64 152.65 51.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.05 92.87 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.32 -26.73 0.78 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.649 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 9.7 m-20 -64.26 140.78 58.9 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 111.12 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -90.47 132.33 35.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 90' ' ' VAL . 33.5 tp -80.73 112.7 18.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.833 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.04 -38.6 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.296 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' HD2' ' A' ' 107' ' ' ARG . 3.0 tt0 -148.88 150.59 33.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.275 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.484 HG23 HG23 ' A' ' 67' ' ' VAL . 86.5 t -132.21 111.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.176 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 53.44 37.06 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.798 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.06 9.6 58.11 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.674 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.498 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.6 tp10 -120.23 130.83 54.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.439 0.619 . . . . 0.0 111.039 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -72.53 101.44 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.7 m -102.74 5.96 10.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.253 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -8.92 41.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' CD ' HD11 ' A' ' 35' ' ' LEU . 30.4 mmtp -125.0 17.02 8.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.799 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.553 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 39.9 mt-10 -107.12 -172.2 2.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 112.483 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 p -107.63 170.47 7.96 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.049 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.45 ' O ' HG21 ' A' ' 76' ' ' VAL . 10.0 t60 -57.36 -47.55 81.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.023 177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -63.8 -47.59 80.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 28.1 mt-30 -61.71 -43.6 98.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.567 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 79' ' ' ILE . 70.3 t -66.73 -44.02 89.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.572 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 72' ' ' HIS . 50.1 t -57.8 -37.49 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.777 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 t -62.79 -39.34 93.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mtt-85 -68.91 -36.39 77.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 75' ' ' VAL . 78.3 mt -63.26 -42.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.76 -23.29 63.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -12.71 61.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.212 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.57 123.26 30.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.952 0.406 . . . . 0.0 109.942 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.47 -64.54 1.14 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.319 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -104.0 -28.81 11.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.57 32.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.777 0.322 . . . . 0.0 111.488 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.98 146.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.627 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.29 114.25 26.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 53' ' ' LEU . 84.1 mt -114.63 126.02 54.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -95.15 119.57 33.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.9 m -132.8 160.03 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.685 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.9 p -147.77 143.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.372 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.3 t70 -67.26 126.78 93.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.298 175.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 31.6 Cg_exo -59.46 -32.82 97.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.625 2.883 . . . . 0.0 113.971 -174.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -72.1 -41.31 67.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.647 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 30.5 m -69.52 -39.59 77.45 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.272 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.48 -33.41 69.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.93 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.49 -40.56 78.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.76 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.65 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 96.8 mt-30 -72.78 -49.15 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 173.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 95' ' ' THR . 30.1 mt -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.401 -166.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.15 -35.73 81.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -71.46 -36.04 71.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 66.7 mt -63.32 -59.53 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.193 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 146.11 -154.45 25.96 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.602 HG12 ' HG ' ' A' ' 110' ' ' LEU . 91.7 t 67.0 146.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.861 0.864 . . . . 0.0 112.491 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 14.6 mm100 -81.3 91.69 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 0.0 109.857 175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.559 HG12 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -55.35 -25.07 16.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.643 -1.162 . . . . 0.0 114.013 -171.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.647 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 17.8 ptt180 -66.4 -17.67 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -170.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.542 ' HA ' HD22 ' A' ' 111' ' ' LEU . 33.2 tt0 179.99 -13.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.2 tt0 -55.56 -37.42 67.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 110.976 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.618 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 52.4 mt -73.09 -39.68 65.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 108' ' ' GLU . 3.5 mm? -67.02 -35.85 80.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.928 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -76.91 -30.15 56.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.47 -41.79 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 11.5 pt20 -120.86 45.06 2.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.974 0.416 . . . . 0.0 111.391 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.01 149.62 44.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.043 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -156.36 120.67 2.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.708 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.95 110.59 1.17 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.838 2.359 . . . . 0.0 111.777 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 148.45 -28.18 1.35 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.774 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 69.39 -72.44 0.1 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.438 0.695 . . . . 0.0 111.852 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.329 -178.605 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 111.904 -0.479 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -130.55 139.88 50.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.762 0.315 . . . . 0.0 110.17 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -103.85 135.8 19.3 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.152 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.81 -28.13 36.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.045 2.497 . . . . 0.0 112.356 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -150.58 149.54 30.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.251 0.548 . . . . 0.0 111.733 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 95' ' ' THR . 5.1 t -170.63 123.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.603 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.5 ttt 53.54 54.21 10.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.571 0.7 . . . . 0.0 110.338 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.839 HD21 ' H ' ' A' ' 11' ' ' LEU . 1.3 pt? -80.36 162.25 61.91 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' CG ' HG11 ' A' ' 106' ' ' VAL . 81.1 Cg_endo -88.52 172.66 4.77 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.718 2.279 . . . . 0.0 113.833 -166.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -138.11 154.09 49.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.853 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.9 111.5 19.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 64.0 m -92.55 109.72 21.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.472 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -95.48 110.7 22.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.381 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -113.98 149.57 35.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.956 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -112.9 134.89 54.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.472 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 33.1 ttpt -68.99 112.66 5.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.007 -174.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.27 -156.02 30.19 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.129 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.18 -8.95 24.58 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.014 2.476 . . . . 0.0 113.81 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -126.45 10.77 7.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 104.22 -139.14 14.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.311 -173.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.519 ' HB3' HD11 ' A' ' 17' ' ' LEU . 98.5 m-85 -103.17 -32.43 9.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.551 0.675 . . . . 0.0 112.072 -174.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.25 32.17 7.18 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.069 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -138.85 150.69 46.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -123.11 130.28 52.57 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.71 139.23 36.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.703 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -142.18 152.74 43.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.89 19.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.376 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HG3' ' CE2' ' A' ' 38' ' ' TYR . 51.3 mt-10 -78.22 -172.37 2.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -75.45 92.42 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.117 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.33 -83.98 0.75 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 37.83 -154.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.288 -0.956 . . . . 0.0 112.378 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 68' ' ' GLU . 1.8 pp -145.0 5.0 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.008 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.52 154.05 21.29 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.041 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -105.38 148.59 26.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.0 110.191 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 31' ' ' GLU . 8.4 m-85 -126.93 153.29 45.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 110.538 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.69 121.35 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.187 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 tmm_? -88.99 -46.69 8.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.7 tp -147.39 144.29 28.59 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.083 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 49' ' ' GLU . 2.2 p -129.97 113.72 27.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG3' ' CA ' ' A' ' 25' ' ' GLY . 1.7 mt-10 -70.34 132.76 87.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.195 -166.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.19 118.14 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.407 2.071 . . . . 0.0 111.89 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.85 -1.43 33.85 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.382 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.47 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 99.3 p -85.45 158.95 56.83 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.181 -177.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -17.86 49.02 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 111.339 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -63.53 -43.39 97.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.721 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 42' ' ' VAL . 44.6 mt-10 -60.15 -44.16 95.18 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.279 0.561 . . . . 0.0 110.004 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.41 -17.67 63.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.511 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . . . -83.27 -18.83 37.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 0.0 110.286 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.41 26.41 6.56 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.07 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.68 136.23 33.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.76 0.315 . . . . 0.0 110.634 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 55' ' ' ALA . 3.8 tt -137.41 143.37 41.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.55 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -58.03 117.65 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.305 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.55 -26.51 6.27 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.126 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 94.3 m-20 -58.17 141.73 49.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.025 0.441 . . . . 0.0 111.792 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 46.8 ttt180 -85.31 122.68 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.436 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.74 118.8 21.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.908 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.55 -41.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.576 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 11.6 tt0 -149.96 150.94 32.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.729 0.3 . . . . 0.0 110.731 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.699 HG23 HG12 ' A' ' 75' ' ' VAL . 48.8 t -128.81 116.11 39.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.585 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 62.8 m-80 68.39 -58.25 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.427 1.091 . . . . 0.0 111.171 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.11 28.21 0.06 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.189 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.7 tp10 -125.54 127.26 46.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -69.92 115.72 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.32 . . . . 0.0 110.489 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 31.4 m -111.52 29.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.13 0.49 . . . . 0.0 111.486 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 35' ' ' LEU . 4.4 mm-40 -73.14 -8.72 57.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.732 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -138.43 32.45 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 111.169 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.458 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 61.4 mm-40 -107.11 -172.17 2.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.363 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -123.48 174.1 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.56 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.424 ' O ' HG22 ' A' ' 76' ' ' VAL . 9.5 t60 -55.3 -47.9 74.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.001 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -65.73 -43.36 89.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.151 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 14.0 mm-40 -60.76 -42.9 98.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.571 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.699 HG12 HG23 ' A' ' 62' ' ' VAL . 90.1 t -70.79 -38.9 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.504 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 72' ' ' HIS . 25.4 t -58.88 -39.85 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -59.13 -41.78 89.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.277 0.561 . . . . 0.0 109.856 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' NE ' ' HG2' ' A' ' 65' ' ' GLU . 53.1 mtt180 -69.34 -35.88 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.9 mt -65.18 -32.59 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.202 0.525 . . . . 0.0 109.898 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.91 -17.3 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 109.997 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.53 114.29 20.83 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.562 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.53 -63.7 1.01 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.575 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -135.38 -0.12 2.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.149 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.98 141.65 20.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -126.62 144.15 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.839 0.352 . . . . 0.0 110.246 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 59.6 mtm-85 -103.31 113.23 26.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.152 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD11 HD22 ' A' ' 17' ' ' LEU . 99.0 mt -112.37 118.47 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.014 0.435 . . . . 0.0 110.968 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.462 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 32.8 tp -95.1 116.32 28.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 31.8 m -130.02 154.08 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.842 0.353 . . . . 0.0 110.6 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.83 147.57 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.154 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.54 121.75 69.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.604 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.43 -31.1 92.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.526 2.817 . . . . 0.0 113.508 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.84 -44.74 63.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.003 0.43 . . . . 0.0 110.241 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 9' ' ' THR . 23.7 m -71.13 -36.74 72.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.735 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 9.1 t70 -56.92 -33.28 66.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.872 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 8.7 mm-40 -59.03 -49.66 77.04 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -72.74 -39.77 66.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.931 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.84 -33.9 76.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.988 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.592 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 1.3 tt0 -57.23 -49.14 76.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.495 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 14.0 mptt -68.94 -18.32 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.515 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.06 -10.81 59.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.84 46.3 38.43 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.614 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.591 HG23 HG23 ' A' ' 106' ' ' VAL . 24.0 m -91.72 160.86 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.278 0.561 . . . . 0.0 111.96 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -104.32 69.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.9 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.591 HG23 HG23 ' A' ' 104' ' ' VAL . 16.8 t -56.72 -27.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.466 ' HB2' ' OE1' ' A' ' 61' ' ' GLU . 7.6 ptm180 -59.9 -29.22 68.2 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -165.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -174.59 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.177 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.22 -32.28 70.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.81 -19.73 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.197 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.97 -38.0 46.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.426 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -81.3 -18.83 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.216 0.531 . . . . 0.0 110.055 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.04 -171.74 3.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.964 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.551 ' NE2' HD13 ' A' ' 11' ' ' LEU . 37.7 mt-30 54.08 37.29 26.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.347 0.594 . . . . 0.0 110.473 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.66 16.2 5.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.98 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 59.25 79.78 0.29 Allowed Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.301 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 95.73 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.833 2.356 . . . . 0.0 111.815 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -146.76 18.76 1.63 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.309 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -71.25 -46.97 59.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.153 0.501 . . . . 0.0 110.168 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.833 177.634 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -85.06 140.96 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 7' ' ' PRO . 16.7 t0 -78.36 115.49 51.65 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 6' ' ' ASP . 37.2 Cg_endo -68.05 -21.62 42.71 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.893 2.395 . . . . 0.0 112.034 -175.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.543 ' CE1' HD11 ' A' ' 110' ' ' LEU . 17.4 m-85 -146.78 147.32 30.79 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.519 0.676 . . . . 0.0 112.255 -174.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 10' ' ' MET . 4.0 t -172.0 133.74 0.73 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.794 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.55 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 16.4 tpt 75.2 -60.58 0.51 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.708 0.803 . . . . 0.0 110.493 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 51.91 132.91 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.296 1.438 . . . . 0.0 114.178 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.984 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 84.9 Cg_endo -76.8 173.43 14.49 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.577 2.851 . . . . 0.0 113.514 -176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -143.04 157.69 44.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.124 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 89' ' ' LEU . 29.6 mt -84.54 115.98 22.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.2 m -94.49 108.31 20.25 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.517 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -94.62 111.62 23.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -121.88 150.31 42.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 36.3 mt-10 -112.97 134.76 54.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.786 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.87 117.58 4.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -172.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.63 -161.67 32.16 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.489 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.74 -33.15 93.35 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.42 2.747 . . . . 0.0 113.046 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -136.98 24.01 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 111.544 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.43 -153.26 18.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.758 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.513 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.4 m-85 -104.08 -29.91 10.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.967 0.383 . . . . 0.0 111.985 -173.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.14 29.65 6.69 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.79 172.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -134.0 141.07 47.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.429 -0.454 . . . . 0.0 110.32 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -101.6 144.17 30.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.53 128.32 49.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.493 0.187 . . . . 0.0 111.311 -172.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.4 p80 -123.94 140.27 53.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -118.1 6.48 15.17 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 64.16 -173.7 0.17 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.978 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -107.61 122.09 45.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.46 61.98 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.68 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 4.2 mptp? -96.44 167.71 11.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.855 HD13 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -130.51 20.48 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.061 175.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 144.05 15.8 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HB2' HD23 ' A' ' 59' ' ' LEU . 12.5 mm100 -103.86 146.22 28.97 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 117.007 0.404 . . . . 0.0 110.299 -173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -128.22 152.69 47.77 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' A' ' 55' ' ' ALA . 28.5 mm -70.09 118.3 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 109.952 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.493 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 1.2 tpt180 -93.96 -49.67 5.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.521 -173.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.7 tm? -152.5 141.37 21.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 41' ' ' LEU . 25.0 t -118.82 127.29 75.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -80.88 120.05 77.79 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.92 101.94 1.14 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.511 2.14 . . . . 0.0 112.386 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.2 22.11 1.26 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.99 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.49 173.84 3.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.77 0.319 . . . . 0.0 110.196 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.545 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 56.1 Cg_endo -70.34 -13.46 33.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.405 2.07 . . . . 0.0 112.922 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -47.9 81.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.402 . . . . 0.0 110.891 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' CG1' ' A' ' 42' ' ' VAL . 1.7 mp0 -67.34 -32.97 74.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.406 0.622 . . . . 0.0 109.791 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 27.3 mtpp -69.56 -21.02 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.908 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 17' ' ' LEU . . . -91.67 -17.81 24.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.37 38.11 4.1 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.52 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 48' ' ' ALA . 94.6 mt -92.9 130.86 38.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.432 HD21 ' N ' ' A' ' 55' ' ' ALA . 6.9 tt -129.09 138.74 52.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 39' ' ' ILE . . . -63.4 103.89 0.56 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.183 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.99 -26.89 2.58 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.654 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.7 m-20 -65.25 149.39 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.33 0.586 . . . . 0.0 111.549 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 58.8 ttt180 -92.13 125.51 36.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 37' ' ' GLN . 48.2 tp -80.42 100.71 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.032 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 106' ' ' VAL . 41.9 t -86.32 -39.51 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.161 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -146.73 151.42 37.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 111.534 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 75' ' ' VAL . 83.9 t -131.3 111.3 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.617 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.99 -24.0 0.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.844 0.858 . . . . 0.0 112.03 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 148.0 13.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.454 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -126.0 135.39 51.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.393 0.597 . . . . 0.0 110.185 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.22 102.49 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.916 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 62' ' ' VAL . 29.9 m -92.61 12.7 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -170.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.5 -3.22 19.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.185 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.855 ' HA ' HD13 ' A' ' 35' ' ' LEU . 97.9 mttt -132.64 31.16 4.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.172 0.51 . . . . 0.0 110.086 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -116.9 -164.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.261 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 75' ' ' VAL . 59.6 p -133.29 167.1 21.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.102 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.556 ' O ' HG22 ' A' ' 76' ' ' VAL . 20.4 t60 -53.88 -47.34 71.18 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.16 -46.81 88.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.2 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 48.6 mt-30 -65.32 -38.12 89.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 62' ' ' VAL . 75.7 t -66.05 -39.55 84.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.924 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 72' ' ' HIS . 62.0 t -57.54 -46.1 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.614 0.245 . . . . 0.0 111.069 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -37.33 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.674 0.273 . . . . 0.0 110.989 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 85.9 mtt-85 -66.57 -36.38 82.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.974 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.2 mt -65.52 -39.87 86.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.0 110.173 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.4 mmt180 -71.21 -20.87 62.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.687 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.63 62.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.963 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' HH ' ' A' ' 24' ' ' TYR . . . -65.2 131.01 45.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.77 -52.27 10.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.216 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.87 -22.19 2.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.3 153.28 34.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.705 0.288 . . . . 0.0 110.937 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.0 141.71 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.12 114.51 27.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.438 HD13 HD12 ' A' ' 53' ' ' LEU . 94.3 mt -109.62 119.46 39.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 14' ' ' LEU . 26.8 tp -94.33 116.01 28.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 29.3 m -127.89 153.09 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.12 0.486 . . . . 0.0 111.041 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.984 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 10.6 p -148.26 153.51 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.326 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.89 118.69 16.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.41 -40.96 77.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.542 2.828 . . . . 0.0 113.597 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.34 -37.47 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -66.21 -38.28 87.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.913 0.387 . . . . 0.0 110.271 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.7 t70 -61.68 -36.7 81.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.88 -48.33 80.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.296 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.537 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 17.0 pt20 -72.43 -42.87 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.998 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 mt -59.44 -43.98 93.02 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.639 0.257 . . . . 0.0 111.203 -177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 96' ' ' ASP . 77.5 mm-40 -61.9 -38.16 87.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.796 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 98' ' ' GLN . 12.5 pttp -75.55 -19.79 59.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.366 . . . . 0.0 110.453 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 86.4 mt -76.89 -3.65 39.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.488 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.82 30.48 26.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.737 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 39.8 t -89.35 131.28 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.869 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -95.18 85.29 4.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.336 174.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -65.47 -17.47 22.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.222 -175.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -59.39 -45.91 90.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HA ' HD13 ' A' ' 111' ' ' LEU . 21.3 tt0 -166.79 -10.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.137 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.52 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 42.1 mm-40 -55.69 -40.79 72.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 110.6 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.543 HD11 ' CE1' ' A' ' 8' ' ' PHE . 45.1 mt -65.23 -40.22 93.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.392 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 108' ' ' GLU . 4.9 mp -83.91 -13.93 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.052 -170.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -78.61 -49.2 13.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.829 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.24 84.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.771 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -98.29 98.31 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.888 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.74 102.64 2.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.483 0.658 . . . . 0.0 110.311 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.08 129.61 77.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.985 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.73 84.79 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.597 2.198 . . . . 0.0 112.383 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 -43.49 36.95 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -149.13 47.77 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.41 -179.651 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.0 mt -107.15 150.6 9.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -93.29 104.43 12.21 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.78 -30.55 78.05 Favored 'Trans proline' 0 CA--C 1.513 -0.56 0 C-N-CA 122.848 2.365 . . . . 0.0 111.498 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -149.53 139.67 22.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.317 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -148.56 -45.52 0.15 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.974 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.515 ' HB3' HG23 ' A' ' 95' ' ' THR . 51.0 tpp -138.9 78.57 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.887 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.54 155.8 85.35 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 -179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.686 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 55.3 Cg_endo -93.75 160.01 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.166 2.578 . . . . 0.0 112.775 -173.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -136.38 150.01 48.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.377 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.508 HD22 ' HD3' ' A' ' 87' ' ' ARG . 33.1 tp -82.21 106.79 14.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -92.49 111.66 23.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.051 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.616 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 42.6 m -97.31 110.9 23.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.256 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -110.97 154.98 23.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.339 176.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.96 130.41 55.69 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 -167.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -65.19 126.34 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.18 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.6 -169.18 21.82 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.24 -16.73 56.64 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.443 2.095 . . . . 0.0 112.135 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -97.81 0.74 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.132 0.492 . . . . 0.0 110.087 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.49 -119.76 5.81 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.526 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 91.7 m-85 -119.26 -24.55 6.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.114 0.457 . . . . 0.0 110.661 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.0 31.18 29.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.576 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -128.7 156.6 43.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.361 0.581 . . . . 0.0 110.056 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -126.16 144.61 50.69 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -120.15 143.18 48.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -139.48 147.35 41.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.706 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.36 108.81 2.29 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.736 ' O ' ' HD2' ' A' ' 34' ' ' LYS . 9.1 mm-40 -70.53 147.01 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -67.4 116.93 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 50.81 2.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.784 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.736 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -134.76 -171.87 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 110.55 -177.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 pt? -129.4 -29.27 2.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.752 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.06 -163.95 12.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.04 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -111.93 155.69 23.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.892 0.377 . . . . 0.0 110.622 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.516 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 83.2 m-85 -131.16 151.9 50.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.534 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.1 mm -72.53 124.91 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.806 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 2.4 tmm_? -89.06 -40.73 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 7.7 tp -161.9 150.07 14.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.478 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 65.0 t -129.29 129.9 67.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -76.94 115.97 53.04 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.31 114.2 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.207 1.938 . . . . 0.0 111.051 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 40.81 2.75 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.842 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.754 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 34.3 p -119.64 -164.16 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 74.5 Cg_endo -90.31 -13.36 2.42 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.245 1.296 . . . . 0.0 112.919 163.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -73.81 -41.62 62.1 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -74.73 -35.14 62.66 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.392 1.091 . . . . 0.0 108.14 -174.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -57.29 -34.66 68.9 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.938 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -78.87 -17.32 55.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.24 24.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.618 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.69 130.44 37.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.765 0.317 . . . . 0.0 110.495 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.3 tp -137.31 150.83 48.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.999 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 94.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.272 0.558 . . . . 0.0 111.179 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.71 -25.25 1.05 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.1 m-20 -62.26 140.81 58.48 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.137 0.494 . . . . 0.0 111.231 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.516 ' HE ' ' HE1' ' A' ' 38' ' ' TYR . 42.1 ttm180 -88.9 126.7 35.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.907 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.471 ' HA ' HG12 ' A' ' 90' ' ' VAL . 46.3 tp -80.46 117.36 21.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.02 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' HB ' HD22 ' A' ' 89' ' ' LEU . 52.6 t -102.21 -37.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.463 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.65 149.73 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.632 -178.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 HG13 ' A' ' 75' ' ' VAL . 86.8 t -137.05 117.68 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.617 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 60.44 37.42 19.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.386 0.613 . . . . 0.0 110.147 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.52 16.24 76.25 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.705 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 7.3 tp10 -125.16 135.15 52.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.519 -0.401 . . . . 0.0 110.957 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.711 HD21 ' HD3' ' A' ' 107' ' ' ARG . 23.1 t-20 -70.02 113.96 7.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.375 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.545 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.9 m -111.99 26.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.327 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.444 ' CD ' HD22 ' A' ' 66' ' ' ASN . 81.2 mt-10 -61.24 -25.4 67.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.424 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 5.7 ptpp? -141.94 34.98 1.56 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.037 0.446 . . . . 0.0 111.543 -170.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mt-10 -110.56 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.019 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.3 p -113.48 167.62 10.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.535 ' O ' HG21 ' A' ' 76' ' ' VAL . 16.6 t60 -56.71 -44.52 81.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.853 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.62 -46.01 90.24 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.607 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.598 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 56.8 mt-30 -61.38 -42.4 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.806 HG13 HG22 ' A' ' 62' ' ' VAL . 74.3 t -64.97 -41.14 91.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.506 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 72' ' ' HIS . 73.1 t -58.01 -44.21 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.625 0.25 . . . . 0.0 111.425 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 p -64.0 -36.48 84.11 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.534 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 44.6 mtt-85 -64.94 -37.67 88.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 75' ' ' VAL . 77.2 mt -63.22 -32.8 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 110.268 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.6 mmt180 -70.34 -21.06 62.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -6.69 51.02 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' ALA . . . -90.14 125.23 35.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.707 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.55 -75.86 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.144 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -118.64 -1.92 11.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.506 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -151.98 149.58 29.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 174.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.23 142.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.616 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 94.1 mtt180 -98.68 117.37 33.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.98 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 17' ' ' LEU . 89.3 mt -121.75 125.92 47.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 10.4 tp -100.25 115.94 31.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.3 m -127.93 155.79 39.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.067 0.461 . . . . 0.0 110.375 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.3 p -148.0 154.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.039 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.62 123.37 56.93 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.95 -35.34 98.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.55 2.833 . . . . 0.0 113.246 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -72.22 -43.58 64.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 10' ' ' MET . 27.6 m -66.38 -37.43 85.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.689 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HB2' HG13 ' A' ' 91' ' ' VAL . 30.5 t70 -57.92 -39.74 78.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.347 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -58.51 -49.05 78.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.281 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.3 pt20 -72.64 -39.59 67.08 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.765 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.439 ' HG ' HG21 ' A' ' 95' ' ' THR . 38.8 mt -70.48 -42.78 70.93 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -47.93 82.49 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.7 -18.92 65.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.685 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 95.8 mt -69.49 -20.84 63.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.54 33.09 4.59 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.058 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.26 132.1 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.049 0.452 . . . . 0.0 111.139 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.82 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -87.08 88.58 7.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.91 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.463 HG12 ' CG ' ' A' ' 12' ' ' PRO . 2.3 t -65.64 -29.62 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.121 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.711 ' HD3' HD21 ' A' ' 66' ' ' ASN . 15.1 ttp85 -60.69 -44.02 97.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -168.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -158.81 -34.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.965 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.82 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 8.4 tp10 -55.52 -39.51 70.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.621 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 38.6 tp -68.86 -20.86 64.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.385 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.73 -32.55 16.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.968 0.414 . . . . 0.0 110.857 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.504 ' HD3' ' HA ' ' A' ' 109' ' ' GLU . 10.3 ptm180 -83.07 -30.69 27.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.938 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.98 98.01 3.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.636 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 2.9 mt-30 -98.41 16.12 22.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.292 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.38 81.08 8.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.287 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.78 113.81 40.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.229 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.87 157.31 57.27 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.021 2.481 . . . . 0.0 112.406 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.49 -101.03 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.171 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -113.03 7.17 17.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.864 -178.573 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.7 138.36 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.706 ' HB2' HE22 ' A' ' 98' ' ' GLN . 63.7 m-20 -104.3 128.1 27.75 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.04 -30.58 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.445 2.097 . . . . 0.0 110.776 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.412 ' HB3' HD21 ' A' ' 11' ' ' LEU . 37.2 m-85 -153.97 145.11 22.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.74 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 10' ' ' MET . 1.5 t -142.68 -98.49 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.135 -169.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.453 ' H ' HG21 ' A' ' 9' ' ' THR . 82.6 mtp -97.41 -28.05 14.18 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.573 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 28.1 mt 76.36 160.09 0.15 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.083 167.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 58.5 Cg_endo -69.03 157.32 62.27 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.103 2.536 . . . . 0.0 112.732 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -129.75 126.27 37.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 87' ' ' ARG . 58.8 tp -90.9 106.62 18.64 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.511 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.74 107.96 20.16 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.27 111.62 23.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.26 0.552 . . . . 0.0 110.126 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -114.89 165.43 12.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.386 -178.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.1 147.38 44.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.859 -170.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -72.03 107.52 4.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.41 -163.76 39.28 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.55 -26.72 81.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.74 2.293 . . . . 0.0 112.71 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -112.63 25.67 11.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.475 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -105.05 2.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.958 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 46' ' ' SER . 90.3 m-85 -131.7 -42.07 1.04 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.488 -0.419 . . . . 0.0 111.662 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 42.72 4.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.397 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.82 158.3 43.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.491 0.646 . . . . 0.0 110.171 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.432 ' CD2' HD22 ' A' ' 41' ' ' LEU . 60.8 m-70 -128.27 143.83 51.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.166 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.68 155.91 38.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.212 0.529 . . . . 0.0 111.748 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -140.17 139.1 35.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.43 117.57 5.57 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -74.75 134.87 41.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 111.38 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -59.82 108.33 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.945 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.6 -31.46 3.96 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 12.0 mptt -110.25 159.51 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 109.864 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.618 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 1.5 pp -106.51 -4.05 20.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.076 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.06 147.99 24.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HG3' HG22 ' A' ' 75' ' ' VAL . 33.8 mm-40 -103.33 152.4 21.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.953 0.406 . . . . 0.0 110.061 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -126.39 144.75 50.72 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.1 120.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.27 -47.2 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.9 tp -146.66 149.41 33.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -123.67 120.04 58.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.163 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 53.0 mm-40 -64.29 131.91 95.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.5 Cg_exo -70.89 123.85 10.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.887 1.725 . . . . 0.0 111.786 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.7 22.07 24.67 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.055 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 89.9 p -104.24 158.08 32.69 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.746 0.308 . . . . 0.0 110.564 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.75 -14.82 46.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.601 2.201 . . . . 0.0 111.7 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -66.47 -40.69 89.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.347 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 28.8 mt-10 -64.94 -37.68 88.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.874 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.67 -29.11 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.006 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -79.16 -18.89 52.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.34 33.66 5.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.481 HD11 ' HB3' ' A' ' 48' ' ' ALA . 83.4 mt -86.89 134.74 33.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.281 . . . . 0.0 110.444 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.71 153.33 51.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 128.1 34.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.468 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.71 -15.73 21.61 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.149 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 1.7 m-20 -78.29 147.18 34.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.925 0.393 . . . . 0.0 110.761 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 61.0 ttt180 -92.48 126.9 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.4 tp -77.58 112.79 14.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.163 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.503 ' HB ' HD21 ' A' ' 89' ' ' LEU . 40.8 t -104.88 -31.37 2.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.428 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -143.13 149.96 38.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.055 -0.403 . . . . 0.0 110.78 -178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.59 113.59 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.315 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.82 35.28 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.837 0.827 . . . . 0.0 110.844 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.66 10.96 69.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.147 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.7 tp10 -124.79 132.05 53.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.112 0.456 . . . . 0.0 110.868 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.26 108.95 3.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.7 16.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.698 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -76.39 7.54 4.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.46 23.48 2.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.668 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -109.25 -172.61 2.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.811 -174.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 75' ' ' VAL . 69.5 p -128.19 175.22 8.61 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.579 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 t60 -61.57 -46.56 89.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -66.51 -41.46 88.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.846 0.355 . . . . 0.0 110.716 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 15.8 mt-30 -67.17 -38.71 85.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 37' ' ' GLN . 17.8 m -68.64 -41.18 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.08 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 72' ' ' HIS . 76.3 t -56.31 -39.13 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 m -61.94 -38.64 89.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.387 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.2 mtt-85 -67.37 -36.57 81.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.625 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 75' ' ' VAL . 71.7 mt -63.17 -37.71 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.208 0.528 . . . . 0.0 110.004 175.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -68.96 -24.52 64.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.074 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.82 58.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.8 130.89 46.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.203 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.05 -67.05 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.858 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.37 -24.58 9.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.09 157.93 43.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.793 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 ' CE1' ' A' ' 24' ' ' TYR . 11.5 p -130.05 143.36 41.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.479 ' HB3' HD12 ' A' ' 14' ' ' LEU . 9.9 mtm180 -98.74 128.51 45.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD13 HD13 ' A' ' 53' ' ' LEU . 94.4 mt -122.12 110.57 15.92 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 11.9 tp -93.62 126.46 38.79 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.3 m -130.97 165.36 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 96' ' ' ASP . 8.7 p -148.14 140.1 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.569 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.5 p30 -75.1 145.12 80.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 50.4 Cg_exo -55.21 -31.52 76.47 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.017 3.145 . . . . 0.0 114.512 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.93 -47.89 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.777 0.323 . . . . 0.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.426 HG23 HG21 ' A' ' 9' ' ' THR . 99.1 m -64.19 -44.78 90.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.622 0.725 . . . . 0.0 109.879 174.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.443 ' HB2' HG13 ' A' ' 91' ' ' VAL . 17.6 t70 -59.24 -39.64 83.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.507 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 1.9 tm-20 -57.41 -49.81 75.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.136 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.706 HE22 ' HB2' ' A' ' 6' ' ' ASP . 6.0 pt20 -73.96 -47.34 38.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.416 HD13 HG23 ' A' ' 104' ' ' VAL . 2.7 mm? -58.76 -38.9 79.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 7.4 pt20 -64.53 -40.64 95.98 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.212 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 97' ' ' GLU . 44.1 mtmt -75.52 -34.98 60.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.878 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 90.6 mt -63.16 -27.3 69.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.606 -177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.61 73.92 0.9 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG23 HD13 ' A' ' 99' ' ' LEU . 57.4 t -121.37 153.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.566 0.222 . . . . 0.0 110.605 -173.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.81 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 11.5 pt20 -71.22 57.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.36 0.6 . . . . 0.0 111.171 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.507 HG12 ' HG3' ' A' ' 12' ' ' PRO . 47.8 t -63.66 -27.57 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.775 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 39.4 ptt180 -60.61 -23.04 64.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -169.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 112' ' ' ARG . 17.8 tt0 171.18 -41.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.418 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.81 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.0 mt-10 -54.47 -32.5 57.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.206 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 61.7 tp -70.28 -41.97 72.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 0.0 111.245 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -90.37 -12.65 36.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.257 0.551 . . . . 0.0 111.135 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.439 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.2 ttp180 -78.88 -46.94 17.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.663 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.24 39.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.345 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -120.0 112.09 18.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.261 0.553 . . . . 0.0 111.072 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.53 6.63 10.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.41 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 61.77 80.19 0.26 Allowed Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.905 -175.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.44 87.71 1.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.662 2.241 . . . . 0.0 111.854 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.74 60.26 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -70.68 148.67 47.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.8 0.333 . . . . 0.0 110.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.205 178.642 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.85 135.9 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.91 0.355 . . . . 0.0 110.226 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.03 110.18 48.55 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.358 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.82 -16.36 18.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.747 2.298 . . . . 0.0 111.581 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -144.75 142.83 30.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.609 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 179.7 132.11 0.09 Allowed 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.496 0.498 . . . . 0.0 110.39 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.8 mtt 44.06 47.06 7.31 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.74 0.65 . . . . 0.0 111.622 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.75 135.74 96.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.363 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.1 155.43 69.54 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.132 2.555 . . . . 0.0 113.518 -174.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -116.81 154.09 31.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.315 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' A' ' 87' ' ' ARG . 58.4 tp -82.06 115.48 21.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.8 m -93.41 115.85 28.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -104.38 112.21 25.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.727 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.66 155.68 34.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.182 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -104.34 145.77 29.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.512 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 26.0 ttpt -77.74 119.53 21.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.373 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.16 -158.36 25.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.701 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.12 -27.45 65.12 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.77 2.313 . . . . 0.0 112.457 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -110.25 26.1 11.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.274 0.559 . . . . 0.0 110.208 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 80.91 -100.58 1.99 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.5 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . 87.1 m-85 -133.72 -22.63 1.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.302 0.551 . . . . 0.0 111.804 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.05 28.96 24.23 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.76 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -127.31 140.6 52.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -109.85 138.77 45.75 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.54 132.18 56.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.739 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -122.78 146.74 47.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.977 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.89 113.0 1.95 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 8.8 mm-40 -61.57 133.71 55.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.612 0.244 . . . . 0.0 110.833 -175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.12 98.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.276 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.01 -13.16 9.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.229 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 27.8 mmmt -91.54 155.66 18.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.2 pp -102.57 19.28 19.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.31 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.39 152.47 20.64 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.666 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -103.71 137.52 41.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.907 0.384 . . . . 0.0 110.578 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -125.08 155.41 39.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.013 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.33 127.83 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -101.14 -45.15 5.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.807 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -146.68 141.22 26.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.53 -172.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.578 ' N ' HD12 ' A' ' 41' ' ' LEU . 55.1 t -121.67 113.79 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.9 mm-40 -73.59 130.14 84.28 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.16 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.3 Cg_exo -70.13 124.04 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.367 2.044 . . . . 0.0 111.815 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.9 16.93 29.34 Favored Glycine 0 C--N 1.317 -0.496 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.899 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 95.9 p -101.71 159.54 29.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 0.0 110.829 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.96 -20.25 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.83 172.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -64.19 -42.13 96.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.21 -42.0 89.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.307 0.575 . . . . 0.0 110.362 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.65 -22.93 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.11 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -87.28 -17.83 31.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.901 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.67 29.96 5.71 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.202 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.13 133.51 36.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 tt -139.97 141.06 36.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.86 100.03 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.382 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.04 -31.23 1.74 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.9 m-20 -60.28 140.9 56.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.519 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -89.04 132.35 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.861 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HA ' HG11 ' A' ' 90' ' ' VAL . 32.7 tp -75.2 114.06 13.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.758 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 106' ' ' VAL . 46.3 t -101.7 -36.45 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.07 150.25 35.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.003 -178.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 67' ' ' VAL . 93.0 t -136.17 107.24 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.123 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.5 m120 62.99 22.4 13.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.346 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.401 ' H ' ' CD ' ' A' ' 61' ' ' GLU . . . 106.67 4.22 36.94 Favored Glycine 0 C--N 1.321 -0.285 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.218 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.626 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.1 tp10 -109.09 128.7 55.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.725 0.298 . . . . 0.0 110.356 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.36 93.29 1.91 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.422 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 35.7 m -95.41 35.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -173.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.48 -18.69 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.1 19.2 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.673 -177.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mp0 -93.93 141.12 28.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.99 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 75' ' ' VAL . 82.2 p -81.01 175.14 10.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.908 -174.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.435 ' O ' HG21 ' A' ' 76' ' ' VAL . 21.9 t60 -53.84 -47.04 71.34 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.029 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.95 -40.97 91.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 84.1 mm-40 -62.86 -44.03 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.958 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 71' ' ' THR . 12.6 m -71.71 -44.96 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 72' ' ' HIS . 77.7 t -59.22 -35.88 60.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.027 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 t -57.53 -40.95 79.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.317 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.626 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 68.2 mtt-85 -70.0 -37.68 75.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.44 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.8 mt -64.61 -37.92 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.353 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.776 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.48 -22.33 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 127.68 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 83' ' ' LEU . 6.8 mp -78.06 -62.29 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.755 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -128.33 -12.58 5.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.379 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.55 31.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.628 0.251 . . . . 0.0 110.81 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 24' ' ' TYR . 12.1 p -126.21 146.99 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 8.4 mtm180 -98.61 120.83 39.71 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 17' ' ' LEU . 92.6 mt -122.33 116.07 23.41 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.65 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 29.3 tp -101.54 117.37 34.77 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.663 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 25.8 m -131.04 153.77 39.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.943 0.402 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 96' ' ' ASP . 11.3 p -142.65 149.04 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.185 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.39 129.35 68.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.31 -34.11 88.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.61 2.873 . . . . 0.0 113.576 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.35 -43.34 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 17.3 m -66.39 -41.4 89.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 91' ' ' VAL . 14.0 t70 -58.84 -42.75 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.75 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.22 -47.03 84.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.019 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 13.6 pt20 -73.27 -38.67 65.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.0 111.001 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.97 -40.3 91.12 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -175.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.81 -37.18 85.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -71.67 -17.9 62.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.526 . . . . 0.0 110.655 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 77.0 mt -79.51 -3.85 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.906 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.84 41.71 72.26 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.104 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.91 137.64 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.859 0.361 . . . . 0.0 111.668 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 109' ' ' GLU . 17.3 mm-40 -79.33 54.64 1.73 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.483 HG12 HG13 ' A' ' 60' ' ' VAL . 1.5 t -60.57 -26.61 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.946 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.678 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -65.72 -5.44 8.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 33.3 tt0 168.55 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.934 0.397 . . . . 0.0 110.634 171.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 31.7 tt0 -55.54 -37.68 68.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.412 -172.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 110' ' ' LEU . 2.2 tm? -65.73 -26.79 67.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.97 -177.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.39 -11.99 54.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.555 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -63.33 -72.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.3 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -177.58 -70.03 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.351 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.459 ' NE2' ' HA ' ' A' ' 110' ' ' LEU . 2.2 mp0 52.64 40.78 30.75 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.791 -173.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.54 100.2 9.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 65.49 92.17 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 O-C-N 124.067 0.854 . . . . 0.0 109.705 -168.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 104.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.213 2.609 . . . . 0.0 112.684 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -125.17 38.6 2.26 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.926 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -127.81 95.47 4.22 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.78 178.153 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -133.41 133.6 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.863 0.364 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -112.75 125.44 29.89 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.566 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.41 -28.87 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.711 2.274 . . . . 0.0 112.588 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.444 ' HD2' HD12 ' A' ' 11' ' ' LEU . 16.2 m-85 -144.81 151.87 39.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 -174.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 95' ' ' THR . 10.1 t 175.96 142.74 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -169.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.431 ' HB2' HG21 ' A' ' 95' ' ' THR . 86.1 mtp 48.44 47.4 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.807 0.692 . . . . 0.0 111.651 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.69 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 2.0 mm? -72.8 157.61 88.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.515 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 37.7 Cg_endo -64.45 178.88 1.44 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.438 2.759 . . . . 0.0 113.709 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -143.3 149.37 37.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.626 -178.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.461 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 13.4 mt -84.22 108.01 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.6 m -94.38 108.41 20.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.044 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -95.1 111.85 23.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.915 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -122.04 150.79 41.61 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.42 147.83 29.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.558 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -69.43 97.53 1.0 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.653 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 -167.09 14.56 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.836 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.23 -34.2 98.15 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.928 2.418 . . . . 0.0 112.261 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -102.34 24.37 10.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.547 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.63 64.27 3.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.37 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' HB3' HD11 ' A' ' 17' ' ' LEU . 98.7 m-85 78.74 -38.57 0.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.215 1.006 . . . . 0.0 111.374 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.51 12.45 53.83 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -123.35 149.76 44.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.126 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 41' ' ' LEU . 39.6 m-70 -124.3 131.94 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.806 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -104.71 142.05 35.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.42 -172.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -133.42 134.93 44.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.149 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.39 104.04 2.15 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.5 mt-10 -60.39 146.37 44.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.095 0.474 . . . . 0.0 111.635 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.78 117.98 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.636 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.0 -38.3 3.36 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.851 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 70.7 mmtt -66.85 157.18 33.71 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -113.0 5.08 17.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.88 165.69 16.65 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.676 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.433 ' HG2' HG23 ' A' ' 75' ' ' VAL . 3.1 mp0 -103.66 148.56 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.804 0.335 . . . . 0.0 110.411 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.451 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 32.6 m-85 -131.44 154.47 48.65 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.91 113.41 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 ttp180 -85.48 -47.51 9.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.491 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 HD21 ' CD2' ' A' ' 27' ' ' HIS . 26.7 tp -145.7 142.49 29.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.704 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 54' ' ' LEU . 1.7 p -135.66 112.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -78.87 135.43 59.25 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.68 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -61.67 129.17 26.82 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.609 2.206 . . . . 0.0 112.057 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.79 1.38 45.99 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.942 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.596 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 96.0 p -93.76 152.14 40.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.156 0.503 . . . . 0.0 110.947 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.24 -13.7 41.04 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.86 2.373 . . . . 0.0 112.17 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -63.98 -39.96 95.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.001 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' CD ' ' HA ' ' A' ' 44' ' ' PRO . 30.1 mt-10 -62.92 -39.46 94.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.963 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -65.6 -29.84 70.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.934 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.12 -19.42 51.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.331 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.63 49.98 1.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -124.68 121.13 33.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.526 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.17 171.24 10.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.729 173.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.55 78.62 6.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.39 0.614 . . . . 0.0 111.191 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.33 -21.2 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.957 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 67.3 m-20 -63.97 141.75 58.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.686 0.279 . . . . 0.0 111.114 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.18 124.92 34.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.78 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.534 ' HA ' HG12 ' A' ' 90' ' ' VAL . 51.8 tp -78.4 119.48 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 HG22 ' A' ' 106' ' ' VAL . 60.2 t -103.78 -34.97 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.388 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 16.6 tt0 -150.55 151.18 32.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.761 0.315 . . . . 0.0 111.17 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 64' ' ' GLY . 65.6 t -132.4 119.92 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.469 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 72.9 -26.1 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.027 0.931 . . . . 0.0 111.729 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 145.16 10.68 0.28 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.604 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.3 tp10 -125.81 128.97 48.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.44 132.41 53.64 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.456 0.472 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 33.0 m -128.16 29.55 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.8 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.72 -24.28 66.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 35' ' ' LEU . 98.3 mttt -129.95 29.83 4.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.813 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 15.9 mm-40 -95.19 179.93 5.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.934 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 74' ' ' GLN . 25.1 p -107.63 167.62 9.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.695 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.417 ' O ' HG21 ' A' ' 76' ' ' VAL . 27.2 t60 -62.69 -44.13 97.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -64.83 -36.75 85.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 0.0 109.973 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.655 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -62.96 -45.4 92.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.819 -177.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 67' ' ' VAL . 4.7 m -71.32 -40.14 73.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.348 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 72' ' ' HIS . 45.1 t -57.55 -36.92 55.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.6 t -57.96 -41.53 83.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -69.09 -36.69 77.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -64.22 -32.8 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 109.906 176.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -21.34 62.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.847 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.09 -18.35 46.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.424 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.18 119.07 26.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.832 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.96 -62.85 1.43 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.295 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -107.15 -27.52 10.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.306 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.63 155.06 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.994 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.457 HG11 ' CE1' ' A' ' 24' ' ' TYR . 9.8 p -131.5 153.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.802 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -106.7 125.19 50.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 99.5 mt -120.37 127.68 52.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.2 tp -103.37 116.73 32.98 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.7 m -130.54 153.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -131.9 148.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.296 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.0 m-20 -68.24 123.14 86.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 33.0 Cg_exo -57.62 -31.74 92.61 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.541 2.827 . . . . 0.0 113.318 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.77 -48.46 81.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 109.897 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 9' ' ' THR . 2.6 m -73.67 -36.04 65.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.261 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.07 -40.42 76.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 43.7 mt-10 -61.04 -43.51 98.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.775 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -74.41 -39.89 62.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.076 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' A' ' 102' ' ' LEU . 52.2 mt -64.94 -34.18 77.8 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 18.1 pt20 -60.17 -34.33 73.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.42 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 7.5 mtpm? -71.71 -37.77 70.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.321 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 99' ' ' LEU . 27.2 mt -76.89 -44.51 31.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.458 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.58 94.19 0.16 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.05 95.54 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.14 0.971 . . . . 0.0 112.072 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -113.08 28.33 8.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.418 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.776 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 21.8 m -66.35 -14.19 17.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.29 -37.76 75.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -166.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.556 ' HA ' HD22 ' A' ' 111' ' ' LEU . 39.0 tt0 -162.13 -19.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.175 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.26 -36.2 65.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.722 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.69 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 3.9 mm? -77.92 -28.64 49.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.087 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 108' ' ' GLU . 3.6 mm? -74.94 -22.09 58.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.235 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -60.4 -35.56 76.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.505 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 69.88 112.84 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' A' ' 110' ' ' LEU . 0.7 OUTLIER -84.28 92.11 7.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.951 -174.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.55 131.24 41.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.871 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 119' ' ' GLN . . . -98.88 110.97 59.48 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.203 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.19 104.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.193 2.595 . . . . 0.0 112.871 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.7 31.45 67.66 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.219 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.644 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 9.2 pt20 -171.4 -173.26 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.851 0.325 . . . . 0.0 110.336 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.591 173.485 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.46 136.83 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -71.59 137.22 83.24 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.73 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' HD13 ' A' ' 102' ' ' LEU . 30.0 Cg_endo -64.79 -24.33 61.72 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.639 2.893 . . . . 0.0 113.298 -173.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -146.01 150.05 35.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.066 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -173.71 126.58 0.39 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.453 -171.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt 72.8 -71.0 0.14 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.884 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 HD13 HG13 ' A' ' 106' ' ' VAL . 2.8 mm? 65.74 156.89 0.13 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 72.4 Cg_endo -74.01 158.99 45.35 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.774 2.316 . . . . 0.0 112.553 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -115.33 143.98 44.45 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.737 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -83.19 106.3 14.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.3 m -96.24 108.52 21.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.671 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 22.0 m -91.82 111.75 23.4 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 48' ' ' ALA . 21.1 mt -88.27 163.65 15.99 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 41.6 mt-10 -115.34 121.85 44.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.19 101.75 2.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.932 0.396 . . . . 0.0 110.666 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.59 -157.87 33.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.709 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 -26.82 73.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.59 14.8 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 -124.44 6.47 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.155 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -108.47 -22.55 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.896 0.379 . . . . 0.0 110.932 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.06 33.94 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.112 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.17 149.9 52.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.458 0.629 . . . . 0.0 110.182 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -105.78 134.53 48.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.3 tp -119.87 124.25 45.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.572 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.1 p80 -123.88 146.0 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.074 -175.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.62 105.01 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.941 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.615 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 41.8 mt-10 -74.78 -178.33 3.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.655 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -99.2 138.68 35.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.64 -1.46 60.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.957 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HE2' ' O ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -104.65 -173.95 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.612 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -127.99 -12.67 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.588 174.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.12 -173.41 13.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.898 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.66 149.78 26.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.661 0.267 . . . . 0.0 110.658 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -125.91 152.17 45.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.532 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.3 mm -70.57 122.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.691 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -91.7 -48.52 6.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.973 -177.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.534 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 2.8 tp -154.93 152.09 29.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.534 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 54.8 t -119.52 115.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.19 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 69.4 mm-40 -62.94 127.66 91.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 7.6 Cg_exo -69.77 109.72 2.38 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.215 1.943 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.91 28.76 4.88 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.507 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.436 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 96.7 p -115.18 161.38 29.85 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.712 0.291 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.541 ' HA ' ' HG2' ' A' ' 50' ' ' LYS . 38.6 Cg_endo -66.86 -13.41 39.83 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.132 2.555 . . . . 0.0 112.501 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HA ' HD23 ' A' ' 17' ' ' LEU . . . -65.67 -39.94 91.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.359 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.41 -46.98 74.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 47' ' ' PRO . 21.2 ptmt -61.12 -34.77 75.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.951 -174.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.04 -17.68 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 58.92 0.71 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.494 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.51 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.7 mp -120.11 126.31 50.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -127.84 166.6 17.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.3 0.571 . . . . 0.0 110.826 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.9 105.48 6.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.263 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.92 -24.73 2.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.175 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 27.8 m-20 -63.87 144.4 57.09 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -95.75 133.05 40.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HA ' HG11 ' A' ' 90' ' ' VAL . 28.9 tp -73.33 110.37 7.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.004 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -95.33 -45.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.073 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -143.59 149.78 37.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.602 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 67' ' ' VAL . 82.3 t -137.04 119.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.965 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.29 37.79 13.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.2 5.86 82.3 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.526 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' HG11 ' A' ' 67' ' ' VAL . 32.9 tt0 -126.09 128.75 47.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.17 0.485 . . . . 0.0 111.07 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -58.86 119.95 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.702 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 36.0 m -116.96 21.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.411 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.0 -14.89 61.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.86 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -122.69 19.01 10.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.964 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 21.6 mm-40 -92.0 -176.82 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.039 0.447 . . . . 0.0 111.202 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.557 ' O ' HG23 ' A' ' 75' ' ' VAL . 55.5 p -115.19 169.34 9.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.853 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.514 ' O ' HG21 ' A' ' 76' ' ' VAL . 29.4 t60 -55.1 -47.0 75.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.741 0.305 . . . . 0.0 110.263 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -65.6 -46.35 79.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.444 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -62.57 -40.64 97.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.45 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 71' ' ' THR . 15.9 m -70.18 -42.98 79.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.668 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 72' ' ' HIS . 71.3 t -58.64 -36.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.731 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.8 m -59.52 -40.15 86.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 110.184 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.21 -36.85 82.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.34 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 76' ' ' VAL . 74.0 mt -63.53 -38.04 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.659 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.2 mmt180 -71.82 -22.71 61.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.666 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.23 -19.28 63.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.374 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -82.06 127.89 33.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.85 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.62 -71.15 0.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.465 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -108.45 -17.66 13.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.353 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.501 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.276 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.4 146.64 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.604 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 98.6 mtt180 -98.68 119.88 38.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.205 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.7 mt -121.67 121.96 38.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.396 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.9 tp -102.42 118.27 36.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.231 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 23.8 m -128.59 153.49 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.612 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 150.17 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.483 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.8 116.16 45.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.446 174.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -58.07 -24.89 68.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.897 2.398 . . . . 0.0 112.277 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.31 -47.79 75.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.059 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 m -73.75 -38.83 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.488 . . . . 0.0 110.909 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 11.8 t70 -58.48 -32.16 68.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.78 -48.28 80.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.397 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -74.28 -40.14 62.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.015 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.84 -38.3 85.04 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 46.8 mt-30 -58.07 -35.9 72.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.417 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -72.66 -19.43 61.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 7' ' ' PRO . 16.2 mt -101.55 -35.09 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.3 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.79 86.21 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.956 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 106' ' ' VAL . 3.0 p -85.45 102.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.772 0.796 . . . . 0.0 111.942 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -126.71 49.18 2.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.109 0.957 . . . . 0.0 108.504 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.746 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 30.7 m -67.17 -13.42 16.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.063 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.629 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.59 -35.43 72.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -163.081 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 111' ' ' LEU . 22.5 tt0 -164.66 -22.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.191 0.52 . . . . 0.0 110.986 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -55.39 -45.57 76.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.526 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.16 -18.54 55.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 111.408 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 89' ' ' LEU . 73.3 mt -76.01 -30.64 58.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.228 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 112' ' ' ARG . 9.2 ptp85 -88.89 -31.49 18.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.834 0.35 . . . . 0.0 110.864 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.93 143.57 11.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -123.81 126.4 46.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.86 130.49 43.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.098 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 61.51 70.11 0.93 Allowed Pre-proline 0 C--O 1.233 0.229 0 O-C-N 124.231 0.957 . . . . 0.0 110.218 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.27 115.89 2.95 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.894 2.396 . . . . 0.0 112.585 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.37 40.73 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.008 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -107.71 -87.57 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.187 178.283 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mt -124.55 132.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 0.0 110.89 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.47 141.71 23.58 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.845 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.04 -21.88 68.12 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.109 2.539 . . . . 0.0 112.642 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.33 156.2 36.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.897 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.485 HG23 ' NE2' ' A' ' 98' ' ' GLN . 5.1 t -170.42 127.52 0.8 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.151 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.469 ' HB3' HG23 ' A' ' 95' ' ' THR . 26.1 ttt 43.9 64.03 1.41 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.902 0.751 . . . . 0.0 111.302 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -75.81 146.85 80.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 -176.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 1.074 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 55.2 Cg_endo -67.15 140.14 52.91 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 123.342 2.695 . . . . 0.0 112.274 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -113.71 140.68 48.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.967 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.53 105.01 12.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.514 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 56.3 m -96.09 113.07 24.65 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.891 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.32 115.98 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.151 0.501 . . . . 0.0 109.851 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 24' ' ' TYR . 15.1 mt -98.59 147.55 24.69 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.396 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -100.17 122.43 42.99 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -65.75 111.31 3.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.85 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.44 -160.5 36.54 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.889 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.44 -29.65 71.63 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.777 2.318 . . . . 0.0 112.417 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -113.19 31.99 6.05 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -116.0 4.13 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.215 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' HB3' HD13 ' A' ' 17' ' ' LEU . 45.8 m-85 -125.16 -25.67 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.985 0.393 . . . . 0.0 111.274 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.58 30.44 11.85 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.562 -0.828 . . . . 0.0 114.026 172.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -125.46 152.2 45.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.577 0.688 . . . . 0.0 110.051 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 51.1 m-70 -117.52 139.3 51.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.391 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.35 127.84 49.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.064 -169.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.54 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.0 p80 -116.55 133.54 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.34 6.79 42.66 Favored Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.989 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.797 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 11.7 mm-40 64.16 172.3 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.816 0.817 . . . . 0.0 112.708 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -125.14 101.26 6.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.296 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.69 -19.19 10.53 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.797 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -98.44 -177.24 3.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' N ' HD21 ' A' ' 35' ' ' LEU . 2.0 pt? -141.22 35.72 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.858 0.361 . . . . 0.0 110.952 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.94 155.72 24.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.833 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HG3' HG21 ' A' ' 75' ' ' VAL . 68.2 mm-40 -104.0 137.22 42.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.54 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 7.2 m-85 -134.07 152.9 52.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.729 0.3 . . . . 0.0 110.633 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.46 120.37 18.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -99.12 -26.81 14.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.598 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.6 tp -163.93 150.15 11.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.468 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.7 t -125.24 118.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.395 173.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 40.5 mm-40 -64.17 129.87 94.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.0 Cg_exo -69.3 123.11 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.075 1.85 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.44 20.58 26.85 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.593 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 90.7 p -104.17 159.3 29.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.87 -21.31 56.73 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.695 2.263 . . . . 0.0 111.887 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HA ' HD23 ' A' ' 17' ' ' LEU . . . -61.73 -38.78 89.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.151 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 21.3 mt-10 -71.08 -33.1 69.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.31 -36.69 77.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.41 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -80.44 -17.98 50.14 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.115 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 38.32 4.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.525 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.62 127.79 34.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 tp -121.02 141.48 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.67 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.62 102.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.331 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.9 -28.3 2.01 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.394 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.623 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 31.7 m-20 -62.23 139.41 58.5 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.57 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 42.7 ttp180 -89.75 132.68 35.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.53 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.2 tp -74.72 112.5 10.99 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.729 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.437 HG11 ' CD ' ' A' ' 68' ' ' GLU . 57.3 t -95.7 -44.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.24 -175.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.84 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -145.58 150.04 35.66 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.619 -175.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.605 HG21 HG13 ' A' ' 75' ' ' VAL . 92.3 t -137.13 116.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m120 62.2 30.38 17.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.471 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.52 7.01 58.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.553 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.5 tp10 -125.53 135.4 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.603 0.701 . . . . 0.0 111.684 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -67.25 117.16 8.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.822 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 75' ' ' VAL . 29.6 m -117.9 26.38 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' CD ' HG11 ' A' ' 60' ' ' VAL . 53.8 mt-10 -73.53 -19.7 60.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.836 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -122.06 21.48 10.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.599 0.714 . . . . 0.0 109.84 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -101.54 153.82 19.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.472 -177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.8 p -77.1 162.32 27.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.354 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -56.38 -42.31 77.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.85 0.357 . . . . 0.0 110.166 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.515 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.1 tt0 -66.66 -40.79 88.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.053 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 88.7 mt-30 -62.01 -39.97 94.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 0.0 110.669 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 62' ' ' VAL . 93.5 t -67.24 -50.44 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.324 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 73' ' ' GLN . 26.8 m -61.08 -35.34 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 111.631 -177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 t -57.99 -43.12 86.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 83.7 mtt-85 -64.55 -39.9 94.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.999 0.428 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.7 -33.13 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -73.13 -20.99 60.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.123 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.8 -17.57 55.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.809 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.76 30.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.9 -66.98 0.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.645 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -116.23 -19.43 10.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.452 . . . . 0.0 110.351 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 153.66 35.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.317 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -127.55 145.23 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -107.83 117.56 34.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.06 123.35 45.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.487 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HD23 ' A' ' 111' ' ' LEU . 37.8 tp -97.12 120.01 36.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 21.4 m -132.09 154.96 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.727 0.298 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.2 p -147.15 140.96 19.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.963 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.93 119.26 43.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.797 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 35.9 Cg_exo -59.33 -32.36 96.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.52 2.813 . . . . 0.0 113.018 -172.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.94 -37.46 69.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.848 0.356 . . . . 0.0 110.189 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 10' ' ' MET . 27.8 m -72.14 -38.61 69.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 173.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.92 -35.66 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.245 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 43.9 tt0 -58.23 -37.6 75.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.661 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 27.6 mt-30 -72.07 -48.82 41.35 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.3 mt -62.69 -35.79 80.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.511 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.71 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -64.1 -36.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.604 178.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 65.0 mmtt -71.04 -25.1 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.518 . . . . 0.0 109.837 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 14.8 mt -82.61 -10.25 59.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.747 -177.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.7 19.88 42.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.256 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -92.51 142.54 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.654 -0.321 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -116.91 98.16 6.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 1.074 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.3 m -65.7 -13.96 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.668 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 60.3 mtp180 -58.41 -29.53 66.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -167.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 9.2 tm-20 175.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -54.06 -38.36 65.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.244 0.545 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 11' ' ' LEU . 66.8 tp -77.38 -27.32 52.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.46 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.872 HD23 HD11 ' A' ' 89' ' ' LEU . 11.0 mp -71.76 -12.38 61.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.706 -175.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -73.18 -51.23 18.59 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.543 . . . . 0.0 110.284 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.24 69.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.475 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 26.9 pt20 -86.82 127.9 35.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.712 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.88 159.03 15.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.09 0.471 . . . . 0.0 110.975 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.9 115.13 27.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.004 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.22 112.01 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.982 2.454 . . . . 0.0 111.83 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -99.91 103.17 2.62 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.404 -174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.3 52.3 1.25 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.626 0.727 . . . . 0.0 109.758 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.029 -179.462 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.3 mt -117.15 134.47 60.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.636 ' OD2' ' HB ' ' A' ' 9' ' ' THR . 14.6 t0 -92.94 117.42 67.53 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.46 -28.41 86.66 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.327 2.685 . . . . 0.0 112.859 -171.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.64 146.19 6.86 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.636 ' HB ' ' OD2' ' A' ' 6' ' ' ASP . 2.5 t -163.29 136.59 5.67 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.687 ' HB2' HG21 ' A' ' 95' ' ' THR . 61.8 mtt 57.18 45.82 19.93 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.873 0.733 . . . . 0.0 109.676 176.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.25 145.62 89.93 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.643 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.991 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.6 Cg_endo -70.97 149.06 58.56 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.297 2.665 . . . . 0.0 112.647 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -119.2 142.58 47.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 89' ' ' LEU . 58.9 tp -82.64 108.6 16.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.9 m -108.75 118.86 37.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.217 -169.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -95.04 133.86 38.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.016 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -133.91 153.46 51.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.721 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -100.34 151.4 21.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 0.0 110.349 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' CG ' ' HA2' ' A' ' 23' ' ' GLY . 34.6 ttpt -87.85 115.11 25.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.834 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.45 -154.12 29.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.303 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.9 -29.58 58.07 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.278 2.652 . . . . 0.0 111.96 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.67 28.47 8.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.294 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 19' ' ' LYS . . . 82.1 -146.38 25.19 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.708 -177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 17' ' ' LEU . 85.0 m-85 -93.29 -22.88 18.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.959 0.38 . . . . 0.0 111.234 -176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 30.1 22.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.216 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -131.03 157.45 42.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.212 0.506 . . . . 0.0 109.959 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.429 ' CD2' HD22 ' A' ' 41' ' ' LEU . 84.8 m-70 -127.26 145.11 50.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.4 tp -122.92 137.18 55.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.773 0.321 . . . . 0.0 111.776 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.432 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 2.9 p80 -133.25 140.29 47.42 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.06 2.42 20.98 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 58.25 -169.3 0.12 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.709 0.403 . . . . 0.0 111.094 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -131.56 133.2 44.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.2 -21.13 46.96 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -86.32 173.61 9.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.4 pt? -130.98 16.52 5.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.24 161.94 25.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.711 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 34.9 mm-40 -103.3 145.36 30.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.404 . . . . 0.0 110.304 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.9 m-85 -128.73 150.94 50.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.722 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -70.7 125.16 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -91.7 -36.33 13.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 14.6 tp -164.08 148.33 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -125.01 118.72 53.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.169 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -63.9 128.34 92.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.462 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.78 127.73 22.37 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.302 2.001 . . . . 0.0 112.557 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.04 75.13 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.192 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.498 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 87.7 p -84.6 164.47 42.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.814 0.307 . . . . 0.0 110.583 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 12.3 Cg_endo -57.71 -26.32 72.48 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.555 2.17 . . . . 0.0 112.176 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HA ' HD11 ' A' ' 17' ' ' LEU . . . -65.29 -31.8 73.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.74 -28.55 65.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.12 -37.07 84.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 110.119 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -78.96 -17.31 55.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.235 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.7 29.67 7.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.0 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 51' ' ' ALA . 11.1 mp -84.56 138.0 32.99 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.682 -0.305 . . . . 0.0 110.514 177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.3 tt -145.59 143.13 29.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -59.56 103.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.293 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -31.63 1.57 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.717 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 14.7 m-20 -61.54 141.49 57.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -89.36 124.99 34.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.394 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.54 ' HA ' HG12 ' A' ' 90' ' ' VAL . 48.2 tp -78.39 112.46 15.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.893 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 ' HG ' ' A' ' 89' ' ' LEU . 5.0 m -105.94 -26.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.792 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -146.41 150.64 36.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.778 0.323 . . . . 0.0 111.21 175.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.66 HG23 HG13 ' A' ' 75' ' ' VAL . 62.1 t -136.39 113.81 13.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 57.0 41.3 27.86 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.528 0.517 . . . . 0.0 112.344 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.85 -8.38 59.6 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.359 171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.413 ' CD ' HH12 ' A' ' 78' ' ' ARG . 44.2 tt0 -126.36 128.62 47.35 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.127 0.963 . . . . 0.0 109.613 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 27.0 m120 -69.53 135.13 49.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.235 -174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 23.1 m -118.91 24.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.922 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 8.0 mt-10 -54.84 -33.15 61.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.508 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HE3' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -131.48 21.06 4.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.71 -175.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 1.4 mp0 -98.15 161.56 13.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.118 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.1 p -89.54 165.13 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.728 -172.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.444 ' O ' HG22 ' A' ' 76' ' ' VAL . 65.3 t60 -58.62 -46.62 86.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.95 -41.48 96.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.843 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 98.2 mt-30 -63.57 -43.78 96.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 62' ' ' VAL . 94.1 t -63.7 -46.2 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.419 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 72' ' ' HIS . 95.5 t -59.94 -39.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 0.0 110.991 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 m -58.45 -38.13 76.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 86.6 mtt-85 -61.73 -34.61 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.331 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.91 -31.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 -177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -69.88 -22.67 63.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 110.731 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.76 62.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.109 0.481 . . . . 0.0 110.07 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -72.32 121.09 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.837 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.78 -61.27 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.703 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.48 -7.26 4.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.23 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.41 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.78 154.48 36.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.513 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.499 HG13 ' CE1' ' A' ' 24' ' ' TYR . 11.2 p -130.65 144.59 37.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -101.55 117.63 35.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 17' ' ' LEU . 98.5 mt -119.9 123.23 43.09 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.792 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 45.0 tp -101.9 118.32 36.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.587 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 59' ' ' LEU . 28.5 m -131.36 158.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.0 p -135.11 144.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.703 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.16 126.71 61.87 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.624 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 57' ' ' ASP . 19.9 Cg_endo -58.7 -40.18 75.52 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.714 2.942 . . . . 0.0 113.929 -170.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 95' ' ' THR . 8.3 pt-20 -72.35 -39.86 67.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 10' ' ' MET . 1.8 m -71.76 -36.51 70.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' HG13 ' A' ' 91' ' ' VAL . 6.7 t70 -56.88 -43.89 81.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.707 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 32.5 mt-10 -67.92 -36.42 80.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.686 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.22 -39.17 60.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.443 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 102' ' ' LEU . 53.6 mt -67.41 -31.95 72.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 23.6 pt20 -56.62 -36.71 69.77 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -172.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.44 -20.08 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.691 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.456 HD11 HD22 ' A' ' 99' ' ' LEU . 55.7 mt -84.02 -40.11 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.242 0.544 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.56 0.52 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.412 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.578 HG21 HH21 ' A' ' 107' ' ' ARG . 18.6 m -85.09 41.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.825 0.821 . . . . 0.0 110.427 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -83.44 5.31 24.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.197 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.991 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 2.5 m -65.12 -15.71 18.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.197 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.578 HH21 HG21 ' A' ' 104' ' ' VAL . 27.7 mtt180 -59.65 -32.19 70.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.027 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 51.0 tt0 171.65 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.703 0.627 . . . . 0.0 109.363 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -55.67 -51.84 65.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.629 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.8 tp -60.19 -30.14 69.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.773 0.321 . . . . 0.0 110.602 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.46 -26.29 62.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.382 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -63.05 -32.5 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.544 0.688 . . . . 0.0 109.849 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 67.73 44.54 1.61 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.444 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.582 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -71.52 0.74 7.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.406 -177.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -105.81 150.0 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.553 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 60.22 74.48 0.55 Allowed Pre-proline 0 C--O 1.235 0.332 0 O-C-N 123.962 0.789 . . . . 0.0 111.344 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.31 111.64 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.941 2.427 . . . . 0.0 111.762 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.93 -29.51 58.93 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.456 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.26 -86.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.587 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.0 mm -83.72 137.14 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.18 127.65 93.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.28 -20.03 32.89 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 123.101 2.534 . . . . 0.0 111.653 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.95 147.0 26.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.544 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -157.26 122.67 4.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.981 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt 62.74 65.54 0.82 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.708 0.766 . . . . 0.0 109.991 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.59 138.09 47.7 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.807 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.988 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 66.5 Cg_endo -72.83 171.15 17.98 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.171 2.58 . . . . 0.0 113.653 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 156.56 46.82 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.694 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' ' 111' ' ' LEU . 32.8 tp -83.99 117.91 23.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 m -94.53 111.22 22.98 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.8 p -100.69 111.09 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 110.195 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -116.6 146.61 42.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.408 -177.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.14 141.6 44.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.1 -170.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.0 ttmt -68.07 119.57 12.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.926 0.393 . . . . 0.0 111.201 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.1 -149.32 25.34 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.267 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.62 -27.27 45.67 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.947 2.432 . . . . 0.0 112.468 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -132.86 53.03 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 0.0 110.497 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 79.14 -121.6 5.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.441 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' HD11 ' A' ' 17' ' ' LEU . 97.6 m-85 -123.15 -27.74 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.38 29.31 9.6 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.322 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -141.1 143.2 34.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.308 0.554 . . . . 0.0 110.328 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -129.68 143.46 50.83 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.91 150.05 32.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.978 -173.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.489 ' HD2' ' O ' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -134.73 144.01 47.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.325 176.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.43 114.94 3.93 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.77 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.625 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 38.5 mt-10 -55.58 125.45 21.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -67.42 133.95 50.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.34 -15.41 63.02 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.722 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -100.91 178.33 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -129.93 25.29 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.46 166.61 25.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.857 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -104.24 136.91 42.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 0.0 110.594 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.489 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 89.3 m-85 -121.43 157.36 30.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.544 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.0 mm -71.35 114.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -85.19 -43.14 14.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.2 tp -149.37 141.95 24.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.415 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.84 114.51 46.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -70.73 112.93 14.84 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 14.0 Cg_endo -58.32 121.55 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 112.232 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.96 13.78 26.43 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.082 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.489 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 89.8 p -103.91 160.22 26.8 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 37.1 Cg_endo -66.46 -16.19 50.29 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.803 2.335 . . . . 0.0 112.106 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 53' ' ' LEU . . . -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.117 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 42.2 mt-10 -63.06 -43.64 98.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.6 mttm -62.72 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.31 -19.66 31.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.269 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 44.36 1.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' A' ' 48' ' ' ALA . 85.0 mt -102.67 146.95 27.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 174.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tt -145.96 143.62 29.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.77 101.48 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.4 -25.41 1.85 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.97 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 71.0 m-20 -75.28 148.56 39.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -92.74 133.57 35.9 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.445 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.503 ' HA ' HG13 ' A' ' 90' ' ' VAL . 40.7 tp -75.91 107.12 7.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.648 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.873 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 47.2 t -95.31 -33.96 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -175.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -147.09 150.55 35.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 0.0 111.008 -178.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG22 HG21 ' A' ' 67' ' ' VAL . 81.3 t -136.58 113.83 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.096 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.46 33.27 20.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.077 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.65 16.13 60.55 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.859 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -123.87 135.23 53.61 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.591 -0.358 . . . . 0.0 110.617 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.55 114.75 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.663 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.601 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 17.4 m -128.47 11.53 2.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -172.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.873 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -72.34 -21.7 61.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.768 -174.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 33.8 mtmm -110.23 18.21 20.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.215 174.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.601 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 36.9 mm-40 -97.3 175.57 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.314 0.578 . . . . 0.0 111.97 -176.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.4 p -89.58 173.98 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.073 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.499 ' O ' HG22 ' A' ' 76' ' ' VAL . 61.8 t60 -65.31 -44.43 87.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 175.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.79 -39.29 90.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.703 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 11.1 mm-40 -61.39 -45.82 92.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.05 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 79' ' ' ILE . 18.6 m -68.68 -45.15 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.369 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 72' ' ' HIS . 80.2 t -54.7 -43.77 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.994 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -60.27 -41.26 92.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 75.1 mtt-85 -69.18 -36.23 77.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.189 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.1 mt -62.26 -42.19 94.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 7.8 mpt_? -64.89 -20.79 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.16 64.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.65 0.262 . . . . 0.0 111.507 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.48 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.27 142.29 54.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.308 0.575 . . . . 0.0 110.746 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 -56.55 4.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.884 -175.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.87 -28.75 3.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.8 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -146.18 143.42 29.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.359 -172.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG11 ' CB ' ' A' ' 82' ' ' ALA . 3.2 m -109.56 158.4 9.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.142 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.26 119.21 38.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 86' ' ' VAL . 88.2 mt -119.7 128.54 53.9 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.902 0.382 . . . . 0.0 110.831 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 15.6 tp -106.46 121.8 45.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.978 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.503 HG13 ' HA ' ' A' ' 59' ' ' LEU . 26.7 m -131.69 155.29 41.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.05 0.452 . . . . 0.0 110.983 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.79 150.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.074 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 18.3 t70 -64.5 120.51 66.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 32.9 Cg_exo -60.89 -29.46 88.15 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.448 2.765 . . . . 0.0 113.208 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.8 -47.87 50.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 20.3 m -66.24 -37.18 84.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 22.0 t70 -58.5 -36.14 73.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.61 -48.16 81.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.8 pt20 -71.63 -38.79 70.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.47 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.83 -33.87 73.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.749 0.309 . . . . 0.0 110.926 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 67.3 mt-30 -57.86 -41.61 82.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.927 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -71.12 -21.26 62.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.982 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.38 -43.03 8.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.369 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.2 84.69 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -66.85 90.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 122.228 1.013 . . . . 0.0 111.834 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 23.7 mt-30 -103.14 22.1 14.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.16 177.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.988 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.9 m -66.0 -18.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.582 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.38 -33.73 76.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -170.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -179.68 -27.83 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.104 0.478 . . . . 0.0 109.995 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 5.0 mm-40 -55.74 -40.95 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.312 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 52.8 mt -78.72 -17.48 55.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 111.898 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 89' ' ' LEU . 7.9 mp -79.9 -12.61 59.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -96.83 -60.85 1.51 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.334 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.0 143.84 23.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 111.714 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -84.58 99.33 10.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.938 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.81 80.58 2.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.926 0.869 . . . . 0.0 111.382 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -177.96 72.38 0.22 Allowed Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.83 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.4 71.8 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.063 2.509 . . . . 0.0 112.385 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.47 -45.41 4.34 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.04 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -64.22 -35.73 81.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.011 179.371 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.93 133.73 60.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.18 122.9 42.55 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.433 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.57 -26.97 11.31 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.582 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 104' ' ' VAL . 7.3 m-85 -149.01 150.88 33.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 t -172.16 101.98 0.17 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.875 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.1 tpt 69.42 64.06 0.27 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -172.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.579 HD22 ' H ' ' A' ' 11' ' ' LEU . 2.7 pt? -80.15 160.1 69.03 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.933 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.865 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 73.7 Cg_endo -73.35 165.76 31.71 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.768 2.312 . . . . 0.0 113.049 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' HA ' HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -143.16 146.19 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 111' ' ' LEU . 47.0 tp -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -93.66 115.89 28.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.45 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 m -103.97 111.24 23.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.808 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -117.21 154.63 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.845 -177.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -111.59 136.51 50.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 38.9 ttmt -67.27 131.09 45.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.341 0.591 . . . . 0.0 111.928 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.86 -148.74 10.45 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.618 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.27 -2.67 12.72 Favored 'Trans proline' 0 N--CA 1.472 0.209 0 C-N-CA 123.157 2.572 . . . . 0.0 112.444 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -128.08 22.22 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.235 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 77.28 -106.11 2.17 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 -172.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CZ ' HG13 ' A' ' 86' ' ' VAL . 84.0 m-85 -127.79 -15.93 4.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.1 0.45 . . . . 0.0 111.332 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.19 32.57 43.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.102 -0.57 . . . . 0.0 114.078 173.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.26 151.79 50.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.618 0.709 . . . . 0.0 110.225 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.468 ' CD2' HD21 ' A' ' 41' ' ' LEU . 26.1 m-70 -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 37' ' ' GLN . 14.1 mt -118.45 151.36 37.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.106 0.479 . . . . 0.0 111.809 -177.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.557 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.6 p80 -130.86 144.84 51.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.67 108.65 3.04 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 33.4 mm-40 -71.51 125.0 25.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.073 0.464 . . . . 0.0 110.176 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.05 133.75 52.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.107 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.6 -28.22 11.82 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.819 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 12.1 mptt -93.13 -32.75 14.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.837 0.351 . . . . 0.0 111.383 -177.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt 74.65 -50.32 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.578 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.61 157.95 8.14 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.683 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HB3' HD21 ' A' ' 28' ' ' LEU . 35.8 mm-40 -102.09 144.64 30.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.033 0.445 . . . . 0.0 110.11 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.557 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 19.5 m-85 -122.53 152.15 40.65 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mm -70.83 108.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -81.12 -42.9 20.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 27' ' ' HIS . 22.9 tp -147.31 145.27 29.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.162 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -135.76 120.96 28.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -63.99 126.07 89.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.59 -172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.52 109.06 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.316 2.011 . . . . 0.0 111.721 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.84 12.91 21.46 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.987 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.411 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 88.1 p -91.57 159.4 38.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.7 Cg_endo -69.07 -13.66 36.83 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.555 2.17 . . . . 0.0 112.355 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -67.51 -45.45 75.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.726 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.71 -39.14 83.64 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.39 0.614 . . . . 0.0 110.207 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -75.96 -11.17 59.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.399 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -91.07 -17.61 25.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.105 0.479 . . . . 0.0 110.237 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.75 53.05 0.72 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.2 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.31 114.74 16.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.466 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.8 tp -118.0 162.12 18.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.06 43.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.961 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.22 5.6 0.32 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.416 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.9 m-20 -91.1 146.6 23.71 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.597 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 41.0 ttp180 -99.78 130.33 45.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.554 ' HA ' HG12 ' A' ' 90' ' ' VAL . 41.7 tp -77.71 109.16 11.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.216 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.68 -42.84 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.11 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -144.21 150.84 38.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 0.0 110.427 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.612 HG23 HG13 ' A' ' 75' ' ' VAL . 61.3 t -135.78 107.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.238 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 58.74 39.06 24.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.129 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.68 35.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.718 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.89 136.68 54.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.298 1.049 . . . . 0.0 111.826 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -67.95 115.72 7.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.535 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.536 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 29.0 m -102.57 18.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -67.3 -16.7 64.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.336 0.588 . . . . 0.0 111.211 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -122.5 22.29 9.98 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.947 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 33.9 mm-40 -105.07 -173.62 2.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.1 p -117.16 173.93 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.1 t60 -60.49 -47.06 87.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.872 0.368 . . . . 0.0 110.153 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.71 -44.76 89.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.823 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 51.3 mt-30 -63.89 -41.32 97.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG13 HG23 ' A' ' 62' ' ' VAL . 55.1 t -62.79 -44.99 99.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.133 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 72' ' ' HIS . 96.9 t -61.15 -38.68 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -60.13 -38.21 82.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 110.402 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 77.0 mtt-85 -68.48 -36.04 78.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.697 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.6 -35.82 75.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.163 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 40.0 mmt180 -68.6 -21.96 64.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.98 95.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.619 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -77.2 132.79 38.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.299 0.571 . . . . 0.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.47 -68.05 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.41 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -110.87 -16.66 13.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.43 134.98 17.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.542 HG13 ' CZ ' ' A' ' 24' ' ' TYR . 3.2 m -110.68 158.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.5 ' HD3' HD21 ' A' ' 14' ' ' LEU . 62.5 mtt180 -112.58 114.63 27.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.561 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HG ' HG23 ' A' ' 86' ' ' VAL . 71.2 mt -118.72 119.33 34.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.831 0.348 . . . . 0.0 110.773 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 111' ' ' LEU . 21.7 tp -94.53 124.11 38.36 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.2 m -132.58 155.16 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.928 0.394 . . . . 0.0 111.412 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.0 p -139.24 144.32 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.345 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.11 116.97 28.67 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.597 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 34.5 Cg_exo -58.17 -24.95 69.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.959 2.44 . . . . 0.0 112.243 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.21 -47.06 68.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.01 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.49 HG21 ' HG ' ' A' ' 99' ' ' LEU . 90.3 m -72.02 -38.39 69.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.87 -31.19 66.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.187 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -57.38 -45.68 84.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.699 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 1.9 mp0 -72.42 -48.1 43.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 110.394 175.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.596 ' HB3' HG23 ' A' ' 104' ' ' VAL . 22.7 mt -59.72 -40.87 89.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.482 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -59.5 -38.64 81.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -75.13 -19.91 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.124 0.488 . . . . 0.0 110.337 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 50.0 mt -83.48 -6.57 59.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.72 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.14 41.45 39.3 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.662 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 99' ' ' LEU . 14.9 m -90.23 169.16 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 111.504 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -125.17 83.23 2.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.077 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.865 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 8.5 m -67.5 -17.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.9 ttm180 -60.63 -44.68 96.06 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -168.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.505 ' HA ' HD13 ' A' ' 111' ' ' LEU . 31.2 tt0 -161.25 -18.75 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.985 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.84 -47.37 74.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 111.603 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.79 -18.18 56.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 89' ' ' LEU . 38.0 mt -81.61 -22.42 37.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.802 0.81 . . . . 0.0 108.969 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.73 -51.97 5.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.296 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -95.88 86.62 4.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.805 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -120.5 57.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -111.21 156.25 21.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.608 -169.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.01 109.04 45.33 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.551 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.71 90.69 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.67 2.246 . . . . 0.0 112.544 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.6 179.07 41.26 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.566 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 63.08 20.72 12.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 112.248 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.745 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.158 179.07 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 CA--C 1.513 -0.542 0 CA-C-O 121.256 0.44 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.463 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 9.0 m-85 -148.04 151.94 36.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.241 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 t -170.38 126.37 0.77 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.994 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt 47.86 60.98 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.714 0.634 . . . . 0.0 110.572 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.849 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.55 164.61 59.67 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.29 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HG3' HG13 ' A' ' 106' ' ' VAL . 18.1 Cg_endo -56.63 161.48 9.84 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.754 2.97 . . . . 0.0 113.099 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -144.27 127.27 16.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.127 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 tp -84.08 106.34 15.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 30.7 m -96.47 114.7 26.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.54 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.8 m -98.97 111.78 24.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -121.38 153.49 37.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.467 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.59 147.45 30.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.139 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.82 117.92 20.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.382 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.41 -151.43 20.29 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.041 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.08 -17.3 36.21 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.987 2.458 . . . . 0.0 113.238 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -119.88 30.21 7.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.202 0.525 . . . . 0.0 110.626 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.89 -122.0 5.73 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.5 m-85 -110.73 -13.79 14.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.431 0.616 . . . . 0.0 111.18 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 80.32 32.89 33.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.438 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.52 152.05 46.63 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.419 -0.46 . . . . 0.0 109.976 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.8 m-70 -112.18 125.36 54.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.77 131.52 54.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -138.45 151.19 47.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.015 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.21 6.16 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.17 133.14 44.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.873 0.368 . . . . 0.0 111.523 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.96 138.51 55.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.511 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.31 -44.23 2.48 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.638 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.76 173.15 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -129.9 35.81 4.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.299 0.571 . . . . 0.0 110.456 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.94 167.51 25.62 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.844 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.631 ' HG3' HG21 ' A' ' 75' ' ' VAL . 36.4 mm-40 -103.66 146.03 29.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.705 0.288 . . . . 0.0 110.379 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.43 152.35 51.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.6 mm -70.76 113.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 3.6 tmm_? -86.94 -39.91 15.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 110.086 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 46.2 tp -153.39 143.97 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.69 116.23 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.32 111.13 10.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.66 119.46 6.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 112.346 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.71 30.32 Favored Glycine 0 C--N 1.316 -0.561 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.165 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 79.9 p -95.76 160.22 30.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.985 0.421 . . . . 0.0 111.281 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.27 -17.56 58.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.841 2.361 . . . . 0.0 112.138 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.19 -38.34 90.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.75 -38.97 92.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.046 0.45 . . . . 0.0 110.007 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -64.36 -32.51 74.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.652 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.21 -18.16 53.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.97 37.8 4.82 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.989 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 48' ' ' ALA . 98.3 mt -91.04 130.14 36.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.89 0.345 . . . . 0.0 110.162 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 tt -126.84 141.63 51.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.06 95.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 111.225 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.12 -26.65 1.13 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.485 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 70.2 m-20 -63.71 139.07 58.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.714 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -85.1 132.23 34.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.303 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 54.9 tp -76.26 117.12 17.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.554 ' HB ' HD12 ' A' ' 89' ' ' LEU . 57.9 t -103.47 -36.2 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.274 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 8.7 tt0 -152.01 151.49 31.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 111.142 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.66 116.85 44.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.453 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.1 m120 68.61 -60.9 0.42 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.281 1.033 . . . . 0.0 111.059 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.26 26.89 0.07 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -125.79 129.01 48.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -68.34 125.25 25.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.272 0.358 . . . . 0.0 111.044 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' HG12 ' A' ' 75' ' ' VAL . 29.8 m -127.7 24.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.461 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' HG2' HG13 ' A' ' 60' ' ' VAL . 53.5 mt-10 -53.08 -47.52 68.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.951 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -111.0 9.47 22.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.223 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.27 157.73 19.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.457 0.646 . . . . 0.0 112.088 -171.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -85.56 169.06 13.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.909 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 64.3 t60 -56.74 -45.55 81.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.928 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -65.85 -38.61 89.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 111.057 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.07 -38.79 86.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.489 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG21 ' HG3' ' A' ' 37' ' ' GLN . 29.3 m -70.26 -43.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.442 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.9 t -54.69 -42.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.4 m -60.07 -40.65 90.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -68.52 -35.85 78.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.458 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 75' ' ' VAL . 83.7 mt -62.77 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.7 mmt180 -61.53 -23.22 65.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.86 -6.99 53.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.16 117.16 17.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.96 -60.13 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -129.61 -20.04 3.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.75 145.96 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.042 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 24' ' ' TYR . 14.5 p -116.82 141.81 33.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.128 0.49 . . . . 0.0 110.407 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 95.8 mtt180 -101.92 117.02 33.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.807 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.493 HD12 HD11 ' A' ' 53' ' ' LEU . 92.6 mt -112.75 118.96 36.43 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 1.6 tm? -93.48 116.55 29.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 35.4 m -134.02 154.15 37.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.158 0.504 . . . . 0.0 111.338 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.4 p -148.73 150.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.181 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.08 125.46 74.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 109.973 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.67 -38.36 94.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.921 3.081 . . . . 0.0 113.905 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.75 -39.15 80.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.098 0.475 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 17.4 m -71.33 -36.52 71.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.303 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 8.9 t70 -56.97 -45.87 82.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 57.2 mt-10 -65.85 -39.36 90.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 95' ' ' THR . 21.0 pt20 -72.38 -39.85 67.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.535 HD13 HD11 ' A' ' 110' ' ' LEU . 53.4 mt -70.43 -34.04 72.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.72 0.295 . . . . 0.0 110.746 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 49.0 mt-30 -66.05 -34.46 78.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.619 0.247 . . . . 0.0 110.825 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.5 mttp -61.92 -19.07 62.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.01 -9.81 57.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.71 11.48 63.77 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.175 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.463 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -92.91 138.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 0.0 111.102 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 20.7 mp0 -77.95 98.45 5.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.407 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 12' ' ' PRO . 67.0 t -66.18 -22.38 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.08 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -59.89 -35.36 74.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -173.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 111' ' ' LEU . 65.4 tt0 -165.86 -40.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.94 0.4 . . . . 0.0 110.989 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.805 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 30.4 mm-40 -55.74 -30.83 61.87 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 99' ' ' LEU . 2.1 tt -65.44 -40.26 93.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.137 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 108' ' ' GLU . 6.0 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 110.387 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' HD13 ' A' ' 102' ' ' LEU . 18.3 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 CA-C-O 120.955 0.315 . . . . 0.0 111.825 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 38.0 m-85 -152.59 149.21 28.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.475 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -160.37 -43.51 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.201 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.425 ' HB3' HG21 ' A' ' 95' ' ' THR . 15.0 tpt -139.82 90.89 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.807 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.69 157.84 83.61 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.819 -177.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.048 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 57.9 Cg_endo -67.72 149.56 78.85 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.067 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.492 HH21 ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.93 128.25 48.33 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.187 178.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.78 107.27 16.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 67.5 m -94.02 111.47 23.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' HH11 ' A' ' 87' ' ' ARG . 4.3 p -98.62 110.79 23.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.069 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.4 156.37 32.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.393 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.74 138.7 49.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 35.2 ttpt -71.55 124.64 25.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.914 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.15 -162.2 35.41 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.31 -28.84 87.62 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.989 2.459 . . . . 0.0 112.711 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -122.41 40.89 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.902 0.382 . . . . 0.0 110.681 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 84.21 -144.2 21.56 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.363 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.8 m-85 -101.66 -25.62 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.84 32.82 12.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.739 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -127.46 141.26 51.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.457 0.629 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.47 ' C ' ' HB3' ' A' ' 40' ' ' ARG . 30.4 m-70 -100.94 144.69 29.58 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 37' ' ' GLN . 21.0 tp -124.82 137.25 54.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.118 0.261 . . . . 0.0 110.541 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -138.47 149.35 45.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.65 117.31 3.47 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.9 137.61 43.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.03 100.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.827 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.11 -38.27 1.62 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.5 -179.24 7.11 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.509 -0.845 . . . . 0.0 109.043 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.58 21.27 2.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 110.449 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.1 176.38 18.44 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' A' ' 75' ' ' VAL . 35.0 mm-40 -104.14 143.51 32.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.076 0.465 . . . . 0.0 110.89 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.91 156.72 41.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.884 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 55' ' ' ALA . 31.7 mm -70.39 120.51 18.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.979 0.418 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB3' ' C ' ' A' ' 27' ' ' HIS . 0.5 OUTLIER -93.52 -47.96 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -173.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.5 tm? -158.57 140.12 13.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' N ' HD13 ' A' ' 41' ' ' LEU . 48.2 t -117.63 115.74 49.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.21 130.99 89.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.2 127.46 18.4 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.008 1.806 . . . . 0.0 111.892 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.92 28.69 40.96 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.58 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.8 p -102.36 162.3 20.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 122.674 -0.31 . . . . 0.0 110.811 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 18.6 Cg_endo -62.31 -23.5 75.28 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.467 2.112 . . . . 0.0 112.23 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.45 -41.73 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.305 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -59.92 -43.58 94.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.756 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -59.6 -37.35 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.7 -11.79 59.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.056 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.11 31.89 15.87 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.146 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.34 104.54 11.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.0 140.97 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.366 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . . . -70.79 106.88 3.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.806 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.43 -16.5 3.83 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.553 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -73.73 146.39 44.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 0.0 110.859 176.112 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -91.26 127.39 36.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.8 tp -77.8 109.84 12.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.727 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -99.11 -32.87 3.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.468 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -147.71 149.72 32.96 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.407 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 75' ' ' VAL . 96.8 t -136.67 116.55 16.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.325 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 64.53 26.28 13.32 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.649 0.738 . . . . 0.0 110.683 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.36 16.03 59.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.366 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.547 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 8.9 tp10 -124.74 133.08 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.16 128.45 36.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.675 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 75' ' ' VAL . 35.7 m -123.63 26.83 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.56 -27.31 64.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.661 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -118.12 14.0 13.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.386 0.612 . . . . 0.0 109.583 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -96.47 146.51 24.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.19 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.1 p -81.28 178.04 8.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 57.3 t60 -58.02 -46.35 85.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.148 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.61 -42.88 91.1 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 57.9 mt-30 -61.49 -41.14 96.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 67' ' ' VAL . 94.5 t -71.42 -44.61 71.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 25.4 t -54.57 -45.26 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.66 0.267 . . . . 0.0 111.611 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -59.93 -37.02 78.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.944 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.2 mtt-85 -68.3 -37.03 80.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.598 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 75' ' ' VAL . 68.7 mt -64.77 -35.47 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mpt_? -73.34 -20.57 60.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.28 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 134.79 40.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.286 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.63 -70.74 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.579 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -112.57 -19.73 11.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.847 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.16 145.08 26.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.44 149.41 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.955 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.469 HH11 ' HB2' ' A' ' 16' ' ' CYS . 22.1 mmt180 -108.88 113.19 25.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.445 HD12 HD21 ' A' ' 17' ' ' LEU . 74.9 mt -109.38 118.62 37.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.683 0.278 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.1 tp -93.82 122.22 36.07 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.6 m -133.34 154.6 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.416 0.627 . . . . 0.0 111.431 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.09 145.14 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.327 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.01 122.06 45.03 Favored Pre-proline 0 C--O 1.225 -0.237 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.2 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.579 -172.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.97 -38.97 66.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 19.4 m -70.03 -37.87 75.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.27 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.76 -39.29 77.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.33 -49.2 78.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.445 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.668 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 pt20 -72.97 -46.69 50.92 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.653 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 95' ' ' THR . 29.6 mt -62.33 -43.77 98.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 111.537 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -67.75 -36.6 80.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.874 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -70.24 -23.04 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 96.3 mt -71.79 -22.28 61.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.38 19.94 8.11 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.464 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -107.07 134.76 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.82 102.66 13.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.827 0.822 . . . . 0.0 110.925 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.048 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 14.8 m -65.2 -13.33 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.608 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -58.36 -31.36 67.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -167.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -171.14 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.415 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -54.4 -42.07 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' O ' HD22 ' A' ' 110' ' ' LEU . 1.8 tm? -60.09 -29.18 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.545 -177.305 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.46 -0.47 0 CA-C-O 121.075 0.365 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.574 ' HB3' HD12 ' A' ' 11' ' ' LEU . 29.3 m-85 -148.61 154.04 39.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.326 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -172.52 123.58 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.687 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.57 61.09 2.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.89 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.0 140.43 96.05 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.578 -169.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 19.4 Cg_endo -61.62 159.28 33.06 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.024 2.483 . . . . 0.0 111.524 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -143.07 156.64 44.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.133 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -84.21 114.17 21.62 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.717 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.9 m -93.55 107.76 19.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.09 111.71 23.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.971 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.7 148.68 39.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 85' ' ' ALA . 32.8 mt-10 -122.92 129.31 51.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.161 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.9 ttmt -54.94 126.42 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.625 -170.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.7 12.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.378 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.32 -19.56 13.24 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.545 2.163 . . . . 0.0 112.701 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -124.23 27.15 7.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.261 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 89.72 -114.6 4.38 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.562 -175.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.7 m-85 -123.89 -22.9 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.238 0.519 . . . . 0.0 111.642 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.73 33.83 23.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.966 171.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -132.66 142.63 49.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.396 0.598 . . . . 0.0 110.086 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 41' ' ' LEU . 29.3 m-70 -111.32 131.69 54.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.5 tp -101.96 144.4 30.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.299 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.435 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 3.1 p80 -141.69 153.05 44.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.916 0.388 . . . . 0.0 111.259 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.74 125.87 4.9 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.522 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.21 -175.77 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.896 0.379 . . . . 0.0 110.431 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -109.5 135.62 50.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.987 0.422 . . . . 0.0 110.133 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.83 15.49 57.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.5 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 -174.38 2.51 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.741 0.305 . . . . 0.0 110.365 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.1 pt? -125.4 -33.53 2.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.621 172.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.9 177.8 21.24 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.587 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -104.99 155.13 19.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -130.73 153.21 49.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 0.0 110.577 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 mm -71.58 123.54 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.633 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HG2' ' CG ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.6 -45.91 8.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.0 tm? -150.67 140.88 22.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 41' ' ' LEU . 96.6 t -122.14 116.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.487 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -58.8 126.78 81.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -63.4 115.44 3.02 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.035 1.824 . . . . 0.0 111.972 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . 84.76 41.76 7.55 Favored Glycine 0 C--N 1.317 -0.517 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.536 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 77.3 p -112.23 168.06 8.23 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' A' ' 24' ' ' TYR . 10.2 Cg_endo -56.07 -30.38 78.5 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.241 1.961 . . . . 0.0 112.313 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -61.7 -38.66 88.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 0.0 110.332 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 45' ' ' GLY . 6.9 mm-40 -62.03 -39.35 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.462 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.2 mttm -64.61 -29.39 70.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.044 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -88.24 -17.88 29.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.32 35.79 5.37 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.926 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.1 mt -92.67 138.95 31.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.6 tp -145.87 153.2 40.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.874 0.369 . . . . 0.0 110.716 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.54 104.58 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.035 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.31 -30.01 2.46 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.902 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 14.1 m-20 -63.23 136.15 57.54 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.004 0.43 . . . . 0.0 110.664 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -87.79 128.71 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.361 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 90' ' ' VAL . 58.5 tp -80.23 121.31 25.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.123 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 89' ' ' LEU . 50.0 t -105.53 -42.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.585 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.1 tt0 -144.75 151.63 39.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.836 0.35 . . . . 0.0 111.181 -177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 66.0 t -132.31 114.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.323 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.08 36.29 27.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.418 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.09 1.83 59.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.134 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 8.6 tp10 -125.52 136.61 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.855 0.828 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -68.17 125.71 27.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.064 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 62' ' ' VAL . 34.3 m -122.78 31.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.895 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -66.51 -21.0 66.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 34.8 mtmm -127.5 5.43 6.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.464 . . . . 0.0 111.046 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.8 mp0 -79.01 164.97 23.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -175.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.2 p -99.87 170.39 8.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -54.51 -47.93 72.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.53 -45.24 93.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.294 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -64.62 -39.2 93.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.77 -40.18 76.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.019 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 19.1 t -58.39 -39.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.4 m -57.74 -40.66 80.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 0.0 110.596 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -68.83 -37.19 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.699 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -65.12 -36.23 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 6.3 mpt_? -73.7 -22.82 59.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.267 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.16 59.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 110.19 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 113.58 12.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -84.71 -66.01 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.38 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -97.39 -33.12 11.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.023 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 18' ' ' GLU . . . -151.77 156.56 40.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.403 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.24 141.36 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.453 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -105.98 112.95 26.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.81 122.55 45.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 16.9 tp -94.88 118.77 32.34 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.5 m -129.89 161.08 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.991 0.424 . . . . 0.0 110.707 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.5 p -131.93 138.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.163 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.65 125.63 54.34 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.567 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -44.83 45.82 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.966 2.444 . . . . 0.0 115.117 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 41.0 mt-10 -73.53 -31.18 63.53 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.258 0.551 . . . . 0.0 110.584 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.441 HG22 ' HG ' ' A' ' 99' ' ' LEU . 40.4 m -71.95 -36.28 69.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.63 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' HG13 ' A' ' 91' ' ' VAL . 11.3 t70 -56.16 -43.73 78.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 40.2 mt-10 -59.3 -41.13 88.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.495 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 29.8 mm-40 -73.07 -50.01 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 102' ' ' LEU . 23.6 mt -68.56 -31.64 71.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.185 -170.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.618 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 pt20 -57.93 -41.9 83.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 28.5 mtpp -77.47 -37.12 52.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.258 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 99' ' ' LEU . 70.5 mt -69.43 -39.92 77.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.3 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.31 90.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 6.1 p -80.64 80.62 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.271 1.034 . . . . 0.0 112.087 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -112.61 34.79 4.15 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 170.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 13.3 m -67.23 -14.65 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.753 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 78.8 ttt180 -58.91 -45.31 90.64 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -167.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 34.5 tt0 -167.26 -24.1 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.414 . . . . 0.0 110.474 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.18 -47.07 79.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.32 0.581 . . . . 0.0 110.281 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 11' ' ' LEU . 57.5 tp -67.46 -19.98 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.349 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 10.9 mp . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 N--CA 1.471 0.197 0 N-CA-C 113.534 0.552 . . . . 0.0 113.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -156.15 163.16 39.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.933 0.397 . . . . 0.0 110.956 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 95' ' ' THR . 4.5 t -173.13 128.42 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.092 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.708 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 22.2 ttt 73.54 -51.51 0.7 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.672 0.789 . . . . 0.0 112.313 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER 55.8 133.53 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.801 1.241 . . . . 0.0 113.131 -174.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 75.7 Cg_endo -75.22 167.99 25.65 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.465 2.777 . . . . 0.0 113.24 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.52 144.63 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.652 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.18 109.04 19.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 167.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 51.0 m -94.17 116.45 28.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.852 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -104.12 112.3 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.01 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -120.72 154.48 35.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.2 142.49 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 38.4 ttmt -74.07 115.83 14.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.735 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.63 -150.95 18.17 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.727 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.83 -29.25 42.25 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.732 2.288 . . . . 0.0 112.556 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -130.69 43.99 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.164 0.507 . . . . 0.0 111.351 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 93.59 -108.76 3.71 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.992 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.648 ' HB3' HD12 ' A' ' 17' ' ' LEU . 99.5 m-85 -135.88 -21.98 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 112.774 -172.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 27.61 20.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.378 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -123.96 142.93 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 10.2 m170 -101.27 119.71 39.16 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.8 tp -102.46 133.15 47.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.769 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.5 p80 -123.57 143.69 50.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.469 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.9 93.95 0.52 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 45.2 mt-10 -55.99 130.36 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.853 0.384 . . . . 0.0 111.45 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -66.52 119.1 11.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.68 -37.31 3.34 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 37.2 mmtm -77.57 160.38 28.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.8 0.333 . . . . 0.0 110.163 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.4 pp -113.1 19.87 16.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.724 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.67 167.01 28.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.913 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG3' HG21 ' A' ' 75' ' ' VAL . 25.6 mm-40 -105.93 151.84 24.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 m-85 -138.54 153.77 48.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.58 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.456 HG12 ' OD1' ' A' ' 57' ' ' ASP . 9.7 mm -71.07 121.87 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -98.27 -25.69 14.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 42' ' ' VAL . 9.9 tt -164.85 147.1 8.22 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.67 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' N ' HD23 ' A' ' 41' ' ' LEU . 1.8 p -131.96 122.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.044 0.449 . . . . 0.0 109.806 173.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 37.2 mm-40 -60.22 130.1 89.15 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.987 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 18.1 Cg_exo -65.27 119.4 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.429 2.086 . . . . 0.0 111.451 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 13.92 52.41 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.334 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 98.4 p -91.82 160.4 36.2 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.809 0.338 . . . . 0.0 110.287 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 32.1 Cg_endo -65.23 -17.41 58.41 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 111.39 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.638 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.74 -43.04 90.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 42' ' ' VAL . 26.4 mt-10 -65.61 -37.01 85.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.108 0.48 . . . . 0.0 109.961 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -67.76 -26.04 65.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.045 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -81.8 -18.8 42.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.145 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.29 29.59 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.939 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.1 mt -86.38 147.94 25.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.95 0.375 . . . . 0.0 110.262 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 tt -146.13 140.3 26.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.24 81.18 1.0 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.463 0.649 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 93' ' ' PRO . . . 157.06 39.03 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 8.6 p-10 -105.76 -169.97 1.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.47 0.652 . . . . 0.0 111.165 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 96' ' ' ASP . 25.1 ttm-85 -132.76 124.1 27.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 156.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.439 HD11 HD22 ' A' ' 88' ' ' LEU . 34.6 tp -71.39 102.33 2.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.092 0.472 . . . . 0.0 109.775 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.27 -41.11 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.491 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.0 tt0 -148.55 151.06 34.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.705 0.288 . . . . 0.0 111.188 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.542 HG23 HG21 ' A' ' 67' ' ' VAL . 69.9 t -132.16 117.23 32.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.311 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 82' ' ' ALA . 95.0 m-20 61.46 21.73 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.532 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.29 7.38 46.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.923 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.8 tp10 -124.41 133.03 53.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 110.696 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.78 126.97 30.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.098 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.619 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 33.6 m -126.52 27.73 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.431 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.19 -28.18 66.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.33 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 13.7 ptmm? -128.64 39.32 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.289 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 50.9 mm-40 -103.67 168.85 8.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 0.0 112.086 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 75' ' ' VAL . 66.9 p -97.78 178.61 5.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.366 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -65.45 -46.6 79.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.488 ' HA ' HG12 ' A' ' 76' ' ' VAL . 30.4 tt0 -66.46 -32.83 74.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.439 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 16.3 mm100 -70.42 -46.1 64.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.976 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 71' ' ' THR . 14.5 m -72.51 -41.2 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.6 p -57.74 -36.36 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.072 0.463 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -64.11 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.937 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.6 mtt-85 -66.52 -36.05 81.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.567 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -63.01 -38.12 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.262 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 22.2 mmt85 -73.36 -25.01 60.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.323 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.73 55.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HB2' HD21 ' A' ' 63' ' ' ASN . . . -71.64 122.65 20.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.145 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.17 -83.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.515 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.01 -11.96 13.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.96 25.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.82 144.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -109.9 112.88 25.18 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.439 HD22 HD11 ' A' ' 59' ' ' LEU . 78.9 mt -115.61 122.75 46.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.634 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 18.6 tp -95.27 116.41 28.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 35.5 m -129.97 154.65 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.692 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.9 p -144.73 145.93 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -65.95 133.16 94.8 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.676 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 38.8 Cg_exo -59.87 -28.24 86.75 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.7 2.934 . . . . 0.0 113.736 -171.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.5 -48.25 67.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 109.86 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 9' ' ' THR . 15.0 m -71.78 -37.32 70.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.269 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.651 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 2.6 t70 -57.21 -47.13 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.607 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 28.5 tt0 -72.48 -39.37 67.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.041 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 95' ' ' THR . 20.0 pt20 -69.47 -38.72 77.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.572 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 95' ' ' THR . 43.7 mt -68.83 -39.13 80.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 10.6 pt20 -66.32 -33.16 75.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.16 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 34.4 mmtp -57.22 -35.33 69.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.414 0.626 . . . . 0.0 109.34 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.39 -55.57 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.707 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.22 -108.09 0.48 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.1 t 68.74 125.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.532 0.682 . . . . 0.0 112.572 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.82 71.86 10.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.66 . . . . 0.0 109.924 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 12' ' ' PRO . 2.4 t -56.12 -24.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.421 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.634 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 14.7 ptm180 -60.6 -26.71 67.18 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -165.62 -26.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -44.3 67.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.762 0.315 . . . . 0.0 111.406 -167.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 3.0 mm? -68.66 -31.09 69.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.4 mp . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.105 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.722 0.239 . . . . 0.0 112.722 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -154.0 137.65 16.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.516 0.674 . . . . 0.0 111.272 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -141.33 111.71 6.9 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.859 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.4 mtm 48.93 54.98 9.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.071 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.987 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.04 144.56 82.29 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.878 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.932 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 28.9 Cg_endo -63.85 159.93 39.52 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.447 2.765 . . . . 0.0 112.762 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -143.16 155.1 44.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.971 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 87' ' ' ARG . 45.9 tp -84.9 109.55 18.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.54 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -93.79 108.09 19.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -96.92 114.84 26.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.509 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.81 154.13 37.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.471 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.24 146.7 28.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.226 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -74.99 118.16 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.946 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -149.12 17.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.477 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 -20.06 20.03 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.98 2.454 . . . . 0.0 112.78 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -124.48 39.07 4.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.076 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.65 -122.99 7.96 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.41 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.3 m-85 -112.26 -30.18 7.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.17 0.485 . . . . 0.0 110.658 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.96 27.83 8.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.243 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.9 142.26 51.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.238 0.519 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -107.3 144.36 34.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 HG21 ' A' ' 75' ' ' VAL . 27.0 tp -119.49 129.84 54.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.497 0.189 . . . . 0.0 110.967 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -127.19 150.42 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 110.56 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.71 129.09 9.37 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.4 mm-40 -70.37 128.26 35.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.01 110.24 5.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.341 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.51 -12.18 33.11 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.466 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 4.2 mptp? -96.17 178.96 5.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.5 pp -122.27 16.46 10.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.608 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.67 168.58 25.19 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.909 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -104.54 146.35 29.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 110.204 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -133.11 157.12 46.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.244 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 53' ' ' LEU . 16.2 mm -70.75 122.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.034 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -85.15 -47.65 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.171 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -164.05 140.88 6.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.509 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.459 HG11 ' HG2' ' A' ' 49' ' ' GLU . 18.3 t -110.7 124.42 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.737 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.07 124.15 87.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.46 126.64 18.08 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.845 1.697 . . . . 0.0 112.074 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.81 17.69 37.37 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.254 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -97.89 158.94 32.04 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.9 -20.03 67.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.651 2.234 . . . . 0.0 111.994 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.26 -45.7 92.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HG2' HG11 ' A' ' 42' ' ' VAL . 30.8 mt-10 -63.09 -37.24 86.42 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.148 0.499 . . . . 0.0 110.011 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -70.23 -23.51 62.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.923 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -84.06 -17.84 38.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.21 22.65 10.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.26 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 39' ' ' ILE . 15.5 tp -93.46 113.06 25.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' LEU . 2.7 mm? -117.83 166.55 12.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.344 0.592 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.56 122.16 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.133 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.59 -20.44 12.13 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.022 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 6.0 m-20 -59.47 141.86 53.75 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.288 0.566 . . . . 0.0 111.597 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 30.1 ttt180 -85.73 121.78 28.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.822 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HA ' HG12 ' A' ' 90' ' ' VAL . 27.1 tp -78.95 109.43 13.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.118 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.29 -37.86 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.409 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 25.6 tt0 -144.95 151.76 39.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.68 HG23 HG21 ' A' ' 67' ' ' VAL . 74.0 t -134.5 119.75 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.694 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.59 -43.65 0.56 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.86 3.86 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.125 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -126.69 146.97 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.193 0.996 . . . . 0.0 111.251 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -63.48 123.16 18.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.843 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.68 HG21 HG23 ' A' ' 62' ' ' VAL . 32.6 m -118.39 17.98 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.214 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.19 -22.54 63.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.834 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.6 ptpp? -131.42 28.88 4.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.588 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 7.5 mm-40 -103.5 -174.55 2.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 28.4 p -112.71 169.79 8.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.072 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.3 t60 -58.58 -48.68 80.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.511 0.196 . . . . 0.0 110.914 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -66.97 -38.66 86.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.794 0.807 . . . . 0.0 110.334 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.481 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 5.3 tp-100 -61.18 -44.64 96.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.133 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' THR . 15.6 m -72.77 -42.69 61.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 43.5 t -54.88 -40.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.402 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 m -58.24 -38.06 76.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 0.0 110.655 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' NH1' ' HG3' ' A' ' 74' ' ' GLN . 61.2 mtt85 -68.62 -35.89 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.852 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 76' ' ' VAL . 69.0 mt -62.61 -33.65 60.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.492 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 4.3 mpt_? -66.92 -21.79 65.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.1 -2.11 57.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.23 128.53 36.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.242 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.55 -73.39 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.546 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -131.83 -4.88 3.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.19 158.5 44.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.856 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.7 p -127.83 146.4 33.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.541 ' HB3' HD11 ' A' ' 14' ' ' LEU . 14.8 mtm180 -97.7 122.84 41.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 17' ' ' LEU . 89.4 mt -121.46 113.63 20.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.962 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 26.9 tp -94.1 116.08 28.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.2 m -133.01 157.41 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.221 0.534 . . . . 0.0 111.765 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 11.7 p -147.98 148.43 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.866 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.82 118.26 33.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' ARG . 34.6 Cg_endo -63.53 -31.88 70.77 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.239 2.626 . . . . 0.0 113.169 -172.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.26 -37.04 69.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.025 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.5 m -71.79 -40.3 69.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.99 -30.84 66.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.194 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.31 -50.77 70.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.85 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.641 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 11.4 pt20 -74.87 -39.48 61.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.021 0.439 . . . . 0.0 110.839 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 102' ' ' LEU . 27.6 tp -66.13 -43.07 88.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.981 -164.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -68.19 -36.23 79.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.309 0.576 . . . . 0.0 110.245 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.27 -18.29 62.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.277 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 92.9 mt -70.15 -15.06 62.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.36 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 62.15 0.93 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.537 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.28 131.66 41.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.548 0.213 . . . . 0.0 110.773 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 10.7 mt-30 -83.15 85.89 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.572 0.701 . . . . 0.0 109.754 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.651 HG13 ' HG3' ' A' ' 12' ' ' PRO . 3.8 t -59.99 -27.82 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.734 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.71 -25.52 66.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -175.18 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.122 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 33.7 tt0 -55.79 -41.02 73.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.108 0.48 . . . . 0.0 110.961 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 11' ' ' LEU . 49.0 tp -64.39 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.396 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 -177.397 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 CA--C 1.519 -0.253 0 N-CA-C 113.012 0.351 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -157.03 120.09 4.07 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.407 0.622 . . . . 0.0 110.557 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -159.4 126.53 4.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.79 -168.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.7 mtm 54.21 30.92 13.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.878 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -58.31 139.77 84.17 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.024 -176.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 40.5 Cg_endo -65.66 158.39 53.61 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.598 2.865 . . . . 0.0 113.588 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -143.69 169.96 16.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 111' ' ' LEU . 17.5 mt -84.34 122.5 29.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.756 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.1 m -94.37 108.28 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.357 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -95.62 111.82 23.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.115 0.483 . . . . 0.0 110.585 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.49 147.8 40.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.516 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -112.59 135.32 53.45 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.376 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 33.2 ttpt -71.05 120.53 16.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.284 -173.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.35 -170.13 44.64 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.52 -29.91 91.15 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.651 2.234 . . . . 0.0 112.747 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -99.36 -0.56 40.8 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.166 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.37 -141.82 16.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.134 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 46' ' ' SER . 84.4 m-85 -105.72 -36.34 7.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.0 111.33 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 40.59 4.81 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.928 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -135.56 152.96 51.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.504 0.652 . . . . 0.0 110.405 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -124.36 144.51 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.467 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.4 mt -120.96 154.59 35.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 0.0 111.17 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.422 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 12.4 p-80 -144.13 151.65 39.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.44 141.42 15.27 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.499 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.0 mt-10 -107.69 152.14 24.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.799 0.333 . . . . 0.0 111.169 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.81 141.78 38.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.25 -43.6 2.81 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 27.0 mmtp -78.07 175.32 10.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 pt? -144.0 29.05 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.38 -163.79 9.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.96 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HG3' HG21 ' A' ' 75' ' ' VAL . 31.1 mm-40 -112.27 148.03 35.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -134.39 160.83 36.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.426 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.491 HG12 ' CG ' ' A' ' 57' ' ' ASP . 31.8 mm -68.59 119.59 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.203 0.525 . . . . 0.0 110.86 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.25 -36.95 13.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 tp -161.94 143.31 10.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.8 117.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.823 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.4 mm-40 -68.8 129.54 92.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.835 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.5 Cg_exo -70.02 121.38 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 111.355 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.94 17.24 21.39 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.549 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 91.4 p -105.41 154.97 38.66 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 -15.24 49.22 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.747 2.298 . . . . 0.0 111.813 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 53' ' ' LEU . . . -66.38 -35.88 81.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.602 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.23 -38.65 91.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.0 110.091 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.42 -20.12 62.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.165 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.55 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.92 -18.0 33.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.21 28.11 7.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.172 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 48' ' ' ALA . 11.2 mp -79.2 136.36 37.06 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.582 -0.363 . . . . 0.0 110.489 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 tt -146.46 142.2 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.2 109.09 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.122 0.487 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.71 6.85 2.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.88 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' HG12 ' A' ' 39' ' ' ILE . 6.8 p-10 -72.16 -173.11 1.0 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.923 0.868 . . . . 0.0 111.787 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -135.96 115.37 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.661 165.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.2 tp -78.31 106.65 10.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 109.809 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -97.5 -38.06 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.873 -175.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 25.2 tt0 -149.77 151.8 34.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.709 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.492 HG23 HG21 ' A' ' 67' ' ' VAL . 90.4 t -134.62 117.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.217 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 56.46 29.82 15.99 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.22 5.73 57.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.563 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 9.2 tp10 -124.41 130.32 52.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.432 0.616 . . . . 0.0 110.656 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.97 127.08 31.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 35.3 m -123.79 24.21 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 52.1 mt-10 -68.26 -25.35 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.633 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 1.3 ptpt -126.44 29.93 5.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -177.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 44.4 mm-40 -93.17 -171.36 2.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 74' ' ' GLN . 33.6 p -113.16 -179.79 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.683 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 75.1 t60 -64.38 -47.0 80.9 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -67.55 -37.83 83.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.764 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' HG2' ' OG1' ' A' ' 71' ' ' THR . 85.5 mm-40 -60.51 -43.23 97.32 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.735 0.303 . . . . 0.0 110.908 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 37' ' ' GLN . 13.4 m -71.58 -40.21 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.835 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 72' ' ' HIS . 72.5 t -54.09 -37.91 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.451 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -57.14 -44.51 83.47 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.284 0.564 . . . . 0.0 110.122 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -69.23 -36.19 76.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.121 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 75' ' ' VAL . 72.6 mt -64.21 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.486 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 41.6 mmt180 -69.78 -22.55 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.98 55.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.896 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.8 116.83 15.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.92 -66.5 0.78 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.55 -172.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.75 -17.84 10.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.002 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.65 150.07 29.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.0 111.19 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -123.79 141.09 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.594 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -105.84 111.16 23.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 109.969 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.56 129.87 53.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.028 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 14.7 tp -102.01 118.81 37.69 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.4 154.92 40.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.114 0.483 . . . . 0.0 110.686 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.6 p -140.64 145.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.3 138.18 68.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.1 -25.63 64.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.701 2.934 . . . . 0.0 113.995 -172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.96 -50.39 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.532 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -42.6 83.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.658 0.742 . . . . 0.0 110.158 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -58.14 -45.71 86.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.66 -43.25 89.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.567 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.2 pt20 -72.21 -44.35 63.08 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.038 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 12.7 mt -67.16 -40.17 86.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.415 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 14.8 pt20 -64.67 -36.08 83.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.757 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 99.1 mttt -70.58 -19.7 62.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.367 . . . . 0.0 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 74.5 mt -81.76 -8.24 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.266 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.97 24.19 30.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.08 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.439 HG13 HD21 ' A' ' 110' ' ' LEU . 98.6 t -89.55 128.42 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.815 0.34 . . . . 0.0 111.141 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 37.0 mt-30 -96.51 83.85 3.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.032 0.444 . . . . 0.0 109.884 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 19.7 m -59.23 -14.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.97 -25.75 63.83 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.19 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.809 0.337 . . . . 0.0 110.938 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 105' ' ' GLN . 44.9 tt0 -54.98 -38.03 67.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.439 HD21 HG13 ' A' ' 104' ' ' VAL . 57.3 mt -79.21 -40.26 31.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.455 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.489 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 7.3 mp . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.464 -0.238 0 N-CA-C 113.285 0.456 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.498 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 7.2 m-85 -156.61 118.36 3.87 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.216 1.008 . . . . 0.0 112.172 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 95' ' ' THR . 4.6 t -153.49 125.66 7.96 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.434 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.6 mtt 53.77 48.79 20.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.039 0.447 . . . . 0.0 110.434 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -74.04 152.92 88.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.641 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.943 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.0 Cg_endo -68.79 151.45 74.31 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.943 2.429 . . . . 0.0 112.694 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.545 ' HA ' HD11 ' A' ' 111' ' ' LEU . 69.6 mtp180 -126.05 153.72 44.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.618 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 40.9 tp -89.64 106.07 18.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.682 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 68.8 m -93.22 108.03 19.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 p -95.31 120.78 36.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.96 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -125.51 151.52 46.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.37 135.14 42.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.479 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 ttmt -68.47 119.33 12.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.06 -144.03 14.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.069 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.36 -14.2 25.35 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.072 2.514 . . . . 0.0 113.398 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -137.85 35.94 2.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.945 0.402 . . . . 0.0 111.015 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 84.1 -104.72 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.544 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.2 m-85 -132.53 -22.13 2.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.411 0.605 . . . . 0.0 112.255 -175.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.47 28.38 24.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.497 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.94 155.72 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 91.1 m-70 -122.06 134.19 54.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.404 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.3 tp -108.45 135.66 49.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.8 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -128.85 152.1 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.77 119.92 3.15 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.811 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.46 118.85 11.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.657 0.265 . . . . 0.0 110.448 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -63.36 125.36 23.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.045 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.3 -36.33 3.66 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -106.3 165.95 10.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -112.22 10.06 20.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.681 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.9 143.1 16.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.564 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -105.04 143.88 32.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.409 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 53.0 m-85 -129.02 151.5 49.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 0.0 110.794 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.11 121.89 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.879 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 -26.25 14.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.68 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 8.1 tp -162.45 151.56 15.35 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 111.311 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.532 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.6 t -128.8 119.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.614 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.07 125.75 90.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.64 111.63 2.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.038 1.825 . . . . 0.0 111.386 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.59 10.97 20.59 Favored Glycine 0 C--N 1.311 -0.852 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.948 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.3 p -99.1 159.75 29.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.231 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 36.1 Cg_endo -65.91 -14.41 44.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.99 2.46 . . . . 0.0 112.409 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.05 -40.43 94.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.779 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -62.64 -33.09 74.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 110.242 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -71.69 -13.27 61.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.067 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -100.24 -17.66 17.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.24 7.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.863 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.5 mp -84.83 134.15 34.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.715 0.258 . . . . 0.0 110.324 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -137.84 152.22 48.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 110.577 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.7 107.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.533 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.27 3.75 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.944 -176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 42.8 m-20 -66.68 142.58 57.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 111.443 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.581 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 71.1 ttt180 -91.43 121.66 33.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HA ' HG12 ' A' ' 90' ' ' VAL . 53.6 tp -79.03 104.76 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 0.0 110.22 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 41.5 t -91.39 -40.93 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 10.7 tt0 -144.74 150.98 38.18 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.527 HG21 HG13 ' A' ' 75' ' ' VAL . 90.0 t -130.24 117.57 40.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 9.9 t-20 70.92 -61.2 0.49 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.151 0.98 . . . . 0.0 110.631 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.0 20.65 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -125.85 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.715 0.257 . . . . 0.0 110.506 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -71.9 99.65 2.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.452 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.0 m -82.75 0.93 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.233 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 24.2 mm-40 -70.79 -3.99 21.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 171.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -113.53 6.89 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.025 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 13.5 mm-40 -110.75 -165.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.298 -172.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 75' ' ' VAL . 65.3 p -132.29 176.34 8.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.119 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 76' ' ' VAL . 13.4 t60 -54.16 -48.05 71.31 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 176.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -65.34 -43.01 92.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.185 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 54.9 mt-30 -66.88 -44.07 81.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 67' ' ' VAL . 91.4 t -62.29 -42.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.963 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' HIS . 52.3 t -57.95 -45.03 87.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 110.27 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 m -58.4 -39.33 79.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 84.0 mtt-85 -65.92 -34.53 78.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 75' ' ' VAL . 67.6 mt -62.5 -33.92 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.686 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.32 60.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.77 115.03 10.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.851 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.95 -74.49 0.24 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.304 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -101.32 -28.84 12.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.417 0.627 . . . . 0.0 109.902 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.77 159.01 44.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.761 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.48 142.27 41.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.857 0.36 . . . . 0.0 110.37 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 14' ' ' LEU . 96.2 mtt180 -98.74 112.87 24.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.888 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 53' ' ' LEU . 91.9 mt -114.06 113.67 25.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 28.2 tp -94.11 116.78 29.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.4 m -130.84 153.67 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.053 0.454 . . . . 0.0 111.459 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.1 p -142.54 142.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.8 114.63 10.85 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 32.4 Cg_exo -57.75 -29.39 85.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.095 2.53 . . . . 0.0 112.767 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.7 -47.58 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.955 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 7.5 m -72.46 -35.23 68.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.898 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -56.33 -39.79 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.741 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 10.2 tp10 -58.73 -48.35 81.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.9 pt20 -72.92 -40.13 65.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.361 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.79 -43.18 80.33 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 104' ' ' VAL . 29.6 pt20 -60.44 -34.38 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.318 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 55.7 mttm -67.56 -18.94 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 111.077 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.34 -3.73 58.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.19 42.86 8.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.815 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 100' ' ' GLN . 19.7 m -90.72 171.75 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 111.666 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 109' ' ' GLU . 57.6 mt-30 -133.97 83.4 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.943 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.7 m -66.34 -16.47 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 41.1 ttm180 -59.29 -43.96 92.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HA ' HD23 ' A' ' 111' ' ' LEU . 35.3 tt0 -169.77 -11.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.975 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -55.48 -39.91 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.058 0.456 . . . . 0.0 110.141 -177.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.498 HD21 ' CZ ' ' A' ' 8' ' ' PHE . 46.8 mt -73.61 -39.48 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.485 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.0 mm? . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.087 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 CA-C-O 121.279 0.449 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.525 ' CE1' HD22 ' A' ' 110' ' ' LEU . 2.6 m-85 -148.77 146.79 28.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.791 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -171.03 134.72 0.96 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 95' ' ' THR . 13.7 tpt 53.36 63.98 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.843 0.83 . . . . 0.0 109.538 -174.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.574 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -65.56 140.47 97.55 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.624 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 77.0 Cg_endo -72.76 169.23 22.5 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.298 2.665 . . . . 0.0 112.147 -176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -130.02 136.1 49.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.838 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 87' ' ' ARG . 57.2 tp -83.9 104.83 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -94.87 115.78 27.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.697 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.0 110.37 22.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.826 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -110.21 152.69 25.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.434 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -103.69 143.03 33.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.553 -170.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -72.83 104.95 4.17 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.8 -151.01 21.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.543 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 -22.57 23.61 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.876 2.384 . . . . 0.0 112.478 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -124.38 39.02 4.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.473 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.2 -125.61 8.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.44 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' HD12 ' A' ' 17' ' ' LEU . 88.3 m-85 -111.29 -28.04 8.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.145 0.472 . . . . 0.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.51 36.58 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.28 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -123.9 146.41 48.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.472 0.636 . . . . 0.0 110.458 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.5 m-70 -106.8 125.16 50.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.247 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.31 127.29 54.95 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.494 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -113.18 132.12 55.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.341 0.591 . . . . 0.0 109.983 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.63 112.23 2.95 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 11.8 mm-40 -57.1 132.02 51.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.189 0.518 . . . . 0.0 111.126 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.41 119.7 14.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.564 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.65 -36.41 3.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.652 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 58.4 mmtt -76.01 160.8 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -100.77 16.14 26.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.017 0.436 . . . . 0.0 111.615 -177.308 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.41 132.06 10.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.53 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.06 137.88 40.65 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.0 m-85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.618 0.247 . . . . 0.0 110.424 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.79 119.61 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -100.56 -25.79 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 -175.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.2 tm? -164.62 145.91 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.529 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -132.6 132.98 59.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 34.9 mm-40 -78.73 98.39 0.32 Allowed Pre-proline 0 N--CA 1.465 0.325 0 O-C-N 123.355 0.409 . . . . 0.0 110.734 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' VAL . 14.5 Cg_exo -34.67 94.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.469 3.446 . . . . 0.0 114.301 -168.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.04 25.16 1.91 Allowed Glycine 0 C--N 1.314 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.742 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -96.03 163.01 21.99 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 117.228 0.514 . . . . 0.0 110.193 178.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 29.7 Cg_endo -64.22 -17.38 59.51 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.324 2.016 . . . . 0.0 111.686 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.51 -48.73 76.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.197 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 46' ' ' SER . 1.9 mp0 -66.12 -38.74 88.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 29.5 mtpp -62.41 -32.16 72.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.35 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.19 -19.19 51.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.03 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.27 39.94 1.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.823 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.56 134.3 47.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 tt -137.4 138.08 39.49 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.19 99.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.418 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.06 -24.88 1.91 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.119 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 68.0 m-20 -70.73 141.68 51.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.653 0.263 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -88.47 134.56 33.82 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.225 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -75.49 124.83 27.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.785 177.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.4 -43.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -145.14 150.32 36.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.864 0.364 . . . . 0.0 110.802 -178.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 63.6 t -133.65 111.67 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.051 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 60.71 38.64 18.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.868 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.0 9.73 80.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.952 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG2' ' NE ' ' A' ' 78' ' ' ARG . 7.2 tp10 -120.81 127.05 51.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -69.7 129.14 38.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.75 -0.204 . . . . 0.0 110.751 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.559 HG12 ' NH1' ' A' ' 78' ' ' ARG . 20.4 m -120.94 31.21 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.262 0.553 . . . . 0.0 111.418 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 35' ' ' LEU . 58.0 mt-10 -71.33 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.398 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.918 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.3 mtmp? -130.02 16.76 5.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.451 0.644 . . . . 0.0 110.106 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.403 ' CG ' HH12 ' A' ' 78' ' ' ARG . 1.0 OUTLIER -95.78 -174.45 3.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.302 -169.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.491 ' H ' ' HB3' ' A' ' 74' ' ' GLN . 32.5 p -119.68 166.98 12.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.863 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 76' ' ' VAL . 49.5 t60 -58.11 -48.4 80.31 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.899 0.124 . . . . 0.0 110.684 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.08 -41.35 99.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.801 0.81 . . . . 0.0 110.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 71' ' ' THR . 6.6 tp60 -60.87 -39.25 88.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.811 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 74.4 t -71.69 -41.34 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.406 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 72' ' ' HIS . 69.6 t -55.69 -41.15 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.673 0.273 . . . . 0.0 111.729 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -57.86 -40.0 79.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.208 0.527 . . . . 0.0 110.442 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.559 ' NH1' HG12 ' A' ' 67' ' ' VAL . 59.6 mtt180 -69.98 -36.05 74.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.123 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.57 -36.33 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.057 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -72.94 -22.59 60.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.842 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.25 -15.52 59.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.981 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.72 128.55 36.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.747 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.48 -67.66 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.36 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -111.18 -26.93 8.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.349 0.595 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.2 155.42 38.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.09 144.56 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HD3' HD21 ' A' ' 14' ' ' LEU . 84.9 mtt180 -98.82 118.49 35.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.94 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.546 HD12 HD21 ' A' ' 17' ' ' LEU . 88.9 mt -121.86 115.51 22.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.245 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 18.4 tp -95.09 123.34 38.53 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.8 m -133.3 155.74 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.291 0.567 . . . . 0.0 112.349 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.7 p -146.7 146.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 p30 -73.23 134.29 80.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.93 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 58.3 Cg_exo -53.4 -34.1 69.69 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.064 3.176 . . . . 0.0 114.301 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.58 -46.7 78.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.835 0.35 . . . . 0.0 110.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 10' ' ' MET . 24.9 m -69.78 -37.18 76.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 3.9 t70 -57.51 -45.1 85.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.429 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 39.8 mt-10 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.927 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 9.5 pt20 -74.8 -42.53 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.079 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 102' ' ' LEU . 25.7 mt -62.43 -34.15 76.21 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 9.6 pt20 -64.7 -35.6 81.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.383 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -74.56 -24.98 59.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.072 0.463 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 99' ' ' LEU . 37.1 mt -84.8 -46.47 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.422 0.629 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.99 96.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.01 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -76.67 86.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 122.309 1.052 . . . . 0.0 111.85 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 77.9 mt-30 -104.7 17.49 24.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.43 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m -66.66 -16.33 20.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.441 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.45 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 96.3 mtt180 -60.73 -43.77 97.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.9 -172.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.497 ' HA ' HD13 ' A' ' 111' ' ' LEU . 30.0 tt0 -172.66 -21.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 110.348 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 2.5 mp0 -55.15 -46.33 75.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.322 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.525 HD22 ' CE1' ' A' ' 8' ' ' PHE . 52.0 tp -65.39 -35.54 81.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 108' ' ' GLU . 7.0 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.307 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.778 0.241 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.449 ' CD1' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -159.81 138.73 10.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.406 176.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -136.95 113.64 10.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.491 -167.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.3 mtp 54.32 57.04 6.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.566 0.698 . . . . 0.0 109.663 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.767 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -64.26 161.59 39.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.392 -173.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HG3' HG13 ' A' ' 106' ' ' VAL . 22.1 Cg_endo -59.52 164.24 11.52 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.546 2.831 . . . . 0.0 112.419 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' HD11 ' A' ' 111' ' ' LEU . 28.2 mmm180 -136.96 139.72 41.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.945 -172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' A' ' 89' ' ' LEU . 48.6 tp -84.63 105.02 15.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 29.9 m -95.17 108.35 20.47 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.09 -173.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.9 110.9 22.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -114.67 148.98 37.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.765 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -119.54 128.08 53.6 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.008 -168.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 30.9 ttpt -65.4 114.75 5.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.291 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.04 -166.24 37.01 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.27 -12.54 33.32 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.578 2.185 . . . . 0.0 112.39 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -103.78 1.6 31.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.97 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.36 -133.75 11.89 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.132 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.6 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.9 m-85 -106.71 -28.83 9.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.263 0.532 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.85 39.59 9.37 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 114.267 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -138.4 157.83 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 109.999 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.548 ' CD2' HD23 ' A' ' 41' ' ' LEU . 52.9 m-70 -125.55 139.07 53.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -110.35 141.86 42.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.721 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 1.4 p80 -136.2 151.85 50.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.47 112.12 1.01 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.978 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 46.0 mt-10 -65.8 176.81 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 0.0 110.881 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -103.29 137.82 40.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.85 15.22 63.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.177 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.37 -171.33 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD12 ' HD3' ' A' ' 69' ' ' LYS . 1.8 pt? -124.38 -34.29 2.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.172 172.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.0 -177.94 15.32 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.247 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -104.66 150.24 24.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.589 0.356 . . . . 0.0 110.106 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 15.8 m-85 -126.69 151.43 48.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.66 0.266 . . . . 0.0 110.422 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.93 122.59 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.054 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 5.6 tmm_? -92.43 -42.14 9.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.989 0.423 . . . . 0.0 110.051 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 27' ' ' HIS . 23.7 tp -149.22 150.22 32.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.451 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -125.7 118.84 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.22 121.53 76.98 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.985 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.64 121.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.222 1.948 . . . . 0.0 111.808 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.04 43.81 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.368 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 99.3 p -83.28 164.81 44.0 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.561 -0.376 . . . . 0.0 111.054 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.2 Cg_endo -67.81 -18.38 47.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.48 2.12 . . . . 0.0 112.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.65 -43.15 99.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.625 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.05 -38.7 89.73 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.338 0.59 . . . . 0.0 110.035 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 60.1 mttp -68.88 -25.05 64.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.86 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -84.61 -18.55 35.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.87 10.46 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.506 HD21 HD12 ' A' ' 88' ' ' LEU . 10.2 mp -81.48 131.7 35.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.999 0.4 . . . . 0.0 110.45 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.64 152.65 51.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.05 92.87 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.32 -26.73 0.78 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.649 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 9.7 m-20 -64.26 140.78 58.9 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 111.12 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -90.47 132.33 35.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 90' ' ' VAL . 33.5 tp -80.73 112.7 18.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.833 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.04 -38.6 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.296 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.577 ' OE1' ' HD2' ' A' ' 107' ' ' ARG . 3.0 tt0 -148.88 150.59 33.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.275 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 67' ' ' VAL . 86.5 t -132.21 111.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.176 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 53.44 37.06 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.798 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.06 9.6 58.11 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.674 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.6 tp10 -120.23 130.83 54.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.439 0.619 . . . . 0.0 111.039 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -72.53 101.44 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 62' ' ' VAL . 32.7 m -102.74 5.96 10.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.253 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -8.92 41.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD3' HD12 ' A' ' 35' ' ' LEU . 30.4 mmtp -125.0 17.02 8.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.799 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 39.9 mt-10 -107.12 -172.2 2.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 112.483 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 p -107.63 170.47 7.96 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.049 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 76' ' ' VAL . 10.0 t60 -57.36 -47.55 81.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.023 177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -63.8 -47.59 80.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 80.1 mt-30 -61.71 -43.6 98.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.567 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' ILE . 70.3 t -66.73 -44.02 89.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.572 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 72' ' ' HIS . 50.1 t -57.8 -37.49 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.777 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 t -62.79 -39.34 93.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mtt-85 -68.91 -36.39 77.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' VAL . 78.3 mt -63.26 -42.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.76 -23.29 63.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -12.71 61.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.212 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.57 123.26 30.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.952 0.406 . . . . 0.0 109.942 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.47 -64.54 1.14 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.319 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -104.0 -28.81 11.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.57 32.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.777 0.322 . . . . 0.0 111.488 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.98 146.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.627 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.29 114.25 26.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.506 HD12 HD21 ' A' ' 53' ' ' LEU . 84.1 mt -114.63 126.02 54.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -95.15 119.57 33.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.9 m -132.8 160.03 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.9 p -147.77 143.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.372 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.3 t70 -67.26 126.78 93.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.298 175.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 31.6 Cg_exo -59.46 -32.82 97.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.625 2.883 . . . . 0.0 113.971 -174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -72.1 -41.31 67.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.663 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 30.5 m -69.52 -39.59 77.45 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.272 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.48 -33.41 69.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.93 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 10.7 tp10 -57.49 -40.56 78.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.76 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 96.8 mt-30 -72.78 -49.15 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 173.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 95' ' ' THR . 30.1 mt -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.401 -166.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.15 -35.73 81.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 47.9 mmtm -71.46 -36.04 71.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 66.7 mt -63.32 -59.53 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.193 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 146.11 -154.45 25.96 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 110' ' ' LEU . 91.7 t 67.0 146.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.861 0.864 . . . . 0.0 112.491 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 80.6 mm-40 -81.3 91.69 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 0.0 109.857 175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -55.35 -25.07 16.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.643 -1.162 . . . . 0.0 114.013 -171.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 17.8 ptt180 -66.4 -17.67 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -170.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 111' ' ' LEU . 33.2 tt0 179.99 -13.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.2 tt0 -55.56 -37.42 67.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 110.976 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 104' ' ' VAL . 52.4 mt -73.09 -39.68 65.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.5 mm? . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.928 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.709 0.212 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -150.58 149.54 30.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.251 0.548 . . . . 0.0 111.733 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG21 ' A' ' 95' ' ' THR . 5.1 t -170.63 123.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.603 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.5 ttt 53.54 54.21 10.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.571 0.7 . . . . 0.0 110.338 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.3 pt? -80.36 162.25 61.91 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' CG ' HG13 ' A' ' 106' ' ' VAL . 81.1 Cg_endo -88.52 172.66 4.77 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.718 2.279 . . . . 0.0 113.833 -166.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -138.11 154.09 49.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.853 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.9 111.5 19.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.0 m -92.55 109.72 21.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.472 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -95.48 110.7 22.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.381 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -113.98 149.57 35.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.956 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -112.9 134.89 54.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.472 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 33.1 ttpt -68.99 112.66 5.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.007 -174.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.27 -156.02 30.19 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.129 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.18 -8.95 24.58 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.014 2.476 . . . . 0.0 113.81 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -126.45 10.77 7.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 104.22 -139.14 14.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.311 -173.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.5 m-85 -103.17 -32.43 9.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.551 0.675 . . . . 0.0 112.072 -174.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.25 32.17 7.18 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.069 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -138.85 150.69 46.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -123.11 130.28 52.57 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.71 139.23 36.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.703 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -142.18 152.74 43.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.89 19.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.376 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' CE2' ' A' ' 38' ' ' TYR . 51.3 mt-10 -78.22 -172.37 2.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -75.45 92.42 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.117 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.33 -83.98 0.75 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 37.83 -154.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.288 -0.956 . . . . 0.0 112.378 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 1.8 pp -145.0 5.0 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.008 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.52 154.05 21.29 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.041 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -105.38 148.59 26.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.0 110.191 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 31' ' ' GLU . 8.4 m-85 -126.93 153.29 45.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 110.538 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.69 121.35 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.187 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 tmm_? -88.99 -46.69 8.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 40' ' ' ARG . 34.7 tp -147.39 144.29 28.59 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.083 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 49' ' ' GLU . 2.2 p -129.97 113.72 27.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG3' ' CA ' ' A' ' 25' ' ' GLY . 1.7 mt-10 -70.34 132.76 87.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.195 -166.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.19 118.14 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.407 2.071 . . . . 0.0 111.89 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.85 -1.43 33.85 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.382 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.483 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 99.3 p -85.45 158.95 56.83 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.181 -177.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -17.86 49.02 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 111.339 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.53 -43.39 97.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.721 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 42' ' ' VAL . 44.6 mt-10 -60.15 -44.16 95.18 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.279 0.561 . . . . 0.0 110.004 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.41 -17.67 63.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.511 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -83.27 -18.83 37.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 0.0 110.286 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.41 26.41 6.56 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.07 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.68 136.23 33.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.76 0.315 . . . . 0.0 110.634 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 55' ' ' ALA . 3.8 tt -137.41 143.37 41.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -58.03 117.65 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.305 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.55 -26.51 6.27 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.126 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 94.3 m-20 -58.17 141.73 49.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.025 0.441 . . . . 0.0 111.792 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 46.8 ttt180 -85.31 122.68 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.436 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.74 118.8 21.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.908 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.55 -41.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.576 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 11.6 tt0 -149.96 150.94 32.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.729 0.3 . . . . 0.0 110.731 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 75' ' ' VAL . 48.8 t -128.81 116.11 39.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 23.1 m120 68.39 -58.25 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.427 1.091 . . . . 0.0 111.171 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.11 28.21 0.06 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.189 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.7 tp10 -125.54 127.26 46.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -69.92 115.72 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.32 . . . . 0.0 110.489 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.454 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 31.4 m -111.52 29.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.13 0.49 . . . . 0.0 111.486 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 35' ' ' LEU . 4.4 mm-40 -73.14 -8.72 57.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.732 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 99.8 mttt -138.43 32.45 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 111.169 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 61.4 mm-40 -107.11 -172.17 2.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.363 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 74' ' ' GLN . 65.1 p -123.48 174.1 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 76' ' ' VAL . 9.5 t60 -55.3 -47.9 74.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.001 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -65.73 -43.36 89.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.151 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 14.0 mm-40 -60.76 -42.9 98.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.571 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.721 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.79 -38.9 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.504 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 72' ' ' HIS . 25.4 t -58.88 -39.85 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -59.13 -41.78 89.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.277 0.561 . . . . 0.0 109.856 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.506 ' NE ' ' HG2' ' A' ' 65' ' ' GLU . 53.1 mtt180 -69.34 -35.88 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.9 mt -65.18 -32.59 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.202 0.525 . . . . 0.0 109.898 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.91 -17.3 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 109.997 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.53 114.29 20.83 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.562 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.53 -63.7 1.01 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.575 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -135.38 -0.12 2.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.149 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.98 141.65 20.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -126.62 144.15 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.839 0.352 . . . . 0.0 110.246 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 59.6 mtm-85 -103.31 113.23 26.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.152 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 17' ' ' LEU . 99.0 mt -112.37 118.47 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.014 0.435 . . . . 0.0 110.968 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 32.8 tp -95.1 116.32 28.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 31.8 m -130.02 154.08 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.842 0.353 . . . . 0.0 110.6 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.83 147.57 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.154 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 13.5 t70 -62.54 121.75 69.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.604 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 37.0 Cg_exo -60.43 -31.1 92.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.526 2.817 . . . . 0.0 113.508 -173.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.84 -44.74 63.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.003 0.43 . . . . 0.0 110.241 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 9' ' ' THR . 23.7 m -71.13 -36.74 72.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.735 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 9.1 t70 -56.92 -33.28 66.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.872 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 8.7 mm-40 -59.03 -49.66 77.04 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -72.74 -39.77 66.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.931 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.84 -33.9 76.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.988 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.59 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -57.23 -49.14 76.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.495 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 14.0 mptt -68.94 -18.32 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.515 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.06 -10.81 59.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.84 46.3 38.43 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.614 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 106' ' ' VAL . 24.0 m -91.72 160.86 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.278 0.561 . . . . 0.0 111.96 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -104.32 69.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.9 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 104' ' ' VAL . 16.8 t -56.72 -27.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.6 ptm180 -59.9 -29.22 68.2 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -165.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -174.59 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.177 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.22 -32.28 70.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.81 -19.73 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.197 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.426 -174.047 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.461 -0.436 0 CA-C-O 120.697 0.207 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' LEU . 17.4 m-85 -146.78 147.32 30.79 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.519 0.676 . . . . 0.0 112.255 -174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 10' ' ' MET . 4.0 t -172.0 133.74 0.73 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.794 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 16.4 tpt 75.2 -60.58 0.51 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.708 0.803 . . . . 0.0 110.493 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 51.91 132.91 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.296 1.438 . . . . 0.0 114.178 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.025 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 84.9 Cg_endo -76.8 173.43 14.49 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.577 2.851 . . . . 0.0 113.514 -176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -143.04 157.69 44.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.124 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 89' ' ' LEU . 29.6 mt -84.54 115.98 22.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.2 m -94.49 108.31 20.25 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.517 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -94.62 111.62 23.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -121.88 150.31 42.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 36.3 mt-10 -112.97 134.76 54.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.786 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.87 117.58 4.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -172.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.63 -161.67 32.16 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.489 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.74 -33.15 93.35 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.42 2.747 . . . . 0.0 113.046 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -136.98 24.01 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 111.544 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.43 -153.26 18.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.758 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.694 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.4 m-85 -104.08 -29.91 10.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.967 0.383 . . . . 0.0 111.985 -173.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.14 29.65 6.69 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.79 172.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -134.0 141.07 47.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.429 -0.454 . . . . 0.0 110.32 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -101.6 144.17 30.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.53 128.32 49.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.493 0.187 . . . . 0.0 111.311 -172.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.5 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.4 p80 -123.94 140.27 53.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -118.1 6.48 15.17 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 64.16 -173.7 0.17 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.978 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -107.61 122.09 45.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.46 61.98 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.68 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 4.2 mptp? -96.44 167.71 11.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -130.51 20.48 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.061 175.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 144.05 15.8 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG3' HG21 ' A' ' 75' ' ' VAL . 69.6 mm-40 -103.86 146.22 28.97 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 117.007 0.404 . . . . 0.0 110.299 -173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -128.22 152.69 47.77 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 55' ' ' ALA . 28.5 mm -70.09 118.3 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 109.952 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 1.2 tpt180 -93.96 -49.67 5.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.521 -173.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.7 tm? -152.5 141.37 21.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.561 ' N ' HD13 ' A' ' 41' ' ' LEU . 25.0 t -118.82 127.29 75.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.1 mm-40 -80.88 120.05 77.79 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 11.7 Cg_exo -70.92 101.94 1.14 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.511 2.14 . . . . 0.0 112.386 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.2 22.11 1.26 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.99 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -118.49 173.84 3.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.77 0.319 . . . . 0.0 110.196 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 56.1 Cg_endo -70.34 -13.46 33.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.405 2.07 . . . . 0.0 112.922 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -47.9 81.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.402 . . . . 0.0 110.891 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.7 mp0 -67.34 -32.97 74.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.406 0.622 . . . . 0.0 109.791 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 27.3 mtpp -69.56 -21.02 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.908 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.67 -17.81 24.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.37 38.11 4.1 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.52 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 88' ' ' LEU . 94.6 mt -92.9 130.86 38.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.9 tt -129.09 138.74 52.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HG22 ' A' ' 39' ' ' ILE . . . -63.4 103.89 0.56 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.183 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.99 -26.89 2.58 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.654 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.647 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.7 m-20 -65.25 149.39 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.33 0.586 . . . . 0.0 111.549 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 58.8 ttt180 -92.13 125.51 36.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 37' ' ' GLN . 48.2 tp -80.42 100.71 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.032 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -86.32 -39.51 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.161 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 4.1 tt0 -146.73 151.42 37.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 111.534 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.767 HG21 HG13 ' A' ' 75' ' ' VAL . 83.9 t -131.3 111.3 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.617 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.99 -24.0 0.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.844 0.858 . . . . 0.0 112.03 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 148.0 13.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.454 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -126.0 135.39 51.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.393 0.597 . . . . 0.0 110.185 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.22 102.49 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.916 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG21 HG23 ' A' ' 62' ' ' VAL . 29.9 m -92.61 12.7 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -170.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.5 -3.22 19.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.185 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 35' ' ' LEU . 97.9 mttt -132.64 31.16 4.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.172 0.51 . . . . 0.0 110.086 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -116.9 -164.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.261 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 59.6 p -133.29 167.1 21.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.102 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 76' ' ' VAL . 20.4 t60 -53.88 -47.34 71.18 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.16 -46.81 88.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.2 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 48.6 mt-30 -65.32 -38.12 89.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.767 HG13 HG21 ' A' ' 62' ' ' VAL . 75.7 t -66.05 -39.55 84.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.924 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 72' ' ' HIS . 62.0 t -57.54 -46.1 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.614 0.245 . . . . 0.0 111.069 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -37.33 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.674 0.273 . . . . 0.0 110.989 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 85.9 mtt-85 -66.57 -36.38 82.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.974 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.2 mt -65.52 -39.87 86.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.0 110.173 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.4 mmt180 -71.21 -20.87 62.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.687 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.63 62.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.963 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 131.01 45.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.77 -52.27 10.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.216 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.87 -22.19 2.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.3 153.28 34.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.705 0.288 . . . . 0.0 110.937 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.0 141.71 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.12 114.51 27.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 53' ' ' LEU . 94.3 mt -109.62 119.46 39.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.423 ' HB2' HD23 ' A' ' 14' ' ' LEU . 26.8 tp -94.33 116.01 28.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 29.3 m -127.89 153.09 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.12 0.486 . . . . 0.0 111.041 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 10.6 p -148.26 153.51 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.326 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.89 118.69 16.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.41 -40.96 77.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.542 2.828 . . . . 0.0 113.597 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.34 -37.47 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -66.21 -38.28 87.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.913 0.387 . . . . 0.0 110.271 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.7 t70 -61.68 -36.7 81.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.88 -48.33 80.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.296 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 17.0 pt20 -72.43 -42.87 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.998 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 mt -59.44 -43.98 93.02 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.639 0.257 . . . . 0.0 111.203 -177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 96' ' ' ASP . 77.5 mm-40 -61.9 -38.16 87.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.796 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 98' ' ' GLN . 12.5 pttp -75.55 -19.79 59.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.366 . . . . 0.0 110.453 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 86.4 mt -76.89 -3.65 39.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.488 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.82 30.48 26.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.737 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 39.8 t -89.35 131.28 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.869 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 15.5 mp0 -95.18 85.29 4.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.336 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.557 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.47 -17.47 22.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.222 -175.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -59.39 -45.91 90.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.545 ' HA ' HD13 ' A' ' 111' ' ' LEU . 21.3 tt0 -166.79 -10.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.137 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 42.1 mm-40 -55.69 -40.79 72.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 110.6 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 8' ' ' PHE . 45.1 mt -65.23 -40.22 93.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.392 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 108' ' ' GLU . 4.9 mp . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.052 -170.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 CA--C 1.513 -0.56 0 CA-C-O 121.443 0.518 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -149.53 139.67 22.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.317 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -148.56 -45.52 0.15 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.974 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.558 ' HB3' HG21 ' A' ' 95' ' ' THR . 51.0 tpp -138.9 78.57 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.924 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.54 155.8 85.35 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 -179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.715 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 55.3 Cg_endo -93.75 160.01 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.166 2.578 . . . . 0.0 112.775 -173.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -136.38 150.01 48.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.377 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD21 ' HD3' ' A' ' 87' ' ' ARG . 33.1 tp -82.21 106.79 14.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -92.49 111.66 23.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.051 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.632 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 42.6 m -97.31 110.9 23.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.256 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -110.97 154.98 23.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.339 176.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.96 130.41 55.69 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 -167.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -65.19 126.34 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.18 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.6 -169.18 21.82 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.24 -16.73 56.64 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.443 2.095 . . . . 0.0 112.135 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -97.81 0.74 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.132 0.492 . . . . 0.0 110.087 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.49 -119.76 5.81 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 17' ' ' LEU . 91.7 m-85 -119.26 -24.55 6.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.114 0.457 . . . . 0.0 110.661 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.0 31.18 29.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.576 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -128.7 156.6 43.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.361 0.581 . . . . 0.0 110.056 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.441 ' CD2' HD23 ' A' ' 41' ' ' LEU . 69.5 m-70 -126.16 144.61 50.69 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -120.15 143.18 48.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -139.48 147.35 41.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.706 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.36 108.81 2.29 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.733 ' O ' ' HD2' ' A' ' 34' ' ' LYS . 9.1 mm-40 -70.53 147.01 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -67.4 116.93 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 50.81 2.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.784 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -134.76 -171.87 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 110.55 -177.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 pt? -129.4 -29.27 2.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.752 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.06 -163.95 12.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.04 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -111.93 155.69 23.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.892 0.377 . . . . 0.0 110.622 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.567 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 83.2 m-85 -131.16 151.9 50.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.534 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.1 mm -72.53 124.91 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.806 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 2.4 tmm_? -89.06 -40.73 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 7.7 tp -161.9 150.07 14.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.487 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 65.0 t -129.29 129.9 67.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -76.94 115.97 53.04 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.31 114.2 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.207 1.938 . . . . 0.0 111.051 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 40.81 2.75 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.842 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.775 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 34.3 p -119.64 -164.16 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 74.5 Cg_endo -90.31 -13.36 2.42 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.245 1.296 . . . . 0.0 112.919 163.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -73.81 -41.62 62.1 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -74.73 -35.14 62.66 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.392 1.091 . . . . 0.0 108.14 -174.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -57.29 -34.66 68.9 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.938 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -78.87 -17.32 55.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.24 24.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.618 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.69 130.44 37.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.765 0.317 . . . . 0.0 110.495 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.3 tp -137.31 150.83 48.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.999 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 94.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.272 0.558 . . . . 0.0 111.179 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.71 -25.25 1.05 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.1 m-20 -62.26 140.81 58.48 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.137 0.494 . . . . 0.0 111.231 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 38' ' ' TYR . 42.1 ttm180 -88.9 126.7 35.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.907 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 46.3 tp -80.46 117.36 21.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.02 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HB ' HD23 ' A' ' 89' ' ' LEU . 52.6 t -102.21 -37.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.463 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.65 149.73 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.632 -178.01 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 75' ' ' VAL . 86.8 t -137.05 117.68 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.617 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 60.44 37.42 19.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.386 0.613 . . . . 0.0 110.147 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.52 16.24 76.25 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.705 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 7.3 tp10 -125.16 135.15 52.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.519 -0.401 . . . . 0.0 110.957 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.508 HD22 ' HB2' ' A' ' 68' ' ' GLU . 6.6 t30 -70.02 113.96 7.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.375 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.9 m -111.99 26.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.327 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB2' HD22 ' A' ' 66' ' ' ASN . 81.2 mt-10 -61.24 -25.4 67.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.424 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 5.7 ptpp? -141.94 34.98 1.56 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.037 0.446 . . . . 0.0 111.543 -170.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mt-10 -110.56 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.019 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.3 p -113.48 167.62 10.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.6 t60 -56.71 -44.52 81.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.853 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.62 -46.01 90.24 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.607 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 56.8 mt-30 -61.38 -42.4 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 62' ' ' VAL . 74.3 t -64.97 -41.14 91.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.506 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 72' ' ' HIS . 73.1 t -58.01 -44.21 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.625 0.25 . . . . 0.0 111.425 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 p -64.0 -36.48 84.11 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.534 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 44.6 mtt-85 -64.94 -37.67 88.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 75' ' ' VAL . 77.2 mt -63.22 -32.8 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 110.268 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.6 mmt180 -70.34 -21.06 62.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -6.69 51.02 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -90.14 125.23 35.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.707 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.55 -75.86 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.144 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -118.64 -1.92 11.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.506 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.98 149.58 29.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 174.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.23 142.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.632 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 94.1 mtt180 -98.68 117.37 33.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.98 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.463 HD12 HD21 ' A' ' 17' ' ' LEU . 89.3 mt -121.75 125.92 47.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 10.4 tp -100.25 115.94 31.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.3 m -127.93 155.79 39.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.067 0.461 . . . . 0.0 110.375 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.3 p -148.0 154.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.039 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.62 123.37 56.93 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.95 -35.34 98.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.55 2.833 . . . . 0.0 113.246 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -72.22 -43.58 64.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.6 m -66.38 -37.43 85.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.689 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.51 ' HB2' HG13 ' A' ' 91' ' ' VAL . 30.5 t70 -57.92 -39.74 78.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.347 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -58.51 -49.05 78.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.281 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.546 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.3 pt20 -72.64 -39.59 67.08 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.765 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 102' ' ' LEU . 38.8 mt -70.48 -42.78 70.93 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -47.93 82.49 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.7 -18.92 65.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.685 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 95.8 mt -69.49 -20.84 63.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.54 33.09 4.59 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.058 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.26 132.1 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.049 0.452 . . . . 0.0 111.139 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 19.9 mp0 -87.08 88.58 7.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.91 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 12' ' ' PRO . 2.3 t -65.64 -29.62 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.121 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 15.1 ttp85 -60.69 -44.02 97.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -168.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -158.81 -34.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.965 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.848 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 8.4 tp10 -55.52 -39.51 70.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.6 tp -68.86 -20.86 64.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 mp . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 120.968 0.414 . . . . 0.0 110.857 -178.536 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 CA-C-O 121.458 0.524 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 11' ' ' LEU . 37.2 m-85 -153.97 145.11 22.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.74 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 10' ' ' MET . 1.5 t -142.68 -98.49 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.135 -169.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.47 ' H ' HG23 ' A' ' 9' ' ' THR . 82.6 mtp -97.41 -28.05 14.18 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 28.1 mt 76.36 160.09 0.15 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.083 167.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 58.5 Cg_endo -69.03 157.32 62.27 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.103 2.536 . . . . 0.0 112.732 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -129.75 126.27 37.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.8 tp -90.9 106.62 18.64 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.511 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.427 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 55.8 m -99.74 107.96 20.16 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.27 111.62 23.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.26 0.552 . . . . 0.0 110.126 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -114.89 165.43 12.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.386 -178.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.1 147.38 44.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.859 -170.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -72.03 107.52 4.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.41 -163.76 39.28 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.55 -26.72 81.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.74 2.293 . . . . 0.0 112.71 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -112.63 25.67 11.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.475 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -105.05 2.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.958 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' SER . 90.3 m-85 -131.7 -42.07 1.04 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.488 -0.419 . . . . 0.0 111.662 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 42.72 4.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.397 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.82 158.3 43.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.491 0.646 . . . . 0.0 110.171 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 60.8 m-70 -128.27 143.83 51.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.166 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.68 155.91 38.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.212 0.529 . . . . 0.0 111.748 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -140.17 139.1 35.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.43 117.57 5.57 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -74.75 134.87 41.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 111.38 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -59.82 108.33 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.945 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.6 -31.46 3.96 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 12.0 mptt -110.25 159.51 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 109.864 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 1.5 pp -106.51 -4.05 20.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.076 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.06 147.99 24.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 75' ' ' VAL . 33.8 mm-40 -103.33 152.4 21.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.953 0.406 . . . . 0.0 110.061 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -126.39 144.75 50.72 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.1 120.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.27 -47.2 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.9 tp -146.66 149.41 33.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -123.67 120.04 58.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.163 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 53.0 mm-40 -64.29 131.91 95.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.5 Cg_exo -70.89 123.85 10.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.887 1.725 . . . . 0.0 111.786 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.7 22.07 24.67 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.055 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 89.9 p -104.24 158.08 32.69 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.746 0.308 . . . . 0.0 110.564 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.75 -14.82 46.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.601 2.201 . . . . 0.0 111.7 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -66.47 -40.69 89.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.347 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HG2' HG11 ' A' ' 42' ' ' VAL . 28.8 mt-10 -64.94 -37.68 88.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.874 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.67 -29.11 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.006 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.16 -18.89 52.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.34 33.66 5.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 88' ' ' LEU . 83.4 mt -86.89 134.74 33.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.281 . . . . 0.0 110.444 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.71 153.33 51.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 128.1 34.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.468 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.71 -15.73 21.61 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.149 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 1.7 m-20 -78.29 147.18 34.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.925 0.393 . . . . 0.0 110.761 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 61.0 ttt180 -92.48 126.9 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.4 tp -77.58 112.79 14.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.163 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.532 ' HB ' HD23 ' A' ' 89' ' ' LEU . 40.8 t -104.88 -31.37 2.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.428 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -143.13 149.96 38.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.055 -0.403 . . . . 0.0 110.78 -178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.59 113.59 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.315 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.82 35.28 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.837 0.827 . . . . 0.0 110.844 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.66 10.96 69.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.147 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.7 tp10 -124.79 132.05 53.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.112 0.456 . . . . 0.0 110.868 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.26 108.95 3.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.7 16.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.698 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -76.39 7.54 4.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.46 23.48 2.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.668 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -109.25 -172.61 2.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.811 -174.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 69.5 p -128.19 175.22 8.61 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.551 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 t60 -61.57 -46.56 89.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -66.51 -41.46 88.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.846 0.355 . . . . 0.0 110.716 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 74.1 mt-30 -67.17 -38.71 85.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 37' ' ' GLN . 17.8 m -68.64 -41.18 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.08 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 72' ' ' HIS . 76.3 t -56.31 -39.13 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 m -61.94 -38.64 89.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.387 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 63.2 mtt-85 -67.37 -36.57 81.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.625 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 71.7 mt -63.17 -37.71 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.208 0.528 . . . . 0.0 110.004 175.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -68.96 -24.52 64.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.074 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.82 58.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.8 130.89 46.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.203 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.05 -67.05 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.858 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.37 -24.58 9.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.09 157.93 43.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.793 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.5 p -130.05 143.36 41.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 14' ' ' LEU . 9.9 mtm180 -98.74 128.51 45.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 53' ' ' LEU . 94.4 mt -122.12 110.57 15.92 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 11.9 tp -93.62 126.46 38.79 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.3 m -130.97 165.36 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 96' ' ' ASP . 8.7 p -148.14 140.1 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.569 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.5 p30 -75.1 145.12 80.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 50.4 Cg_exo -55.21 -31.52 76.47 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.017 3.145 . . . . 0.0 114.512 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.93 -47.89 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.777 0.323 . . . . 0.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.1 m -64.19 -44.78 90.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.622 0.725 . . . . 0.0 109.879 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 17.6 t70 -59.24 -39.64 83.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.507 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.48 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 1.9 tm-20 -57.41 -49.81 75.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.136 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.597 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 6.0 pt20 -73.96 -47.34 38.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 104' ' ' VAL . 2.7 mm? -58.76 -38.9 79.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 7.4 pt20 -64.53 -40.64 95.98 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.212 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 97' ' ' GLU . 44.1 mtmt -75.52 -34.98 60.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.878 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 90.6 mt -63.16 -27.3 69.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.606 -177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.61 73.92 0.9 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 99' ' ' LEU . 57.4 t -121.37 153.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.566 0.222 . . . . 0.0 110.605 -173.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 11.5 pt20 -71.22 57.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.36 0.6 . . . . 0.0 111.171 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.506 HG13 ' HG3' ' A' ' 12' ' ' PRO . 47.8 t -63.66 -27.57 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.775 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.549 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 39.4 ptt180 -60.61 -23.04 64.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -169.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 17.8 tt0 171.18 -41.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.418 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.0 mt-10 -54.47 -32.5 57.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.206 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 61.7 tp -70.28 -41.97 72.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 0.0 111.245 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.257 0.551 . . . . 0.0 111.135 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 CA-C-O 121.528 0.554 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -144.75 142.83 30.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.609 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 179.7 132.11 0.09 Allowed 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.496 0.498 . . . . 0.0 110.39 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.8 mtt 44.06 47.06 7.31 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.74 0.65 . . . . 0.0 111.622 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.75 135.74 96.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.363 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 54.4 Cg_endo -68.1 155.43 69.54 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.132 2.555 . . . . 0.0 113.518 -174.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -116.81 154.09 31.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.315 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.4 tp -82.06 115.48 21.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.8 m -93.41 115.85 28.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -104.38 112.21 25.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.727 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.66 155.68 34.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.182 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -104.34 145.77 29.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.512 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 26.0 ttpt -77.74 119.53 21.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.373 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.16 -158.36 25.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.701 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.12 -27.45 65.12 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.77 2.313 . . . . 0.0 112.457 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -110.25 26.1 11.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.274 0.559 . . . . 0.0 110.208 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 80.91 -100.58 1.99 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.5 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 87.1 m-85 -133.72 -22.63 1.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.302 0.551 . . . . 0.0 111.804 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.05 28.96 24.23 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.76 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -127.31 140.6 52.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 41' ' ' LEU . 93.6 m-70 -109.85 138.77 45.75 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.54 132.18 56.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.739 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.415 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 5.0 p80 -122.78 146.74 47.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.977 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.89 113.0 1.95 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.563 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 8.8 mm-40 -61.57 133.71 55.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.612 0.244 . . . . 0.0 110.833 -175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.12 98.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.276 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.01 -13.16 9.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.229 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 27.8 mmmt -91.54 155.66 18.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.2 pp -102.57 19.28 19.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.31 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.39 152.47 20.64 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.666 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -103.71 137.52 41.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.907 0.384 . . . . 0.0 110.578 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m-85 -125.08 155.41 39.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.013 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.33 127.83 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 3.9 tmm_? -101.14 -45.15 5.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.807 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -146.68 141.22 26.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.53 -172.56 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 41' ' ' LEU . 55.1 t -121.67 113.79 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.9 mm-40 -73.59 130.14 84.28 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.16 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.3 Cg_exo -70.13 124.04 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.367 2.044 . . . . 0.0 111.815 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.9 16.93 29.34 Favored Glycine 0 C--N 1.317 -0.496 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.899 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 95.9 p -101.71 159.54 29.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 0.0 110.829 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.96 -20.25 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.83 172.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -64.19 -42.13 96.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.21 -42.0 89.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.307 0.575 . . . . 0.0 110.362 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.65 -22.93 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.11 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -87.28 -17.83 31.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.901 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.67 29.96 5.71 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.202 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.13 133.51 36.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 tt -139.97 141.06 36.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.86 100.03 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.382 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.04 -31.23 1.74 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.9 m-20 -60.28 140.9 56.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.519 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -89.04 132.35 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.861 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 90' ' ' VAL . 32.7 tp -75.2 114.06 13.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.758 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG11 HG12 ' A' ' 106' ' ' VAL . 46.3 t -101.7 -36.45 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.07 150.25 35.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.003 -178.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.618 HG23 HG21 ' A' ' 67' ' ' VAL . 93.0 t -136.17 107.24 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.123 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.5 m120 62.99 22.4 13.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.346 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' A' ' 61' ' ' GLU . . . 106.67 4.22 36.94 Favored Glycine 0 C--N 1.321 -0.285 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.218 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.642 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.1 tp10 -109.09 128.7 55.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.725 0.298 . . . . 0.0 110.356 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -73.36 93.29 1.91 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.422 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 62' ' ' VAL . 35.7 m -95.41 35.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -173.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.48 -18.69 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.1 19.2 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.673 -177.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mp0 -93.93 141.12 28.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.99 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . 82.2 p -81.01 175.14 10.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.908 -174.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 21.9 t60 -53.84 -47.04 71.34 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.029 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.95 -40.97 91.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 84.1 mm-40 -62.86 -44.03 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.958 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 71' ' ' THR . 12.6 m -71.71 -44.96 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.7 t -59.22 -35.88 60.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.027 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 t -57.53 -40.95 79.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.317 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.642 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 68.2 mtt-85 -70.0 -37.68 75.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.44 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.8 mt -64.61 -37.92 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.353 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.776 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.48 -22.33 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 127.68 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.8 mp -78.06 -62.29 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.755 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -128.33 -12.58 5.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.379 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.55 31.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.628 0.251 . . . . 0.0 110.81 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.1 p -126.21 146.99 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.504 ' HB3' HD11 ' A' ' 14' ' ' LEU . 8.4 mtm180 -98.61 120.83 39.71 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 17' ' ' LEU . 92.6 mt -122.33 116.07 23.41 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.65 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 29.3 tp -101.54 117.37 34.77 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 25.8 m -131.04 153.77 39.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.943 0.402 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 96' ' ' ASP . 11.3 p -142.65 149.04 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.185 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.39 129.35 68.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.31 -34.11 88.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.61 2.873 . . . . 0.0 113.576 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.35 -43.34 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 17.3 m -66.39 -41.4 89.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HB2' HG13 ' A' ' 91' ' ' VAL . 14.0 t70 -58.84 -42.75 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.75 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.22 -47.03 84.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.019 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 13.6 pt20 -73.27 -38.67 65.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.0 111.001 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.97 -40.3 91.12 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -175.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.81 -37.18 85.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -71.67 -17.9 62.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.526 . . . . 0.0 110.655 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 77.0 mt -79.51 -3.85 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.906 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.84 41.71 72.26 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.104 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.91 137.64 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.859 0.361 . . . . 0.0 111.668 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 109' ' ' GLU . 17.3 mm-40 -79.33 54.64 1.73 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.475 HG12 HG11 ' A' ' 60' ' ' VAL . 1.5 t -60.57 -26.61 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.946 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.715 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -65.72 -5.44 8.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 33.3 tt0 168.55 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.934 0.397 . . . . 0.0 110.634 171.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 31.7 tt0 -55.54 -37.68 68.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.412 -172.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 110' ' ' LEU . 2.2 tm? -65.73 -26.79 67.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.97 -177.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.555 -177.912 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.856 0.274 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HD2' HD11 ' A' ' 11' ' ' LEU . 16.2 m-85 -144.81 151.87 39.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 -174.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.482 ' O ' HG21 ' A' ' 95' ' ' THR . 10.1 t 175.96 142.74 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -169.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 95' ' ' THR . 86.1 mtp 48.44 47.4 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.807 0.692 . . . . 0.0 111.651 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 2.0 mm? -72.8 157.61 88.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.515 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 37.7 Cg_endo -64.45 178.88 1.44 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.438 2.759 . . . . 0.0 113.709 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -143.3 149.37 37.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.626 -178.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 13.4 mt -84.22 108.01 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.6 m -94.38 108.41 20.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.044 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -95.1 111.85 23.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.915 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -122.04 150.79 41.61 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.42 147.83 29.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.558 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -69.43 97.53 1.0 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.653 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 -167.09 14.56 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.836 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.23 -34.2 98.15 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.928 2.418 . . . . 0.0 112.261 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -102.34 24.37 10.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.547 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.63 64.27 3.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.37 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.7 m-85 78.74 -38.57 0.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.215 1.006 . . . . 0.0 111.374 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.617 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.51 12.45 53.83 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -123.35 149.76 44.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.126 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.492 ' CD2' HD23 ' A' ' 41' ' ' LEU . 39.6 m-70 -124.3 131.94 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.806 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -104.71 142.05 35.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.42 -172.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 2.9 p-80 -133.42 134.93 44.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.149 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.39 104.04 2.15 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.585 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.5 mt-10 -60.39 146.37 44.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.095 0.474 . . . . 0.0 111.635 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.78 117.98 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.636 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.0 -38.3 3.36 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.851 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.585 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 70.7 mmtt -66.85 157.18 33.71 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.503 HD13 ' HG2' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -113.0 5.08 17.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.88 165.69 16.65 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.676 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 75' ' ' VAL . 3.1 mp0 -103.66 148.56 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.804 0.335 . . . . 0.0 110.411 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' HB2' ' CE1' ' A' ' 29' ' ' HIS . 32.6 m-85 -131.44 154.47 48.65 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.91 113.41 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 ttp180 -85.48 -47.51 9.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.491 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 27' ' ' HIS . 26.7 tp -145.7 142.49 29.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.704 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 54' ' ' LEU . 1.7 p -135.66 112.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -78.87 135.43 59.25 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.68 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' CD ' ' A' ' 49' ' ' GLU . 27.8 Cg_exo -61.67 129.17 26.82 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.609 2.206 . . . . 0.0 112.057 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.79 1.38 45.99 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.942 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.617 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 96.0 p -93.76 152.14 40.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.156 0.503 . . . . 0.0 110.947 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.24 -13.7 41.04 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.86 2.373 . . . . 0.0 112.17 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.98 -39.96 95.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.001 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' CD ' ' HA ' ' A' ' 44' ' ' PRO . 30.1 mt-10 -62.92 -39.46 94.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.963 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -65.6 -29.84 70.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.934 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.12 -19.42 51.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.331 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.63 49.98 1.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -124.68 121.13 33.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.17 171.24 10.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.729 173.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.55 78.62 6.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.39 0.614 . . . . 0.0 111.191 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.33 -21.2 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.957 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 67.3 m-20 -63.97 141.75 58.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.686 0.279 . . . . 0.0 111.114 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.18 124.92 34.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.78 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.578 ' HA ' HG12 ' A' ' 90' ' ' VAL . 51.8 tp -78.4 119.48 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 106' ' ' VAL . 60.2 t -103.78 -34.97 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.388 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 16.6 tt0 -150.55 151.18 32.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.761 0.315 . . . . 0.0 111.17 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG23 HG21 ' A' ' 67' ' ' VAL . 65.6 t -132.4 119.92 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.469 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 72.9 -26.1 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.027 0.931 . . . . 0.0 111.729 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 145.16 10.68 0.28 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.604 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.3 tp10 -125.81 128.97 48.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.44 132.41 53.64 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.456 0.472 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 HG12 ' A' ' 75' ' ' VAL . 33.0 m -128.16 29.55 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.8 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.72 -24.28 66.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.503 ' HG2' HD13 ' A' ' 35' ' ' LEU . 98.3 mttt -129.95 29.83 4.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.813 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 15.9 mm-40 -95.19 179.93 5.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.934 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.65 ' OG1' ' HB2' ' A' ' 74' ' ' GLN . 25.1 p -107.63 167.62 9.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.695 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 48.5 t-80 -62.69 -44.13 97.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -64.83 -36.75 85.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 0.0 109.973 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.65 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -62.96 -45.4 92.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.819 -177.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG12 HG11 ' A' ' 67' ' ' VAL . 4.7 m -71.32 -40.14 73.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.348 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' HIS . 45.1 t -57.55 -36.92 55.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.6 t -57.96 -41.53 83.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -69.09 -36.69 77.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -64.22 -32.8 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 109.906 176.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -21.34 62.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.847 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.09 -18.35 46.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.424 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.18 119.07 26.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.832 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.96 -62.85 1.43 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.295 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -107.15 -27.52 10.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.306 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.63 155.06 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.994 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 24' ' ' TYR . 9.8 p -131.5 153.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.802 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -106.7 125.19 50.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 99.5 mt -120.37 127.68 52.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.2 tp -103.37 116.73 32.98 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.7 m -130.54 153.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -131.9 148.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.296 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.0 m-20 -68.24 123.14 86.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 33.0 Cg_exo -57.62 -31.74 92.61 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.541 2.827 . . . . 0.0 113.318 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.77 -48.46 81.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 109.897 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 9' ' ' THR . 2.6 m -73.67 -36.04 65.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.261 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.07 -40.42 76.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 43.7 mt-10 -61.04 -43.51 98.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.775 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -74.41 -39.89 62.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.076 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 mt -64.94 -34.18 77.8 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 18.1 pt20 -60.17 -34.33 73.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.42 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -71.71 -37.77 70.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.321 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 99' ' ' LEU . 27.2 mt -76.89 -44.51 31.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.458 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.58 94.19 0.16 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.05 95.54 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.14 0.971 . . . . 0.0 112.072 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -113.08 28.33 8.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.418 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.807 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 21.8 m -66.35 -14.19 17.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.551 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.29 -37.76 75.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -166.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HD23 ' A' ' 111' ' ' LEU . 39.0 tt0 -162.13 -19.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.175 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.26 -36.2 65.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.722 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 3.9 mm? -77.92 -28.64 49.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.087 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.6 mm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.235 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.62 ' HA ' HD13 ' A' ' 102' ' ' LEU . 30.0 Cg_endo . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 113.298 0.461 . . . . 0.0 113.298 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.525 ' HD1' HD21 ' A' ' 11' ' ' LEU . 16.2 m-85 -146.01 150.05 35.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.066 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -173.71 126.58 0.39 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.453 -171.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt 72.8 -71.0 0.14 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.884 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.525 HD21 ' HD1' ' A' ' 8' ' ' PHE . 2.8 mm? 65.74 156.89 0.13 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.778 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 72.4 Cg_endo -74.01 158.99 45.35 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.774 2.316 . . . . 0.0 112.553 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -115.33 143.98 44.45 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.737 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -83.19 106.3 14.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.3 m -96.24 108.52 21.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.671 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 22.0 m -91.82 111.75 23.4 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 48' ' ' ALA . 21.1 mt -88.27 163.65 15.99 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 41.6 mt-10 -115.34 121.85 44.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.19 101.75 2.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.932 0.396 . . . . 0.0 110.666 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.59 -157.87 33.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.709 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 -26.82 73.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.59 14.8 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 -124.44 6.47 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.155 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 86' ' ' VAL . 91.4 m-85 -108.47 -22.55 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.896 0.379 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.06 33.94 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.112 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.17 149.9 52.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.458 0.629 . . . . 0.0 110.182 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -105.78 134.53 48.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.3 tp -119.87 124.25 45.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.1 p80 -123.88 146.0 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.074 -175.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.62 105.01 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.941 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.613 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 41.8 mt-10 -74.78 -178.33 3.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.655 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -99.2 138.68 35.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.64 -1.46 60.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.957 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -104.65 -173.95 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.612 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -127.99 -12.67 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.588 174.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.12 -173.41 13.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.898 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -105.66 149.78 26.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.661 0.267 . . . . 0.0 110.658 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -125.91 152.17 45.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.532 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.3 mm -70.57 122.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.691 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.585 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -91.7 -48.52 6.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.973 -177.079 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.548 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 2.8 tp -154.93 152.09 29.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 54.8 t -119.52 115.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.19 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 69.4 mm-40 -62.94 127.66 91.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 7.6 Cg_exo -69.77 109.72 2.38 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.215 1.943 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.91 28.76 4.88 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.507 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 96.7 p -115.18 161.38 29.85 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.712 0.291 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 50' ' ' LYS . 38.6 Cg_endo -66.86 -13.41 39.83 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.132 2.555 . . . . 0.0 112.501 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.55 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -65.67 -39.94 91.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.359 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.41 -46.98 74.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 47' ' ' PRO . 21.2 ptmt -61.12 -34.77 75.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.951 -174.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.04 -17.68 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 58.92 0.71 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.494 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.7 mp -120.11 126.31 50.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 54' ' ' LEU . 2.9 mm? -127.84 166.6 17.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.3 0.571 . . . . 0.0 110.826 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.9 105.48 6.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.263 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.92 -24.73 2.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.175 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.586 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 27.8 m-20 -63.87 144.4 57.09 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -95.75 133.05 40.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 90' ' ' VAL . 28.9 tp -73.33 110.37 7.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.004 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -95.33 -45.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.073 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -143.59 149.78 37.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.602 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 67' ' ' VAL . 82.3 t -137.04 119.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.965 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.29 37.79 13.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.2 5.86 82.3 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.526 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' VAL . 32.9 tt0 -126.09 128.75 47.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.17 0.485 . . . . 0.0 111.07 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -58.86 119.95 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.702 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 62' ' ' VAL . 36.0 m -116.96 21.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.411 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.0 -14.89 61.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.86 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -122.69 19.01 10.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.964 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 21.6 mm-40 -92.0 -176.82 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.039 0.447 . . . . 0.0 111.202 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 75' ' ' VAL . 55.5 p -115.19 169.34 9.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.853 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.4 t60 -55.1 -47.0 75.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.741 0.305 . . . . 0.0 110.263 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -65.6 -46.35 79.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.444 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -62.57 -40.64 97.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.45 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 71' ' ' THR . 15.9 m -70.18 -42.98 79.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.668 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 72' ' ' HIS . 71.3 t -58.64 -36.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.731 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.8 m -59.52 -40.15 86.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 110.184 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.21 -36.85 82.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.34 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 76' ' ' VAL . 74.0 mt -63.53 -38.04 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.659 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.2 mmt180 -71.82 -22.71 61.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.666 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.23 -19.28 63.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.374 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -82.06 127.89 33.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.85 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.62 -71.15 0.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.465 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -108.45 -17.66 13.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.353 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.514 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.276 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 ' CE1' ' A' ' 24' ' ' TYR . 7.5 p -131.4 146.64 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.612 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 98.6 mtt180 -98.68 119.88 38.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.205 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.7 mt -121.67 121.96 38.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.396 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.9 tp -102.42 118.27 36.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.231 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 23.8 m -128.59 153.49 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.612 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 150.17 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.483 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 5.1 m-20 -71.8 116.16 45.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.446 174.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 43.1 Cg_exo -58.07 -24.89 68.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.897 2.398 . . . . 0.0 112.277 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 7.1 pt-20 -65.31 -47.79 75.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.059 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 m -73.75 -38.83 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.488 . . . . 0.0 110.909 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 11.8 t70 -58.48 -32.16 68.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.78 -48.28 80.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.397 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -74.28 -40.14 62.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.015 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.84 -38.3 85.04 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 46.8 mt-30 -58.07 -35.9 72.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.417 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -72.66 -19.43 61.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 7' ' ' PRO . 16.2 mt -101.55 -35.09 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.3 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.79 86.21 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.956 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 106' ' ' VAL . 3.0 p -85.45 102.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.772 0.796 . . . . 0.0 111.942 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -126.71 49.18 2.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.109 0.957 . . . . 0.0 108.504 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 30.7 m -67.17 -13.42 16.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.063 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.59 -35.43 72.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -163.081 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' HD12 ' A' ' 111' ' ' LEU . 22.5 tt0 -164.66 -22.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.191 0.52 . . . . 0.0 110.986 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -55.39 -45.57 76.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.526 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 110' ' ' LEU . 3.5 mm? -78.16 -18.54 55.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 89' ' ' LEU . 73.3 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.228 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 CA--C 1.522 -0.095 0 CA-C-O 120.776 0.24 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.33 156.2 36.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.897 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -170.42 127.52 0.8 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.151 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.554 ' HB3' HG21 ' A' ' 95' ' ' THR . 26.1 ttt 43.9 64.03 1.41 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.902 0.751 . . . . 0.0 111.302 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.84 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -75.81 146.85 80.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 -176.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.114 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 55.2 Cg_endo -67.15 140.14 52.91 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 123.342 2.695 . . . . 0.0 112.274 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -113.71 140.68 48.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.967 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.53 105.01 12.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.626 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 56.3 m -96.09 113.07 24.65 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.891 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.32 115.98 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.151 0.501 . . . . 0.0 109.851 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 24' ' ' TYR . 15.1 mt -98.59 147.55 24.69 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.396 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -100.17 122.43 42.99 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -65.75 111.31 3.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.85 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.44 -160.5 36.54 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.889 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.44 -29.65 71.63 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.777 2.318 . . . . 0.0 112.417 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -113.19 31.99 6.05 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -116.0 4.13 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.215 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 17' ' ' LEU . 45.8 m-85 -125.16 -25.67 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.985 0.393 . . . . 0.0 111.274 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.58 30.44 11.85 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.562 -0.828 . . . . 0.0 114.026 172.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -125.46 152.2 45.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.577 0.688 . . . . 0.0 110.051 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 51.1 m-70 -117.52 139.3 51.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.391 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.35 127.84 49.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.064 -169.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.0 p80 -116.55 133.54 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.34 6.79 42.66 Favored Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.989 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.818 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 11.7 mm-40 64.16 172.3 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.816 0.817 . . . . 0.0 112.708 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -125.14 101.26 6.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.296 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.69 -19.19 10.53 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -98.44 -177.24 3.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.235 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.0 pt? -141.22 35.72 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.858 0.361 . . . . 0.0 110.952 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.94 155.72 24.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.833 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.542 ' HG3' HG21 ' A' ' 75' ' ' VAL . 68.2 mm-40 -104.0 137.22 42.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.553 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 7.2 m-85 -134.07 152.9 52.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.729 0.3 . . . . 0.0 110.633 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.46 120.37 18.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -99.12 -26.81 14.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.598 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.6 tp -163.93 150.15 11.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.7 t -125.24 118.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.395 173.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 40.5 mm-40 -64.17 129.87 94.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.0 Cg_exo -69.3 123.11 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.075 1.85 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.44 20.58 26.85 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.593 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 90.7 p -104.17 159.3 29.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.87 -21.31 56.73 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.695 2.263 . . . . 0.0 111.887 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -61.73 -38.78 89.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.151 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.426 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 21.3 mt-10 -71.08 -33.1 69.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.31 -36.69 77.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.41 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -80.44 -17.98 50.14 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.115 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 38.32 4.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.525 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.62 127.79 34.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 tp -121.02 141.48 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.67 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.62 102.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.331 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.9 -28.3 2.01 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.394 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 31.7 m-20 -62.23 139.41 58.5 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.595 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 42.7 ttp180 -89.75 132.68 35.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.2 tp -74.72 112.5 10.99 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.729 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG13 ' CD ' ' A' ' 68' ' ' GLU . 57.3 t -95.7 -44.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.24 -175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -145.58 150.04 35.66 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.619 -175.243 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.588 HG21 HG13 ' A' ' 75' ' ' VAL . 92.3 t -137.13 116.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m120 62.2 30.38 17.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.471 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.52 7.01 58.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.553 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.5 tp10 -125.53 135.4 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.603 0.701 . . . . 0.0 111.684 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -67.25 117.16 8.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.822 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 62' ' ' VAL . 29.6 m -117.9 26.38 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CD ' HG13 ' A' ' 60' ' ' VAL . 53.8 mt-10 -73.53 -19.7 60.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.836 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -122.06 21.48 10.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.599 0.714 . . . . 0.0 109.84 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 2.5 mp0 -101.54 153.82 19.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.472 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.8 p -77.1 162.32 27.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.354 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -56.38 -42.31 77.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.85 0.357 . . . . 0.0 110.166 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 48.7 tt0 -66.66 -40.79 88.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.053 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 88.7 mt-30 -62.01 -39.97 94.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 0.0 110.669 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 62' ' ' VAL . 93.5 t -67.24 -50.44 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.324 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 73' ' ' GLN . 26.8 m -61.08 -35.34 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 111.631 -177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 t -57.99 -43.12 86.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 83.7 mtt-85 -64.55 -39.9 94.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.999 0.428 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.7 -33.13 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -73.13 -20.99 60.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.123 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.8 -17.57 55.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.809 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.76 30.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.9 -66.98 0.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.645 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -116.23 -19.43 10.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.452 . . . . 0.0 110.351 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 153.66 35.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.317 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -127.55 145.23 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -107.83 117.56 34.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.06 123.35 45.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.487 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 111' ' ' LEU . 37.8 tp -97.12 120.01 36.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 21.4 m -132.09 154.96 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.727 0.298 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.828 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.2 p -147.15 140.96 19.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.963 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.93 119.26 43.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.797 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.595 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 35.9 Cg_exo -59.33 -32.36 96.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.52 2.813 . . . . 0.0 113.018 -172.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.94 -37.46 69.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.848 0.356 . . . . 0.0 110.189 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.8 m -72.14 -38.61 69.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 173.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.92 -35.66 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.245 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 43.9 tt0 -58.23 -37.6 75.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 72.9 mt-30 -72.07 -48.82 41.35 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.3 mt -62.69 -35.79 80.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.511 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -64.1 -36.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.604 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 65.0 mmtt -71.04 -25.1 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.518 . . . . 0.0 109.837 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 14.8 mt -82.61 -10.25 59.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.747 -177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.7 19.88 42.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.256 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -92.51 142.54 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.654 -0.321 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -116.91 98.16 6.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.114 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.3 m -65.7 -13.96 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.668 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 60.3 mtp180 -58.41 -29.53 66.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -167.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 9.2 tm-20 175.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -54.06 -38.36 65.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.244 0.545 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 11' ' ' LEU . 66.8 tp -77.38 -27.32 52.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.46 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.89 HD21 HD13 ' A' ' 89' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.465 0.316 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.706 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.471 0.192 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.64 146.19 6.86 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -163.29 136.59 5.67 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.711 ' HB2' HG21 ' A' ' 95' ' ' THR . 61.8 mtt 57.18 45.82 19.93 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.873 0.733 . . . . 0.0 109.676 176.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.25 145.62 89.93 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.643 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.012 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.6 Cg_endo -70.97 149.06 58.56 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.297 2.665 . . . . 0.0 112.647 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HD2' HH11 ' A' ' 13' ' ' ARG . 47.1 mtm180 -119.2 142.58 47.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.41 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 89' ' ' LEU . 58.9 tp -82.64 108.6 16.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.611 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.9 m -108.75 118.86 37.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.217 -169.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -95.04 133.86 38.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.016 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -133.91 153.46 51.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.721 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -100.34 151.4 21.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 0.0 110.349 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 34.6 ttpt -87.85 115.11 25.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.834 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.45 -154.12 29.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.303 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.9 -29.58 58.07 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.278 2.652 . . . . 0.0 111.96 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.67 28.47 8.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.294 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 82.1 -146.38 25.19 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.708 -177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 85.0 m-85 -93.29 -22.88 18.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.959 0.38 . . . . 0.0 111.234 -176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 30.1 22.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.216 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -131.03 157.45 42.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.212 0.506 . . . . 0.0 109.959 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' CD2' HD23 ' A' ' 41' ' ' LEU . 84.8 m-70 -127.26 145.11 50.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 37' ' ' GLN . 23.4 tp -122.92 137.18 55.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.773 0.321 . . . . 0.0 111.776 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 2.9 p80 -133.25 140.29 47.42 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.06 2.42 20.98 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 58.25 -169.3 0.12 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.709 0.403 . . . . 0.0 111.094 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -131.56 133.2 44.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.2 -21.13 46.96 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -86.32 173.61 9.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.4 pt? -130.98 16.52 5.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.24 161.94 25.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.711 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 34.9 mm-40 -103.3 145.36 30.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.404 . . . . 0.0 110.304 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.9 m-85 -128.73 150.94 50.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.722 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -70.7 125.16 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -91.7 -36.33 13.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 14.6 tp -164.08 148.33 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.469 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -125.01 118.72 53.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.169 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -63.9 128.34 92.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.462 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.78 127.73 22.37 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.302 2.001 . . . . 0.0 112.557 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.04 75.13 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.192 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.494 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 87.7 p -84.6 164.47 42.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.814 0.307 . . . . 0.0 110.583 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 12.3 Cg_endo -57.71 -26.32 72.48 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.555 2.17 . . . . 0.0 112.176 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.29 -31.8 73.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 3.7 mt-10 -69.74 -28.55 65.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.12 -37.07 84.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 110.119 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -78.96 -17.31 55.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.235 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.7 29.67 7.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.0 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.56 138.0 32.99 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.682 -0.305 . . . . 0.0 110.514 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.3 tt -145.59 143.13 29.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 41' ' ' LEU . . . -59.56 103.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.293 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -31.63 1.57 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.717 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 14.7 m-20 -61.54 141.49 57.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -89.36 124.99 34.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.394 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.555 ' HA ' HG12 ' A' ' 90' ' ' VAL . 48.2 tp -78.39 112.46 15.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.893 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.419 HG23 ' HG ' ' A' ' 89' ' ' LEU . 5.0 m -105.94 -26.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -146.41 150.64 36.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.778 0.323 . . . . 0.0 111.21 175.497 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG21 HG13 ' A' ' 75' ' ' VAL . 62.1 t -136.39 113.81 13.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 57.0 41.3 27.86 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.528 0.517 . . . . 0.0 112.344 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.85 -8.38 59.6 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.359 171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 78' ' ' ARG . 44.2 tt0 -126.36 128.62 47.35 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.127 0.963 . . . . 0.0 109.613 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 64.7 m-80 -69.53 135.13 49.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.235 -174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 23.1 m -118.91 24.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.922 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 8.0 mt-10 -54.84 -33.15 61.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.508 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HE3' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -131.48 21.06 4.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.71 -175.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 1.4 mp0 -98.15 161.56 13.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.118 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.1 p -89.54 165.13 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.728 -172.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.3 t60 -58.62 -46.62 86.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.95 -41.48 96.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.843 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 98.2 mt-30 -63.57 -43.78 96.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG13 HG21 ' A' ' 62' ' ' VAL . 94.1 t -63.7 -46.2 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.419 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 72' ' ' HIS . 95.5 t -59.94 -39.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 0.0 110.991 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 m -58.45 -38.13 76.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 86.6 mtt-85 -61.73 -34.61 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.331 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.91 -31.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 -177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -69.88 -22.67 63.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 110.731 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.76 62.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.109 0.481 . . . . 0.0 110.07 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -72.32 121.09 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.837 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.78 -61.27 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.703 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.48 -7.26 4.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.23 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.78 154.48 36.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.513 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.2 p -130.65 144.59 37.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -101.55 117.63 35.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.486 HD12 HD21 ' A' ' 17' ' ' LEU . 98.5 mt -119.9 123.23 43.09 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 45.0 tp -101.9 118.32 36.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.587 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 59' ' ' LEU . 28.5 m -131.36 158.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.0 p -135.11 144.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.703 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.16 126.71 61.87 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.624 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' A' ' 57' ' ' ASP . 19.9 Cg_endo -58.7 -40.18 75.52 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.714 2.942 . . . . 0.0 113.929 -170.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 95' ' ' THR . 8.3 pt-20 -72.35 -39.86 67.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 10' ' ' MET . 1.8 m -71.76 -36.51 70.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 91' ' ' VAL . 6.7 t70 -56.88 -43.89 81.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.707 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 32.5 mt-10 -67.92 -36.42 80.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.686 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.22 -39.17 60.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.443 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 102' ' ' LEU . 53.6 mt -67.41 -31.95 72.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 23.6 pt20 -56.62 -36.71 69.77 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -172.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.44 -20.08 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.691 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 99' ' ' LEU . 55.7 mt -84.02 -40.11 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.242 0.544 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.56 0.52 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.412 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 107' ' ' ARG . 18.6 m -85.09 41.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.825 0.821 . . . . 0.0 110.427 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -83.44 5.31 24.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.197 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.012 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 2.5 m -65.12 -15.71 18.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.197 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.535 HH21 HG21 ' A' ' 104' ' ' VAL . 27.7 mtt180 -59.65 -32.19 70.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.027 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 51.0 tt0 171.65 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.703 0.627 . . . . 0.0 109.363 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -55.67 -51.84 65.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.629 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.8 tp -60.19 -30.14 69.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.773 0.321 . . . . 0.0 110.602 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.382 -176.478 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.464 -0.222 0 CA-C-O 121.262 0.442 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 110' ' ' LEU . 2.6 m-85 -150.95 147.0 26.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.544 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -157.26 122.67 4.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.981 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt 62.74 65.54 0.82 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.708 0.766 . . . . 0.0 109.991 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -81.59 138.09 47.7 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.807 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.008 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 66.5 Cg_endo -72.83 171.15 17.98 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.171 2.58 . . . . 0.0 113.653 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 156.56 46.82 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.694 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' HD23 ' A' ' 111' ' ' LEU . 32.8 tp -83.99 117.91 23.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 41.3 m -94.53 111.22 22.98 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.8 p -100.69 111.09 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 110.195 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -116.6 146.61 42.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.408 -177.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.14 141.6 44.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.1 -170.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.0 ttmt -68.07 119.57 12.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.926 0.393 . . . . 0.0 111.201 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.1 -149.32 25.34 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.267 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.62 -27.27 45.67 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.947 2.432 . . . . 0.0 112.468 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -132.86 53.03 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 0.0 110.497 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 79.14 -121.6 5.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.441 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.558 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.6 m-85 -123.15 -27.74 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.38 29.31 9.6 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.322 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -141.1 143.2 34.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.308 0.554 . . . . 0.0 110.328 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -129.68 143.46 50.83 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.91 150.05 32.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.978 -173.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -134.73 144.01 47.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.325 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.43 114.94 3.93 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.77 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 38.5 mt-10 -55.58 125.45 21.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 20.8 tptp -67.42 133.95 50.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.34 -15.41 63.02 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.722 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -100.91 178.33 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -129.93 25.29 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.46 166.61 25.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.857 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -104.24 136.91 42.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 0.0 110.594 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.43 157.36 30.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.544 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.0 mm -71.35 114.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -85.19 -43.14 14.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.2 tp -149.37 141.95 24.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.415 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.84 114.51 46.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -70.73 112.93 14.84 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 14.0 Cg_endo -58.32 121.55 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 112.232 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.96 13.78 26.43 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.082 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.501 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 89.8 p -103.91 160.22 26.8 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 37.1 Cg_endo -66.46 -16.19 50.29 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.803 2.335 . . . . 0.0 112.106 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.117 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 42.2 mt-10 -63.06 -43.64 98.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.6 mttm -62.72 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.31 -19.66 31.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.269 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 44.36 1.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.551 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.0 mt -102.67 146.95 27.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 174.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tt -145.96 143.62 29.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.77 101.48 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.4 -25.41 1.85 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.97 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 71.0 m-20 -75.28 148.56 39.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -92.74 133.57 35.9 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.445 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 40.7 tp -75.91 107.12 7.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.648 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.872 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 47.2 t -95.31 -33.96 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -175.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -147.09 150.55 35.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 0.0 111.008 -178.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 81.3 t -136.58 113.83 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.096 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.46 33.27 20.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.077 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.65 16.13 60.55 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.859 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -123.87 135.23 53.61 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.591 -0.358 . . . . 0.0 110.617 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.404 ' CG ' HH12 ' A' ' 107' ' ' ARG . 3.4 t-20 -73.55 114.75 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.663 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 62' ' ' VAL . 17.4 m -128.47 11.53 2.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -172.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.872 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -72.34 -21.7 61.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.768 -174.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 33.8 mtmm -110.23 18.21 20.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.215 174.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 36.9 mm-40 -97.3 175.57 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.314 0.578 . . . . 0.0 111.97 -176.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.4 p -89.58 173.98 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.073 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 76' ' ' VAL . 61.8 t60 -65.31 -44.43 87.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 175.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.79 -39.29 90.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.71 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 11.1 mm-40 -61.39 -45.82 92.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.05 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 79' ' ' ILE . 18.6 m -68.68 -45.15 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.369 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 80.2 t -54.7 -43.77 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.994 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -60.27 -41.26 92.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 75.1 mtt-85 -69.18 -36.23 77.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.189 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 86' ' ' VAL . 89.1 mt -62.26 -42.19 94.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 7.8 mpt_? -64.89 -20.79 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.16 64.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.65 0.262 . . . . 0.0 111.507 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.641 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -69.27 142.29 54.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.308 0.575 . . . . 0.0 110.746 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 -56.55 4.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.884 -175.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -123.87 -28.75 3.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.8 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -146.18 143.42 29.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.359 -172.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -109.56 158.4 9.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.142 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.26 119.21 38.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 88.2 mt -119.7 128.54 53.9 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.902 0.382 . . . . 0.0 110.831 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 15.6 tp -106.46 121.8 45.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.978 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.7 m -131.69 155.29 41.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.05 0.452 . . . . 0.0 110.983 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.79 150.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.074 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 18.3 t70 -64.5 120.51 66.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 32.9 Cg_exo -60.89 -29.46 88.15 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.448 2.765 . . . . 0.0 113.208 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.8 -47.87 50.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 20.3 m -66.24 -37.18 84.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 22.0 t70 -58.5 -36.14 73.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.61 -48.16 81.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.8 pt20 -71.63 -38.79 70.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.47 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.83 -33.87 73.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.749 0.309 . . . . 0.0 110.926 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 67.3 mt-30 -57.86 -41.61 82.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.927 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -71.12 -21.26 62.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.982 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.38 -43.03 8.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.369 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.2 84.69 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -66.85 90.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 122.228 1.013 . . . . 0.0 111.834 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mt-30 -103.14 22.1 14.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.16 177.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.008 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.9 m -66.0 -18.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.582 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 66' ' ' ASN . 5.8 ptp180 -63.38 -33.73 76.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -170.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -179.68 -27.83 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.104 0.478 . . . . 0.0 109.995 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 5.0 mm-40 -55.74 -40.95 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.312 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 8' ' ' PHE . 52.8 mt -78.72 -17.48 55.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 111.898 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.571 HD21 HD13 ' A' ' 89' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.32 -0.709 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 121.346 0.477 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.611 ' CZ ' ' HB ' ' A' ' 104' ' ' VAL . 7.3 m-85 -149.01 150.88 33.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 9' ' ' THR . 7.3 t -172.16 101.98 0.17 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.875 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.1 tpt 69.42 64.06 0.27 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -172.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.7 pt? -80.15 160.1 69.03 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.933 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.88 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 73.7 Cg_endo -73.35 165.76 31.71 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.768 2.312 . . . . 0.0 113.049 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -143.16 146.19 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 111' ' ' LEU . 47.0 tp -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -93.66 115.89 28.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.45 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 m -103.97 111.24 23.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.808 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -117.21 154.63 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.845 -177.123 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -111.59 136.51 50.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.565 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 38.9 ttmt -67.27 131.09 45.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.341 0.591 . . . . 0.0 111.928 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.86 -148.74 10.45 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.618 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.27 -2.67 12.72 Favored 'Trans proline' 0 N--CA 1.472 0.209 0 C-N-CA 123.157 2.572 . . . . 0.0 112.444 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -128.08 22.22 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.235 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 77.28 -106.11 2.17 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 -172.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.0 m-85 -127.79 -15.93 4.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.1 0.45 . . . . 0.0 111.332 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.19 32.57 43.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.102 -0.57 . . . . 0.0 114.078 173.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.26 151.79 50.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.618 0.709 . . . . 0.0 110.225 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.475 ' CD2' HD23 ' A' ' 41' ' ' LEU . 26.1 m-70 -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 37' ' ' GLN . 14.1 mt -118.45 151.36 37.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.106 0.479 . . . . 0.0 111.809 -177.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.6 p80 -130.86 144.84 51.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.67 108.65 3.04 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 33.4 mm-40 -71.51 125.0 25.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.073 0.464 . . . . 0.0 110.176 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.05 133.75 52.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.107 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.6 -28.22 11.82 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.819 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 12.1 mptt -93.13 -32.75 14.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.837 0.351 . . . . 0.0 111.383 -177.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt 74.65 -50.32 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.578 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.61 157.95 8.14 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.683 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.461 ' HB3' HD22 ' A' ' 28' ' ' LEU . 35.8 mm-40 -102.09 144.64 30.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.033 0.445 . . . . 0.0 110.11 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.572 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 19.5 m-85 -122.53 152.15 40.65 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mm -70.83 108.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -81.12 -42.9 20.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 27' ' ' HIS . 22.9 tp -147.31 145.27 29.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.162 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -135.76 120.96 28.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -63.99 126.07 89.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.59 -172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.52 109.06 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.316 2.011 . . . . 0.0 111.721 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.84 12.91 21.46 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.987 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 88.1 p -91.57 159.4 38.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.7 Cg_endo -69.07 -13.66 36.83 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.555 2.17 . . . . 0.0 112.355 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.616 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -67.51 -45.45 75.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.726 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.71 -39.14 83.64 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.39 0.614 . . . . 0.0 110.207 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -75.96 -11.17 59.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.399 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.07 -17.61 25.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.105 0.479 . . . . 0.0 110.237 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.75 53.05 0.72 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.2 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.31 114.74 16.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.466 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.8 tp -118.0 162.12 18.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.06 43.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.961 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.22 5.6 0.32 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.416 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.9 m-20 -91.1 146.6 23.71 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.622 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 41.0 ttp180 -99.78 130.33 45.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 41.7 tp -77.71 109.16 11.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.216 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.68 -42.84 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.11 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -144.21 150.84 38.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 0.0 110.427 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 75' ' ' VAL . 61.3 t -135.78 107.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.238 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 58.74 39.06 24.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.129 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.68 35.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.718 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.89 136.68 54.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.298 1.049 . . . . 0.0 111.826 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -67.95 115.72 7.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.535 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 29.0 m -102.57 18.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -67.3 -16.7 64.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.336 0.588 . . . . 0.0 111.211 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -122.5 22.29 9.98 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.947 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 33.9 mm-40 -105.07 -173.62 2.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.1 p -117.16 173.93 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.1 t60 -60.49 -47.06 87.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.872 0.368 . . . . 0.0 110.153 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.71 -44.76 89.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.823 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 51.3 mt-30 -63.89 -41.32 97.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 HG21 ' A' ' 62' ' ' VAL . 55.1 t -62.79 -44.99 99.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.133 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 72' ' ' HIS . 96.9 t -61.15 -38.68 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -60.13 -38.21 82.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 110.402 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 77.0 mtt-85 -68.48 -36.04 78.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.697 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.6 -35.82 75.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.163 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 40.0 mmt180 -68.6 -21.96 64.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.98 95.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.619 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -77.2 132.79 38.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.299 0.571 . . . . 0.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.47 -68.05 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.41 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -110.87 -16.66 13.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -150.43 134.98 17.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -110.68 158.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HD3' HD21 ' A' ' 14' ' ' LEU . 62.5 mtt180 -112.58 114.63 27.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.561 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 71.2 mt -118.72 119.33 34.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.831 0.348 . . . . 0.0 110.773 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.708 HD13 HD11 ' A' ' 111' ' ' LEU . 21.7 tp -94.53 124.11 38.36 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.2 m -132.58 155.16 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.928 0.394 . . . . 0.0 111.412 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.0 p -139.24 144.32 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.345 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.11 116.97 28.67 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 34.5 Cg_exo -58.17 -24.95 69.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.959 2.44 . . . . 0.0 112.243 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.21 -47.06 68.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.01 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 90.3 m -72.02 -38.39 69.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.87 -31.19 66.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.187 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -57.38 -45.68 84.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.699 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 27.2 mp0 -72.42 -48.1 43.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 110.394 175.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.618 ' HB3' HG21 ' A' ' 104' ' ' VAL . 22.7 mt -59.72 -40.87 89.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.482 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -59.5 -38.64 81.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -75.13 -19.91 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.124 0.488 . . . . 0.0 110.337 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 99' ' ' LEU . 50.0 mt -83.48 -6.57 59.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.72 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.14 41.45 39.3 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.662 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 99' ' ' LEU . 14.9 m -90.23 169.16 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 111.504 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -125.17 83.23 2.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.077 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.88 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 8.5 m -67.5 -17.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.9 ttm180 -60.63 -44.68 96.06 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -168.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 111' ' ' LEU . 31.2 tt0 -161.25 -18.75 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.985 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.84 -47.37 74.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 111.603 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.79 -18.18 56.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.708 HD11 HD13 ' A' ' 89' ' ' LEU . 38.0 mt . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 121.802 0.81 . . . . 0.0 108.969 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.5 mm -97.97 139.71 19.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -91.04 117.8 68.13 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.63 -22.05 38.43 Favored 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 123.039 2.492 . . . . 0.0 112.065 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.463 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 9.0 m-85 -148.04 151.94 36.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.241 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 t -170.38 126.37 0.77 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.994 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt 47.86 60.98 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.714 0.634 . . . . 0.0 110.572 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.849 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.55 164.61 59.67 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.29 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HG3' HG13 ' A' ' 106' ' ' VAL . 18.1 Cg_endo -56.63 161.48 9.84 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.754 2.97 . . . . 0.0 113.099 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -144.27 127.27 16.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.127 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 tp -84.08 106.34 15.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 30.7 m -96.47 114.7 26.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.54 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.8 m -98.97 111.78 24.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -121.38 153.49 37.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.467 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.59 147.45 30.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.139 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.82 117.92 20.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.382 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.41 -151.43 20.29 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.041 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.08 -17.3 36.21 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.987 2.458 . . . . 0.0 113.238 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -119.88 30.21 7.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.202 0.525 . . . . 0.0 110.626 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.89 -122.0 5.73 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.5 m-85 -110.73 -13.79 14.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.431 0.616 . . . . 0.0 111.18 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 80.32 32.89 33.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.438 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.52 152.05 46.63 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.419 -0.46 . . . . 0.0 109.976 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.8 m-70 -112.18 125.36 54.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.77 131.52 54.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -138.45 151.19 47.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.015 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.21 6.16 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.17 133.14 44.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.873 0.368 . . . . 0.0 111.523 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.96 138.51 55.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.511 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.31 -44.23 2.48 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.638 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.76 173.15 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -129.9 35.81 4.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.299 0.571 . . . . 0.0 110.456 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.94 167.51 25.62 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.844 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.631 ' HG3' HG21 ' A' ' 75' ' ' VAL . 36.4 mm-40 -103.66 146.03 29.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.705 0.288 . . . . 0.0 110.379 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.43 152.35 51.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.6 mm -70.76 113.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 3.6 tmm_? -86.94 -39.91 15.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 110.086 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 46.2 tp -153.39 143.97 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.69 116.23 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.32 111.13 10.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.66 119.46 6.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 112.346 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.71 30.32 Favored Glycine 0 C--N 1.316 -0.561 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.165 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 79.9 p -95.76 160.22 30.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.985 0.421 . . . . 0.0 111.281 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.27 -17.56 58.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.841 2.361 . . . . 0.0 112.138 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.19 -38.34 90.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.75 -38.97 92.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.046 0.45 . . . . 0.0 110.007 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -64.36 -32.51 74.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.652 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.21 -18.16 53.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.97 37.8 4.82 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.989 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 48' ' ' ALA . 98.3 mt -91.04 130.14 36.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.89 0.345 . . . . 0.0 110.162 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 tt -126.84 141.63 51.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.06 95.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 111.225 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.12 -26.65 1.13 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.485 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 70.2 m-20 -63.71 139.07 58.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.714 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -85.1 132.23 34.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.303 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 54.9 tp -76.26 117.12 17.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.554 ' HB ' HD12 ' A' ' 89' ' ' LEU . 57.9 t -103.47 -36.2 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.274 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 8.7 tt0 -152.01 151.49 31.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 111.142 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.66 116.85 44.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.453 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.1 m120 68.61 -60.9 0.42 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.281 1.033 . . . . 0.0 111.059 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.26 26.89 0.07 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -125.79 129.01 48.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -68.34 125.25 25.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.272 0.358 . . . . 0.0 111.044 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' HG12 ' A' ' 75' ' ' VAL . 29.8 m -127.7 24.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.461 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' HG2' HG13 ' A' ' 60' ' ' VAL . 53.5 mt-10 -53.08 -47.52 68.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.951 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -111.0 9.47 22.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.223 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.27 157.73 19.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.457 0.646 . . . . 0.0 112.088 -171.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -85.56 169.06 13.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.909 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 64.3 t60 -56.74 -45.55 81.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.928 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -65.85 -38.61 89.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 111.057 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.07 -38.79 86.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.489 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG21 ' HG3' ' A' ' 37' ' ' GLN . 29.3 m -70.26 -43.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.442 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.9 t -54.69 -42.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.4 m -60.07 -40.65 90.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -68.52 -35.85 78.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.458 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 75' ' ' VAL . 83.7 mt -62.77 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.7 mmt180 -61.53 -23.22 65.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.86 -6.99 53.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.16 117.16 17.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.96 -60.13 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -129.61 -20.04 3.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.75 145.96 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.042 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 24' ' ' TYR . 14.5 p -116.82 141.81 33.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.128 0.49 . . . . 0.0 110.407 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 95.8 mtt180 -101.92 117.02 33.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.807 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.493 HD12 HD11 ' A' ' 53' ' ' LEU . 92.6 mt -112.75 118.96 36.43 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 1.6 tm? -93.48 116.55 29.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 35.4 m -134.02 154.15 37.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.158 0.504 . . . . 0.0 111.338 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.4 p -148.73 150.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.181 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.08 125.46 74.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 109.973 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.67 -38.36 94.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.921 3.081 . . . . 0.0 113.905 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.75 -39.15 80.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.098 0.475 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 17.4 m -71.33 -36.52 71.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.303 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 8.9 t70 -56.97 -45.87 82.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 57.2 mt-10 -65.85 -39.36 90.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 95' ' ' THR . 21.0 pt20 -72.38 -39.85 67.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.535 HD13 HD11 ' A' ' 110' ' ' LEU . 53.4 mt -70.43 -34.04 72.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.72 0.295 . . . . 0.0 110.746 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 49.0 mt-30 -66.05 -34.46 78.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.619 0.247 . . . . 0.0 110.825 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.5 mttp -61.92 -19.07 62.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.01 -9.81 57.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.71 11.48 63.77 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.175 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.463 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -92.91 138.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 0.0 111.102 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 20.7 mp0 -77.95 98.45 5.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.407 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 12' ' ' PRO . 67.0 t -66.18 -22.38 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.08 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -59.89 -35.36 74.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -173.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 111' ' ' LEU . 65.4 tt0 -165.86 -40.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.94 0.4 . . . . 0.0 110.989 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.805 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 30.4 mm-40 -55.74 -30.83 61.87 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 99' ' ' LEU . 2.1 tt -65.44 -40.26 93.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.137 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 108' ' ' GLU . 6.0 mp -69.41 -31.21 69.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 110.387 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.4 -54.63 6.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB1' ' H ' ' A' ' 118' ' ' GLY . . . -74.27 46.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.749 -175.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -85.72 -7.85 58.53 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 170.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.13 104.63 13.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.587 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 62.1 94.56 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.669 0.605 . . . . 0.0 110.429 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -51.67 101.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.589 2.86 . . . . 0.0 113.654 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.496 ' H ' ' HB1' ' A' ' 113' ' ' ALA . . . 144.39 -174.26 24.7 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.07 -19.18 58.81 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.076 179.605 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.07 144.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.6 118.16 70.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.988 0.423 . . . . 0.0 110.172 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' HD13 ' A' ' 102' ' ' LEU . 18.3 Cg_endo -66.51 -29.08 45.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.848 2.365 . . . . 0.0 111.825 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 38.0 m-85 -152.59 149.21 28.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.475 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -160.37 -43.51 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.201 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.425 ' HB3' HG21 ' A' ' 95' ' ' THR . 15.0 tpt -139.82 90.89 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.807 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.69 157.84 83.61 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.819 -177.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.048 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 57.9 Cg_endo -67.72 149.56 78.85 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.067 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.492 HH21 ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.93 128.25 48.33 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.187 178.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.78 107.27 16.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 67.5 m -94.02 111.47 23.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' HH11 ' A' ' 87' ' ' ARG . 4.3 p -98.62 110.79 23.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.069 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.4 156.37 32.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.393 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.74 138.7 49.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 35.2 ttpt -71.55 124.64 25.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.914 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.15 -162.2 35.41 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.31 -28.84 87.62 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.989 2.459 . . . . 0.0 112.711 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -122.41 40.89 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.902 0.382 . . . . 0.0 110.681 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 84.21 -144.2 21.56 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.363 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.8 m-85 -101.66 -25.62 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.84 32.82 12.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.739 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -127.46 141.26 51.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.457 0.629 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.47 ' C ' ' HB3' ' A' ' 40' ' ' ARG . 30.4 m-70 -100.94 144.69 29.58 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 37' ' ' GLN . 21.0 tp -124.82 137.25 54.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.118 0.261 . . . . 0.0 110.541 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -138.47 149.35 45.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.65 117.31 3.47 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.9 137.61 43.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.03 100.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.827 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.11 -38.27 1.62 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.5 -179.24 7.11 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.509 -0.845 . . . . 0.0 109.043 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.58 21.27 2.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 110.449 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.1 176.38 18.44 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' A' ' 75' ' ' VAL . 35.0 mm-40 -104.14 143.51 32.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.076 0.465 . . . . 0.0 110.89 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.91 156.72 41.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.884 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 55' ' ' ALA . 31.7 mm -70.39 120.51 18.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.979 0.418 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB3' ' C ' ' A' ' 27' ' ' HIS . 0.5 OUTLIER -93.52 -47.96 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -173.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.5 tm? -158.57 140.12 13.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' N ' HD13 ' A' ' 41' ' ' LEU . 48.2 t -117.63 115.74 49.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.21 130.99 89.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.2 127.46 18.4 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.008 1.806 . . . . 0.0 111.892 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.92 28.69 40.96 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.58 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.8 p -102.36 162.3 20.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 122.674 -0.31 . . . . 0.0 110.811 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 18.6 Cg_endo -62.31 -23.5 75.28 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.467 2.112 . . . . 0.0 112.23 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.45 -41.73 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.305 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -59.92 -43.58 94.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.756 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -59.6 -37.35 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.7 -11.79 59.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.056 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.11 31.89 15.87 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.146 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.34 104.54 11.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.0 140.97 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.366 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . . . -70.79 106.88 3.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.806 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.43 -16.5 3.83 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.553 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -73.73 146.39 44.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 0.0 110.859 176.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -91.26 127.39 36.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.8 tp -77.8 109.84 12.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.727 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -99.11 -32.87 3.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.468 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -147.71 149.72 32.96 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.407 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 75' ' ' VAL . 96.8 t -136.67 116.55 16.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.325 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 64.53 26.28 13.32 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.649 0.738 . . . . 0.0 110.683 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.36 16.03 59.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.366 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.547 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 8.9 tp10 -124.74 133.08 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.16 128.45 36.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.675 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 75' ' ' VAL . 35.7 m -123.63 26.83 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.56 -27.31 64.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.661 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -118.12 14.0 13.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.386 0.612 . . . . 0.0 109.583 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -96.47 146.51 24.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.19 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.1 p -81.28 178.04 8.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 57.3 t60 -58.02 -46.35 85.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.148 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.61 -42.88 91.1 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 57.9 mt-30 -61.49 -41.14 96.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 67' ' ' VAL . 94.5 t -71.42 -44.61 71.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 25.4 t -54.57 -45.26 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.66 0.267 . . . . 0.0 111.611 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -59.93 -37.02 78.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.944 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.2 mtt-85 -68.3 -37.03 80.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.598 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 75' ' ' VAL . 68.7 mt -64.77 -35.47 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mpt_? -73.34 -20.57 60.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.28 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 134.79 40.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.286 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.63 -70.74 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.579 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -112.57 -19.73 11.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.847 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.16 145.08 26.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.44 149.41 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.955 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.469 HH11 ' HB2' ' A' ' 16' ' ' CYS . 22.1 mmt180 -108.88 113.19 25.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.445 HD12 HD21 ' A' ' 17' ' ' LEU . 74.9 mt -109.38 118.62 37.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.683 0.278 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.1 tp -93.82 122.22 36.07 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.6 m -133.34 154.6 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.416 0.627 . . . . 0.0 111.431 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.09 145.14 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.327 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.01 122.06 45.03 Favored Pre-proline 0 C--O 1.225 -0.237 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.2 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.579 -172.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.97 -38.97 66.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 19.4 m -70.03 -37.87 75.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.27 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.76 -39.29 77.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.33 -49.2 78.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.445 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.668 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 pt20 -72.97 -46.69 50.92 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.653 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 95' ' ' THR . 29.6 mt -62.33 -43.77 98.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 111.537 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -67.75 -36.6 80.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.874 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -70.24 -23.04 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 96.3 mt -71.79 -22.28 61.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.38 19.94 8.11 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.464 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -107.07 134.76 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.82 102.66 13.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.827 0.822 . . . . 0.0 110.925 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.048 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 14.8 m -65.2 -13.33 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.608 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -58.36 -31.36 67.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -167.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -171.14 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.415 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -54.4 -42.07 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.889 HD23 ' HG2' ' A' ' 114' ' ' GLN . 1.8 tm? -60.09 -29.18 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.49 -12.28 59.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.545 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -83.78 -81.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.311 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.96 109.88 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.648 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.889 ' HG2' HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -97.06 76.33 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.92 0.39 . . . . 0.0 110.057 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -107.41 133.75 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.029 0.442 . . . . 0.0 110.929 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.38 130.84 10.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.878 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.73 76.89 1.47 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.27 73.9 1.08 Allowed Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.94 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -95.09 126.32 40.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.237 -179.36 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.04 132.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.51 125.61 53.25 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.961 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -71.05 -25.64 22.47 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.861 2.374 . . . . 0.0 111.758 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.574 ' HB3' HD12 ' A' ' 11' ' ' LEU . 29.3 m-85 -148.61 154.04 39.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.326 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -172.52 123.58 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.687 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.57 61.09 2.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.89 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.0 140.43 96.05 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.578 -169.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 19.4 Cg_endo -61.62 159.28 33.06 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.024 2.483 . . . . 0.0 111.524 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -143.07 156.64 44.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.133 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -84.21 114.17 21.62 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.717 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.9 m -93.55 107.76 19.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.09 111.71 23.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.971 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.7 148.68 39.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 85' ' ' ALA . 32.8 mt-10 -122.92 129.31 51.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.161 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.9 ttmt -54.94 126.42 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.625 -170.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.7 12.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.378 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.32 -19.56 13.24 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.545 2.163 . . . . 0.0 112.701 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -124.23 27.15 7.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.261 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 89.72 -114.6 4.38 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.562 -175.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.7 m-85 -123.89 -22.9 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.238 0.519 . . . . 0.0 111.642 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.73 33.83 23.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.966 171.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -132.66 142.63 49.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.396 0.598 . . . . 0.0 110.086 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 41' ' ' LEU . 29.3 m-70 -111.32 131.69 54.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.5 tp -101.96 144.4 30.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.299 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.435 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 3.1 p80 -141.69 153.05 44.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.916 0.388 . . . . 0.0 111.259 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.74 125.87 4.9 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.522 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.21 -175.77 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.896 0.379 . . . . 0.0 110.431 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -109.5 135.62 50.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.987 0.422 . . . . 0.0 110.133 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.83 15.49 57.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.5 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 -174.38 2.51 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.741 0.305 . . . . 0.0 110.365 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.1 pt? -125.4 -33.53 2.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.621 172.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.9 177.8 21.24 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.587 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -104.99 155.13 19.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -130.73 153.21 49.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 0.0 110.577 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 mm -71.58 123.54 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.633 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HG2' ' CG ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.6 -45.91 8.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.0 tm? -150.67 140.88 22.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 41' ' ' LEU . 96.6 t -122.14 116.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.487 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -58.8 126.78 81.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -63.4 115.44 3.02 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.035 1.824 . . . . 0.0 111.972 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . 84.76 41.76 7.55 Favored Glycine 0 C--N 1.317 -0.517 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.536 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 77.3 p -112.23 168.06 8.23 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' A' ' 24' ' ' TYR . 10.2 Cg_endo -56.07 -30.38 78.5 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.241 1.961 . . . . 0.0 112.313 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -61.7 -38.66 88.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 0.0 110.332 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 45' ' ' GLY . 6.9 mm-40 -62.03 -39.35 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.462 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.2 mttm -64.61 -29.39 70.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.044 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -88.24 -17.88 29.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.32 35.79 5.37 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.926 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.1 mt -92.67 138.95 31.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.6 tp -145.87 153.2 40.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.874 0.369 . . . . 0.0 110.716 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.54 104.58 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.035 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.31 -30.01 2.46 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.902 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 14.1 m-20 -63.23 136.15 57.54 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.004 0.43 . . . . 0.0 110.664 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -87.79 128.71 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.361 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 90' ' ' VAL . 58.5 tp -80.23 121.31 25.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.123 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 89' ' ' LEU . 50.0 t -105.53 -42.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.585 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.1 tt0 -144.75 151.63 39.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.836 0.35 . . . . 0.0 111.181 -177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 66.0 t -132.31 114.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.323 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.08 36.29 27.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.418 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.09 1.83 59.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.134 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 8.6 tp10 -125.52 136.61 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.855 0.828 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -68.17 125.71 27.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.064 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 62' ' ' VAL . 34.3 m -122.78 31.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.895 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -66.51 -21.0 66.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 34.8 mtmm -127.5 5.43 6.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.464 . . . . 0.0 111.046 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.8 mp0 -79.01 164.97 23.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -175.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.2 p -99.87 170.39 8.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -54.51 -47.93 72.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.53 -45.24 93.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.294 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -64.62 -39.2 93.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.77 -40.18 76.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.019 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 19.1 t -58.39 -39.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.4 m -57.74 -40.66 80.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 0.0 110.596 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -68.83 -37.19 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.699 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -65.12 -36.23 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 6.3 mpt_? -73.7 -22.82 59.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.267 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.16 59.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 110.19 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 113.58 12.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -84.71 -66.01 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.38 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -97.39 -33.12 11.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.023 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 18' ' ' GLU . . . -151.77 156.56 40.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.403 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.24 141.36 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.453 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -105.98 112.95 26.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.81 122.55 45.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 16.9 tp -94.88 118.77 32.34 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.5 m -129.89 161.08 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.991 0.424 . . . . 0.0 110.707 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.5 p -131.93 138.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.163 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.65 125.63 54.34 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.567 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -44.83 45.82 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.966 2.444 . . . . 0.0 115.117 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 41.0 mt-10 -73.53 -31.18 63.53 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.258 0.551 . . . . 0.0 110.584 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.441 HG22 ' HG ' ' A' ' 99' ' ' LEU . 40.4 m -71.95 -36.28 69.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.63 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' HG13 ' A' ' 91' ' ' VAL . 11.3 t70 -56.16 -43.73 78.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 40.2 mt-10 -59.3 -41.13 88.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.495 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 29.8 mm-40 -73.07 -50.01 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 102' ' ' LEU . 23.6 mt -68.56 -31.64 71.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.185 -170.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.618 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 pt20 -57.93 -41.9 83.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 28.5 mtpp -77.47 -37.12 52.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.258 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 99' ' ' LEU . 70.5 mt -69.43 -39.92 77.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.3 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.31 90.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 6.1 p -80.64 80.62 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.271 1.034 . . . . 0.0 112.087 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -112.61 34.79 4.15 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 170.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 13.3 m -67.23 -14.65 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.753 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 78.8 ttt180 -58.91 -45.31 90.64 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -167.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 34.5 tt0 -167.26 -24.1 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.414 . . . . 0.0 110.474 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.18 -47.07 79.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.32 0.581 . . . . 0.0 110.281 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 11' ' ' LEU . 57.5 tp -67.46 -19.98 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.349 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.538 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 10.9 mp -71.92 -36.92 70.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.49 ' N ' ' HD3' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -81.32 -20.5 40.58 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 109.682 176.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.53 -22.04 51.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.905 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 11.7 pt20 -96.55 3.3 52.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.891 0.376 . . . . 0.0 110.828 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -135.14 174.88 10.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.68 107.05 5.46 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.458 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.17 64.43 5.25 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.153 2.568 . . . . 0.0 112.351 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.37 103.94 0.2 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.226 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -158.42 97.03 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.01 0.433 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.256 -179.259 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG21 HD21 ' A' ' 102' ' ' LEU . 60.3 mt -101.45 143.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.09 134.45 30.02 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.8 -28.2 75.81 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.465 2.777 . . . . 0.0 113.534 -170.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -156.15 163.16 39.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.933 0.397 . . . . 0.0 110.956 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 95' ' ' THR . 4.5 t -173.13 128.42 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.092 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.708 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 22.2 ttt 73.54 -51.51 0.7 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.672 0.789 . . . . 0.0 112.313 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER 55.8 133.53 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.801 1.241 . . . . 0.0 113.131 -174.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 75.7 Cg_endo -75.22 167.99 25.65 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.465 2.777 . . . . 0.0 113.24 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.52 144.63 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.652 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.18 109.04 19.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 167.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 51.0 m -94.17 116.45 28.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.852 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -104.12 112.3 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.01 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -120.72 154.48 35.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.2 142.49 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 38.4 ttmt -74.07 115.83 14.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.735 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.63 -150.95 18.17 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.727 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.83 -29.25 42.25 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.732 2.288 . . . . 0.0 112.556 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -130.69 43.99 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.164 0.507 . . . . 0.0 111.351 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 93.59 -108.76 3.71 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.992 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.648 ' HB3' HD12 ' A' ' 17' ' ' LEU . 99.5 m-85 -135.88 -21.98 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 112.774 -172.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 27.61 20.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.378 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -123.96 142.93 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 10.2 m170 -101.27 119.71 39.16 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.8 tp -102.46 133.15 47.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.769 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.5 p80 -123.57 143.69 50.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.469 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.9 93.95 0.52 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 45.2 mt-10 -55.99 130.36 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.853 0.384 . . . . 0.0 111.45 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -66.52 119.1 11.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.68 -37.31 3.34 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 37.2 mmtm -77.57 160.38 28.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.8 0.333 . . . . 0.0 110.163 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.4 pp -113.1 19.87 16.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.724 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.67 167.01 28.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.913 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG3' HG21 ' A' ' 75' ' ' VAL . 25.6 mm-40 -105.93 151.84 24.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 m-85 -138.54 153.77 48.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.58 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.456 HG12 ' OD1' ' A' ' 57' ' ' ASP . 9.7 mm -71.07 121.87 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -98.27 -25.69 14.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 42' ' ' VAL . 9.9 tt -164.85 147.1 8.22 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.67 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' N ' HD23 ' A' ' 41' ' ' LEU . 1.8 p -131.96 122.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.044 0.449 . . . . 0.0 109.806 173.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 37.2 mm-40 -60.22 130.1 89.15 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.987 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 18.1 Cg_exo -65.27 119.4 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.429 2.086 . . . . 0.0 111.451 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 13.92 52.41 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.334 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 98.4 p -91.82 160.4 36.2 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.809 0.338 . . . . 0.0 110.287 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 32.1 Cg_endo -65.23 -17.41 58.41 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 111.39 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.638 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.74 -43.04 90.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 42' ' ' VAL . 26.4 mt-10 -65.61 -37.01 85.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.108 0.48 . . . . 0.0 109.961 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -67.76 -26.04 65.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.045 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -81.8 -18.8 42.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.145 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.29 29.59 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.939 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.1 mt -86.38 147.94 25.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.95 0.375 . . . . 0.0 110.262 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 tt -146.13 140.3 26.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.24 81.18 1.0 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.463 0.649 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 93' ' ' PRO . . . 157.06 39.03 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 8.6 p-10 -105.76 -169.97 1.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.47 0.652 . . . . 0.0 111.165 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 96' ' ' ASP . 25.1 ttm-85 -132.76 124.1 27.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 156.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.439 HD11 HD22 ' A' ' 88' ' ' LEU . 34.6 tp -71.39 102.33 2.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.092 0.472 . . . . 0.0 109.775 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.27 -41.11 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.491 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.0 tt0 -148.55 151.06 34.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.705 0.288 . . . . 0.0 111.188 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG23 HG21 ' A' ' 67' ' ' VAL . 69.9 t -132.16 117.23 32.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.311 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 82' ' ' ALA . 95.0 m-20 61.46 21.73 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.532 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.29 7.38 46.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.923 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.8 tp10 -124.41 133.03 53.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 110.696 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.78 126.97 30.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.098 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.619 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 33.6 m -126.52 27.73 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.431 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.19 -28.18 66.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.33 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 13.7 ptmm? -128.64 39.32 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.289 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 50.9 mm-40 -103.67 168.85 8.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 0.0 112.086 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 75' ' ' VAL . 66.9 p -97.78 178.61 5.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.366 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -65.45 -46.6 79.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.488 ' HA ' HG12 ' A' ' 76' ' ' VAL . 30.4 tt0 -66.46 -32.83 74.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.439 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 16.3 mm100 -70.42 -46.1 64.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.976 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 71' ' ' THR . 14.5 m -72.51 -41.2 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.6 p -57.74 -36.36 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.072 0.463 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -64.11 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.937 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.6 mtt-85 -66.52 -36.05 81.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.567 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -63.01 -38.12 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.262 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 22.2 mmt85 -73.36 -25.01 60.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.323 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.73 55.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HB2' HD21 ' A' ' 63' ' ' ASN . . . -71.64 122.65 20.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.145 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.17 -83.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.515 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.01 -11.96 13.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.96 25.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.82 144.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -109.9 112.88 25.18 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.439 HD22 HD11 ' A' ' 59' ' ' LEU . 78.9 mt -115.61 122.75 46.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.634 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 18.6 tp -95.27 116.41 28.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 35.5 m -129.97 154.65 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.692 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.9 p -144.73 145.93 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -65.95 133.16 94.8 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.676 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 38.8 Cg_exo -59.87 -28.24 86.75 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.7 2.934 . . . . 0.0 113.736 -171.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.5 -48.25 67.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 109.86 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 9' ' ' THR . 15.0 m -71.78 -37.32 70.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.269 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.651 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 2.6 t70 -57.21 -47.13 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.607 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 28.5 tt0 -72.48 -39.37 67.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.041 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 95' ' ' THR . 20.0 pt20 -69.47 -38.72 77.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.572 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 95' ' ' THR . 43.7 mt -68.83 -39.13 80.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 10.6 pt20 -66.32 -33.16 75.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.16 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 34.4 mmtp -57.22 -35.33 69.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.414 0.626 . . . . 0.0 109.34 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 5' ' ' ILE . 15.8 mt -80.39 -55.57 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.22 -108.09 0.48 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.1 t 68.74 125.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.532 0.682 . . . . 0.0 112.572 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.82 71.86 10.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.66 . . . . 0.0 109.924 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 12' ' ' PRO . 2.4 t -56.12 -24.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.421 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.634 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 14.7 ptm180 -60.6 -26.71 67.18 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -165.62 -26.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -44.3 67.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.762 0.315 . . . . 0.0 111.406 -167.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 3.0 mm? -68.66 -31.09 69.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.4 mp -85.62 -31.46 22.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.105 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 2.9 tpm_? -58.1 -60.96 2.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.771 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.8 -4.63 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -100.88 12.74 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 112' ' ' ARG . 8.0 pt-20 -87.04 57.73 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 110.481 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.25 100.22 1.13 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.804 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -84.54 172.71 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.739 2.292 . . . . 0.0 112.077 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 119' ' ' GLN . . . 130.09 -17.16 5.43 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.784 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 118' ' ' GLY . 27.6 tt0 74.26 -42.14 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 111.604 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.327 177.299 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.73 136.99 46.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.88 0.371 . . . . 0.0 110.085 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -98.05 129.16 31.6 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.33 -25.08 79.78 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.975 2.45 . . . . 0.0 112.722 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -154.0 137.65 16.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.516 0.674 . . . . 0.0 111.272 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -141.33 111.71 6.9 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.859 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.4 mtm 48.93 54.98 9.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.071 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.987 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.04 144.56 82.29 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.878 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.932 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 28.9 Cg_endo -63.85 159.93 39.52 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.447 2.765 . . . . 0.0 112.762 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -143.16 155.1 44.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.971 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 87' ' ' ARG . 45.9 tp -84.9 109.55 18.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.54 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -93.79 108.09 19.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -96.92 114.84 26.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.509 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.81 154.13 37.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.471 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.24 146.7 28.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.226 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -74.99 118.16 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.946 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -149.12 17.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.477 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 -20.06 20.03 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.98 2.454 . . . . 0.0 112.78 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -124.48 39.07 4.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.076 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.65 -122.99 7.96 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.41 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.3 m-85 -112.26 -30.18 7.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.17 0.485 . . . . 0.0 110.658 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.96 27.83 8.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.243 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.9 142.26 51.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.238 0.519 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -107.3 144.36 34.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 HG21 ' A' ' 75' ' ' VAL . 27.0 tp -119.49 129.84 54.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.497 0.189 . . . . 0.0 110.967 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -127.19 150.42 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 110.56 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.71 129.09 9.37 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.4 mm-40 -70.37 128.26 35.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.01 110.24 5.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.341 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.51 -12.18 33.11 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.466 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 4.2 mptp? -96.17 178.96 5.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.5 pp -122.27 16.46 10.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.608 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.67 168.58 25.19 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.909 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -104.54 146.35 29.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 110.204 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -133.11 157.12 46.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.244 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 53' ' ' LEU . 16.2 mm -70.75 122.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.034 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -85.15 -47.65 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.171 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -164.05 140.88 6.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.509 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.459 HG11 ' HG2' ' A' ' 49' ' ' GLU . 18.3 t -110.7 124.42 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.737 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.07 124.15 87.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.46 126.64 18.08 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.845 1.697 . . . . 0.0 112.074 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.81 17.69 37.37 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.254 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -97.89 158.94 32.04 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.9 -20.03 67.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.651 2.234 . . . . 0.0 111.994 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.26 -45.7 92.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HG2' HG11 ' A' ' 42' ' ' VAL . 30.8 mt-10 -63.09 -37.24 86.42 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.148 0.499 . . . . 0.0 110.011 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -70.23 -23.51 62.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.923 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -84.06 -17.84 38.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.21 22.65 10.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.26 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 39' ' ' ILE . 15.5 tp -93.46 113.06 25.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' LEU . 2.7 mm? -117.83 166.55 12.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.344 0.592 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.56 122.16 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.133 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.59 -20.44 12.13 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.022 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 6.0 m-20 -59.47 141.86 53.75 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.288 0.566 . . . . 0.0 111.597 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 30.1 ttt180 -85.73 121.78 28.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.822 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HA ' HG12 ' A' ' 90' ' ' VAL . 27.1 tp -78.95 109.43 13.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.118 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.29 -37.86 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.409 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 25.6 tt0 -144.95 151.76 39.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.68 HG23 HG21 ' A' ' 67' ' ' VAL . 74.0 t -134.5 119.75 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.694 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.59 -43.65 0.56 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.86 3.86 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.125 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -126.69 146.97 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.193 0.996 . . . . 0.0 111.251 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -63.48 123.16 18.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.843 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.68 HG21 HG23 ' A' ' 62' ' ' VAL . 32.6 m -118.39 17.98 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.214 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.19 -22.54 63.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.834 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.6 ptpp? -131.42 28.88 4.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.588 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 7.5 mm-40 -103.5 -174.55 2.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 28.4 p -112.71 169.79 8.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.072 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.3 t60 -58.58 -48.68 80.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.511 0.196 . . . . 0.0 110.914 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -66.97 -38.66 86.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.794 0.807 . . . . 0.0 110.334 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.481 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 5.3 tp-100 -61.18 -44.64 96.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.133 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' THR . 15.6 m -72.77 -42.69 61.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 43.5 t -54.88 -40.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.402 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 m -58.24 -38.06 76.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 0.0 110.655 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' NH1' ' HG3' ' A' ' 74' ' ' GLN . 61.2 mtt85 -68.62 -35.89 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.852 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 76' ' ' VAL . 69.0 mt -62.61 -33.65 60.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.492 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 4.3 mpt_? -66.92 -21.79 65.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.1 -2.11 57.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.23 128.53 36.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.242 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.55 -73.39 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.546 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -131.83 -4.88 3.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.19 158.5 44.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.856 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.7 p -127.83 146.4 33.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.541 ' HB3' HD11 ' A' ' 14' ' ' LEU . 14.8 mtm180 -97.7 122.84 41.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 17' ' ' LEU . 89.4 mt -121.46 113.63 20.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.962 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 26.9 tp -94.1 116.08 28.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.2 m -133.01 157.41 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.221 0.534 . . . . 0.0 111.765 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 11.7 p -147.98 148.43 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.866 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.82 118.26 33.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' ARG . 34.6 Cg_endo -63.53 -31.88 70.77 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.239 2.626 . . . . 0.0 113.169 -172.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.26 -37.04 69.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.025 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.5 m -71.79 -40.3 69.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.99 -30.84 66.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.194 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.31 -50.77 70.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.85 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.641 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 11.4 pt20 -74.87 -39.48 61.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.021 0.439 . . . . 0.0 110.839 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 102' ' ' LEU . 27.6 tp -66.13 -43.07 88.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.981 -164.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -68.19 -36.23 79.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.309 0.576 . . . . 0.0 110.245 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.27 -18.29 62.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.277 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 92.9 mt -70.15 -15.06 62.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.36 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 62.15 0.93 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.537 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.28 131.66 41.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.548 0.213 . . . . 0.0 110.773 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 10.7 mt-30 -83.15 85.89 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.572 0.701 . . . . 0.0 109.754 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.651 HG13 ' HG3' ' A' ' 12' ' ' PRO . 3.8 t -59.99 -27.82 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.734 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.71 -25.52 66.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -175.18 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.122 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 33.7 tt0 -55.79 -41.02 73.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.108 0.48 . . . . 0.0 110.961 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 11' ' ' LEU . 49.0 tp -64.39 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.396 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.701 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 9.8 mp -73.99 -26.24 60.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -63.06 -25.99 68.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.743 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.31 55.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.701 ' HG2' ' HA ' ' A' ' 111' ' ' LEU . 12.2 pt20 -118.99 24.89 10.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -134.6 138.52 44.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.13 0.49 . . . . 0.0 111.307 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.78 82.64 55.3 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.76 176.07 8.77 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.584 2.189 . . . . 0.0 113.653 -171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 179.5 -98.23 0.11 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -159.03 104.83 1.73 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.228 -178.62 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 mp -99.61 132.47 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 109.924 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' HB ' ' A' ' 9' ' ' THR . 21.5 t70 -81.2 129.43 66.85 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.91 -34.69 95.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.254 2.636 . . . . 0.0 113.012 -171.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -157.03 120.09 4.07 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.407 0.622 . . . . 0.0 110.557 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' ' OD2' ' A' ' 6' ' ' ASP . 10.2 t -159.4 126.53 4.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.79 -168.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.7 mtm 54.21 30.92 13.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.878 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -58.31 139.77 84.17 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.024 -176.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 40.5 Cg_endo -65.66 158.39 53.61 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.598 2.865 . . . . 0.0 113.588 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -143.69 169.96 16.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 111' ' ' LEU . 17.5 mt -84.34 122.5 29.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.756 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.1 m -94.37 108.28 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.357 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -95.62 111.82 23.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.115 0.483 . . . . 0.0 110.585 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.49 147.8 40.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.516 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -112.59 135.32 53.45 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.376 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 33.2 ttpt -71.05 120.53 16.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.284 -173.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.35 -170.13 44.64 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.52 -29.91 91.15 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.651 2.234 . . . . 0.0 112.747 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -99.36 -0.56 40.8 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.166 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.37 -141.82 16.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.134 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 46' ' ' SER . 84.4 m-85 -105.72 -36.34 7.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.0 111.33 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 40.59 4.81 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.928 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -135.56 152.96 51.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.504 0.652 . . . . 0.0 110.405 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -124.36 144.51 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.467 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.4 mt -120.96 154.59 35.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 0.0 111.17 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 12.4 p-80 -144.13 151.65 39.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.44 141.42 15.27 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.499 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.0 mt-10 -107.69 152.14 24.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.799 0.333 . . . . 0.0 111.169 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.81 141.78 38.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.25 -43.6 2.81 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 27.0 mmtp -78.07 175.32 10.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 pt? -144.0 29.05 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.38 -163.79 9.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.96 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HG3' HG21 ' A' ' 75' ' ' VAL . 31.1 mm-40 -112.27 148.03 35.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -134.39 160.83 36.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.426 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.491 HG12 ' CG ' ' A' ' 57' ' ' ASP . 31.8 mm -68.59 119.59 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.203 0.525 . . . . 0.0 110.86 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.25 -36.95 13.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 tp -161.94 143.31 10.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.8 117.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.823 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.4 mm-40 -68.8 129.54 92.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.835 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.5 Cg_exo -70.02 121.38 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 111.355 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.94 17.24 21.39 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.549 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 91.4 p -105.41 154.97 38.66 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 -15.24 49.22 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.747 2.298 . . . . 0.0 111.813 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 53' ' ' LEU . . . -66.38 -35.88 81.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.602 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.23 -38.65 91.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.0 110.091 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.42 -20.12 62.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.165 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.55 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.92 -18.0 33.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.21 28.11 7.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.172 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 48' ' ' ALA . 11.2 mp -79.2 136.36 37.06 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.582 -0.363 . . . . 0.0 110.489 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 tt -146.46 142.2 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.2 109.09 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.122 0.487 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.71 6.85 2.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.88 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' HG12 ' A' ' 39' ' ' ILE . 6.8 p-10 -72.16 -173.11 1.0 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.923 0.868 . . . . 0.0 111.787 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -135.96 115.37 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.661 165.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.2 tp -78.31 106.65 10.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 109.809 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -97.5 -38.06 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.873 -175.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 25.2 tt0 -149.77 151.8 34.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.709 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.492 HG23 HG21 ' A' ' 67' ' ' VAL . 90.4 t -134.62 117.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.217 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 56.46 29.82 15.99 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.22 5.73 57.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.563 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 9.2 tp10 -124.41 130.32 52.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.432 0.616 . . . . 0.0 110.656 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.97 127.08 31.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 35.3 m -123.79 24.21 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 52.1 mt-10 -68.26 -25.35 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.633 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 1.3 ptpt -126.44 29.93 5.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -177.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 44.4 mm-40 -93.17 -171.36 2.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 74' ' ' GLN . 33.6 p -113.16 -179.79 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.683 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 75.1 t60 -64.38 -47.0 80.9 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -67.55 -37.83 83.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.764 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' HG2' ' OG1' ' A' ' 71' ' ' THR . 85.5 mm-40 -60.51 -43.23 97.32 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.735 0.303 . . . . 0.0 110.908 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 37' ' ' GLN . 13.4 m -71.58 -40.21 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.835 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 72' ' ' HIS . 72.5 t -54.09 -37.91 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.451 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -57.14 -44.51 83.47 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.284 0.564 . . . . 0.0 110.122 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -69.23 -36.19 76.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.121 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 75' ' ' VAL . 72.6 mt -64.21 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.486 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 41.6 mmt180 -69.78 -22.55 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.98 55.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.896 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.8 116.83 15.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.92 -66.5 0.78 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.55 -172.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.75 -17.84 10.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.002 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.65 150.07 29.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.0 111.19 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -123.79 141.09 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.594 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -105.84 111.16 23.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 109.969 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.56 129.87 53.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.028 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 14.7 tp -102.01 118.81 37.69 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.4 154.92 40.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.114 0.483 . . . . 0.0 110.686 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.6 p -140.64 145.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.3 138.18 68.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.1 -25.63 64.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.701 2.934 . . . . 0.0 113.995 -172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.96 -50.39 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.532 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -42.6 83.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.658 0.742 . . . . 0.0 110.158 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -58.14 -45.71 86.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.66 -43.25 89.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.567 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.2 pt20 -72.21 -44.35 63.08 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.038 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 12.7 mt -67.16 -40.17 86.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.415 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 14.8 pt20 -64.67 -36.08 83.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.757 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 99.1 mttt -70.58 -19.7 62.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.367 . . . . 0.0 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 74.5 mt -81.76 -8.24 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.266 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.97 24.19 30.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.08 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.439 HG13 HD21 ' A' ' 110' ' ' LEU . 98.6 t -89.55 128.42 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.815 0.34 . . . . 0.0 111.141 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 37.0 mt-30 -96.51 83.85 3.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.032 0.444 . . . . 0.0 109.884 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 19.7 m -59.23 -14.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.97 -25.75 63.83 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.19 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.809 0.337 . . . . 0.0 110.938 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 105' ' ' GLN . 44.9 tt0 -54.98 -38.03 67.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 57.3 mt -79.21 -40.26 31.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.455 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.489 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 7.3 mp -66.54 -26.76 67.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.23 -49.49 60.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.136 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.73 -31.94 68.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.561 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 63.4 mt-30 -77.99 62.46 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.133 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.34 159.84 38.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.965 0.412 . . . . 0.0 111.242 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.54 121.88 3.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.041 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 99.13 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.119 2.546 . . . . 0.0 112.481 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.86 -128.55 47.78 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.587 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 71.11 -11.38 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.384 0.674 . . . . 0.0 112.183 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.993 178.913 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.9 mt -122.32 143.56 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.1 126.72 90.18 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 -28.92 69.91 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.075 2.517 . . . . 0.0 113.285 -172.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.498 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 7.2 m-85 -156.61 118.36 3.87 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.216 1.008 . . . . 0.0 112.172 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 95' ' ' THR . 4.6 t -153.49 125.66 7.96 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.434 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.6 mtt 53.77 48.79 20.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.039 0.447 . . . . 0.0 110.434 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -74.04 152.92 88.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.641 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.943 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.0 Cg_endo -68.79 151.45 74.31 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.943 2.429 . . . . 0.0 112.694 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.545 ' HA ' HD11 ' A' ' 111' ' ' LEU . 69.6 mtp180 -126.05 153.72 44.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.618 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 40.9 tp -89.64 106.07 18.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.682 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 68.8 m -93.22 108.03 19.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 p -95.31 120.78 36.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.96 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -125.51 151.52 46.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.37 135.14 42.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.479 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 ttmt -68.47 119.33 12.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.06 -144.03 14.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.069 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.36 -14.2 25.35 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.072 2.514 . . . . 0.0 113.398 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -137.85 35.94 2.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.945 0.402 . . . . 0.0 111.015 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 84.1 -104.72 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.544 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.2 m-85 -132.53 -22.13 2.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.411 0.605 . . . . 0.0 112.255 -175.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.47 28.38 24.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.497 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.94 155.72 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 91.1 m-70 -122.06 134.19 54.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.404 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.3 tp -108.45 135.66 49.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.8 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -128.85 152.1 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.77 119.92 3.15 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.811 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.46 118.85 11.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.657 0.265 . . . . 0.0 110.448 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -63.36 125.36 23.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.045 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.3 -36.33 3.66 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -106.3 165.95 10.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -112.22 10.06 20.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.681 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.9 143.1 16.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.564 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -105.04 143.88 32.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.409 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 53.0 m-85 -129.02 151.5 49.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 0.0 110.794 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.11 121.89 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.879 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 -26.25 14.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.68 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 8.1 tp -162.45 151.56 15.35 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 111.311 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.532 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.6 t -128.8 119.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.614 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.07 125.75 90.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.64 111.63 2.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.038 1.825 . . . . 0.0 111.386 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.59 10.97 20.59 Favored Glycine 0 C--N 1.311 -0.852 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.948 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.3 p -99.1 159.75 29.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.231 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 36.1 Cg_endo -65.91 -14.41 44.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.99 2.46 . . . . 0.0 112.409 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.05 -40.43 94.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.779 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -62.64 -33.09 74.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 110.242 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -71.69 -13.27 61.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.067 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -100.24 -17.66 17.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.24 7.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.863 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.5 mp -84.83 134.15 34.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.715 0.258 . . . . 0.0 110.324 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -137.84 152.22 48.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 110.577 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.7 107.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.533 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.27 3.75 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.944 -176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 42.8 m-20 -66.68 142.58 57.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 111.443 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.581 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 71.1 ttt180 -91.43 121.66 33.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HA ' HG12 ' A' ' 90' ' ' VAL . 53.6 tp -79.03 104.76 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 0.0 110.22 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 41.5 t -91.39 -40.93 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 10.7 tt0 -144.74 150.98 38.18 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.527 HG21 HG13 ' A' ' 75' ' ' VAL . 90.0 t -130.24 117.57 40.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 9.9 t-20 70.92 -61.2 0.49 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.151 0.98 . . . . 0.0 110.631 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.0 20.65 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -125.85 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.715 0.257 . . . . 0.0 110.506 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -71.9 99.65 2.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.452 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.0 m -82.75 0.93 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.233 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 24.2 mm-40 -70.79 -3.99 21.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 171.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -113.53 6.89 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.025 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 13.5 mm-40 -110.75 -165.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.298 -172.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 75' ' ' VAL . 65.3 p -132.29 176.34 8.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.119 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 76' ' ' VAL . 13.4 t60 -54.16 -48.05 71.31 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 176.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -65.34 -43.01 92.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.185 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 54.9 mt-30 -66.88 -44.07 81.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 67' ' ' VAL . 91.4 t -62.29 -42.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.963 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' HIS . 52.3 t -57.95 -45.03 87.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 110.27 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 m -58.4 -39.33 79.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 84.0 mtt-85 -65.92 -34.53 78.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 75' ' ' VAL . 67.6 mt -62.5 -33.92 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.686 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.32 60.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.77 115.03 10.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.851 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.95 -74.49 0.24 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.304 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -101.32 -28.84 12.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.417 0.627 . . . . 0.0 109.902 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.77 159.01 44.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.761 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.48 142.27 41.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.857 0.36 . . . . 0.0 110.37 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 14' ' ' LEU . 96.2 mtt180 -98.74 112.87 24.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.888 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 53' ' ' LEU . 91.9 mt -114.06 113.67 25.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 28.2 tp -94.11 116.78 29.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.4 m -130.84 153.67 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.053 0.454 . . . . 0.0 111.459 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.1 p -142.54 142.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.8 114.63 10.85 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 32.4 Cg_exo -57.75 -29.39 85.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.095 2.53 . . . . 0.0 112.767 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.7 -47.58 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.955 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 7.5 m -72.46 -35.23 68.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.898 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -56.33 -39.79 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.741 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 10.2 tp10 -58.73 -48.35 81.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.9 pt20 -72.92 -40.13 65.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.361 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.79 -43.18 80.33 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 104' ' ' VAL . 29.6 pt20 -60.44 -34.38 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.318 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 55.7 mttm -67.56 -18.94 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 111.077 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.34 -3.73 58.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.19 42.86 8.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.815 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 100' ' ' GLN . 19.7 m -90.72 171.75 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 111.666 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 109' ' ' GLU . 57.6 mt-30 -133.97 83.4 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.943 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.7 m -66.34 -16.47 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 41.1 ttm180 -59.29 -43.96 92.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HA ' HD23 ' A' ' 111' ' ' LEU . 35.3 tt0 -169.77 -11.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.975 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -55.48 -39.91 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.058 0.456 . . . . 0.0 110.141 -177.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 46.8 mt -73.61 -39.48 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.485 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.0 mm? -70.09 -34.24 72.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.087 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -76.91 -17.78 58.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 110.686 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.5 -10.54 31.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.871 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 78.6 mt-30 -87.5 85.98 7.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.036 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -76.64 163.3 26.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.674 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.8 99.3 15.42 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.35 -166.32 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.337 2.691 . . . . 0.0 111.829 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.5 67.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.977 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.977 0.418 . . . . 0.0 111.311 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.934 178.481 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.8 mt -75.26 140.12 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -84.99 130.71 51.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.023 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.68 -24.23 48.02 Favored 'Trans proline' 0 CA--C 1.518 -0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 111.656 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.525 ' CE1' HD22 ' A' ' 110' ' ' LEU . 2.6 m-85 -148.77 146.79 28.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.791 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -171.03 134.72 0.96 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 95' ' ' THR . 13.7 tpt 53.36 63.98 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.843 0.83 . . . . 0.0 109.538 -174.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.574 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -65.56 140.47 97.55 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.624 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 77.0 Cg_endo -72.76 169.23 22.5 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.298 2.665 . . . . 0.0 112.147 -176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -130.02 136.1 49.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.838 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 87' ' ' ARG . 57.2 tp -83.9 104.83 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -94.87 115.78 27.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.697 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.0 110.37 22.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.826 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -110.21 152.69 25.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.434 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -103.69 143.03 33.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.553 -170.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -72.83 104.95 4.17 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.8 -151.01 21.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.543 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 -22.57 23.61 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.876 2.384 . . . . 0.0 112.478 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -124.38 39.02 4.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.473 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.2 -125.61 8.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.44 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' HD12 ' A' ' 17' ' ' LEU . 88.3 m-85 -111.29 -28.04 8.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.145 0.472 . . . . 0.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.51 36.58 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.28 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -123.9 146.41 48.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.472 0.636 . . . . 0.0 110.458 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.5 m-70 -106.8 125.16 50.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.247 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.31 127.29 54.95 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.494 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -113.18 132.12 55.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.341 0.591 . . . . 0.0 109.983 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.63 112.23 2.95 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 11.8 mm-40 -57.1 132.02 51.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.189 0.518 . . . . 0.0 111.126 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.41 119.7 14.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.564 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.65 -36.41 3.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.652 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 58.4 mmtt -76.01 160.8 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -100.77 16.14 26.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.017 0.436 . . . . 0.0 111.615 -177.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.41 132.06 10.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.53 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.06 137.88 40.65 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.0 m-85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.618 0.247 . . . . 0.0 110.424 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.79 119.61 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -100.56 -25.79 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 -175.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.2 tm? -164.62 145.91 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.529 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -132.6 132.98 59.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 34.9 mm-40 -78.73 98.39 0.32 Allowed Pre-proline 0 N--CA 1.465 0.325 0 O-C-N 123.355 0.409 . . . . 0.0 110.734 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' VAL . 14.5 Cg_exo -34.67 94.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.469 3.446 . . . . 0.0 114.301 -168.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.04 25.16 1.91 Allowed Glycine 0 C--N 1.314 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.742 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -96.03 163.01 21.99 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 117.228 0.514 . . . . 0.0 110.193 178.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 29.7 Cg_endo -64.22 -17.38 59.51 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.324 2.016 . . . . 0.0 111.686 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.51 -48.73 76.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.197 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 46' ' ' SER . 1.9 mp0 -66.12 -38.74 88.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 29.5 mtpp -62.41 -32.16 72.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.35 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.19 -19.19 51.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.03 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.27 39.94 1.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.823 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.56 134.3 47.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 tt -137.4 138.08 39.49 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.19 99.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.418 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.06 -24.88 1.91 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.119 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 68.0 m-20 -70.73 141.68 51.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.653 0.263 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -88.47 134.56 33.82 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.225 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -75.49 124.83 27.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.785 177.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.4 -43.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -145.14 150.32 36.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.864 0.364 . . . . 0.0 110.802 -178.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 63.6 t -133.65 111.67 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.051 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 60.71 38.64 18.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.868 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.0 9.73 80.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.952 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG2' ' NE ' ' A' ' 78' ' ' ARG . 7.2 tp10 -120.81 127.05 51.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -69.7 129.14 38.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.75 -0.204 . . . . 0.0 110.751 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.559 HG12 ' NH1' ' A' ' 78' ' ' ARG . 20.4 m -120.94 31.21 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.262 0.553 . . . . 0.0 111.418 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 35' ' ' LEU . 58.0 mt-10 -71.33 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.398 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.918 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.3 mtmp? -130.02 16.76 5.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.451 0.644 . . . . 0.0 110.106 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.403 ' CG ' HH12 ' A' ' 78' ' ' ARG . 1.0 OUTLIER -95.78 -174.45 3.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.302 -169.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.491 ' H ' ' HB3' ' A' ' 74' ' ' GLN . 32.5 p -119.68 166.98 12.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.863 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 76' ' ' VAL . 49.5 t60 -58.11 -48.4 80.31 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.899 0.124 . . . . 0.0 110.684 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.08 -41.35 99.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.801 0.81 . . . . 0.0 110.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 71' ' ' THR . 6.6 tp60 -60.87 -39.25 88.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.811 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 74.4 t -71.69 -41.34 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.406 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 72' ' ' HIS . 69.6 t -55.69 -41.15 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.673 0.273 . . . . 0.0 111.729 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -57.86 -40.0 79.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.208 0.527 . . . . 0.0 110.442 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.559 ' NH1' HG12 ' A' ' 67' ' ' VAL . 59.6 mtt180 -69.98 -36.05 74.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.123 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.57 -36.33 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.057 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -72.94 -22.59 60.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.842 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.25 -15.52 59.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.981 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.72 128.55 36.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.747 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.48 -67.66 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.36 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -111.18 -26.93 8.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.349 0.595 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.2 155.42 38.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.09 144.56 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HD3' HD21 ' A' ' 14' ' ' LEU . 84.9 mtt180 -98.82 118.49 35.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.94 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.546 HD12 HD21 ' A' ' 17' ' ' LEU . 88.9 mt -121.86 115.51 22.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.245 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 18.4 tp -95.09 123.34 38.53 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.8 m -133.3 155.74 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.291 0.567 . . . . 0.0 112.349 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.7 p -146.7 146.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 p30 -73.23 134.29 80.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.93 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 58.3 Cg_exo -53.4 -34.1 69.69 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.064 3.176 . . . . 0.0 114.301 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.58 -46.7 78.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.835 0.35 . . . . 0.0 110.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 10' ' ' MET . 24.9 m -69.78 -37.18 76.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 3.9 t70 -57.51 -45.1 85.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.429 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 39.8 mt-10 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.927 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 9.5 pt20 -74.8 -42.53 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.079 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 102' ' ' LEU . 25.7 mt -62.43 -34.15 76.21 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 9.6 pt20 -64.7 -35.6 81.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.383 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -74.56 -24.98 59.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.072 0.463 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 99' ' ' LEU . 37.1 mt -84.8 -46.47 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.422 0.629 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.99 96.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.01 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -76.67 86.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 122.309 1.052 . . . . 0.0 111.85 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 77.9 mt-30 -104.7 17.49 24.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.43 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m -66.66 -16.33 20.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.441 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.45 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 96.3 mtt180 -60.73 -43.77 97.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.9 -172.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.497 ' HA ' HD13 ' A' ' 111' ' ' LEU . 30.0 tt0 -172.66 -21.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 110.348 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 2.5 mp0 -55.15 -46.33 75.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.322 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.525 HD22 ' CE1' ' A' ' 8' ' ' PHE . 52.0 tp -65.39 -35.54 81.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 108' ' ' GLU . 7.0 mp -68.6 -18.0 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.307 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -73.24 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.01 102.81 11.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.669 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -88.23 8.32 27.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.62 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.93 -81.63 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.681 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.4 108.85 2.41 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.715 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.7 156.56 63.18 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.575 2.183 . . . . 0.0 112.474 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 112.73 173.93 19.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.019 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.3 37.86 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.071 0.462 . . . . 0.0 110.833 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.985 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.4 mt -123.16 143.19 37.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 7' ' ' PRO . 35.2 t0 -87.22 118.9 70.58 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 6' ' ' ASP . 24.6 Cg_endo -63.69 -27.97 68.83 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 123.014 2.476 . . . . 0.0 112.283 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.449 ' CD1' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -159.81 138.73 10.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.406 176.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -136.95 113.64 10.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.491 -167.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.3 mtp 54.32 57.04 6.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.566 0.698 . . . . 0.0 109.663 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.767 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -64.26 161.59 39.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.392 -173.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HG3' HG13 ' A' ' 106' ' ' VAL . 22.1 Cg_endo -59.52 164.24 11.52 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.546 2.831 . . . . 0.0 112.419 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' HD11 ' A' ' 111' ' ' LEU . 28.2 mmm180 -136.96 139.72 41.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.945 -172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' A' ' 89' ' ' LEU . 48.6 tp -84.63 105.02 15.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 29.9 m -95.17 108.35 20.47 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.09 -173.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.9 110.9 22.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -114.67 148.98 37.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.765 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -119.54 128.08 53.6 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.008 -168.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 30.9 ttpt -65.4 114.75 5.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.291 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.04 -166.24 37.01 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.27 -12.54 33.32 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.578 2.185 . . . . 0.0 112.39 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -103.78 1.6 31.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.97 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.36 -133.75 11.89 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.132 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.6 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.9 m-85 -106.71 -28.83 9.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.263 0.532 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.85 39.59 9.37 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 114.267 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -138.4 157.83 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 109.999 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.548 ' CD2' HD23 ' A' ' 41' ' ' LEU . 52.9 m-70 -125.55 139.07 53.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -110.35 141.86 42.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.721 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 1.4 p80 -136.2 151.85 50.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.47 112.12 1.01 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.978 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 46.0 mt-10 -65.8 176.81 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 0.0 110.881 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -103.29 137.82 40.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.85 15.22 63.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.177 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.37 -171.33 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD12 ' HD3' ' A' ' 69' ' ' LYS . 1.8 pt? -124.38 -34.29 2.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.172 172.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.0 -177.94 15.32 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.247 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -104.66 150.24 24.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.589 0.356 . . . . 0.0 110.106 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 15.8 m-85 -126.69 151.43 48.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.66 0.266 . . . . 0.0 110.422 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.93 122.59 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.054 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 5.6 tmm_? -92.43 -42.14 9.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.989 0.423 . . . . 0.0 110.051 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 27' ' ' HIS . 23.7 tp -149.22 150.22 32.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.451 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -125.7 118.84 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.22 121.53 76.98 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.985 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.64 121.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.222 1.948 . . . . 0.0 111.808 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.04 43.81 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.368 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 99.3 p -83.28 164.81 44.0 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.561 -0.376 . . . . 0.0 111.054 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.2 Cg_endo -67.81 -18.38 47.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.48 2.12 . . . . 0.0 112.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.65 -43.15 99.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.625 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.05 -38.7 89.73 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.338 0.59 . . . . 0.0 110.035 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 60.1 mttp -68.88 -25.05 64.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.86 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -84.61 -18.55 35.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.87 10.46 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.506 HD21 HD12 ' A' ' 88' ' ' LEU . 10.2 mp -81.48 131.7 35.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.999 0.4 . . . . 0.0 110.45 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.64 152.65 51.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.05 92.87 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.32 -26.73 0.78 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.649 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 9.7 m-20 -64.26 140.78 58.9 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 111.12 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -90.47 132.33 35.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 90' ' ' VAL . 33.5 tp -80.73 112.7 18.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.833 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.04 -38.6 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.296 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.577 ' OE1' ' HD2' ' A' ' 107' ' ' ARG . 3.0 tt0 -148.88 150.59 33.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.275 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 67' ' ' VAL . 86.5 t -132.21 111.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.176 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 53.44 37.06 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.798 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.06 9.6 58.11 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.674 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.6 tp10 -120.23 130.83 54.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.439 0.619 . . . . 0.0 111.039 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -72.53 101.44 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 62' ' ' VAL . 32.7 m -102.74 5.96 10.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.253 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -8.92 41.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD3' HD12 ' A' ' 35' ' ' LEU . 30.4 mmtp -125.0 17.02 8.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.799 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 39.9 mt-10 -107.12 -172.2 2.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 112.483 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 p -107.63 170.47 7.96 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.049 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 76' ' ' VAL . 10.0 t60 -57.36 -47.55 81.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.023 177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -63.8 -47.59 80.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 80.1 mt-30 -61.71 -43.6 98.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.567 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' ILE . 70.3 t -66.73 -44.02 89.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.572 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 72' ' ' HIS . 50.1 t -57.8 -37.49 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.777 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 t -62.79 -39.34 93.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mtt-85 -68.91 -36.39 77.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' VAL . 78.3 mt -63.26 -42.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.76 -23.29 63.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -12.71 61.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.212 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.57 123.26 30.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.952 0.406 . . . . 0.0 109.942 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.47 -64.54 1.14 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.319 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -104.0 -28.81 11.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.57 32.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.777 0.322 . . . . 0.0 111.488 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.98 146.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.627 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.29 114.25 26.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.506 HD12 HD21 ' A' ' 53' ' ' LEU . 84.1 mt -114.63 126.02 54.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -95.15 119.57 33.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.9 m -132.8 160.03 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.9 p -147.77 143.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.372 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.3 t70 -67.26 126.78 93.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.298 175.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 31.6 Cg_exo -59.46 -32.82 97.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.625 2.883 . . . . 0.0 113.971 -174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -72.1 -41.31 67.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.663 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 30.5 m -69.52 -39.59 77.45 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.272 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.48 -33.41 69.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.93 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 10.7 tp10 -57.49 -40.56 78.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.76 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 96.8 mt-30 -72.78 -49.15 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 173.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 95' ' ' THR . 30.1 mt -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.401 -166.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.15 -35.73 81.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 47.9 mmtm -71.46 -36.04 71.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 66.7 mt -63.32 -59.53 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.193 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 146.11 -154.45 25.96 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 110' ' ' LEU . 91.7 t 67.0 146.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.861 0.864 . . . . 0.0 112.491 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 80.6 mm-40 -81.3 91.69 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 0.0 109.857 175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -55.35 -25.07 16.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.643 -1.162 . . . . 0.0 114.013 -171.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 17.8 ptt180 -66.4 -17.67 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -170.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 111' ' ' LEU . 33.2 tt0 179.99 -13.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.2 tt0 -55.56 -37.42 67.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 110.976 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.631 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 52.4 mt -73.09 -39.68 65.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.5 mm? -67.02 -35.85 80.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.928 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -76.91 -30.15 56.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.47 -41.79 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 11.5 pt20 -120.86 45.06 2.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.974 0.416 . . . . 0.0 111.391 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -63.01 149.62 44.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.043 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . . . -156.36 120.67 2.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.708 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 116' ' ' ALA . 25.7 Cg_exo -62.95 110.59 1.17 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.838 2.359 . . . . 0.0 111.777 178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 148.45 -28.18 1.35 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.774 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 69.39 -72.44 0.1 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.438 0.695 . . . . 0.0 111.852 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.329 -178.605 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 111.904 -0.479 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -130.55 139.88 50.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.762 0.315 . . . . 0.0 110.17 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -103.85 135.8 19.3 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.152 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.81 -28.13 36.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.045 2.497 . . . . 0.0 112.356 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -150.58 149.54 30.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.251 0.548 . . . . 0.0 111.733 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG21 ' A' ' 95' ' ' THR . 5.1 t -170.63 123.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.603 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.5 ttt 53.54 54.21 10.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.571 0.7 . . . . 0.0 110.338 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.3 pt? -80.36 162.25 61.91 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' CG ' HG13 ' A' ' 106' ' ' VAL . 81.1 Cg_endo -88.52 172.66 4.77 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.718 2.279 . . . . 0.0 113.833 -166.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -138.11 154.09 49.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.853 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.9 111.5 19.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.0 m -92.55 109.72 21.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.472 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -95.48 110.7 22.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.381 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -113.98 149.57 35.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.956 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -112.9 134.89 54.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.472 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 33.1 ttpt -68.99 112.66 5.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.007 -174.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.27 -156.02 30.19 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.129 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.18 -8.95 24.58 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.014 2.476 . . . . 0.0 113.81 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -126.45 10.77 7.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 104.22 -139.14 14.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.311 -173.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.5 m-85 -103.17 -32.43 9.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.551 0.675 . . . . 0.0 112.072 -174.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.25 32.17 7.18 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.069 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -138.85 150.69 46.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -123.11 130.28 52.57 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.71 139.23 36.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.703 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -142.18 152.74 43.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.89 19.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.376 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' CE2' ' A' ' 38' ' ' TYR . 51.3 mt-10 -78.22 -172.37 2.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -75.45 92.42 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.117 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.33 -83.98 0.75 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 37.83 -154.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.288 -0.956 . . . . 0.0 112.378 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 1.8 pp -145.0 5.0 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.008 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.52 154.05 21.29 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.041 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -105.38 148.59 26.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.0 110.191 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 31' ' ' GLU . 8.4 m-85 -126.93 153.29 45.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 110.538 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.69 121.35 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.187 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 tmm_? -88.99 -46.69 8.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 40' ' ' ARG . 34.7 tp -147.39 144.29 28.59 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.083 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 49' ' ' GLU . 2.2 p -129.97 113.72 27.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG3' ' CA ' ' A' ' 25' ' ' GLY . 1.7 mt-10 -70.34 132.76 87.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.195 -166.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.19 118.14 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.407 2.071 . . . . 0.0 111.89 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.85 -1.43 33.85 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.382 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.483 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 99.3 p -85.45 158.95 56.83 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.181 -177.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -17.86 49.02 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 111.339 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.53 -43.39 97.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.721 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 42' ' ' VAL . 44.6 mt-10 -60.15 -44.16 95.18 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.279 0.561 . . . . 0.0 110.004 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.41 -17.67 63.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.511 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -83.27 -18.83 37.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 0.0 110.286 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.41 26.41 6.56 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.07 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.68 136.23 33.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.76 0.315 . . . . 0.0 110.634 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 55' ' ' ALA . 3.8 tt -137.41 143.37 41.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -58.03 117.65 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.305 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.55 -26.51 6.27 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.126 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 94.3 m-20 -58.17 141.73 49.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.025 0.441 . . . . 0.0 111.792 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 46.8 ttt180 -85.31 122.68 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.436 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.74 118.8 21.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.908 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.55 -41.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.576 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 11.6 tt0 -149.96 150.94 32.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.729 0.3 . . . . 0.0 110.731 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 75' ' ' VAL . 48.8 t -128.81 116.11 39.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 23.1 m120 68.39 -58.25 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.427 1.091 . . . . 0.0 111.171 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.11 28.21 0.06 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.189 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.7 tp10 -125.54 127.26 46.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -69.92 115.72 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.32 . . . . 0.0 110.489 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.454 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 31.4 m -111.52 29.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.13 0.49 . . . . 0.0 111.486 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 35' ' ' LEU . 4.4 mm-40 -73.14 -8.72 57.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.732 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 99.8 mttt -138.43 32.45 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 111.169 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 61.4 mm-40 -107.11 -172.17 2.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.363 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 74' ' ' GLN . 65.1 p -123.48 174.1 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 76' ' ' VAL . 9.5 t60 -55.3 -47.9 74.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.001 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -65.73 -43.36 89.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.151 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 14.0 mm-40 -60.76 -42.9 98.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.571 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.721 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.79 -38.9 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.504 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 72' ' ' HIS . 25.4 t -58.88 -39.85 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -59.13 -41.78 89.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.277 0.561 . . . . 0.0 109.856 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.506 ' NE ' ' HG2' ' A' ' 65' ' ' GLU . 53.1 mtt180 -69.34 -35.88 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.9 mt -65.18 -32.59 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.202 0.525 . . . . 0.0 109.898 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.91 -17.3 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 109.997 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.53 114.29 20.83 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.562 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.53 -63.7 1.01 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.575 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -135.38 -0.12 2.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.149 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.98 141.65 20.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -126.62 144.15 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.839 0.352 . . . . 0.0 110.246 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 59.6 mtm-85 -103.31 113.23 26.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.152 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 17' ' ' LEU . 99.0 mt -112.37 118.47 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.014 0.435 . . . . 0.0 110.968 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 32.8 tp -95.1 116.32 28.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 31.8 m -130.02 154.08 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.842 0.353 . . . . 0.0 110.6 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.83 147.57 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.154 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 13.5 t70 -62.54 121.75 69.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.604 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 37.0 Cg_exo -60.43 -31.1 92.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.526 2.817 . . . . 0.0 113.508 -173.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.84 -44.74 63.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.003 0.43 . . . . 0.0 110.241 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 9' ' ' THR . 23.7 m -71.13 -36.74 72.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.735 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 9.1 t70 -56.92 -33.28 66.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.872 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 8.7 mm-40 -59.03 -49.66 77.04 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -72.74 -39.77 66.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.931 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.84 -33.9 76.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.988 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.59 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 0.7 OUTLIER -57.23 -49.14 76.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.495 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 14.0 mptt -68.94 -18.32 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.515 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.06 -10.81 59.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.84 46.3 38.43 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.614 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 106' ' ' VAL . 24.0 m -91.72 160.86 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.278 0.561 . . . . 0.0 111.96 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -104.32 69.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.9 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 104' ' ' VAL . 16.8 t -56.72 -27.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.6 ptm180 -59.9 -29.22 68.2 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -165.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -174.59 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.177 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.22 -32.28 70.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.81 -19.73 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.197 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.97 -38.0 46.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.426 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -81.3 -18.83 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.216 0.531 . . . . 0.0 110.055 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.04 -171.74 3.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.964 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.404 ' OE1' HD11 ' A' ' 11' ' ' LEU . 39.9 mt-30 54.08 37.29 26.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.347 0.594 . . . . 0.0 110.473 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.66 16.2 5.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.98 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 59.25 79.78 0.29 Allowed Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.301 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 95.73 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.833 2.356 . . . . 0.0 111.815 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -146.76 18.76 1.63 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.309 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -71.25 -46.97 59.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.153 0.501 . . . . 0.0 110.168 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.833 177.634 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -85.06 140.96 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.422 ' OD1' ' HD2' ' A' ' 7' ' ' PRO . 16.7 t0 -78.36 115.49 51.65 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HD2' ' OD1' ' A' ' 6' ' ' ASP . 37.2 Cg_endo -68.05 -21.62 42.71 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.893 2.395 . . . . 0.0 112.034 -175.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' LEU . 17.4 m-85 -146.78 147.32 30.79 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.519 0.676 . . . . 0.0 112.255 -174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 10' ' ' MET . 4.0 t -172.0 133.74 0.73 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.794 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 16.4 tpt 75.2 -60.58 0.51 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.708 0.803 . . . . 0.0 110.493 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 51.91 132.91 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.296 1.438 . . . . 0.0 114.178 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.025 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 84.9 Cg_endo -76.8 173.43 14.49 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.577 2.851 . . . . 0.0 113.514 -176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -143.04 157.69 44.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.124 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 89' ' ' LEU . 29.6 mt -84.54 115.98 22.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.2 m -94.49 108.31 20.25 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.517 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -94.62 111.62 23.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -121.88 150.31 42.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 36.3 mt-10 -112.97 134.76 54.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.786 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.87 117.58 4.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -172.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.63 -161.67 32.16 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.489 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.74 -33.15 93.35 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.42 2.747 . . . . 0.0 113.046 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -136.98 24.01 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 111.544 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.43 -153.26 18.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.758 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.694 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.4 m-85 -104.08 -29.91 10.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.967 0.383 . . . . 0.0 111.985 -173.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.14 29.65 6.69 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.79 172.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -134.0 141.07 47.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.429 -0.454 . . . . 0.0 110.32 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -101.6 144.17 30.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.53 128.32 49.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.493 0.187 . . . . 0.0 111.311 -172.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.5 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.4 p80 -123.94 140.27 53.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -118.1 6.48 15.17 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 64.16 -173.7 0.17 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.978 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -107.61 122.09 45.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.46 61.98 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.68 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 4.2 mptp? -96.44 167.71 11.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -130.51 20.48 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.061 175.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 144.05 15.8 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG3' HG21 ' A' ' 75' ' ' VAL . 69.6 mm-40 -103.86 146.22 28.97 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 117.007 0.404 . . . . 0.0 110.299 -173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -128.22 152.69 47.77 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 55' ' ' ALA . 28.5 mm -70.09 118.3 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 109.952 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 1.2 tpt180 -93.96 -49.67 5.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.521 -173.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.7 tm? -152.5 141.37 21.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.561 ' N ' HD13 ' A' ' 41' ' ' LEU . 25.0 t -118.82 127.29 75.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.1 mm-40 -80.88 120.05 77.79 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 11.7 Cg_exo -70.92 101.94 1.14 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.511 2.14 . . . . 0.0 112.386 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.2 22.11 1.26 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.99 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -118.49 173.84 3.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.77 0.319 . . . . 0.0 110.196 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 56.1 Cg_endo -70.34 -13.46 33.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.405 2.07 . . . . 0.0 112.922 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -47.9 81.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.402 . . . . 0.0 110.891 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.7 mp0 -67.34 -32.97 74.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.406 0.622 . . . . 0.0 109.791 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 27.3 mtpp -69.56 -21.02 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.908 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.67 -17.81 24.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.37 38.11 4.1 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.52 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 88' ' ' LEU . 94.6 mt -92.9 130.86 38.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.9 tt -129.09 138.74 52.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HG22 ' A' ' 39' ' ' ILE . . . -63.4 103.89 0.56 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.183 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.99 -26.89 2.58 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.654 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.647 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.7 m-20 -65.25 149.39 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.33 0.586 . . . . 0.0 111.549 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 58.8 ttt180 -92.13 125.51 36.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 37' ' ' GLN . 48.2 tp -80.42 100.71 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.032 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -86.32 -39.51 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.161 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 4.1 tt0 -146.73 151.42 37.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 111.534 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.767 HG21 HG13 ' A' ' 75' ' ' VAL . 83.9 t -131.3 111.3 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.617 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.99 -24.0 0.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.844 0.858 . . . . 0.0 112.03 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 148.0 13.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.454 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -126.0 135.39 51.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.393 0.597 . . . . 0.0 110.185 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -74.22 102.49 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.916 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG21 HG23 ' A' ' 62' ' ' VAL . 29.9 m -92.61 12.7 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -170.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.5 -3.22 19.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.185 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 35' ' ' LEU . 97.9 mttt -132.64 31.16 4.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.172 0.51 . . . . 0.0 110.086 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -116.9 -164.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.261 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 59.6 p -133.29 167.1 21.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.102 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 76' ' ' VAL . 20.4 t60 -53.88 -47.34 71.18 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.16 -46.81 88.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.2 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 48.6 mt-30 -65.32 -38.12 89.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.767 HG13 HG21 ' A' ' 62' ' ' VAL . 75.7 t -66.05 -39.55 84.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.924 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 72' ' ' HIS . 62.0 t -57.54 -46.1 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.614 0.245 . . . . 0.0 111.069 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -37.33 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.674 0.273 . . . . 0.0 110.989 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 85.9 mtt-85 -66.57 -36.38 82.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.974 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.2 mt -65.52 -39.87 86.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.0 110.173 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.4 mmt180 -71.21 -20.87 62.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.687 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.63 62.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.963 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 131.01 45.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.77 -52.27 10.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.216 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.87 -22.19 2.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.3 153.28 34.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.705 0.288 . . . . 0.0 110.937 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.0 141.71 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.12 114.51 27.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 53' ' ' LEU . 94.3 mt -109.62 119.46 39.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.423 ' HB2' HD23 ' A' ' 14' ' ' LEU . 26.8 tp -94.33 116.01 28.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 29.3 m -127.89 153.09 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.12 0.486 . . . . 0.0 111.041 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 10.6 p -148.26 153.51 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.326 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.89 118.69 16.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.41 -40.96 77.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.542 2.828 . . . . 0.0 113.597 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.34 -37.47 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -66.21 -38.28 87.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.913 0.387 . . . . 0.0 110.271 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.7 t70 -61.68 -36.7 81.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.88 -48.33 80.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.296 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 17.0 pt20 -72.43 -42.87 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.998 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 mt -59.44 -43.98 93.02 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.639 0.257 . . . . 0.0 111.203 -177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 96' ' ' ASP . 77.5 mm-40 -61.9 -38.16 87.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.796 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 98' ' ' GLN . 12.5 pttp -75.55 -19.79 59.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.366 . . . . 0.0 110.453 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 86.4 mt -76.89 -3.65 39.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.488 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.82 30.48 26.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.737 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 39.8 t -89.35 131.28 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.869 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 15.5 mp0 -95.18 85.29 4.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.336 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.557 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.47 -17.47 22.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.222 -175.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -59.39 -45.91 90.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.545 ' HA ' HD13 ' A' ' 111' ' ' LEU . 21.3 tt0 -166.79 -10.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.137 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 42.1 mm-40 -55.69 -40.79 72.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 110.6 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 8' ' ' PHE . 45.1 mt -65.23 -40.22 93.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.392 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 108' ' ' GLU . 4.9 mp -83.91 -13.93 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.052 -170.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -78.61 -49.2 13.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.829 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.24 84.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.771 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -98.29 98.31 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.888 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.74 102.64 2.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.483 0.658 . . . . 0.0 110.311 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.08 129.61 77.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.985 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.73 84.79 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.597 2.198 . . . . 0.0 112.383 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 -43.49 36.95 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -149.13 47.77 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.41 -179.651 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.0 mt -107.15 150.6 9.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -93.29 104.43 12.21 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.78 -30.55 78.05 Favored 'Trans proline' 0 CA--C 1.513 -0.56 0 C-N-CA 122.848 2.365 . . . . 0.0 111.498 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -149.53 139.67 22.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.317 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -148.56 -45.52 0.15 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.974 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.558 ' HB3' HG21 ' A' ' 95' ' ' THR . 51.0 tpp -138.9 78.57 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.924 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.54 155.8 85.35 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 -179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.715 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 55.3 Cg_endo -93.75 160.01 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.166 2.578 . . . . 0.0 112.775 -173.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -136.38 150.01 48.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.377 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD21 ' HD3' ' A' ' 87' ' ' ARG . 33.1 tp -82.21 106.79 14.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -92.49 111.66 23.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.051 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.632 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 42.6 m -97.31 110.9 23.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.256 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -110.97 154.98 23.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.339 176.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.96 130.41 55.69 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 -167.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -65.19 126.34 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.18 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.6 -169.18 21.82 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.24 -16.73 56.64 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.443 2.095 . . . . 0.0 112.135 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -97.81 0.74 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.132 0.492 . . . . 0.0 110.087 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.49 -119.76 5.81 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 17' ' ' LEU . 91.7 m-85 -119.26 -24.55 6.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.114 0.457 . . . . 0.0 110.661 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.0 31.18 29.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.576 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -128.7 156.6 43.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.361 0.581 . . . . 0.0 110.056 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.441 ' CD2' HD23 ' A' ' 41' ' ' LEU . 69.5 m-70 -126.16 144.61 50.69 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -120.15 143.18 48.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -139.48 147.35 41.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.706 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.36 108.81 2.29 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.733 ' O ' ' HD2' ' A' ' 34' ' ' LYS . 9.1 mm-40 -70.53 147.01 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -67.4 116.93 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 50.81 2.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.784 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -134.76 -171.87 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 110.55 -177.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 pt? -129.4 -29.27 2.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.752 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.06 -163.95 12.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.04 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -111.93 155.69 23.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.892 0.377 . . . . 0.0 110.622 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.567 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 83.2 m-85 -131.16 151.9 50.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.534 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.1 mm -72.53 124.91 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.806 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 40' ' ' ARG . 2.4 tmm_? -89.06 -40.73 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 7.7 tp -161.9 150.07 14.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.487 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 65.0 t -129.29 129.9 67.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -76.94 115.97 53.04 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.31 114.2 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.207 1.938 . . . . 0.0 111.051 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 40.81 2.75 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.842 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.775 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 34.3 p -119.64 -164.16 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 74.5 Cg_endo -90.31 -13.36 2.42 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.245 1.296 . . . . 0.0 112.919 163.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -73.81 -41.62 62.1 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -74.73 -35.14 62.66 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.392 1.091 . . . . 0.0 108.14 -174.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -57.29 -34.66 68.9 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.938 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -78.87 -17.32 55.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.24 24.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.618 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.69 130.44 37.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.765 0.317 . . . . 0.0 110.495 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.3 tp -137.31 150.83 48.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.999 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 94.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.272 0.558 . . . . 0.0 111.179 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.71 -25.25 1.05 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.1 m-20 -62.26 140.81 58.48 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.137 0.494 . . . . 0.0 111.231 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 38' ' ' TYR . 42.1 ttm180 -88.9 126.7 35.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.907 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 46.3 tp -80.46 117.36 21.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.02 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HB ' HD23 ' A' ' 89' ' ' LEU . 52.6 t -102.21 -37.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.463 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.65 149.73 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.632 -178.01 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 75' ' ' VAL . 86.8 t -137.05 117.68 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.617 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 60.44 37.42 19.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.386 0.613 . . . . 0.0 110.147 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.52 16.24 76.25 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.705 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 7.3 tp10 -125.16 135.15 52.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.519 -0.401 . . . . 0.0 110.957 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.508 HD22 ' HB2' ' A' ' 68' ' ' GLU . 6.6 t30 -70.02 113.96 7.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.375 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.9 m -111.99 26.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.327 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' HB2' HD22 ' A' ' 66' ' ' ASN . 81.2 mt-10 -61.24 -25.4 67.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.424 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 5.7 ptpp? -141.94 34.98 1.56 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.037 0.446 . . . . 0.0 111.543 -170.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mt-10 -110.56 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.019 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.3 p -113.48 167.62 10.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.6 t60 -56.71 -44.52 81.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.853 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.62 -46.01 90.24 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.607 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 56.8 mt-30 -61.38 -42.4 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 62' ' ' VAL . 74.3 t -64.97 -41.14 91.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.506 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 72' ' ' HIS . 73.1 t -58.01 -44.21 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.625 0.25 . . . . 0.0 111.425 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 p -64.0 -36.48 84.11 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.534 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 44.6 mtt-85 -64.94 -37.67 88.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 75' ' ' VAL . 77.2 mt -63.22 -32.8 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 110.268 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.6 mmt180 -70.34 -21.06 62.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -6.69 51.02 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -90.14 125.23 35.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.707 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.55 -75.86 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.144 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -118.64 -1.92 11.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.506 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.98 149.58 29.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 174.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.23 142.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.632 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 94.1 mtt180 -98.68 117.37 33.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.98 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.463 HD12 HD21 ' A' ' 17' ' ' LEU . 89.3 mt -121.75 125.92 47.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 10.4 tp -100.25 115.94 31.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.3 m -127.93 155.79 39.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.067 0.461 . . . . 0.0 110.375 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.3 p -148.0 154.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.039 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.62 123.37 56.93 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.95 -35.34 98.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.55 2.833 . . . . 0.0 113.246 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -72.22 -43.58 64.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.6 m -66.38 -37.43 85.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.689 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.51 ' HB2' HG13 ' A' ' 91' ' ' VAL . 30.5 t70 -57.92 -39.74 78.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.347 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -58.51 -49.05 78.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.281 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.546 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.3 pt20 -72.64 -39.59 67.08 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.765 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 102' ' ' LEU . 38.8 mt -70.48 -42.78 70.93 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -47.93 82.49 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.7 -18.92 65.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.685 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 95.8 mt -69.49 -20.84 63.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.54 33.09 4.59 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.058 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.26 132.1 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.049 0.452 . . . . 0.0 111.139 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 19.9 mp0 -87.08 88.58 7.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.91 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 12' ' ' PRO . 2.3 t -65.64 -29.62 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.121 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 15.1 ttp85 -60.69 -44.02 97.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -168.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -158.81 -34.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.965 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.848 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 8.4 tp10 -55.52 -39.51 70.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.618 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 38.6 tp -68.86 -20.86 64.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.385 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.73 -32.55 16.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.968 0.414 . . . . 0.0 110.857 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.501 ' HD3' ' HA ' ' A' ' 109' ' ' GLU . 10.3 ptm180 -83.07 -30.69 27.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.938 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.98 98.01 3.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.636 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 2.9 mt-30 -98.41 16.12 22.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.292 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.38 81.08 8.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.287 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.78 113.81 40.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.229 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.87 157.31 57.27 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.021 2.481 . . . . 0.0 112.406 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.49 -101.03 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.171 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -113.03 7.17 17.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.864 -178.573 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.7 138.36 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -104.3 128.1 27.75 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.04 -30.58 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.445 2.097 . . . . 0.0 110.776 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 11' ' ' LEU . 37.2 m-85 -153.97 145.11 22.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.74 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 10' ' ' MET . 1.5 t -142.68 -98.49 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.135 -169.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.47 ' H ' HG23 ' A' ' 9' ' ' THR . 82.6 mtp -97.41 -28.05 14.18 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 28.1 mt 76.36 160.09 0.15 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.083 167.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 58.5 Cg_endo -69.03 157.32 62.27 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.103 2.536 . . . . 0.0 112.732 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -129.75 126.27 37.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.8 tp -90.9 106.62 18.64 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.511 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.427 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 55.8 m -99.74 107.96 20.16 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.27 111.62 23.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.26 0.552 . . . . 0.0 110.126 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -114.89 165.43 12.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.386 -178.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.1 147.38 44.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.859 -170.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -72.03 107.52 4.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.41 -163.76 39.28 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.55 -26.72 81.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.74 2.293 . . . . 0.0 112.71 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -112.63 25.67 11.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.475 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -105.05 2.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.958 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' SER . 90.3 m-85 -131.7 -42.07 1.04 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.488 -0.419 . . . . 0.0 111.662 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 42.72 4.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.397 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.82 158.3 43.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.491 0.646 . . . . 0.0 110.171 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 60.8 m-70 -128.27 143.83 51.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.166 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.68 155.91 38.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.212 0.529 . . . . 0.0 111.748 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -140.17 139.1 35.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.43 117.57 5.57 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -74.75 134.87 41.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 111.38 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -59.82 108.33 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.945 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.6 -31.46 3.96 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 12.0 mptt -110.25 159.51 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 109.864 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 1.5 pp -106.51 -4.05 20.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.076 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.06 147.99 24.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 75' ' ' VAL . 33.8 mm-40 -103.33 152.4 21.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.953 0.406 . . . . 0.0 110.061 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -126.39 144.75 50.72 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.1 120.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.27 -47.2 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.9 tp -146.66 149.41 33.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -123.67 120.04 58.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.163 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 53.0 mm-40 -64.29 131.91 95.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.5 Cg_exo -70.89 123.85 10.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.887 1.725 . . . . 0.0 111.786 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.7 22.07 24.67 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.055 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 89.9 p -104.24 158.08 32.69 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.746 0.308 . . . . 0.0 110.564 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.75 -14.82 46.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.601 2.201 . . . . 0.0 111.7 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -66.47 -40.69 89.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.347 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HG2' HG11 ' A' ' 42' ' ' VAL . 28.8 mt-10 -64.94 -37.68 88.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.874 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.67 -29.11 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.006 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.16 -18.89 52.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.34 33.66 5.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 88' ' ' LEU . 83.4 mt -86.89 134.74 33.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.281 . . . . 0.0 110.444 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.71 153.33 51.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 128.1 34.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.468 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.71 -15.73 21.61 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.149 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 1.7 m-20 -78.29 147.18 34.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.925 0.393 . . . . 0.0 110.761 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 61.0 ttt180 -92.48 126.9 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.4 tp -77.58 112.79 14.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.163 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' HB ' HD23 ' A' ' 89' ' ' LEU . 40.8 t -104.88 -31.37 2.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.428 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -143.13 149.96 38.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.055 -0.403 . . . . 0.0 110.78 -178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.59 113.59 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.315 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.82 35.28 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.837 0.827 . . . . 0.0 110.844 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.66 10.96 69.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.147 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.7 tp10 -124.79 132.05 53.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.112 0.456 . . . . 0.0 110.868 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.26 108.95 3.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.7 16.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.698 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -76.39 7.54 4.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.46 23.48 2.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.668 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -109.25 -172.61 2.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.811 -174.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 69.5 p -128.19 175.22 8.61 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.551 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 t60 -61.57 -46.56 89.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -66.51 -41.46 88.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.846 0.355 . . . . 0.0 110.716 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 74.1 mt-30 -67.17 -38.71 85.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 37' ' ' GLN . 17.8 m -68.64 -41.18 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.08 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 72' ' ' HIS . 76.3 t -56.31 -39.13 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 m -61.94 -38.64 89.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.387 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 63.2 mtt-85 -67.37 -36.57 81.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.625 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 71.7 mt -63.17 -37.71 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.208 0.528 . . . . 0.0 110.004 175.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -68.96 -24.52 64.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.074 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.82 58.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.8 130.89 46.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.203 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.05 -67.05 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.858 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.37 -24.58 9.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.09 157.93 43.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.793 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.5 p -130.05 143.36 41.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 14' ' ' LEU . 9.9 mtm180 -98.74 128.51 45.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 53' ' ' LEU . 94.4 mt -122.12 110.57 15.92 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 11.9 tp -93.62 126.46 38.79 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.3 m -130.97 165.36 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 96' ' ' ASP . 8.7 p -148.14 140.1 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.569 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.5 p30 -75.1 145.12 80.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 50.4 Cg_exo -55.21 -31.52 76.47 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.017 3.145 . . . . 0.0 114.512 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.93 -47.89 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.777 0.323 . . . . 0.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.1 m -64.19 -44.78 90.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.622 0.725 . . . . 0.0 109.879 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 17.6 t70 -59.24 -39.64 83.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.507 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.48 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 1.9 tm-20 -57.41 -49.81 75.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.136 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.597 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 7.4 pt20 -73.96 -47.34 38.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 104' ' ' VAL . 2.7 mm? -58.76 -38.9 79.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 7.4 pt20 -64.53 -40.64 95.98 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.212 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 97' ' ' GLU . 44.1 mtmt -75.52 -34.98 60.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.878 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 90.6 mt -63.16 -27.3 69.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.606 -177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.61 73.92 0.9 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 99' ' ' LEU . 57.4 t -121.37 153.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.566 0.222 . . . . 0.0 110.605 -173.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 11.5 pt20 -71.22 57.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.36 0.6 . . . . 0.0 111.171 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.506 HG13 ' HG3' ' A' ' 12' ' ' PRO . 47.8 t -63.66 -27.57 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.775 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.549 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 39.4 ptt180 -60.61 -23.04 64.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -169.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 112' ' ' ARG . 17.8 tt0 171.18 -41.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.418 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.0 mt-10 -54.47 -32.5 57.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.206 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.411 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 61.7 tp -70.28 -41.97 72.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 0.0 111.245 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -90.37 -12.65 36.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.257 0.551 . . . . 0.0 111.135 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.2 ttp180 -78.88 -46.94 17.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.663 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.24 39.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.345 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -120.0 112.09 18.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.261 0.553 . . . . 0.0 111.072 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.53 6.63 10.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.41 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 61.77 80.19 0.26 Allowed Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.905 -175.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.44 87.71 1.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.662 2.241 . . . . 0.0 111.854 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.74 60.26 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -70.68 148.67 47.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.8 0.333 . . . . 0.0 110.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.205 178.642 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.85 135.9 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.91 0.355 . . . . 0.0 110.226 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.03 110.18 48.55 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.358 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.82 -16.36 18.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.747 2.298 . . . . 0.0 111.581 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -144.75 142.83 30.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.609 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 179.7 132.11 0.09 Allowed 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.496 0.498 . . . . 0.0 110.39 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.8 mtt 44.06 47.06 7.31 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.74 0.65 . . . . 0.0 111.622 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.75 135.74 96.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.363 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 54.4 Cg_endo -68.1 155.43 69.54 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.132 2.555 . . . . 0.0 113.518 -174.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -116.81 154.09 31.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.315 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.4 tp -82.06 115.48 21.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.8 m -93.41 115.85 28.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -104.38 112.21 25.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.727 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.66 155.68 34.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.182 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -104.34 145.77 29.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.512 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 26.0 ttpt -77.74 119.53 21.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.373 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.16 -158.36 25.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.701 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.12 -27.45 65.12 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.77 2.313 . . . . 0.0 112.457 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -110.25 26.1 11.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.274 0.559 . . . . 0.0 110.208 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 80.91 -100.58 1.99 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.5 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 87.1 m-85 -133.72 -22.63 1.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.302 0.551 . . . . 0.0 111.804 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.05 28.96 24.23 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.76 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -127.31 140.6 52.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 41' ' ' LEU . 93.6 m-70 -109.85 138.77 45.75 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.54 132.18 56.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.739 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.415 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 5.0 p80 -122.78 146.74 47.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.977 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.89 113.0 1.95 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.563 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 8.8 mm-40 -61.57 133.71 55.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.612 0.244 . . . . 0.0 110.833 -175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.12 98.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.276 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.01 -13.16 9.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.229 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 27.8 mmmt -91.54 155.66 18.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.2 pp -102.57 19.28 19.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.31 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.39 152.47 20.64 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.666 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -103.71 137.52 41.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.907 0.384 . . . . 0.0 110.578 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m-85 -125.08 155.41 39.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.013 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.33 127.83 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 3.9 tmm_? -101.14 -45.15 5.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.807 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -146.68 141.22 26.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.53 -172.56 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 41' ' ' LEU . 55.1 t -121.67 113.79 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.9 mm-40 -73.59 130.14 84.28 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.16 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.3 Cg_exo -70.13 124.04 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.367 2.044 . . . . 0.0 111.815 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.9 16.93 29.34 Favored Glycine 0 C--N 1.317 -0.496 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.899 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 95.9 p -101.71 159.54 29.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 0.0 110.829 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.96 -20.25 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.83 172.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -64.19 -42.13 96.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.21 -42.0 89.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.307 0.575 . . . . 0.0 110.362 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.65 -22.93 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.11 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -87.28 -17.83 31.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.901 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.67 29.96 5.71 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.202 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.13 133.51 36.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 tt -139.97 141.06 36.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.86 100.03 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.382 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.04 -31.23 1.74 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.9 m-20 -60.28 140.9 56.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.519 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -89.04 132.35 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.861 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 90' ' ' VAL . 32.7 tp -75.2 114.06 13.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.758 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG11 HG12 ' A' ' 106' ' ' VAL . 46.3 t -101.7 -36.45 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.07 150.25 35.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.003 -178.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.618 HG23 HG21 ' A' ' 67' ' ' VAL . 93.0 t -136.17 107.24 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.123 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.5 m120 62.99 22.4 13.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.346 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' A' ' 61' ' ' GLU . . . 106.67 4.22 36.94 Favored Glycine 0 C--N 1.321 -0.285 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.218 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.642 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.1 tp10 -109.09 128.7 55.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.725 0.298 . . . . 0.0 110.356 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -73.36 93.29 1.91 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.422 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 62' ' ' VAL . 35.7 m -95.41 35.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -173.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.48 -18.69 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.1 19.2 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.673 -177.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mp0 -93.93 141.12 28.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.99 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . 82.2 p -81.01 175.14 10.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.908 -174.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 21.9 t60 -53.84 -47.04 71.34 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.029 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.95 -40.97 91.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 84.1 mm-40 -62.86 -44.03 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.958 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 71' ' ' THR . 12.6 m -71.71 -44.96 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.7 t -59.22 -35.88 60.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.027 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 t -57.53 -40.95 79.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.317 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.642 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 68.2 mtt-85 -70.0 -37.68 75.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.44 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.8 mt -64.61 -37.92 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.353 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.776 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.48 -22.33 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 127.68 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.8 mp -78.06 -62.29 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.755 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -128.33 -12.58 5.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.379 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.55 31.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.628 0.251 . . . . 0.0 110.81 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.1 p -126.21 146.99 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.504 ' HB3' HD11 ' A' ' 14' ' ' LEU . 8.4 mtm180 -98.61 120.83 39.71 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 17' ' ' LEU . 92.6 mt -122.33 116.07 23.41 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.65 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 29.3 tp -101.54 117.37 34.77 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 25.8 m -131.04 153.77 39.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.943 0.402 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 96' ' ' ASP . 11.3 p -142.65 149.04 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.185 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.39 129.35 68.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.31 -34.11 88.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.61 2.873 . . . . 0.0 113.576 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.35 -43.34 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 17.3 m -66.39 -41.4 89.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HB2' HG13 ' A' ' 91' ' ' VAL . 14.0 t70 -58.84 -42.75 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.75 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.22 -47.03 84.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.019 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 13.6 pt20 -73.27 -38.67 65.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.0 111.001 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.97 -40.3 91.12 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -175.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.81 -37.18 85.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -71.67 -17.9 62.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.526 . . . . 0.0 110.655 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 77.0 mt -79.51 -3.85 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.906 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.84 41.71 72.26 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.104 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.91 137.64 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.859 0.361 . . . . 0.0 111.668 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 109' ' ' GLU . 17.3 mm-40 -79.33 54.64 1.73 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.475 HG12 HG11 ' A' ' 60' ' ' VAL . 1.5 t -60.57 -26.61 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.946 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.715 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -65.72 -5.44 8.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 33.3 tt0 168.55 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.934 0.397 . . . . 0.0 110.634 171.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 31.7 tt0 -55.54 -37.68 68.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.412 -172.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 110' ' ' LEU . 2.2 tm? -65.73 -26.79 67.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.97 -177.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.39 -11.99 54.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.555 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -63.33 -72.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.3 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -177.58 -70.03 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.351 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 110' ' ' LEU . 2.2 mp0 52.64 40.78 30.75 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.791 -173.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.54 100.2 9.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 65.49 92.17 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 O-C-N 124.067 0.854 . . . . 0.0 109.705 -168.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 104.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.213 2.609 . . . . 0.0 112.684 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -125.17 38.6 2.26 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.926 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -127.81 95.47 4.22 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.78 178.153 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -133.41 133.6 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.863 0.364 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -112.75 125.44 29.89 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.566 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.41 -28.87 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.711 2.274 . . . . 0.0 112.588 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HD2' HD11 ' A' ' 11' ' ' LEU . 16.2 m-85 -144.81 151.87 39.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 -174.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.482 ' O ' HG21 ' A' ' 95' ' ' THR . 10.1 t 175.96 142.74 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -169.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 95' ' ' THR . 86.1 mtp 48.44 47.4 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.807 0.692 . . . . 0.0 111.651 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 2.0 mm? -72.8 157.61 88.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.515 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 37.7 Cg_endo -64.45 178.88 1.44 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.438 2.759 . . . . 0.0 113.709 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -143.3 149.37 37.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.626 -178.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 13.4 mt -84.22 108.01 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.6 m -94.38 108.41 20.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.044 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -95.1 111.85 23.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.915 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -122.04 150.79 41.61 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.42 147.83 29.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.558 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -69.43 97.53 1.0 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.653 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 -167.09 14.56 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.836 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.23 -34.2 98.15 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.928 2.418 . . . . 0.0 112.261 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -102.34 24.37 10.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.547 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.63 64.27 3.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.37 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.7 m-85 78.74 -38.57 0.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.215 1.006 . . . . 0.0 111.374 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.617 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.51 12.45 53.83 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -123.35 149.76 44.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.126 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.492 ' CD2' HD23 ' A' ' 41' ' ' LEU . 39.6 m-70 -124.3 131.94 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.806 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -104.71 142.05 35.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.42 -172.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 2.9 p-80 -133.42 134.93 44.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.149 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.39 104.04 2.15 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.585 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.5 mt-10 -60.39 146.37 44.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.095 0.474 . . . . 0.0 111.635 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.78 117.98 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.636 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.0 -38.3 3.36 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.851 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 70.7 mmtt -66.85 157.18 33.71 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.503 HD13 ' HG2' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -113.0 5.08 17.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.88 165.69 16.65 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.676 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 75' ' ' VAL . 3.1 mp0 -103.66 148.56 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.804 0.335 . . . . 0.0 110.411 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' HB2' ' CE1' ' A' ' 29' ' ' HIS . 32.6 m-85 -131.44 154.47 48.65 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.91 113.41 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 ttp180 -85.48 -47.51 9.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.491 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 27' ' ' HIS . 26.7 tp -145.7 142.49 29.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.704 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 54' ' ' LEU . 1.7 p -135.66 112.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -78.87 135.43 59.25 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.68 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' CD ' ' A' ' 49' ' ' GLU . 27.8 Cg_exo -61.67 129.17 26.82 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.609 2.206 . . . . 0.0 112.057 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.79 1.38 45.99 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.942 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.617 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 96.0 p -93.76 152.14 40.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.156 0.503 . . . . 0.0 110.947 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.24 -13.7 41.04 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.86 2.373 . . . . 0.0 112.17 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.98 -39.96 95.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.001 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' CD ' ' HA ' ' A' ' 44' ' ' PRO . 30.1 mt-10 -62.92 -39.46 94.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.963 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -65.6 -29.84 70.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.934 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.12 -19.42 51.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.331 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.63 49.98 1.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -124.68 121.13 33.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.17 171.24 10.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.729 173.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.55 78.62 6.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.39 0.614 . . . . 0.0 111.191 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.33 -21.2 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.957 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 67.3 m-20 -63.97 141.75 58.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.686 0.279 . . . . 0.0 111.114 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.18 124.92 34.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.78 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.578 ' HA ' HG12 ' A' ' 90' ' ' VAL . 51.8 tp -78.4 119.48 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 106' ' ' VAL . 60.2 t -103.78 -34.97 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.388 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 16.6 tt0 -150.55 151.18 32.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.761 0.315 . . . . 0.0 111.17 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG23 HG21 ' A' ' 67' ' ' VAL . 65.6 t -132.4 119.92 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.469 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 72.9 -26.1 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.027 0.931 . . . . 0.0 111.729 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 145.16 10.68 0.28 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.604 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.3 tp10 -125.81 128.97 48.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.44 132.41 53.64 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.456 0.472 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 HG12 ' A' ' 75' ' ' VAL . 33.0 m -128.16 29.55 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.8 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.72 -24.28 66.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.503 ' HG2' HD13 ' A' ' 35' ' ' LEU . 98.3 mttt -129.95 29.83 4.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.813 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 15.9 mm-40 -95.19 179.93 5.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.934 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.65 ' OG1' ' HB2' ' A' ' 74' ' ' GLN . 25.1 p -107.63 167.62 9.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.695 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 48.5 t-80 -62.69 -44.13 97.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -64.83 -36.75 85.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 0.0 109.973 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.65 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -62.96 -45.4 92.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.819 -177.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG12 HG11 ' A' ' 67' ' ' VAL . 4.7 m -71.32 -40.14 73.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.348 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' HIS . 45.1 t -57.55 -36.92 55.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.6 t -57.96 -41.53 83.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -69.09 -36.69 77.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -64.22 -32.8 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 109.906 176.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -21.34 62.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.847 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.09 -18.35 46.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.424 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.18 119.07 26.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.832 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.96 -62.85 1.43 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.295 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -107.15 -27.52 10.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.306 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.63 155.06 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.994 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 24' ' ' TYR . 9.8 p -131.5 153.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.802 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -106.7 125.19 50.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 99.5 mt -120.37 127.68 52.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.2 tp -103.37 116.73 32.98 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.7 m -130.54 153.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -131.9 148.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.296 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.0 m-20 -68.24 123.14 86.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 33.0 Cg_exo -57.62 -31.74 92.61 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.541 2.827 . . . . 0.0 113.318 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.77 -48.46 81.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 109.897 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 9' ' ' THR . 2.6 m -73.67 -36.04 65.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.261 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.07 -40.42 76.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 43.7 mt-10 -61.04 -43.51 98.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.775 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -74.41 -39.89 62.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.076 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 mt -64.94 -34.18 77.8 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 18.1 pt20 -60.17 -34.33 73.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.42 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -71.71 -37.77 70.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.321 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 99' ' ' LEU . 27.2 mt -76.89 -44.51 31.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.458 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.58 94.19 0.16 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.05 95.54 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.14 0.971 . . . . 0.0 112.072 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -113.08 28.33 8.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.418 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.807 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 21.8 m -66.35 -14.19 17.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.551 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.29 -37.76 75.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -166.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HD23 ' A' ' 111' ' ' LEU . 39.0 tt0 -162.13 -19.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.175 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.26 -36.2 65.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.722 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 3.9 mm? -77.92 -28.64 49.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.087 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.6 mm? -74.94 -22.09 58.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.235 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -60.4 -35.56 76.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.505 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 69.88 112.84 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.492 HE22 ' HA ' ' A' ' 110' ' ' LEU . 0.7 OUTLIER -84.28 92.11 7.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.951 -174.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.55 131.24 41.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.871 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.684 ' HB1' ' HG3' ' A' ' 119' ' ' GLN . . . -98.88 110.97 59.48 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.203 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.19 104.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.193 2.595 . . . . 0.0 112.871 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.7 31.45 67.66 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.219 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.684 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 9.2 pt20 -171.4 -173.26 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.851 0.325 . . . . 0.0 110.336 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.591 173.485 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.46 136.83 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -71.59 137.22 83.24 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.73 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.62 ' HA ' HD13 ' A' ' 102' ' ' LEU . 30.0 Cg_endo -64.79 -24.33 61.72 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.639 2.893 . . . . 0.0 113.298 -173.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.525 ' HD1' HD21 ' A' ' 11' ' ' LEU . 16.2 m-85 -146.01 150.05 35.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.066 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -173.71 126.58 0.39 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.453 -171.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt 72.8 -71.0 0.14 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.884 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.525 HD21 ' HD1' ' A' ' 8' ' ' PHE . 2.8 mm? 65.74 156.89 0.13 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.778 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 72.4 Cg_endo -74.01 158.99 45.35 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.774 2.316 . . . . 0.0 112.553 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -115.33 143.98 44.45 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.737 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -83.19 106.3 14.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.3 m -96.24 108.52 21.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.671 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 22.0 m -91.82 111.75 23.4 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 48' ' ' ALA . 21.1 mt -88.27 163.65 15.99 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 41.6 mt-10 -115.34 121.85 44.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.19 101.75 2.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.932 0.396 . . . . 0.0 110.666 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.59 -157.87 33.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.709 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 -26.82 73.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.59 14.8 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 -124.44 6.47 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.155 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 86' ' ' VAL . 91.4 m-85 -108.47 -22.55 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.896 0.379 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.06 33.94 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.112 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.17 149.9 52.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.458 0.629 . . . . 0.0 110.182 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -105.78 134.53 48.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.3 tp -119.87 124.25 45.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.1 p80 -123.88 146.0 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.074 -175.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.62 105.01 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.941 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.613 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 41.8 mt-10 -74.78 -178.33 3.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.655 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -99.2 138.68 35.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.64 -1.46 60.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.957 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -104.65 -173.95 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.612 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -127.99 -12.67 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.588 174.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.12 -173.41 13.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.898 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -105.66 149.78 26.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.661 0.267 . . . . 0.0 110.658 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -125.91 152.17 45.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.532 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.3 mm -70.57 122.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.691 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.585 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -91.7 -48.52 6.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.973 -177.079 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.548 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 2.8 tp -154.93 152.09 29.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 54.8 t -119.52 115.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.19 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 69.4 mm-40 -62.94 127.66 91.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 7.6 Cg_exo -69.77 109.72 2.38 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.215 1.943 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.91 28.76 4.88 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.507 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 96.7 p -115.18 161.38 29.85 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.712 0.291 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 50' ' ' LYS . 38.6 Cg_endo -66.86 -13.41 39.83 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.132 2.555 . . . . 0.0 112.501 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.55 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -65.67 -39.94 91.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.359 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.41 -46.98 74.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 47' ' ' PRO . 21.2 ptmt -61.12 -34.77 75.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.951 -174.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.04 -17.68 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 58.92 0.71 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.494 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.7 mp -120.11 126.31 50.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 54' ' ' LEU . 2.9 mm? -127.84 166.6 17.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.3 0.571 . . . . 0.0 110.826 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.9 105.48 6.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.263 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.92 -24.73 2.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.175 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.586 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 27.8 m-20 -63.87 144.4 57.09 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -95.75 133.05 40.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 90' ' ' VAL . 28.9 tp -73.33 110.37 7.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.004 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -95.33 -45.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.073 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -143.59 149.78 37.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.602 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 67' ' ' VAL . 82.3 t -137.04 119.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.965 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.29 37.79 13.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.2 5.86 82.3 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.526 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' VAL . 32.9 tt0 -126.09 128.75 47.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.17 0.485 . . . . 0.0 111.07 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -58.86 119.95 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.702 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 62' ' ' VAL . 36.0 m -116.96 21.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.411 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.0 -14.89 61.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.86 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -122.69 19.01 10.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.964 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 21.6 mm-40 -92.0 -176.82 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.039 0.447 . . . . 0.0 111.202 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 75' ' ' VAL . 55.5 p -115.19 169.34 9.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.853 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.4 t60 -55.1 -47.0 75.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.741 0.305 . . . . 0.0 110.263 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -65.6 -46.35 79.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.444 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -62.57 -40.64 97.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.45 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 71' ' ' THR . 15.9 m -70.18 -42.98 79.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.668 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 72' ' ' HIS . 71.3 t -58.64 -36.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.731 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.8 m -59.52 -40.15 86.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 110.184 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.21 -36.85 82.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.34 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 76' ' ' VAL . 74.0 mt -63.53 -38.04 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.659 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.2 mmt180 -71.82 -22.71 61.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.666 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.23 -19.28 63.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.374 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -82.06 127.89 33.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.85 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.62 -71.15 0.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.465 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -108.45 -17.66 13.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.353 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.514 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.276 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 ' CE1' ' A' ' 24' ' ' TYR . 7.5 p -131.4 146.64 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.612 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 98.6 mtt180 -98.68 119.88 38.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.205 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.7 mt -121.67 121.96 38.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.396 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.9 tp -102.42 118.27 36.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.231 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 23.8 m -128.59 153.49 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.612 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 150.17 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.483 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 5.1 m-20 -71.8 116.16 45.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.446 174.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 43.1 Cg_exo -58.07 -24.89 68.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.897 2.398 . . . . 0.0 112.277 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 7.1 pt-20 -65.31 -47.79 75.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.059 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 m -73.75 -38.83 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.488 . . . . 0.0 110.909 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 11.8 t70 -58.48 -32.16 68.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.78 -48.28 80.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.397 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -74.28 -40.14 62.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.015 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.84 -38.3 85.04 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 46.8 mt-30 -58.07 -35.9 72.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.417 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -72.66 -19.43 61.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 7' ' ' PRO . 16.2 mt -101.55 -35.09 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.3 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.79 86.21 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.956 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 106' ' ' VAL . 3.0 p -85.45 102.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.772 0.796 . . . . 0.0 111.942 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -126.71 49.18 2.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.109 0.957 . . . . 0.0 108.504 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 30.7 m -67.17 -13.42 16.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.063 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.59 -35.43 72.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -163.081 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' HD12 ' A' ' 111' ' ' LEU . 22.5 tt0 -164.66 -22.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.191 0.52 . . . . 0.0 110.986 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -55.39 -45.57 76.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.526 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 110' ' ' LEU . 3.5 mm? -78.16 -18.54 55.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 89' ' ' LEU . 73.3 mt -76.01 -30.64 58.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.228 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 112' ' ' ARG . 9.2 ptp85 -88.89 -31.49 18.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.834 0.35 . . . . 0.0 110.864 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.93 143.57 11.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -123.81 126.4 46.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.86 130.49 43.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.098 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 61.51 70.11 0.93 Allowed Pre-proline 0 C--O 1.233 0.229 0 O-C-N 124.231 0.957 . . . . 0.0 110.218 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.27 115.89 2.95 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.894 2.396 . . . . 0.0 112.585 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.37 40.73 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.008 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -107.71 -87.57 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.187 178.283 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mt -124.55 132.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 0.0 110.89 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.47 141.71 23.58 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.845 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.04 -21.88 68.12 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.109 2.539 . . . . 0.0 112.642 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.33 156.2 36.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.897 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -170.42 127.52 0.8 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.151 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.554 ' HB3' HG21 ' A' ' 95' ' ' THR . 26.1 ttt 43.9 64.03 1.41 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.902 0.751 . . . . 0.0 111.302 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.84 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -75.81 146.85 80.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 -176.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.114 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 55.2 Cg_endo -67.15 140.14 52.91 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 123.342 2.695 . . . . 0.0 112.274 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -113.71 140.68 48.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.967 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.53 105.01 12.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.626 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 56.3 m -96.09 113.07 24.65 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.891 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.32 115.98 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.151 0.501 . . . . 0.0 109.851 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 24' ' ' TYR . 15.1 mt -98.59 147.55 24.69 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.396 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -100.17 122.43 42.99 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -65.75 111.31 3.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.85 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.44 -160.5 36.54 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.889 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.44 -29.65 71.63 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.777 2.318 . . . . 0.0 112.417 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -113.19 31.99 6.05 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -116.0 4.13 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.215 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 17' ' ' LEU . 45.8 m-85 -125.16 -25.67 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.985 0.393 . . . . 0.0 111.274 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.58 30.44 11.85 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.562 -0.828 . . . . 0.0 114.026 172.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -125.46 152.2 45.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.577 0.688 . . . . 0.0 110.051 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 51.1 m-70 -117.52 139.3 51.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.391 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.35 127.84 49.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.064 -169.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.0 p80 -116.55 133.54 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.34 6.79 42.66 Favored Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.989 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.818 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 11.7 mm-40 64.16 172.3 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.816 0.817 . . . . 0.0 112.708 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -125.14 101.26 6.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.296 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.69 -19.19 10.53 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -98.44 -177.24 3.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.0 pt? -141.22 35.72 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.858 0.361 . . . . 0.0 110.952 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.94 155.72 24.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.833 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.542 ' HG3' HG21 ' A' ' 75' ' ' VAL . 68.2 mm-40 -104.0 137.22 42.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.553 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 7.2 m-85 -134.07 152.9 52.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.729 0.3 . . . . 0.0 110.633 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.46 120.37 18.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -99.12 -26.81 14.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.598 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.6 tp -163.93 150.15 11.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.7 t -125.24 118.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.395 173.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 40.5 mm-40 -64.17 129.87 94.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.0 Cg_exo -69.3 123.11 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.075 1.85 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.44 20.58 26.85 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.593 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 90.7 p -104.17 159.3 29.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.87 -21.31 56.73 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.695 2.263 . . . . 0.0 111.887 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -61.73 -38.78 89.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.151 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 21.3 mt-10 -71.08 -33.1 69.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.31 -36.69 77.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.41 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -80.44 -17.98 50.14 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.115 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 38.32 4.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.525 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.62 127.79 34.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 tp -121.02 141.48 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.67 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.62 102.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.331 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.9 -28.3 2.01 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.394 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 31.7 m-20 -62.23 139.41 58.5 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.595 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 42.7 ttp180 -89.75 132.68 35.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.2 tp -74.72 112.5 10.99 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.729 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG13 ' CD ' ' A' ' 68' ' ' GLU . 57.3 t -95.7 -44.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.24 -175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -145.58 150.04 35.66 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.619 -175.243 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.588 HG21 HG13 ' A' ' 75' ' ' VAL . 92.3 t -137.13 116.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m120 62.2 30.38 17.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.471 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.52 7.01 58.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.553 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.5 tp10 -125.53 135.4 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.603 0.701 . . . . 0.0 111.684 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -67.25 117.16 8.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.822 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 62' ' ' VAL . 29.6 m -117.9 26.38 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CD ' HG13 ' A' ' 60' ' ' VAL . 53.8 mt-10 -73.53 -19.7 60.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.836 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -122.06 21.48 10.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.599 0.714 . . . . 0.0 109.84 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 2.5 mp0 -101.54 153.82 19.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.472 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.8 p -77.1 162.32 27.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.354 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -56.38 -42.31 77.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.85 0.357 . . . . 0.0 110.166 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 48.7 tt0 -66.66 -40.79 88.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.053 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 88.7 mt-30 -62.01 -39.97 94.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 0.0 110.669 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 62' ' ' VAL . 93.5 t -67.24 -50.44 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.324 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 73' ' ' GLN . 26.8 m -61.08 -35.34 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 111.631 -177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 t -57.99 -43.12 86.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 83.7 mtt-85 -64.55 -39.9 94.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.999 0.428 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.7 -33.13 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -73.13 -20.99 60.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.123 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.8 -17.57 55.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.809 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.76 30.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.9 -66.98 0.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.645 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -116.23 -19.43 10.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.452 . . . . 0.0 110.351 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 153.66 35.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.317 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -127.55 145.23 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -107.83 117.56 34.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.06 123.35 45.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.487 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 111' ' ' LEU . 37.8 tp -97.12 120.01 36.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 21.4 m -132.09 154.96 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.727 0.298 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.828 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.2 p -147.15 140.96 19.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.963 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.93 119.26 43.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.797 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.595 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 35.9 Cg_exo -59.33 -32.36 96.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.52 2.813 . . . . 0.0 113.018 -172.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.94 -37.46 69.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.848 0.356 . . . . 0.0 110.189 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.8 m -72.14 -38.61 69.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 173.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.92 -35.66 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.245 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 43.9 tt0 -58.23 -37.6 75.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 72.9 mt-30 -72.07 -48.82 41.35 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.3 mt -62.69 -35.79 80.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.511 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -64.1 -36.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.604 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 65.0 mmtt -71.04 -25.1 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.518 . . . . 0.0 109.837 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 14.8 mt -82.61 -10.25 59.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.747 -177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.7 19.88 42.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.256 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -92.51 142.54 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.654 -0.321 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -116.91 98.16 6.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.114 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.3 m -65.7 -13.96 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.668 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 60.3 mtp180 -58.41 -29.53 66.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -167.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 9.2 tm-20 175.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -54.06 -38.36 65.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.244 0.545 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 11' ' ' LEU . 66.8 tp -77.38 -27.32 52.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.46 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.89 HD21 HD13 ' A' ' 89' ' ' LEU . 11.0 mp -71.76 -12.38 61.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.706 -175.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -73.18 -51.23 18.59 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.543 . . . . 0.0 110.284 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.24 69.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.475 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 26.9 pt20 -86.82 127.9 35.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.712 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.88 159.03 15.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.09 0.471 . . . . 0.0 110.975 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.9 115.13 27.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.004 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.22 112.01 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.982 2.454 . . . . 0.0 111.83 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -99.91 103.17 2.62 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.404 -174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.3 52.3 1.25 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.626 0.727 . . . . 0.0 109.758 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.029 -179.462 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.3 mt -117.15 134.47 60.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' OD2' ' HB ' ' A' ' 9' ' ' THR . 14.6 t0 -92.94 117.42 67.53 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.46 -28.41 86.66 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.327 2.685 . . . . 0.0 112.859 -171.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.64 146.19 6.86 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.644 ' HB ' ' OD2' ' A' ' 6' ' ' ASP . 2.5 t -163.29 136.59 5.67 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.711 ' HB2' HG21 ' A' ' 95' ' ' THR . 61.8 mtt 57.18 45.82 19.93 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.873 0.733 . . . . 0.0 109.676 176.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.25 145.62 89.93 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.643 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.012 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.6 Cg_endo -70.97 149.06 58.56 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.297 2.665 . . . . 0.0 112.647 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HD2' HH11 ' A' ' 13' ' ' ARG . 47.1 mtm180 -119.2 142.58 47.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.41 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 89' ' ' LEU . 58.9 tp -82.64 108.6 16.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.611 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.9 m -108.75 118.86 37.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.217 -169.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -95.04 133.86 38.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.016 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -133.91 153.46 51.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.721 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -100.34 151.4 21.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 0.0 110.349 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 34.6 ttpt -87.85 115.11 25.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.834 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.45 -154.12 29.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.303 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.9 -29.58 58.07 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.278 2.652 . . . . 0.0 111.96 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.67 28.47 8.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.294 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 82.1 -146.38 25.19 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.708 -177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 85.0 m-85 -93.29 -22.88 18.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.959 0.38 . . . . 0.0 111.234 -176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 30.1 22.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.216 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -131.03 157.45 42.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.212 0.506 . . . . 0.0 109.959 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' CD2' HD23 ' A' ' 41' ' ' LEU . 84.8 m-70 -127.26 145.11 50.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 37' ' ' GLN . 23.4 tp -122.92 137.18 55.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.773 0.321 . . . . 0.0 111.776 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 2.9 p80 -133.25 140.29 47.42 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.06 2.42 20.98 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 58.25 -169.3 0.12 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.709 0.403 . . . . 0.0 111.094 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -131.56 133.2 44.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.2 -21.13 46.96 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -86.32 173.61 9.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.4 pt? -130.98 16.52 5.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.24 161.94 25.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.711 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 34.9 mm-40 -103.3 145.36 30.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.404 . . . . 0.0 110.304 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.9 m-85 -128.73 150.94 50.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.722 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -70.7 125.16 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -91.7 -36.33 13.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 14.6 tp -164.08 148.33 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.469 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -125.01 118.72 53.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.169 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -63.9 128.34 92.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.462 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.78 127.73 22.37 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.302 2.001 . . . . 0.0 112.557 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.04 75.13 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.192 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.494 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 87.7 p -84.6 164.47 42.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.814 0.307 . . . . 0.0 110.583 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 12.3 Cg_endo -57.71 -26.32 72.48 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.555 2.17 . . . . 0.0 112.176 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.29 -31.8 73.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 3.7 mt-10 -69.74 -28.55 65.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.12 -37.07 84.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 110.119 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -78.96 -17.31 55.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.235 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.7 29.67 7.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.0 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.56 138.0 32.99 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.682 -0.305 . . . . 0.0 110.514 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.3 tt -145.59 143.13 29.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 41' ' ' LEU . . . -59.56 103.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.293 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -31.63 1.57 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.717 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 14.7 m-20 -61.54 141.49 57.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -89.36 124.99 34.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.394 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.555 ' HA ' HG12 ' A' ' 90' ' ' VAL . 48.2 tp -78.39 112.46 15.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.893 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG23 ' HG ' ' A' ' 89' ' ' LEU . 5.0 m -105.94 -26.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -146.41 150.64 36.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.778 0.323 . . . . 0.0 111.21 175.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG21 HG13 ' A' ' 75' ' ' VAL . 62.1 t -136.39 113.81 13.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 57.0 41.3 27.86 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.528 0.517 . . . . 0.0 112.344 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.85 -8.38 59.6 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.359 171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 78' ' ' ARG . 44.2 tt0 -126.36 128.62 47.35 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.127 0.963 . . . . 0.0 109.613 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 64.7 m-80 -69.53 135.13 49.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.235 -174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 23.1 m -118.91 24.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.922 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 8.0 mt-10 -54.84 -33.15 61.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.508 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HE3' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -131.48 21.06 4.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.71 -175.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 1.4 mp0 -98.15 161.56 13.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.118 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.1 p -89.54 165.13 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.728 -172.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.3 t60 -58.62 -46.62 86.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.95 -41.48 96.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.843 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 98.2 mt-30 -63.57 -43.78 96.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG13 HG21 ' A' ' 62' ' ' VAL . 94.1 t -63.7 -46.2 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.419 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 72' ' ' HIS . 95.5 t -59.94 -39.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 0.0 110.991 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 m -58.45 -38.13 76.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 86.6 mtt-85 -61.73 -34.61 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.331 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.91 -31.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 -177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -69.88 -22.67 63.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 110.731 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.76 62.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.109 0.481 . . . . 0.0 110.07 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -72.32 121.09 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.837 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.78 -61.27 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.703 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.48 -7.26 4.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.23 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.78 154.48 36.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.513 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.2 p -130.65 144.59 37.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -101.55 117.63 35.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.486 HD12 HD21 ' A' ' 17' ' ' LEU . 98.5 mt -119.9 123.23 43.09 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 45.0 tp -101.9 118.32 36.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.587 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 59' ' ' LEU . 28.5 m -131.36 158.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.0 p -135.11 144.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.703 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.16 126.71 61.87 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.624 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' A' ' 57' ' ' ASP . 19.9 Cg_endo -58.7 -40.18 75.52 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.714 2.942 . . . . 0.0 113.929 -170.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 95' ' ' THR . 8.3 pt-20 -72.35 -39.86 67.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 10' ' ' MET . 1.8 m -71.76 -36.51 70.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 91' ' ' VAL . 6.7 t70 -56.88 -43.89 81.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.707 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 32.5 mt-10 -67.92 -36.42 80.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.686 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.22 -39.17 60.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.443 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 102' ' ' LEU . 53.6 mt -67.41 -31.95 72.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 23.6 pt20 -56.62 -36.71 69.77 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -172.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.44 -20.08 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.691 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 99' ' ' LEU . 55.7 mt -84.02 -40.11 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.242 0.544 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.56 0.52 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.412 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 107' ' ' ARG . 18.6 m -85.09 41.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.825 0.821 . . . . 0.0 110.427 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -83.44 5.31 24.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.197 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.012 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 2.5 m -65.12 -15.71 18.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.197 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.535 HH21 HG21 ' A' ' 104' ' ' VAL . 27.7 mtt180 -59.65 -32.19 70.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.027 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 51.0 tt0 171.65 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.703 0.627 . . . . 0.0 109.363 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -55.67 -51.84 65.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.629 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.8 tp -60.19 -30.14 69.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.773 0.321 . . . . 0.0 110.602 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.46 -26.29 62.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.382 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -63.05 -32.5 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.544 0.688 . . . . 0.0 109.849 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 67.73 44.54 1.61 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.444 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.644 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -71.52 0.74 7.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.406 -177.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -105.81 150.0 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.553 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 60.22 74.48 0.55 Allowed Pre-proline 0 C--O 1.235 0.332 0 O-C-N 123.962 0.789 . . . . 0.0 111.344 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.31 111.64 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.941 2.427 . . . . 0.0 111.762 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.93 -29.51 58.93 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.456 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.26 -86.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.587 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.0 mm -83.72 137.14 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.18 127.65 93.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.28 -20.03 32.89 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 123.101 2.534 . . . . 0.0 111.653 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 110' ' ' LEU . 2.6 m-85 -150.95 147.0 26.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.544 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -157.26 122.67 4.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.981 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt 62.74 65.54 0.82 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.708 0.766 . . . . 0.0 109.991 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -81.59 138.09 47.7 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.807 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.008 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 66.5 Cg_endo -72.83 171.15 17.98 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.171 2.58 . . . . 0.0 113.653 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 156.56 46.82 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.694 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' HD23 ' A' ' 111' ' ' LEU . 32.8 tp -83.99 117.91 23.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 41.3 m -94.53 111.22 22.98 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.8 p -100.69 111.09 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 110.195 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -116.6 146.61 42.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.408 -177.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.14 141.6 44.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.1 -170.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.0 ttmt -68.07 119.57 12.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.926 0.393 . . . . 0.0 111.201 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.1 -149.32 25.34 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.267 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.62 -27.27 45.67 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.947 2.432 . . . . 0.0 112.468 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -132.86 53.03 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 0.0 110.497 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 79.14 -121.6 5.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.441 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.558 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.6 m-85 -123.15 -27.74 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.38 29.31 9.6 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.322 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -141.1 143.2 34.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.308 0.554 . . . . 0.0 110.328 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -129.68 143.46 50.83 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.91 150.05 32.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.978 -173.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -134.73 144.01 47.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.325 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.43 114.94 3.93 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.77 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 38.5 mt-10 -55.58 125.45 21.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 20.8 tptp -67.42 133.95 50.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.34 -15.41 63.02 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.722 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -100.91 178.33 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -129.93 25.29 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.46 166.61 25.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.857 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -104.24 136.91 42.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 0.0 110.594 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.43 157.36 30.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.544 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.0 mm -71.35 114.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -85.19 -43.14 14.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.2 tp -149.37 141.95 24.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.415 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.84 114.51 46.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -70.73 112.93 14.84 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 14.0 Cg_endo -58.32 121.55 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 112.232 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.96 13.78 26.43 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.082 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.501 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 89.8 p -103.91 160.22 26.8 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 37.1 Cg_endo -66.46 -16.19 50.29 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.803 2.335 . . . . 0.0 112.106 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.117 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 42.2 mt-10 -63.06 -43.64 98.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.6 mttm -62.72 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.31 -19.66 31.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.269 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 44.36 1.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.551 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.0 mt -102.67 146.95 27.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 174.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tt -145.96 143.62 29.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.77 101.48 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.4 -25.41 1.85 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.97 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 71.0 m-20 -75.28 148.56 39.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -92.74 133.57 35.9 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.445 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 40.7 tp -75.91 107.12 7.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.648 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.872 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 47.2 t -95.31 -33.96 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -175.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -147.09 150.55 35.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 0.0 111.008 -178.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 81.3 t -136.58 113.83 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.096 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.46 33.27 20.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.077 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.65 16.13 60.55 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.859 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -123.87 135.23 53.61 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.591 -0.358 . . . . 0.0 110.617 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.404 ' CG ' HH12 ' A' ' 107' ' ' ARG . 3.4 t-20 -73.55 114.75 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.663 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 62' ' ' VAL . 17.4 m -128.47 11.53 2.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -172.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.872 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -72.34 -21.7 61.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.768 -174.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 33.8 mtmm -110.23 18.21 20.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.215 174.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 36.9 mm-40 -97.3 175.57 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.314 0.578 . . . . 0.0 111.97 -176.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.4 p -89.58 173.98 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.073 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 76' ' ' VAL . 61.8 t60 -65.31 -44.43 87.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 175.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.79 -39.29 90.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.71 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 11.1 mm-40 -61.39 -45.82 92.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.05 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 79' ' ' ILE . 18.6 m -68.68 -45.15 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.369 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 80.2 t -54.7 -43.77 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.994 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -60.27 -41.26 92.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 75.1 mtt-85 -69.18 -36.23 77.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.189 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 86' ' ' VAL . 89.1 mt -62.26 -42.19 94.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 7.8 mpt_? -64.89 -20.79 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.16 64.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.65 0.262 . . . . 0.0 111.507 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.641 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -69.27 142.29 54.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.308 0.575 . . . . 0.0 110.746 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 -56.55 4.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.884 -175.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -123.87 -28.75 3.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.8 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -146.18 143.42 29.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.359 -172.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -109.56 158.4 9.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.142 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.26 119.21 38.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 88.2 mt -119.7 128.54 53.9 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.902 0.382 . . . . 0.0 110.831 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 15.6 tp -106.46 121.8 45.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.978 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.7 m -131.69 155.29 41.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.05 0.452 . . . . 0.0 110.983 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.79 150.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.074 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 18.3 t70 -64.5 120.51 66.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 32.9 Cg_exo -60.89 -29.46 88.15 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.448 2.765 . . . . 0.0 113.208 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.8 -47.87 50.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 20.3 m -66.24 -37.18 84.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 22.0 t70 -58.5 -36.14 73.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.61 -48.16 81.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.8 pt20 -71.63 -38.79 70.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.47 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.83 -33.87 73.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.749 0.309 . . . . 0.0 110.926 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 67.3 mt-30 -57.86 -41.61 82.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.927 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -71.12 -21.26 62.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.982 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.38 -43.03 8.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.369 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.2 84.69 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -66.85 90.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 122.228 1.013 . . . . 0.0 111.834 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mt-30 -103.14 22.1 14.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.16 177.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.008 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.9 m -66.0 -18.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.582 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 66' ' ' ASN . 5.8 ptp180 -63.38 -33.73 76.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -170.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -179.68 -27.83 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.104 0.478 . . . . 0.0 109.995 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 5.0 mm-40 -55.74 -40.95 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.312 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 8' ' ' PHE . 52.8 mt -78.72 -17.48 55.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 111.898 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.571 HD21 HD13 ' A' ' 89' ' ' LEU . 7.9 mp -79.9 -12.61 59.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -96.83 -60.85 1.51 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.334 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.0 143.84 23.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 111.714 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -84.58 99.33 10.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.938 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.81 80.58 2.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.926 0.869 . . . . 0.0 111.382 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -177.96 72.38 0.22 Allowed Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.83 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.4 71.8 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.063 2.509 . . . . 0.0 112.385 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.47 -45.41 4.34 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.04 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -64.22 -35.73 81.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.011 179.371 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.93 133.73 60.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.18 122.9 42.55 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.433 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.57 -26.97 11.31 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.582 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.611 ' CZ ' ' HB ' ' A' ' 104' ' ' VAL . 7.3 m-85 -149.01 150.88 33.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 9' ' ' THR . 7.3 t -172.16 101.98 0.17 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.875 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.1 tpt 69.42 64.06 0.27 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -172.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.7 pt? -80.15 160.1 69.03 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.933 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.88 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 73.7 Cg_endo -73.35 165.76 31.71 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.768 2.312 . . . . 0.0 113.049 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -143.16 146.19 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 111' ' ' LEU . 47.0 tp -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -93.66 115.89 28.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.45 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 m -103.97 111.24 23.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.808 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -117.21 154.63 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.845 -177.123 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -111.59 136.51 50.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.565 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 38.9 ttmt -67.27 131.09 45.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.341 0.591 . . . . 0.0 111.928 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.86 -148.74 10.45 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.618 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.27 -2.67 12.72 Favored 'Trans proline' 0 N--CA 1.472 0.209 0 C-N-CA 123.157 2.572 . . . . 0.0 112.444 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -128.08 22.22 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.235 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 77.28 -106.11 2.17 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 -172.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.0 m-85 -127.79 -15.93 4.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.1 0.45 . . . . 0.0 111.332 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.19 32.57 43.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.102 -0.57 . . . . 0.0 114.078 173.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.26 151.79 50.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.618 0.709 . . . . 0.0 110.225 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.475 ' CD2' HD23 ' A' ' 41' ' ' LEU . 26.1 m-70 -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 37' ' ' GLN . 14.1 mt -118.45 151.36 37.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.106 0.479 . . . . 0.0 111.809 -177.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.6 p80 -130.86 144.84 51.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.67 108.65 3.04 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 33.4 mm-40 -71.51 125.0 25.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.073 0.464 . . . . 0.0 110.176 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.05 133.75 52.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.107 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.6 -28.22 11.82 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.819 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 12.1 mptt -93.13 -32.75 14.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.837 0.351 . . . . 0.0 111.383 -177.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt 74.65 -50.32 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.578 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.61 157.95 8.14 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.683 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.461 ' HB3' HD22 ' A' ' 28' ' ' LEU . 35.8 mm-40 -102.09 144.64 30.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.033 0.445 . . . . 0.0 110.11 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.572 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 19.5 m-85 -122.53 152.15 40.65 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mm -70.83 108.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -81.12 -42.9 20.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 27' ' ' HIS . 22.9 tp -147.31 145.27 29.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.162 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -135.76 120.96 28.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -63.99 126.07 89.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.59 -172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.52 109.06 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.316 2.011 . . . . 0.0 111.721 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.84 12.91 21.46 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.987 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 88.1 p -91.57 159.4 38.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.7 Cg_endo -69.07 -13.66 36.83 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.555 2.17 . . . . 0.0 112.355 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.616 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -67.51 -45.45 75.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.726 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.71 -39.14 83.64 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.39 0.614 . . . . 0.0 110.207 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -75.96 -11.17 59.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.399 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.07 -17.61 25.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.105 0.479 . . . . 0.0 110.237 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.75 53.05 0.72 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.2 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.31 114.74 16.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.466 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.8 tp -118.0 162.12 18.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.06 43.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.961 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.22 5.6 0.32 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.416 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.9 m-20 -91.1 146.6 23.71 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.622 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 41.0 ttp180 -99.78 130.33 45.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 41.7 tp -77.71 109.16 11.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.216 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.68 -42.84 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.11 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -144.21 150.84 38.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 0.0 110.427 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 75' ' ' VAL . 61.3 t -135.78 107.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.238 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 58.74 39.06 24.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.129 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.68 35.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.718 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.89 136.68 54.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.298 1.049 . . . . 0.0 111.826 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -67.95 115.72 7.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.535 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 29.0 m -102.57 18.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -67.3 -16.7 64.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.336 0.588 . . . . 0.0 111.211 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -122.5 22.29 9.98 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.947 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 33.9 mm-40 -105.07 -173.62 2.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.1 p -117.16 173.93 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.1 t60 -60.49 -47.06 87.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.872 0.368 . . . . 0.0 110.153 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.71 -44.76 89.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.823 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 51.3 mt-30 -63.89 -41.32 97.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 HG21 ' A' ' 62' ' ' VAL . 55.1 t -62.79 -44.99 99.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.133 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 72' ' ' HIS . 96.9 t -61.15 -38.68 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -60.13 -38.21 82.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 110.402 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 77.0 mtt-85 -68.48 -36.04 78.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.697 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.6 -35.82 75.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.163 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 40.0 mmt180 -68.6 -21.96 64.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.98 95.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.619 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -77.2 132.79 38.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.299 0.571 . . . . 0.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.47 -68.05 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.41 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -110.87 -16.66 13.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -150.43 134.98 17.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -110.68 158.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HD3' HD21 ' A' ' 14' ' ' LEU . 62.5 mtt180 -112.58 114.63 27.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.561 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 71.2 mt -118.72 119.33 34.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.831 0.348 . . . . 0.0 110.773 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.708 HD13 HD11 ' A' ' 111' ' ' LEU . 21.7 tp -94.53 124.11 38.36 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.2 m -132.58 155.16 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.928 0.394 . . . . 0.0 111.412 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.0 p -139.24 144.32 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.345 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.11 116.97 28.67 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 34.5 Cg_exo -58.17 -24.95 69.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.959 2.44 . . . . 0.0 112.243 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.21 -47.06 68.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.01 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 90.3 m -72.02 -38.39 69.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.87 -31.19 66.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.187 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -57.38 -45.68 84.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.699 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 27.2 mp0 -72.42 -48.1 43.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 110.394 175.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.618 ' HB3' HG21 ' A' ' 104' ' ' VAL . 22.7 mt -59.72 -40.87 89.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.482 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -59.5 -38.64 81.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -75.13 -19.91 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.124 0.488 . . . . 0.0 110.337 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 99' ' ' LEU . 50.0 mt -83.48 -6.57 59.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.72 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.14 41.45 39.3 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.662 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 99' ' ' LEU . 14.9 m -90.23 169.16 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 111.504 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -125.17 83.23 2.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.077 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.88 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 8.5 m -67.5 -17.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.9 ttm180 -60.63 -44.68 96.06 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -168.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 111' ' ' LEU . 31.2 tt0 -161.25 -18.75 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.985 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.84 -47.37 74.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 111.603 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.79 -18.18 56.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.708 HD11 HD13 ' A' ' 89' ' ' LEU . 38.0 mt -81.61 -22.42 37.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.802 0.81 . . . . 0.0 108.969 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.73 -51.97 5.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.296 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -95.88 86.62 4.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.805 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -120.5 57.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -111.21 156.25 21.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.608 -169.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.01 109.04 45.33 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.551 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.71 90.69 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.67 2.246 . . . . 0.0 112.544 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.6 179.07 41.26 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.566 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 63.08 20.72 12.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 112.248 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.745 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.158 179.07 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 CA--C 1.513 -0.542 0 CA-C-O 121.256 0.44 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.463 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 9.0 m-85 -148.04 151.94 36.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.241 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 t -170.38 126.37 0.77 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.994 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt 47.86 60.98 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.714 0.634 . . . . 0.0 110.572 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.849 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.55 164.61 59.67 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.29 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HG3' HG13 ' A' ' 106' ' ' VAL . 18.1 Cg_endo -56.63 161.48 9.84 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.754 2.97 . . . . 0.0 113.099 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -144.27 127.27 16.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.127 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 tp -84.08 106.34 15.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 30.7 m -96.47 114.7 26.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.54 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.8 m -98.97 111.78 24.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -121.38 153.49 37.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.467 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.59 147.45 30.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.139 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.82 117.92 20.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.382 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.41 -151.43 20.29 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.041 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.08 -17.3 36.21 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.987 2.458 . . . . 0.0 113.238 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -119.88 30.21 7.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.202 0.525 . . . . 0.0 110.626 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.89 -122.0 5.73 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.5 m-85 -110.73 -13.79 14.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.431 0.616 . . . . 0.0 111.18 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 80.32 32.89 33.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.438 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.52 152.05 46.63 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.419 -0.46 . . . . 0.0 109.976 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.8 m-70 -112.18 125.36 54.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.77 131.52 54.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.45 151.19 47.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.015 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.21 6.16 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.17 133.14 44.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.873 0.368 . . . . 0.0 111.523 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.96 138.51 55.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.511 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.31 -44.23 2.48 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.638 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.76 173.15 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -129.9 35.81 4.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.299 0.571 . . . . 0.0 110.456 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.94 167.51 25.62 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.844 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.631 ' HG3' HG21 ' A' ' 75' ' ' VAL . 36.4 mm-40 -103.66 146.03 29.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.705 0.288 . . . . 0.0 110.379 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.43 152.35 51.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.6 mm -70.76 113.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 40' ' ' ARG . 3.6 tmm_? -86.94 -39.91 15.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 110.086 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 46.2 tp -153.39 143.97 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.69 116.23 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.32 111.13 10.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.66 119.46 6.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 112.346 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.71 30.32 Favored Glycine 0 C--N 1.316 -0.561 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.165 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 79.9 p -95.76 160.22 30.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.985 0.421 . . . . 0.0 111.281 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.27 -17.56 58.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.841 2.361 . . . . 0.0 112.138 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.19 -38.34 90.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.75 -38.97 92.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.046 0.45 . . . . 0.0 110.007 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -64.36 -32.51 74.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.652 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.21 -18.16 53.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.97 37.8 4.82 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.989 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 48' ' ' ALA . 98.3 mt -91.04 130.14 36.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.89 0.345 . . . . 0.0 110.162 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 tt -126.84 141.63 51.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.06 95.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 111.225 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.12 -26.65 1.13 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.485 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 70.2 m-20 -63.71 139.07 58.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.714 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -85.1 132.23 34.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.303 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 54.9 tp -76.26 117.12 17.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.554 ' HB ' HD12 ' A' ' 89' ' ' LEU . 57.9 t -103.47 -36.2 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.274 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 8.7 tt0 -152.01 151.49 31.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 111.142 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 HD22 ' A' ' 63' ' ' ASN . 51.5 t -127.66 116.85 44.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.453 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 60.6 m-80 68.61 -60.9 0.42 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.281 1.033 . . . . 0.0 111.059 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.26 26.89 0.07 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -125.79 129.01 48.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -68.34 125.25 25.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.272 0.358 . . . . 0.0 111.044 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' HG12 ' A' ' 75' ' ' VAL . 29.8 m -127.7 24.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.461 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' HG2' HG13 ' A' ' 60' ' ' VAL . 53.5 mt-10 -53.08 -47.52 68.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.951 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -111.0 9.47 22.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.223 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.27 157.73 19.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.457 0.646 . . . . 0.0 112.088 -171.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -85.56 169.06 13.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.909 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 64.3 t60 -56.74 -45.55 81.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.928 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.85 -38.61 89.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 111.057 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.07 -38.79 86.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.489 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG21 ' HG3' ' A' ' 37' ' ' GLN . 29.3 m -70.26 -43.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.442 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.9 t -54.69 -42.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.4 m -60.07 -40.65 90.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -68.52 -35.85 78.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.458 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 75' ' ' VAL . 83.7 mt -62.77 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.7 mmt180 -61.53 -23.22 65.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.86 -6.99 53.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.16 117.16 17.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.96 -60.13 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -129.61 -20.04 3.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.75 145.96 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.042 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 24' ' ' TYR . 14.5 p -116.82 141.81 33.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.128 0.49 . . . . 0.0 110.407 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 95.8 mtt180 -101.92 117.02 33.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.807 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.493 HD12 HD11 ' A' ' 53' ' ' LEU . 92.6 mt -112.75 118.96 36.43 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 1.6 tm? -93.48 116.55 29.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 35.4 m -134.02 154.15 37.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.158 0.504 . . . . 0.0 111.338 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.4 p -148.73 150.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.181 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.08 125.46 74.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 109.973 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.67 -38.36 94.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.921 3.081 . . . . 0.0 113.905 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.75 -39.15 80.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.098 0.475 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 17.4 m -71.33 -36.52 71.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.303 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 8.9 t70 -56.97 -45.87 82.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 57.2 mt-10 -65.85 -39.36 90.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 95' ' ' THR . 21.0 pt20 -72.38 -39.85 67.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.535 HD13 HD11 ' A' ' 110' ' ' LEU . 53.4 mt -70.43 -34.04 72.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.72 0.295 . . . . 0.0 110.746 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 49.0 mt-30 -66.05 -34.46 78.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.619 0.247 . . . . 0.0 110.825 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.5 mttp -61.92 -19.07 62.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.01 -9.81 57.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.71 11.48 63.77 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.175 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.463 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -92.91 138.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 0.0 111.102 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -77.95 98.45 5.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.407 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 12' ' ' PRO . 67.0 t -66.18 -22.38 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.08 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -59.89 -35.36 74.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -173.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 111' ' ' LEU . 65.4 tt0 -165.86 -40.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.94 0.4 . . . . 0.0 110.989 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.805 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 30.4 mm-40 -55.74 -30.83 61.87 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 99' ' ' LEU . 2.1 tt -65.44 -40.26 93.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.137 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 108' ' ' GLU . 6.0 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 110.387 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' HD13 ' A' ' 102' ' ' LEU . 18.3 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 CA-C-O 120.955 0.315 . . . . 0.0 111.825 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 38.0 m-85 -152.59 149.21 28.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.475 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -160.37 -43.51 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.201 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.425 ' HB3' HG21 ' A' ' 95' ' ' THR . 15.0 tpt -139.82 90.89 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.807 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.69 157.84 83.61 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.819 -177.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.048 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 57.9 Cg_endo -67.72 149.56 78.85 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.067 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.492 HH21 ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.93 128.25 48.33 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.187 178.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.78 107.27 16.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 67.5 m -94.02 111.47 23.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' HH11 ' A' ' 87' ' ' ARG . 4.3 p -98.62 110.79 23.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.069 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.4 156.37 32.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.393 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.74 138.7 49.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 35.2 ttpt -71.55 124.64 25.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.914 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.15 -162.2 35.41 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.31 -28.84 87.62 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.989 2.459 . . . . 0.0 112.711 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -122.41 40.89 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.902 0.382 . . . . 0.0 110.681 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 84.21 -144.2 21.56 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.363 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.8 m-85 -101.66 -25.62 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.84 32.82 12.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.739 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -127.46 141.26 51.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.457 0.629 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.47 ' C ' ' HB3' ' A' ' 40' ' ' ARG . 30.4 m-70 -100.94 144.69 29.58 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 37' ' ' GLN . 21.0 tp -124.82 137.25 54.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.118 0.261 . . . . 0.0 110.541 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -138.47 149.35 45.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.65 117.31 3.47 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.9 137.61 43.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.03 100.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.827 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.11 -38.27 1.62 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.5 -179.24 7.11 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.509 -0.845 . . . . 0.0 109.043 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.58 21.27 2.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 110.449 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.1 176.38 18.44 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' A' ' 75' ' ' VAL . 35.0 mm-40 -104.14 143.51 32.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.076 0.465 . . . . 0.0 110.89 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.91 156.72 41.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.884 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 55' ' ' ALA . 31.7 mm -70.39 120.51 18.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.979 0.418 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB3' ' C ' ' A' ' 27' ' ' HIS . 0.5 OUTLIER -93.52 -47.96 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -173.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.5 tm? -158.57 140.12 13.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' N ' HD13 ' A' ' 41' ' ' LEU . 48.2 t -117.63 115.74 49.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.21 130.99 89.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.2 127.46 18.4 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.008 1.806 . . . . 0.0 111.892 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.92 28.69 40.96 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.58 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.8 p -102.36 162.3 20.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 122.674 -0.31 . . . . 0.0 110.811 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 18.6 Cg_endo -62.31 -23.5 75.28 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.467 2.112 . . . . 0.0 112.23 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.45 -41.73 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.305 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -59.92 -43.58 94.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.756 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -59.6 -37.35 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.7 -11.79 59.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.056 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.11 31.89 15.87 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.146 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.34 104.54 11.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.0 140.97 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.366 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . . . -70.79 106.88 3.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.806 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.43 -16.5 3.83 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.553 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -73.73 146.39 44.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 0.0 110.859 176.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -91.26 127.39 36.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.8 tp -77.8 109.84 12.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.727 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -99.11 -32.87 3.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.468 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -147.71 149.72 32.96 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.407 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 75' ' ' VAL . 96.8 t -136.67 116.55 16.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.325 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 64.53 26.28 13.32 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.649 0.738 . . . . 0.0 110.683 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.36 16.03 59.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.366 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.547 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 8.9 tp10 -124.74 133.08 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.16 128.45 36.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.675 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 75' ' ' VAL . 35.7 m -123.63 26.83 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.56 -27.31 64.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.661 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -118.12 14.0 13.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.386 0.612 . . . . 0.0 109.583 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -96.47 146.51 24.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.19 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.1 p -81.28 178.04 8.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 57.3 t60 -58.02 -46.35 85.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.148 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.61 -42.88 91.1 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 57.9 mt-30 -61.49 -41.14 96.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 67' ' ' VAL . 94.5 t -71.42 -44.61 71.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 25.4 t -54.57 -45.26 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.66 0.267 . . . . 0.0 111.611 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -59.93 -37.02 78.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.944 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.2 mtt-85 -68.3 -37.03 80.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.598 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 75' ' ' VAL . 68.7 mt -64.77 -35.47 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mpt_? -73.34 -20.57 60.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.28 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 134.79 40.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.286 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.63 -70.74 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.579 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -112.57 -19.73 11.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.847 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.16 145.08 26.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.44 149.41 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.955 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.469 HH11 ' HB2' ' A' ' 16' ' ' CYS . 22.1 mmt180 -108.88 113.19 25.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.445 HD12 HD21 ' A' ' 17' ' ' LEU . 74.9 mt -109.38 118.62 37.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.683 0.278 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.1 tp -93.82 122.22 36.07 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.6 m -133.34 154.6 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.416 0.627 . . . . 0.0 111.431 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.09 145.14 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.327 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.01 122.06 45.03 Favored Pre-proline 0 C--O 1.225 -0.237 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.2 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.579 -172.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.97 -38.97 66.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 19.4 m -70.03 -37.87 75.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.27 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.76 -39.29 77.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.33 -49.2 78.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.445 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.668 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 pt20 -72.97 -46.69 50.92 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.653 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 95' ' ' THR . 29.6 mt -62.33 -43.77 98.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 111.537 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -67.75 -36.6 80.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.874 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -70.24 -23.04 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 96.3 mt -71.79 -22.28 61.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.38 19.94 8.11 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.464 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -107.07 134.76 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.82 102.66 13.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.827 0.822 . . . . 0.0 110.925 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.048 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 14.8 m -65.2 -13.33 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.608 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -58.36 -31.36 67.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -167.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -171.14 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.415 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -54.4 -42.07 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 110' ' ' LEU . 1.8 tm? -60.09 -29.18 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.545 -177.305 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.46 -0.47 0 CA-C-O 121.075 0.365 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.574 ' HB3' HD12 ' A' ' 11' ' ' LEU . 29.3 m-85 -148.61 154.04 39.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.326 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -172.52 123.58 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.687 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.57 61.09 2.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.89 ' H ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.0 140.43 96.05 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.578 -169.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 19.4 Cg_endo -61.62 159.28 33.06 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.024 2.483 . . . . 0.0 111.524 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -143.07 156.64 44.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.133 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -84.21 114.17 21.62 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.717 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.9 m -93.55 107.76 19.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.09 111.71 23.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.971 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.7 148.68 39.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 85' ' ' ALA . 32.8 mt-10 -122.92 129.31 51.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.161 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.9 ttmt -54.94 126.42 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.625 -170.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.7 12.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.378 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.32 -19.56 13.24 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.545 2.163 . . . . 0.0 112.701 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.23 27.15 7.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.261 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 89.72 -114.6 4.38 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.562 -175.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.7 m-85 -123.89 -22.9 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.238 0.519 . . . . 0.0 111.642 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.73 33.83 23.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.966 171.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -132.66 142.63 49.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.396 0.598 . . . . 0.0 110.086 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 41' ' ' LEU . 29.3 m-70 -111.32 131.69 54.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.5 tp -101.96 144.4 30.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.299 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.435 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 3.1 p80 -141.69 153.05 44.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.916 0.388 . . . . 0.0 111.259 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.74 125.87 4.9 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.522 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.21 -175.77 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.896 0.379 . . . . 0.0 110.431 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -109.5 135.62 50.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.987 0.422 . . . . 0.0 110.133 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.83 15.49 57.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.5 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 -174.38 2.51 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.741 0.305 . . . . 0.0 110.365 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.1 pt? -125.4 -33.53 2.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.621 172.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.9 177.8 21.24 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.587 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -104.99 155.13 19.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -130.73 153.21 49.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 0.0 110.577 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 mm -71.58 123.54 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.633 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HG2' ' CG ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.6 -45.91 8.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.0 tm? -150.67 140.88 22.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 41' ' ' LEU . 96.6 t -122.14 116.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.487 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -58.8 126.78 81.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -63.4 115.44 3.02 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.035 1.824 . . . . 0.0 111.972 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . 84.76 41.76 7.55 Favored Glycine 0 C--N 1.317 -0.517 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.536 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 77.3 p -112.23 168.06 8.23 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' A' ' 24' ' ' TYR . 10.2 Cg_endo -56.07 -30.38 78.5 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.241 1.961 . . . . 0.0 112.313 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -61.7 -38.66 88.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 0.0 110.332 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 45' ' ' GLY . 6.9 mm-40 -62.03 -39.35 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.462 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.2 mttm -64.61 -29.39 70.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.044 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -88.24 -17.88 29.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.32 35.79 5.37 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.926 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.1 mt -92.67 138.95 31.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.6 tp -145.87 153.2 40.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.874 0.369 . . . . 0.0 110.716 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.54 104.58 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.035 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.31 -30.01 2.46 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.902 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 14.1 m-20 -63.23 136.15 57.54 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.004 0.43 . . . . 0.0 110.664 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -87.79 128.71 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.361 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 90' ' ' VAL . 58.5 tp -80.23 121.31 25.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.123 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 89' ' ' LEU . 50.0 t -105.53 -42.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.585 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.1 tt0 -144.75 151.63 39.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.836 0.35 . . . . 0.0 111.181 -177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 66.0 t -132.31 114.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.323 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.08 36.29 27.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.418 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.09 1.83 59.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.134 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 8.6 tp10 -125.52 136.61 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.855 0.828 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -68.17 125.71 27.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.064 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 62' ' ' VAL . 34.3 m -122.78 31.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.895 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -66.51 -21.0 66.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 34.8 mtmm -127.5 5.43 6.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.464 . . . . 0.0 111.046 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.8 mp0 -79.01 164.97 23.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -175.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.2 p -99.87 170.39 8.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -54.51 -47.93 72.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.53 -45.24 93.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.294 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -64.62 -39.2 93.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.77 -40.18 76.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.019 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 19.1 t -58.39 -39.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.4 m -57.74 -40.66 80.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 0.0 110.596 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -68.83 -37.19 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.699 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -65.12 -36.23 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 6.3 mpt_? -73.7 -22.82 59.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.267 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.16 59.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 110.19 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 113.58 12.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -84.71 -66.01 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.38 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -97.39 -33.12 11.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.023 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 18' ' ' GLU . . . -151.77 156.56 40.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.403 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.24 141.36 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.453 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -105.98 112.95 26.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.81 122.55 45.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 16.9 tp -94.88 118.77 32.34 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.5 m -129.89 161.08 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.991 0.424 . . . . 0.0 110.707 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.5 p -131.93 138.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.163 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.65 125.63 54.34 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.567 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -44.83 45.82 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.966 2.444 . . . . 0.0 115.117 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 41.0 mt-10 -73.53 -31.18 63.53 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.258 0.551 . . . . 0.0 110.584 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.441 HG22 ' HG ' ' A' ' 99' ' ' LEU . 40.4 m -71.95 -36.28 69.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.63 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' HG13 ' A' ' 91' ' ' VAL . 11.3 t70 -56.16 -43.73 78.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 40.2 mt-10 -59.3 -41.13 88.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.495 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 29.8 mm-40 -73.07 -50.01 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 102' ' ' LEU . 23.6 mt -68.56 -31.64 71.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.185 -170.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.618 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 pt20 -57.93 -41.9 83.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 28.5 mtpp -77.47 -37.12 52.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.258 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 99' ' ' LEU . 70.5 mt -69.43 -39.92 77.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.3 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.31 90.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 6.1 p -80.64 80.62 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.271 1.034 . . . . 0.0 112.087 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -112.61 34.79 4.15 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 170.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 13.3 m -67.23 -14.65 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.753 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 78.8 ttt180 -58.91 -45.31 90.64 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -167.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 34.5 tt0 -167.26 -24.1 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.414 . . . . 0.0 110.474 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.18 -47.07 79.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.32 0.581 . . . . 0.0 110.281 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 11' ' ' LEU . 57.5 tp -67.46 -19.98 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.349 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 10.9 mp . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 N--CA 1.471 0.197 0 N-CA-C 113.534 0.552 . . . . 0.0 113.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -156.15 163.16 39.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.933 0.397 . . . . 0.0 110.956 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 95' ' ' THR . 4.5 t -173.13 128.42 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.092 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.708 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 22.2 ttt 73.54 -51.51 0.7 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.672 0.789 . . . . 0.0 112.313 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER 55.8 133.53 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.801 1.241 . . . . 0.0 113.131 -174.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 75.7 Cg_endo -75.22 167.99 25.65 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.465 2.777 . . . . 0.0 113.24 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.52 144.63 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.652 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.18 109.04 19.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 167.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 51.0 m -94.17 116.45 28.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.852 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -104.12 112.3 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.01 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -120.72 154.48 35.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.2 142.49 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 38.4 ttmt -74.07 115.83 14.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.735 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.63 -150.95 18.17 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.727 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.83 -29.25 42.25 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.732 2.288 . . . . 0.0 112.556 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -130.69 43.99 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.164 0.507 . . . . 0.0 111.351 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 93.59 -108.76 3.71 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.992 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.648 ' HB3' HD12 ' A' ' 17' ' ' LEU . 99.5 m-85 -135.88 -21.98 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 112.774 -172.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 27.61 20.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.378 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -123.96 142.93 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 10.2 m170 -101.27 119.71 39.16 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.8 tp -102.46 133.15 47.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.769 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.5 p80 -123.57 143.69 50.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.469 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.9 93.95 0.52 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 45.2 mt-10 -55.99 130.36 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.853 0.384 . . . . 0.0 111.45 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -66.52 119.1 11.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.68 -37.31 3.34 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 37.2 mmtm -77.57 160.38 28.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.8 0.333 . . . . 0.0 110.163 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.4 pp -113.1 19.87 16.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.724 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.67 167.01 28.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.913 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG3' HG21 ' A' ' 75' ' ' VAL . 25.6 mm-40 -105.93 151.84 24.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 m-85 -138.54 153.77 48.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.58 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.456 HG12 ' OD1' ' A' ' 57' ' ' ASP . 9.7 mm -71.07 121.87 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -98.27 -25.69 14.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 42' ' ' VAL . 9.9 tt -164.85 147.1 8.22 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.67 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' N ' HD23 ' A' ' 41' ' ' LEU . 1.8 p -131.96 122.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.044 0.449 . . . . 0.0 109.806 173.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 37.2 mm-40 -60.22 130.1 89.15 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.987 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 18.1 Cg_exo -65.27 119.4 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.429 2.086 . . . . 0.0 111.451 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 13.92 52.41 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.334 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 98.4 p -91.82 160.4 36.2 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.809 0.338 . . . . 0.0 110.287 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 32.1 Cg_endo -65.23 -17.41 58.41 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 111.39 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.638 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.74 -43.04 90.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 42' ' ' VAL . 26.4 mt-10 -65.61 -37.01 85.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.108 0.48 . . . . 0.0 109.961 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -67.76 -26.04 65.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.045 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -81.8 -18.8 42.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.145 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.29 29.59 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.939 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.1 mt -86.38 147.94 25.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.95 0.375 . . . . 0.0 110.262 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 tt -146.13 140.3 26.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.24 81.18 1.0 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.463 0.649 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 93' ' ' PRO . . . 157.06 39.03 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 8.6 p-10 -105.76 -169.97 1.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.47 0.652 . . . . 0.0 111.165 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 96' ' ' ASP . 25.1 ttm-85 -132.76 124.1 27.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 156.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.439 HD11 HD22 ' A' ' 88' ' ' LEU . 34.6 tp -71.39 102.33 2.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.092 0.472 . . . . 0.0 109.775 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.27 -41.11 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.491 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.0 tt0 -148.55 151.06 34.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.705 0.288 . . . . 0.0 111.188 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.542 HG23 HG21 ' A' ' 67' ' ' VAL . 69.9 t -132.16 117.23 32.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.311 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 82' ' ' ALA . 95.0 m-20 61.46 21.73 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.532 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.29 7.38 46.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.923 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.8 tp10 -124.41 133.03 53.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 110.696 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.78 126.97 30.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.098 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.619 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 33.6 m -126.52 27.73 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.431 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.19 -28.18 66.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.33 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 13.7 ptmm? -128.64 39.32 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.289 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 50.9 mm-40 -103.67 168.85 8.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 0.0 112.086 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 75' ' ' VAL . 66.9 p -97.78 178.61 5.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.366 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -65.45 -46.6 79.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.488 ' HA ' HG12 ' A' ' 76' ' ' VAL . 30.4 tt0 -66.46 -32.83 74.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.439 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 16.3 mm100 -70.42 -46.1 64.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.976 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 71' ' ' THR . 14.5 m -72.51 -41.2 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.6 p -57.74 -36.36 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.072 0.463 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -64.11 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.937 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.6 mtt-85 -66.52 -36.05 81.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.567 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -63.01 -38.12 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.262 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 22.2 mmt85 -73.36 -25.01 60.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.323 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.73 55.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HB2' HD21 ' A' ' 63' ' ' ASN . . . -71.64 122.65 20.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.145 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.17 -83.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.515 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.01 -11.96 13.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.96 25.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.82 144.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -109.9 112.88 25.18 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.439 HD22 HD11 ' A' ' 59' ' ' LEU . 78.9 mt -115.61 122.75 46.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.634 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 18.6 tp -95.27 116.41 28.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 35.5 m -129.97 154.65 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.692 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.9 p -144.73 145.93 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -65.95 133.16 94.8 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.676 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 38.8 Cg_exo -59.87 -28.24 86.75 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.7 2.934 . . . . 0.0 113.736 -171.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.5 -48.25 67.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 109.86 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 9' ' ' THR . 15.0 m -71.78 -37.32 70.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.269 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.651 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 2.6 t70 -57.21 -47.13 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.607 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 28.5 tt0 -72.48 -39.37 67.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.041 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 95' ' ' THR . 20.0 pt20 -69.47 -38.72 77.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.572 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 95' ' ' THR . 43.7 mt -68.83 -39.13 80.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 10.6 pt20 -66.32 -33.16 75.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.16 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 34.4 mmtp -57.22 -35.33 69.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.414 0.626 . . . . 0.0 109.34 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.39 -55.57 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.707 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.22 -108.09 0.48 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.1 t 68.74 125.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.532 0.682 . . . . 0.0 112.572 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.82 71.86 10.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.66 . . . . 0.0 109.924 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 12' ' ' PRO . 2.4 t -56.12 -24.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.421 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.634 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 14.7 ptm180 -60.6 -26.71 67.18 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -165.62 -26.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -44.3 67.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.762 0.315 . . . . 0.0 111.406 -167.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 3.0 mm? -68.66 -31.09 69.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.411 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.4 mp . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.105 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.465 -0.202 0 N-CA-C 112.722 0.239 . . . . 0.0 112.722 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -154.0 137.65 16.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.516 0.674 . . . . 0.0 111.272 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -141.33 111.71 6.9 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.859 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.4 mtm 48.93 54.98 9.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.071 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.04 144.56 82.29 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.878 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.932 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 28.9 Cg_endo -63.85 159.93 39.52 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.447 2.765 . . . . 0.0 112.762 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -143.16 155.1 44.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.971 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 87' ' ' ARG . 45.9 tp -84.9 109.55 18.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.54 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -93.79 108.09 19.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -96.92 114.84 26.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.509 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.81 154.13 37.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.471 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.24 146.7 28.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.226 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -74.99 118.16 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.946 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -149.12 17.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.477 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 -20.06 20.03 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.98 2.454 . . . . 0.0 112.78 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -124.48 39.07 4.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.076 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.65 -122.99 7.96 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.41 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.3 m-85 -112.26 -30.18 7.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.17 0.485 . . . . 0.0 110.658 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.96 27.83 8.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.243 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.9 142.26 51.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.238 0.519 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -107.3 144.36 34.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 HG21 ' A' ' 75' ' ' VAL . 27.0 tp -119.49 129.84 54.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.497 0.189 . . . . 0.0 110.967 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -127.19 150.42 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 110.56 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.71 129.09 9.37 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.4 mm-40 -70.37 128.26 35.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.01 110.24 5.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.341 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.51 -12.18 33.11 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.466 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 4.2 mptp? -96.17 178.96 5.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.5 pp -122.27 16.46 10.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.608 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.67 168.58 25.19 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.909 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -104.54 146.35 29.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 110.204 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -133.11 157.12 46.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.244 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 53' ' ' LEU . 16.2 mm -70.75 122.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.034 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -85.15 -47.65 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.171 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -164.05 140.88 6.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.509 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.459 HG11 ' HG2' ' A' ' 49' ' ' GLU . 18.3 t -110.7 124.42 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.737 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.07 124.15 87.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.46 126.64 18.08 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.845 1.697 . . . . 0.0 112.074 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.81 17.69 37.37 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.254 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -97.89 158.94 32.04 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.9 -20.03 67.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.651 2.234 . . . . 0.0 111.994 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.26 -45.7 92.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HG2' HG11 ' A' ' 42' ' ' VAL . 30.8 mt-10 -63.09 -37.24 86.42 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.148 0.499 . . . . 0.0 110.011 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -70.23 -23.51 62.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.923 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -84.06 -17.84 38.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.21 22.65 10.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.26 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 39' ' ' ILE . 15.5 tp -93.46 113.06 25.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' LEU . 2.7 mm? -117.83 166.55 12.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.344 0.592 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.56 122.16 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.133 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.59 -20.44 12.13 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.022 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 6.0 m-20 -59.47 141.86 53.75 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.288 0.566 . . . . 0.0 111.597 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 30.1 ttt180 -85.73 121.78 28.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.822 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HA ' HG12 ' A' ' 90' ' ' VAL . 27.1 tp -78.95 109.43 13.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.118 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.29 -37.86 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.409 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 25.6 tt0 -144.95 151.76 39.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.68 HG23 HG21 ' A' ' 67' ' ' VAL . 74.0 t -134.5 119.75 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.694 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.59 -43.65 0.56 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.86 3.86 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.125 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -126.69 146.97 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.193 0.996 . . . . 0.0 111.251 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -63.48 123.16 18.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.843 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.68 HG21 HG23 ' A' ' 62' ' ' VAL . 32.6 m -118.39 17.98 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.214 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.19 -22.54 63.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.834 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.6 ptpp? -131.42 28.88 4.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.588 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 7.5 mm-40 -103.5 -174.55 2.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 28.4 p -112.71 169.79 8.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.072 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.3 t60 -58.58 -48.68 80.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.511 0.196 . . . . 0.0 110.914 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.97 -38.66 86.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.794 0.807 . . . . 0.0 110.334 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.481 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 5.3 tp-100 -61.18 -44.64 96.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.133 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' THR . 15.6 m -72.77 -42.69 61.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 43.5 t -54.88 -40.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.402 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 m -58.24 -38.06 76.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 0.0 110.655 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' NH1' ' HG3' ' A' ' 74' ' ' GLN . 61.2 mtt85 -68.62 -35.89 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.852 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 76' ' ' VAL . 69.0 mt -62.61 -33.65 60.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.492 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 4.3 mpt_? -66.92 -21.79 65.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.1 -2.11 57.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.23 128.53 36.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.242 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.55 -73.39 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.546 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -131.83 -4.88 3.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.19 158.5 44.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.856 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.7 p -127.83 146.4 33.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.541 ' HB3' HD11 ' A' ' 14' ' ' LEU . 14.8 mtm180 -97.7 122.84 41.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 17' ' ' LEU . 89.4 mt -121.46 113.63 20.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.962 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 26.9 tp -94.1 116.08 28.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.2 m -133.01 157.41 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.221 0.534 . . . . 0.0 111.765 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 11.7 p -147.98 148.43 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.866 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.82 118.26 33.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' ARG . 34.6 Cg_endo -63.53 -31.88 70.77 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.239 2.626 . . . . 0.0 113.169 -172.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.26 -37.04 69.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.025 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.5 m -71.79 -40.3 69.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.99 -30.84 66.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.194 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.31 -50.77 70.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.85 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.641 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 11.4 pt20 -74.87 -39.48 61.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.021 0.439 . . . . 0.0 110.839 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 102' ' ' LEU . 27.6 tp -66.13 -43.07 88.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.981 -164.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -68.19 -36.23 79.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.309 0.576 . . . . 0.0 110.245 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.27 -18.29 62.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.277 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 92.9 mt -70.15 -15.06 62.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.36 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 62.15 0.93 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.537 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.28 131.66 41.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.548 0.213 . . . . 0.0 110.773 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 10.7 mt-30 -83.15 85.89 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.572 0.701 . . . . 0.0 109.754 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.651 HG13 ' HG3' ' A' ' 12' ' ' PRO . 3.8 t -59.99 -27.82 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.734 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.71 -25.52 66.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -175.18 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.122 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 33.7 tt0 -55.79 -41.02 73.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.108 0.48 . . . . 0.0 110.961 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 11' ' ' LEU . 49.0 tp -64.39 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.396 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 -177.397 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 CA--C 1.519 -0.253 0 N-CA-C 113.012 0.351 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -157.03 120.09 4.07 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.407 0.622 . . . . 0.0 110.557 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -159.4 126.53 4.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.79 -168.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.7 mtm 54.21 30.92 13.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.878 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -58.31 139.77 84.17 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.024 -176.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 40.5 Cg_endo -65.66 158.39 53.61 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.598 2.865 . . . . 0.0 113.588 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -143.69 169.96 16.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 111' ' ' LEU . 17.5 mt -84.34 122.5 29.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.756 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.1 m -94.37 108.28 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.357 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -95.62 111.82 23.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.115 0.483 . . . . 0.0 110.585 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.49 147.8 40.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.516 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -112.59 135.32 53.45 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.376 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 33.2 ttpt -71.05 120.53 16.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.284 -173.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.35 -170.13 44.64 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.52 -29.91 91.15 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.651 2.234 . . . . 0.0 112.747 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -99.36 -0.56 40.8 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.166 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.37 -141.82 16.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.134 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 46' ' ' SER . 84.4 m-85 -105.72 -36.34 7.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.0 111.33 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 40.59 4.81 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.928 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -135.56 152.96 51.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.504 0.652 . . . . 0.0 110.405 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -124.36 144.51 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.467 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.4 mt -120.96 154.59 35.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 0.0 111.17 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.422 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 2.1 p80 -144.13 151.65 39.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.44 141.42 15.27 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.499 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.0 mt-10 -107.69 152.14 24.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.799 0.333 . . . . 0.0 111.169 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.81 141.78 38.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.25 -43.6 2.81 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 27.0 mmtp -78.07 175.32 10.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 pt? -144.0 29.05 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.38 -163.79 9.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.96 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HG3' HG21 ' A' ' 75' ' ' VAL . 31.1 mm-40 -112.27 148.03 35.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -134.39 160.83 36.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.426 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.491 HG12 ' CG ' ' A' ' 57' ' ' ASP . 31.8 mm -68.59 119.59 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.203 0.525 . . . . 0.0 110.86 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.25 -36.95 13.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 tp -161.94 143.31 10.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.8 117.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.823 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.4 mm-40 -68.8 129.54 92.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.835 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.5 Cg_exo -70.02 121.38 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 111.355 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.94 17.24 21.39 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.549 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 91.4 p -105.41 154.97 38.66 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 -15.24 49.22 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.747 2.298 . . . . 0.0 111.813 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 53' ' ' LEU . . . -66.38 -35.88 81.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.602 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.23 -38.65 91.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.0 110.091 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.42 -20.12 62.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.165 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.55 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.92 -18.0 33.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.21 28.11 7.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.172 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 48' ' ' ALA . 11.2 mp -79.2 136.36 37.06 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.582 -0.363 . . . . 0.0 110.489 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 tt -146.46 142.2 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.2 109.09 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.122 0.487 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.71 6.85 2.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.88 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' HG12 ' A' ' 39' ' ' ILE . 6.8 p-10 -72.16 -173.11 1.0 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.923 0.868 . . . . 0.0 111.787 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -135.96 115.37 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.661 165.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.2 tp -78.31 106.65 10.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 109.809 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -97.5 -38.06 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.873 -175.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 25.2 tt0 -149.77 151.8 34.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.709 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.492 HG23 HG21 ' A' ' 67' ' ' VAL . 90.4 t -134.62 117.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.217 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 56.46 29.82 15.99 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.22 5.73 57.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.563 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 9.2 tp10 -124.41 130.32 52.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.432 0.616 . . . . 0.0 110.656 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.97 127.08 31.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 35.3 m -123.79 24.21 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 52.1 mt-10 -68.26 -25.35 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.633 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 1.3 ptpt -126.44 29.93 5.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -177.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 44.4 mm-40 -93.17 -171.36 2.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 74' ' ' GLN . 33.6 p -113.16 -179.79 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.683 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 75.1 t60 -64.38 -47.0 80.9 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -67.55 -37.83 83.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.764 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' HG2' ' OG1' ' A' ' 71' ' ' THR . 14.5 mm100 -60.51 -43.23 97.32 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.735 0.303 . . . . 0.0 110.908 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 37' ' ' GLN . 13.4 m -71.58 -40.21 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.835 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 72' ' ' HIS . 72.5 t -54.09 -37.91 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.451 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -57.14 -44.51 83.47 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.284 0.564 . . . . 0.0 110.122 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -69.23 -36.19 76.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.121 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 75' ' ' VAL . 72.6 mt -64.21 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.486 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 41.6 mmt180 -69.78 -22.55 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.98 55.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.896 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.8 116.83 15.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.92 -66.5 0.78 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.55 -172.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.75 -17.84 10.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.002 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.65 150.07 29.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.0 111.19 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -123.79 141.09 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.594 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -105.84 111.16 23.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 109.969 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.56 129.87 53.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.028 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 14.7 tp -102.01 118.81 37.69 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.4 154.92 40.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.114 0.483 . . . . 0.0 110.686 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.6 p -140.64 145.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.3 138.18 68.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.1 -25.63 64.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.701 2.934 . . . . 0.0 113.995 -172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.96 -50.39 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.532 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -42.6 83.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.658 0.742 . . . . 0.0 110.158 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -58.14 -45.71 86.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.66 -43.25 89.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.567 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.2 pt20 -72.21 -44.35 63.08 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.038 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 12.7 mt -67.16 -40.17 86.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.415 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 1.3 pt20 -64.67 -36.08 83.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.757 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 99.1 mttt -70.58 -19.7 62.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.367 . . . . 0.0 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 74.5 mt -81.76 -8.24 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.266 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.97 24.19 30.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.08 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.439 HG13 HD21 ' A' ' 110' ' ' LEU . 98.6 t -89.55 128.42 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.815 0.34 . . . . 0.0 111.141 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 37.0 mt-30 -96.51 83.85 3.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.032 0.444 . . . . 0.0 109.884 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 19.7 m -59.23 -14.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.97 -25.75 63.83 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.19 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.809 0.337 . . . . 0.0 110.938 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 105' ' ' GLN . 44.9 tt0 -54.98 -38.03 67.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.439 HD21 HG13 ' A' ' 104' ' ' VAL . 57.3 mt -79.21 -40.26 31.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.455 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.489 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 7.3 mp . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 N--CA 1.464 -0.238 0 N-CA-C 113.285 0.456 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.498 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 7.2 m-85 -156.61 118.36 3.87 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.216 1.008 . . . . 0.0 112.172 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 95' ' ' THR . 4.6 t -153.49 125.66 7.96 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.434 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.6 mtt 53.77 48.79 20.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.039 0.447 . . . . 0.0 110.434 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -74.04 152.92 88.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.641 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.943 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.0 Cg_endo -68.79 151.45 74.31 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.943 2.429 . . . . 0.0 112.694 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.545 ' HA ' HD11 ' A' ' 111' ' ' LEU . 69.6 mtp180 -126.05 153.72 44.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.618 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 40.9 tp -89.64 106.07 18.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.682 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 68.8 m -93.22 108.03 19.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 p -95.31 120.78 36.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.96 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -125.51 151.52 46.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.37 135.14 42.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.479 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 ttmt -68.47 119.33 12.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.06 -144.03 14.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.069 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.36 -14.2 25.35 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.072 2.514 . . . . 0.0 113.398 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -137.85 35.94 2.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.945 0.402 . . . . 0.0 111.015 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 84.1 -104.72 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.544 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.2 m-85 -132.53 -22.13 2.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.411 0.605 . . . . 0.0 112.255 -175.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.47 28.38 24.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.497 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.94 155.72 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 91.1 m-70 -122.06 134.19 54.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.404 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.3 tp -108.45 135.66 49.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.8 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -128.85 152.1 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.77 119.92 3.15 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.811 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.46 118.85 11.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.657 0.265 . . . . 0.0 110.448 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -63.36 125.36 23.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.045 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.3 -36.33 3.66 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -106.3 165.95 10.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -112.22 10.06 20.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.681 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.9 143.1 16.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.564 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -105.04 143.88 32.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.409 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 53.0 m-85 -129.02 151.5 49.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 0.0 110.794 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.11 121.89 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.879 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 -26.25 14.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.68 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 8.1 tp -162.45 151.56 15.35 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 111.311 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.532 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.6 t -128.8 119.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.614 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.07 125.75 90.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.64 111.63 2.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.038 1.825 . . . . 0.0 111.386 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.59 10.97 20.59 Favored Glycine 0 C--N 1.311 -0.852 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.948 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.3 p -99.1 159.75 29.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.231 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 36.1 Cg_endo -65.91 -14.41 44.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.99 2.46 . . . . 0.0 112.409 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.05 -40.43 94.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.779 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -62.64 -33.09 74.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 110.242 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -71.69 -13.27 61.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.067 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -100.24 -17.66 17.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.24 7.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.863 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.5 mp -84.83 134.15 34.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.715 0.258 . . . . 0.0 110.324 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -137.84 152.22 48.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 110.577 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.7 107.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.533 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.27 3.75 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.944 -176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 42.8 m-20 -66.68 142.58 57.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 111.443 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.581 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 71.1 ttt180 -91.43 121.66 33.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HA ' HG12 ' A' ' 90' ' ' VAL . 53.6 tp -79.03 104.76 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 0.0 110.22 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.438 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 41.5 t -91.39 -40.93 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 10.7 tt0 -144.74 150.98 38.18 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.527 HG21 HG13 ' A' ' 75' ' ' VAL . 90.0 t -130.24 117.57 40.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 9.9 t-20 70.92 -61.2 0.49 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.151 0.98 . . . . 0.0 110.631 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.0 20.65 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -125.85 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.715 0.257 . . . . 0.0 110.506 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -71.9 99.65 2.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.452 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.0 m -82.75 0.93 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.233 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 24.2 mm-40 -70.79 -3.99 21.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 171.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -113.53 6.89 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.025 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 13.5 mm-40 -110.75 -165.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.298 -172.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 75' ' ' VAL . 65.3 p -132.29 176.34 8.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.119 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 76' ' ' VAL . 13.4 t60 -54.16 -48.05 71.31 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 176.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -65.34 -43.01 92.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.185 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 54.9 mt-30 -66.88 -44.07 81.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 67' ' ' VAL . 91.4 t -62.29 -42.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.963 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' HIS . 52.3 t -57.95 -45.03 87.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 110.27 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 m -58.4 -39.33 79.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 84.0 mtt-85 -65.92 -34.53 78.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 75' ' ' VAL . 67.6 mt -62.5 -33.92 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.686 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.32 60.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.77 115.03 10.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.851 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.95 -74.49 0.24 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.304 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -101.32 -28.84 12.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.417 0.627 . . . . 0.0 109.902 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.77 159.01 44.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.761 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.48 142.27 41.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.857 0.36 . . . . 0.0 110.37 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 14' ' ' LEU . 96.2 mtt180 -98.74 112.87 24.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.888 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 53' ' ' LEU . 91.9 mt -114.06 113.67 25.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 28.2 tp -94.11 116.78 29.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.4 m -130.84 153.67 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.053 0.454 . . . . 0.0 111.459 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.1 p -142.54 142.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.8 114.63 10.85 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 32.4 Cg_exo -57.75 -29.39 85.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.095 2.53 . . . . 0.0 112.767 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.7 -47.58 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.955 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 7.5 m -72.46 -35.23 68.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.898 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -56.33 -39.79 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.741 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 10.2 tp10 -58.73 -48.35 81.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.9 pt20 -72.92 -40.13 65.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.361 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.79 -43.18 80.33 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 104' ' ' VAL . 29.6 pt20 -60.44 -34.38 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.318 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 55.7 mttm -67.56 -18.94 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 111.077 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.34 -3.73 58.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.19 42.86 8.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.815 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 100' ' ' GLN . 19.7 m -90.72 171.75 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 111.666 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 109' ' ' GLU . 57.6 mt-30 -133.97 83.4 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.943 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.7 m -66.34 -16.47 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 41.1 ttm180 -59.29 -43.96 92.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HA ' HD23 ' A' ' 111' ' ' LEU . 35.3 tt0 -169.77 -11.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.975 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -55.48 -39.91 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.058 0.456 . . . . 0.0 110.141 -177.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.498 HD21 ' CZ ' ' A' ' 8' ' ' PHE . 46.8 mt -73.61 -39.48 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.485 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.0 mm? . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.087 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 CA--C 1.518 -0.294 0 CA-C-O 121.279 0.449 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.525 ' CE1' HD22 ' A' ' 110' ' ' LEU . 2.6 m-85 -148.77 146.79 28.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.791 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -171.03 134.72 0.96 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 95' ' ' THR . 13.7 tpt 53.36 63.98 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.843 0.83 . . . . 0.0 109.538 -174.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.574 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -65.56 140.47 97.55 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.624 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 77.0 Cg_endo -72.76 169.23 22.5 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.298 2.665 . . . . 0.0 112.147 -176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -130.02 136.1 49.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.838 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 87' ' ' ARG . 57.2 tp -83.9 104.83 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -94.87 115.78 27.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.697 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.0 110.37 22.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.826 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -110.21 152.69 25.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.434 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -103.69 143.03 33.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.553 -170.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -72.83 104.95 4.17 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.8 -151.01 21.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.543 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 -22.57 23.61 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.876 2.384 . . . . 0.0 112.478 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -124.38 39.02 4.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.473 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.2 -125.61 8.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.44 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' HD12 ' A' ' 17' ' ' LEU . 88.3 m-85 -111.29 -28.04 8.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.145 0.472 . . . . 0.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.51 36.58 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.28 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -123.9 146.41 48.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.472 0.636 . . . . 0.0 110.458 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.5 m-70 -106.8 125.16 50.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.247 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.31 127.29 54.95 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.494 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -113.18 132.12 55.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.341 0.591 . . . . 0.0 109.983 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.63 112.23 2.95 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 11.8 mm-40 -57.1 132.02 51.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.189 0.518 . . . . 0.0 111.126 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.41 119.7 14.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.564 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.65 -36.41 3.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.652 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 58.4 mmtt -76.01 160.8 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -100.77 16.14 26.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.017 0.436 . . . . 0.0 111.615 -177.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.41 132.06 10.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.53 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.06 137.88 40.65 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.0 m-85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.618 0.247 . . . . 0.0 110.424 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.79 119.61 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -100.56 -25.79 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 -175.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.2 tm? -164.62 145.91 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.529 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -132.6 132.98 59.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 34.9 mm-40 -78.73 98.39 0.32 Allowed Pre-proline 0 N--CA 1.465 0.325 0 O-C-N 123.355 0.409 . . . . 0.0 110.734 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' VAL . 14.5 Cg_exo -34.67 94.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.469 3.446 . . . . 0.0 114.301 -168.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.04 25.16 1.91 Allowed Glycine 0 C--N 1.314 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.742 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -96.03 163.01 21.99 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 117.228 0.514 . . . . 0.0 110.193 178.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 29.7 Cg_endo -64.22 -17.38 59.51 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.324 2.016 . . . . 0.0 111.686 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.51 -48.73 76.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.197 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 46' ' ' SER . 1.9 mp0 -66.12 -38.74 88.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 29.5 mtpp -62.41 -32.16 72.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.35 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.19 -19.19 51.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.03 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.27 39.94 1.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.823 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.56 134.3 47.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 tt -137.4 138.08 39.49 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.19 99.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.418 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.06 -24.88 1.91 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.119 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 68.0 m-20 -70.73 141.68 51.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.653 0.263 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -88.47 134.56 33.82 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.225 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -75.49 124.83 27.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.785 177.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.4 -43.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -145.14 150.32 36.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.864 0.364 . . . . 0.0 110.802 -178.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 63.6 t -133.65 111.67 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.051 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 60.71 38.64 18.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.868 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.0 9.73 80.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.952 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG2' ' NE ' ' A' ' 78' ' ' ARG . 7.2 tp10 -120.81 127.05 51.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -69.7 129.14 38.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.75 -0.204 . . . . 0.0 110.751 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.559 HG12 ' NH1' ' A' ' 78' ' ' ARG . 20.4 m -120.94 31.21 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.262 0.553 . . . . 0.0 111.418 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 35' ' ' LEU . 58.0 mt-10 -71.33 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.398 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.918 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.3 mtmp? -130.02 16.76 5.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.451 0.644 . . . . 0.0 110.106 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.403 ' CG ' HH12 ' A' ' 78' ' ' ARG . 1.0 OUTLIER -95.78 -174.45 3.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.302 -169.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.491 ' H ' ' HB3' ' A' ' 74' ' ' GLN . 32.5 p -119.68 166.98 12.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.863 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 76' ' ' VAL . 49.5 t60 -58.11 -48.4 80.31 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.899 0.124 . . . . 0.0 110.684 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.08 -41.35 99.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.801 0.81 . . . . 0.0 110.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 71' ' ' THR . 6.6 tp60 -60.87 -39.25 88.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.811 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 74.4 t -71.69 -41.34 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.406 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 72' ' ' HIS . 69.6 t -55.69 -41.15 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.673 0.273 . . . . 0.0 111.729 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -57.86 -40.0 79.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.208 0.527 . . . . 0.0 110.442 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.559 ' NH1' HG12 ' A' ' 67' ' ' VAL . 59.6 mtt180 -69.98 -36.05 74.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.123 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.57 -36.33 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.057 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -72.94 -22.59 60.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.842 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.25 -15.52 59.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.981 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.72 128.55 36.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.747 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.48 -67.66 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.36 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -111.18 -26.93 8.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.349 0.595 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.2 155.42 38.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.09 144.56 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HD3' HD21 ' A' ' 14' ' ' LEU . 84.9 mtt180 -98.82 118.49 35.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.94 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.546 HD12 HD21 ' A' ' 17' ' ' LEU . 88.9 mt -121.86 115.51 22.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.245 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 18.4 tp -95.09 123.34 38.53 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.8 m -133.3 155.74 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.291 0.567 . . . . 0.0 112.349 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.7 p -146.7 146.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 p30 -73.23 134.29 80.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.93 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 58.3 Cg_exo -53.4 -34.1 69.69 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.064 3.176 . . . . 0.0 114.301 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.58 -46.7 78.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.835 0.35 . . . . 0.0 110.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 10' ' ' MET . 24.9 m -69.78 -37.18 76.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 3.9 t70 -57.51 -45.1 85.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.429 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 39.8 mt-10 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.927 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 9.5 pt20 -74.8 -42.53 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.079 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 102' ' ' LEU . 25.7 mt -62.43 -34.15 76.21 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 9.6 pt20 -64.7 -35.6 81.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.383 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -74.56 -24.98 59.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.072 0.463 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 99' ' ' LEU . 37.1 mt -84.8 -46.47 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.422 0.629 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.99 96.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.01 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -76.67 86.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 122.309 1.052 . . . . 0.0 111.85 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 77.9 mt-30 -104.7 17.49 24.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.43 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m -66.66 -16.33 20.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.441 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.45 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 96.3 mtt180 -60.73 -43.77 97.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.9 -172.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.497 ' HA ' HD13 ' A' ' 111' ' ' LEU . 30.0 tt0 -172.66 -21.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 110.348 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 2.5 mp0 -55.15 -46.33 75.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.322 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.525 HD22 ' CE1' ' A' ' 8' ' ' PHE . 52.0 tp -65.39 -35.54 81.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 108' ' ' GLU . 7.0 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.307 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.778 0.241 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.449 ' CD1' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -159.81 138.73 10.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.406 176.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -136.95 113.64 10.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.491 -167.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.3 mtp 54.32 57.04 6.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.566 0.698 . . . . 0.0 109.663 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.767 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -64.26 161.59 39.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.392 -173.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HG3' HG13 ' A' ' 106' ' ' VAL . 22.1 Cg_endo -59.52 164.24 11.52 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.546 2.831 . . . . 0.0 112.419 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' HD11 ' A' ' 111' ' ' LEU . 28.2 mmm180 -136.96 139.72 41.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.945 -172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' A' ' 89' ' ' LEU . 48.6 tp -84.63 105.02 15.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 29.9 m -95.17 108.35 20.47 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.09 -173.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.9 110.9 22.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -114.67 148.98 37.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.765 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -119.54 128.08 53.6 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.008 -168.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 30.9 ttpt -65.4 114.75 5.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.291 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.04 -166.24 37.01 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.27 -12.54 33.32 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.578 2.185 . . . . 0.0 112.39 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -103.78 1.6 31.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.97 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.36 -133.75 11.89 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.132 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.6 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.9 m-85 -106.71 -28.83 9.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.263 0.532 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.85 39.59 9.37 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 114.267 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -138.4 157.83 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 109.999 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.548 ' CD2' HD23 ' A' ' 41' ' ' LEU . 52.9 m-70 -125.55 139.07 53.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -110.35 141.86 42.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.721 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 1.4 p80 -136.2 151.85 50.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.47 112.12 1.01 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.978 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 46.0 mt-10 -65.8 176.81 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 0.0 110.881 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -103.29 137.82 40.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.85 15.22 63.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.177 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.37 -171.33 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD12 ' HD3' ' A' ' 69' ' ' LYS . 1.8 pt? -124.38 -34.29 2.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.172 172.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.0 -177.94 15.32 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.247 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -104.66 150.24 24.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.589 0.356 . . . . 0.0 110.106 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 15.8 m-85 -126.69 151.43 48.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.66 0.266 . . . . 0.0 110.422 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.93 122.59 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.054 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 5.6 tmm_? -92.43 -42.14 9.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.989 0.423 . . . . 0.0 110.051 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 27' ' ' HIS . 23.7 tp -149.22 150.22 32.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.451 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -125.7 118.84 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.22 121.53 76.98 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.985 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.64 121.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.222 1.948 . . . . 0.0 111.808 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.04 43.81 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.368 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 99.3 p -83.28 164.81 44.0 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.561 -0.376 . . . . 0.0 111.054 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.2 Cg_endo -67.81 -18.38 47.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.48 2.12 . . . . 0.0 112.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.65 -43.15 99.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.625 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.05 -38.7 89.73 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.338 0.59 . . . . 0.0 110.035 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 60.1 mttp -68.88 -25.05 64.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.86 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -84.61 -18.55 35.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.87 10.46 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.506 HD21 HD12 ' A' ' 88' ' ' LEU . 10.2 mp -81.48 131.7 35.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.999 0.4 . . . . 0.0 110.45 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.64 152.65 51.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.05 92.87 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.32 -26.73 0.78 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.649 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 9.7 m-20 -64.26 140.78 58.9 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 111.12 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -90.47 132.33 35.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 90' ' ' VAL . 33.5 tp -80.73 112.7 18.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.833 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.04 -38.6 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.296 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.577 ' OE1' ' HD2' ' A' ' 107' ' ' ARG . 3.0 tt0 -148.88 150.59 33.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.275 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 67' ' ' VAL . 86.5 t -132.21 111.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.176 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 53.44 37.06 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.798 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.06 9.6 58.11 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.674 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.6 tp10 -120.23 130.83 54.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.439 0.619 . . . . 0.0 111.039 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -72.53 101.44 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 62' ' ' VAL . 32.7 m -102.74 5.96 10.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.253 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -8.92 41.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD3' HD12 ' A' ' 35' ' ' LEU . 30.4 mmtp -125.0 17.02 8.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.799 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 39.9 mt-10 -107.12 -172.2 2.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 112.483 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 p -107.63 170.47 7.96 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.049 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 76' ' ' VAL . 10.0 t60 -57.36 -47.55 81.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.023 177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -63.8 -47.59 80.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 28.1 mt-30 -61.71 -43.6 98.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.567 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' ILE . 70.3 t -66.73 -44.02 89.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.572 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 72' ' ' HIS . 50.1 t -57.8 -37.49 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.777 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 t -62.79 -39.34 93.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mtt-85 -68.91 -36.39 77.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' VAL . 78.3 mt -63.26 -42.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.76 -23.29 63.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -12.71 61.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.212 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.57 123.26 30.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.952 0.406 . . . . 0.0 109.942 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.47 -64.54 1.14 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.319 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -104.0 -28.81 11.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.57 32.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.777 0.322 . . . . 0.0 111.488 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.98 146.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.627 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.29 114.25 26.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.506 HD12 HD21 ' A' ' 53' ' ' LEU . 84.1 mt -114.63 126.02 54.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -95.15 119.57 33.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.9 m -132.8 160.03 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.9 p -147.77 143.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.372 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.3 t70 -67.26 126.78 93.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.298 175.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 31.6 Cg_exo -59.46 -32.82 97.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.625 2.883 . . . . 0.0 113.971 -174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -72.1 -41.31 67.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.663 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 30.5 m -69.52 -39.59 77.45 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.272 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.48 -33.41 69.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.93 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 10.7 tp10 -57.49 -40.56 78.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.76 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 96.8 mt-30 -72.78 -49.15 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 173.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 95' ' ' THR . 30.1 mt -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.401 -166.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.15 -35.73 81.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 47.9 mmtm -71.46 -36.04 71.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 66.7 mt -63.32 -59.53 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.193 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 146.11 -154.45 25.96 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 110' ' ' LEU . 91.7 t 67.0 146.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.861 0.864 . . . . 0.0 112.491 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 14.6 mm100 -81.3 91.69 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 0.0 109.857 175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -55.35 -25.07 16.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.643 -1.162 . . . . 0.0 114.013 -171.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 17.8 ptt180 -66.4 -17.67 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -170.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 111' ' ' LEU . 33.2 tt0 179.99 -13.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.2 tt0 -55.56 -37.42 67.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 110.976 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' A' ' 104' ' ' VAL . 52.4 mt -73.09 -39.68 65.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.5 mm? . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.928 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.709 0.212 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -150.58 149.54 30.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.251 0.548 . . . . 0.0 111.733 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG21 ' A' ' 95' ' ' THR . 5.1 t -170.63 123.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.603 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.5 ttt 53.54 54.21 10.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.571 0.7 . . . . 0.0 110.338 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.3 pt? -80.36 162.25 61.91 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' CG ' HG13 ' A' ' 106' ' ' VAL . 81.1 Cg_endo -88.52 172.66 4.77 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.718 2.279 . . . . 0.0 113.833 -166.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -138.11 154.09 49.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.853 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.9 111.5 19.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.0 m -92.55 109.72 21.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.472 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -95.48 110.7 22.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.381 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -113.98 149.57 35.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.956 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -112.9 134.89 54.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.472 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 33.1 ttpt -68.99 112.66 5.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.007 -174.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.27 -156.02 30.19 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.129 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.18 -8.95 24.58 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.014 2.476 . . . . 0.0 113.81 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -126.45 10.77 7.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 104.22 -139.14 14.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.311 -173.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.5 m-85 -103.17 -32.43 9.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.551 0.675 . . . . 0.0 112.072 -174.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.25 32.17 7.18 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.069 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -138.85 150.69 46.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -123.11 130.28 52.57 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.71 139.23 36.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.703 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -142.18 152.74 43.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.89 19.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.376 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' CE2' ' A' ' 38' ' ' TYR . 51.3 mt-10 -78.22 -172.37 2.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -75.45 92.42 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.117 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.33 -83.98 0.75 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 37.83 -154.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.288 -0.956 . . . . 0.0 112.378 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 1.8 pp -145.0 5.0 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.008 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.52 154.05 21.29 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.041 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -105.38 148.59 26.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.0 110.191 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 31' ' ' GLU . 8.4 m-85 -126.93 153.29 45.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 110.538 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.69 121.35 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.187 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 tmm_? -88.99 -46.69 8.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 40' ' ' ARG . 34.7 tp -147.39 144.29 28.59 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.083 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 49' ' ' GLU . 2.2 p -129.97 113.72 27.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG3' ' CA ' ' A' ' 25' ' ' GLY . 1.7 mt-10 -70.34 132.76 87.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.195 -166.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.19 118.14 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.407 2.071 . . . . 0.0 111.89 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.85 -1.43 33.85 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.382 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.483 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 99.3 p -85.45 158.95 56.83 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.181 -177.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -17.86 49.02 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 111.339 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.53 -43.39 97.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.721 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 42' ' ' VAL . 44.6 mt-10 -60.15 -44.16 95.18 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.279 0.561 . . . . 0.0 110.004 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.41 -17.67 63.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.511 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -83.27 -18.83 37.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 0.0 110.286 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.41 26.41 6.56 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.07 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.68 136.23 33.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.76 0.315 . . . . 0.0 110.634 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 55' ' ' ALA . 3.8 tt -137.41 143.37 41.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -58.03 117.65 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.305 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.55 -26.51 6.27 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.126 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 94.3 m-20 -58.17 141.73 49.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.025 0.441 . . . . 0.0 111.792 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 46.8 ttt180 -85.31 122.68 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.436 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.74 118.8 21.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.908 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.55 -41.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.576 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 11.6 tt0 -149.96 150.94 32.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.729 0.3 . . . . 0.0 110.731 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 75' ' ' VAL . 48.8 t -128.81 116.11 39.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 62.8 m-80 68.39 -58.25 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.427 1.091 . . . . 0.0 111.171 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.11 28.21 0.06 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.189 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.7 tp10 -125.54 127.26 46.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -69.92 115.72 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.32 . . . . 0.0 110.489 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.454 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 31.4 m -111.52 29.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.13 0.49 . . . . 0.0 111.486 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 35' ' ' LEU . 4.4 mm-40 -73.14 -8.72 57.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.732 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 99.8 mttt -138.43 32.45 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 111.169 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 61.4 mm-40 -107.11 -172.17 2.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.363 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 74' ' ' GLN . 65.1 p -123.48 174.1 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 76' ' ' VAL . 9.5 t60 -55.3 -47.9 74.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.001 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -65.73 -43.36 89.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.151 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 14.0 mm-40 -60.76 -42.9 98.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.571 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.721 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.79 -38.9 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.504 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 72' ' ' HIS . 25.4 t -58.88 -39.85 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -59.13 -41.78 89.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.277 0.561 . . . . 0.0 109.856 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.506 ' NE ' ' HG2' ' A' ' 65' ' ' GLU . 53.1 mtt180 -69.34 -35.88 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.9 mt -65.18 -32.59 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.202 0.525 . . . . 0.0 109.898 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.91 -17.3 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 109.997 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.53 114.29 20.83 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.562 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.53 -63.7 1.01 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.575 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -135.38 -0.12 2.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.149 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.98 141.65 20.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -126.62 144.15 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.839 0.352 . . . . 0.0 110.246 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 59.6 mtm-85 -103.31 113.23 26.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.152 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 17' ' ' LEU . 99.0 mt -112.37 118.47 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.014 0.435 . . . . 0.0 110.968 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 32.8 tp -95.1 116.32 28.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 31.8 m -130.02 154.08 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.842 0.353 . . . . 0.0 110.6 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.83 147.57 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.154 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 13.5 t70 -62.54 121.75 69.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.604 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 37.0 Cg_exo -60.43 -31.1 92.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.526 2.817 . . . . 0.0 113.508 -173.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.84 -44.74 63.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.003 0.43 . . . . 0.0 110.241 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 9' ' ' THR . 23.7 m -71.13 -36.74 72.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.735 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 9.1 t70 -56.92 -33.28 66.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.872 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 8.7 mm-40 -59.03 -49.66 77.04 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -72.74 -39.77 66.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.931 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.84 -33.9 76.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.988 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.59 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 1.3 tt0 -57.23 -49.14 76.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.495 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 14.0 mptt -68.94 -18.32 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.515 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.06 -10.81 59.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.84 46.3 38.43 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.614 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 106' ' ' VAL . 24.0 m -91.72 160.86 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.278 0.561 . . . . 0.0 111.96 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -104.32 69.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.9 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 104' ' ' VAL . 16.8 t -56.72 -27.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.6 ptm180 -59.9 -29.22 68.2 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -165.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -174.59 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.177 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.22 -32.28 70.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.81 -19.73 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.197 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.426 -174.047 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.461 -0.436 0 CA-C-O 120.697 0.207 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' LEU . 17.4 m-85 -146.78 147.32 30.79 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.519 0.676 . . . . 0.0 112.255 -174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 10' ' ' MET . 4.0 t -172.0 133.74 0.73 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.794 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 16.4 tpt 75.2 -60.58 0.51 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.708 0.803 . . . . 0.0 110.493 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 51.91 132.91 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.296 1.438 . . . . 0.0 114.178 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.025 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 84.9 Cg_endo -76.8 173.43 14.49 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.577 2.851 . . . . 0.0 113.514 -176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -143.04 157.69 44.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.124 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 89' ' ' LEU . 29.6 mt -84.54 115.98 22.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.2 m -94.49 108.31 20.25 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.517 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -94.62 111.62 23.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -121.88 150.31 42.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 36.3 mt-10 -112.97 134.76 54.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.786 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.87 117.58 4.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -172.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.63 -161.67 32.16 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.489 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.74 -33.15 93.35 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.42 2.747 . . . . 0.0 113.046 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -136.98 24.01 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 111.544 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.43 -153.26 18.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.758 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.694 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.4 m-85 -104.08 -29.91 10.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.967 0.383 . . . . 0.0 111.985 -173.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.14 29.65 6.69 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.79 172.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -134.0 141.07 47.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.429 -0.454 . . . . 0.0 110.32 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -101.6 144.17 30.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.53 128.32 49.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.493 0.187 . . . . 0.0 111.311 -172.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.5 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.4 p80 -123.94 140.27 53.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -118.1 6.48 15.17 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 64.16 -173.7 0.17 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.978 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -107.61 122.09 45.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.46 61.98 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.68 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 4.2 mptp? -96.44 167.71 11.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -130.51 20.48 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.061 175.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 144.05 15.8 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG3' HG21 ' A' ' 75' ' ' VAL . 12.5 mm100 -103.86 146.22 28.97 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 117.007 0.404 . . . . 0.0 110.299 -173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -128.22 152.69 47.77 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 55' ' ' ALA . 28.5 mm -70.09 118.3 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 109.952 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 1.2 tpt180 -93.96 -49.67 5.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.521 -173.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.7 tm? -152.5 141.37 21.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.561 ' N ' HD13 ' A' ' 41' ' ' LEU . 25.0 t -118.82 127.29 75.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.1 mm-40 -80.88 120.05 77.79 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 11.7 Cg_exo -70.92 101.94 1.14 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.511 2.14 . . . . 0.0 112.386 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.2 22.11 1.26 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.99 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -118.49 173.84 3.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.77 0.319 . . . . 0.0 110.196 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 56.1 Cg_endo -70.34 -13.46 33.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.405 2.07 . . . . 0.0 112.922 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -47.9 81.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.402 . . . . 0.0 110.891 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.7 mp0 -67.34 -32.97 74.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.406 0.622 . . . . 0.0 109.791 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 27.3 mtpp -69.56 -21.02 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.908 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.67 -17.81 24.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.37 38.11 4.1 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.52 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 88' ' ' LEU . 94.6 mt -92.9 130.86 38.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.9 tt -129.09 138.74 52.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HG22 ' A' ' 39' ' ' ILE . . . -63.4 103.89 0.56 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.183 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.99 -26.89 2.58 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.654 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.647 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.7 m-20 -65.25 149.39 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.33 0.586 . . . . 0.0 111.549 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 58.8 ttt180 -92.13 125.51 36.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 37' ' ' GLN . 48.2 tp -80.42 100.71 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.032 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -86.32 -39.51 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.161 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 4.1 tt0 -146.73 151.42 37.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 111.534 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.767 HG21 HG13 ' A' ' 75' ' ' VAL . 83.9 t -131.3 111.3 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.617 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.99 -24.0 0.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.844 0.858 . . . . 0.0 112.03 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 148.0 13.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.454 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -126.0 135.39 51.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.393 0.597 . . . . 0.0 110.185 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.22 102.49 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.916 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG21 HG23 ' A' ' 62' ' ' VAL . 29.9 m -92.61 12.7 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -170.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.5 -3.22 19.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.185 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 35' ' ' LEU . 97.9 mttt -132.64 31.16 4.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.172 0.51 . . . . 0.0 110.086 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -116.9 -164.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.261 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 59.6 p -133.29 167.1 21.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.102 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 76' ' ' VAL . 20.4 t60 -53.88 -47.34 71.18 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.16 -46.81 88.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.2 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 48.6 mt-30 -65.32 -38.12 89.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.767 HG13 HG21 ' A' ' 62' ' ' VAL . 75.7 t -66.05 -39.55 84.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.924 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 72' ' ' HIS . 62.0 t -57.54 -46.1 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.614 0.245 . . . . 0.0 111.069 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -37.33 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.674 0.273 . . . . 0.0 110.989 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 85.9 mtt-85 -66.57 -36.38 82.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.974 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.2 mt -65.52 -39.87 86.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.0 110.173 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.4 mmt180 -71.21 -20.87 62.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.687 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.63 62.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.963 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 131.01 45.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.77 -52.27 10.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.216 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.87 -22.19 2.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.3 153.28 34.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.705 0.288 . . . . 0.0 110.937 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.0 141.71 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.12 114.51 27.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 53' ' ' LEU . 94.3 mt -109.62 119.46 39.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.423 ' HB2' HD23 ' A' ' 14' ' ' LEU . 26.8 tp -94.33 116.01 28.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 29.3 m -127.89 153.09 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.12 0.486 . . . . 0.0 111.041 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 10.6 p -148.26 153.51 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.326 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.89 118.69 16.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.41 -40.96 77.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.542 2.828 . . . . 0.0 113.597 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.34 -37.47 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -66.21 -38.28 87.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.913 0.387 . . . . 0.0 110.271 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.7 t70 -61.68 -36.7 81.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.88 -48.33 80.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.296 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 17.0 pt20 -72.43 -42.87 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.998 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 mt -59.44 -43.98 93.02 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.639 0.257 . . . . 0.0 111.203 -177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 96' ' ' ASP . 77.5 mm-40 -61.9 -38.16 87.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.796 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 98' ' ' GLN . 12.5 pttp -75.55 -19.79 59.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.366 . . . . 0.0 110.453 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 86.4 mt -76.89 -3.65 39.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.488 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.82 30.48 26.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.737 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 39.8 t -89.35 131.28 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.869 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -95.18 85.29 4.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.336 174.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.557 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.47 -17.47 22.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.222 -175.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -59.39 -45.91 90.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.545 ' HA ' HD13 ' A' ' 111' ' ' LEU . 21.3 tt0 -166.79 -10.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.137 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 42.1 mm-40 -55.69 -40.79 72.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 110.6 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 8' ' ' PHE . 45.1 mt -65.23 -40.22 93.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.392 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 108' ' ' GLU . 4.9 mp . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.052 -170.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 CA--C 1.513 -0.56 0 CA-C-O 121.443 0.518 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -149.53 139.67 22.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.317 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -148.56 -45.52 0.15 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.974 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.558 ' HB3' HG21 ' A' ' 95' ' ' THR . 51.0 tpp -138.9 78.57 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.924 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.54 155.8 85.35 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 -179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.715 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 55.3 Cg_endo -93.75 160.01 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.166 2.578 . . . . 0.0 112.775 -173.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -136.38 150.01 48.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.377 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD21 ' HD3' ' A' ' 87' ' ' ARG . 33.1 tp -82.21 106.79 14.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -92.49 111.66 23.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.051 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.632 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 42.6 m -97.31 110.9 23.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.256 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -110.97 154.98 23.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.339 176.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.96 130.41 55.69 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 -167.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -65.19 126.34 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.18 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.6 -169.18 21.82 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.24 -16.73 56.64 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.443 2.095 . . . . 0.0 112.135 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -97.81 0.74 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.132 0.492 . . . . 0.0 110.087 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.49 -119.76 5.81 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 17' ' ' LEU . 91.7 m-85 -119.26 -24.55 6.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.114 0.457 . . . . 0.0 110.661 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.0 31.18 29.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.576 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -128.7 156.6 43.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.361 0.581 . . . . 0.0 110.056 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.441 ' CD2' HD23 ' A' ' 41' ' ' LEU . 69.5 m-70 -126.16 144.61 50.69 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -120.15 143.18 48.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -139.48 147.35 41.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.706 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.36 108.81 2.29 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.733 ' O ' ' HD2' ' A' ' 34' ' ' LYS . 9.1 mm-40 -70.53 147.01 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -67.4 116.93 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 50.81 2.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.784 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -134.76 -171.87 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 110.55 -177.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 pt? -129.4 -29.27 2.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.752 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.06 -163.95 12.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.04 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -111.93 155.69 23.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.892 0.377 . . . . 0.0 110.622 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.567 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 83.2 m-85 -131.16 151.9 50.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.534 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.1 mm -72.53 124.91 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.806 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.484 ' O ' ' HD2' ' A' ' 40' ' ' ARG . 2.4 tmm_? -89.06 -40.73 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 7.7 tp -161.9 150.07 14.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.487 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 65.0 t -129.29 129.9 67.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -76.94 115.97 53.04 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.31 114.2 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.207 1.938 . . . . 0.0 111.051 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 40.81 2.75 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.842 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.775 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 34.3 p -119.64 -164.16 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 74.5 Cg_endo -90.31 -13.36 2.42 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.245 1.296 . . . . 0.0 112.919 163.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -73.81 -41.62 62.1 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -74.73 -35.14 62.66 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.392 1.091 . . . . 0.0 108.14 -174.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -57.29 -34.66 68.9 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.938 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -78.87 -17.32 55.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.24 24.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.618 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.69 130.44 37.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.765 0.317 . . . . 0.0 110.495 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.3 tp -137.31 150.83 48.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.999 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 94.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.272 0.558 . . . . 0.0 111.179 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.71 -25.25 1.05 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.1 m-20 -62.26 140.81 58.48 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.137 0.494 . . . . 0.0 111.231 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 38' ' ' TYR . 42.1 ttm180 -88.9 126.7 35.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.907 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 46.3 tp -80.46 117.36 21.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.02 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HB ' HD23 ' A' ' 89' ' ' LEU . 52.6 t -102.21 -37.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.463 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.65 149.73 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.632 -178.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 75' ' ' VAL . 86.8 t -137.05 117.68 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.617 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 60.44 37.42 19.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.386 0.613 . . . . 0.0 110.147 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.52 16.24 76.25 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.705 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 7.3 tp10 -125.16 135.15 52.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.519 -0.401 . . . . 0.0 110.957 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.755 HD22 ' HD3' ' A' ' 107' ' ' ARG . 23.1 t-20 -70.02 113.96 7.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.375 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.9 m -111.99 26.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.327 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.462 ' CD ' HD21 ' A' ' 66' ' ' ASN . 81.2 mt-10 -61.24 -25.4 67.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.424 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 5.7 ptpp? -141.94 34.98 1.56 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.037 0.446 . . . . 0.0 111.543 -170.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mt-10 -110.56 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.019 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.3 p -113.48 167.62 10.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.6 t60 -56.71 -44.52 81.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.853 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.62 -46.01 90.24 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.607 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 56.8 mt-30 -61.38 -42.4 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 62' ' ' VAL . 74.3 t -64.97 -41.14 91.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.506 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 72' ' ' HIS . 73.1 t -58.01 -44.21 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.625 0.25 . . . . 0.0 111.425 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 p -64.0 -36.48 84.11 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.534 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 44.6 mtt-85 -64.94 -37.67 88.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 75' ' ' VAL . 77.2 mt -63.22 -32.8 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 110.268 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.6 mmt180 -70.34 -21.06 62.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -6.69 51.02 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -90.14 125.23 35.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.707 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.55 -75.86 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.144 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -118.64 -1.92 11.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.506 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.98 149.58 29.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 174.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.23 142.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.632 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 94.1 mtt180 -98.68 117.37 33.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.98 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.463 HD12 HD21 ' A' ' 17' ' ' LEU . 89.3 mt -121.75 125.92 47.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 10.4 tp -100.25 115.94 31.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.3 m -127.93 155.79 39.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.067 0.461 . . . . 0.0 110.375 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.3 p -148.0 154.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.039 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.62 123.37 56.93 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.95 -35.34 98.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.55 2.833 . . . . 0.0 113.246 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -72.22 -43.58 64.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.6 m -66.38 -37.43 85.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.689 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.51 ' HB2' HG13 ' A' ' 91' ' ' VAL . 30.5 t70 -57.92 -39.74 78.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.347 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -58.51 -49.05 78.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.281 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.546 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.3 pt20 -72.64 -39.59 67.08 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.765 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 102' ' ' LEU . 38.8 mt -70.48 -42.78 70.93 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -47.93 82.49 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.7 -18.92 65.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.685 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 95.8 mt -69.49 -20.84 63.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.54 33.09 4.59 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.058 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.26 132.1 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.049 0.452 . . . . 0.0 111.139 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -87.08 88.58 7.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.91 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 12' ' ' PRO . 2.3 t -65.64 -29.62 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.121 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.755 ' HD3' HD22 ' A' ' 66' ' ' ASN . 15.1 ttp85 -60.69 -44.02 97.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -168.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -158.81 -34.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.965 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.848 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 8.4 tp10 -55.52 -39.51 70.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.6 tp -68.86 -20.86 64.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 mp . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 120.968 0.414 . . . . 0.0 110.857 -178.536 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 CA-C-O 121.458 0.524 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 11' ' ' LEU . 37.2 m-85 -153.97 145.11 22.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.74 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 10' ' ' MET . 1.5 t -142.68 -98.49 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.135 -169.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.47 ' H ' HG23 ' A' ' 9' ' ' THR . 82.6 mtp -97.41 -28.05 14.18 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 28.1 mt 76.36 160.09 0.15 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.083 167.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 58.5 Cg_endo -69.03 157.32 62.27 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.103 2.536 . . . . 0.0 112.732 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -129.75 126.27 37.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.8 tp -90.9 106.62 18.64 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.511 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.427 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 55.8 m -99.74 107.96 20.16 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.27 111.62 23.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.26 0.552 . . . . 0.0 110.126 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -114.89 165.43 12.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.386 -178.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.1 147.38 44.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.859 -170.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -72.03 107.52 4.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.41 -163.76 39.28 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.55 -26.72 81.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.74 2.293 . . . . 0.0 112.71 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -112.63 25.67 11.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.475 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -105.05 2.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.958 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' SER . 90.3 m-85 -131.7 -42.07 1.04 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.488 -0.419 . . . . 0.0 111.662 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 42.72 4.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.397 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.82 158.3 43.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.491 0.646 . . . . 0.0 110.171 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 60.8 m-70 -128.27 143.83 51.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.166 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.68 155.91 38.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.212 0.529 . . . . 0.0 111.748 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -140.17 139.1 35.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.43 117.57 5.57 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -74.75 134.87 41.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 111.38 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -59.82 108.33 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.945 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.6 -31.46 3.96 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 12.0 mptt -110.25 159.51 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 109.864 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 1.5 pp -106.51 -4.05 20.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.076 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.06 147.99 24.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 75' ' ' VAL . 33.8 mm-40 -103.33 152.4 21.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.953 0.406 . . . . 0.0 110.061 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -126.39 144.75 50.72 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.1 120.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.27 -47.2 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.9 tp -146.66 149.41 33.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -123.67 120.04 58.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.163 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 53.0 mm-40 -64.29 131.91 95.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.5 Cg_exo -70.89 123.85 10.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.887 1.725 . . . . 0.0 111.786 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.7 22.07 24.67 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.055 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 89.9 p -104.24 158.08 32.69 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.746 0.308 . . . . 0.0 110.564 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.75 -14.82 46.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.601 2.201 . . . . 0.0 111.7 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -66.47 -40.69 89.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.347 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HG2' HG11 ' A' ' 42' ' ' VAL . 28.8 mt-10 -64.94 -37.68 88.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.874 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.67 -29.11 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.006 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.16 -18.89 52.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.34 33.66 5.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 88' ' ' LEU . 83.4 mt -86.89 134.74 33.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.281 . . . . 0.0 110.444 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.71 153.33 51.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 128.1 34.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.468 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.71 -15.73 21.61 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.149 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 1.7 m-20 -78.29 147.18 34.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.925 0.393 . . . . 0.0 110.761 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 61.0 ttt180 -92.48 126.9 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.4 tp -77.58 112.79 14.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.163 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.532 ' HB ' HD23 ' A' ' 89' ' ' LEU . 40.8 t -104.88 -31.37 2.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.428 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -143.13 149.96 38.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.055 -0.403 . . . . 0.0 110.78 -178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.59 113.59 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.315 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.82 35.28 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.837 0.827 . . . . 0.0 110.844 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.66 10.96 69.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.147 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.7 tp10 -124.79 132.05 53.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.112 0.456 . . . . 0.0 110.868 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.26 108.95 3.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.7 16.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.698 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -76.39 7.54 4.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.46 23.48 2.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.668 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -109.25 -172.61 2.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.811 -174.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 69.5 p -128.19 175.22 8.61 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.551 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 t60 -61.57 -46.56 89.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -66.51 -41.46 88.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.846 0.355 . . . . 0.0 110.716 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 15.8 mt-30 -67.17 -38.71 85.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 37' ' ' GLN . 17.8 m -68.64 -41.18 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.08 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 72' ' ' HIS . 76.3 t -56.31 -39.13 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 m -61.94 -38.64 89.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.387 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 63.2 mtt-85 -67.37 -36.57 81.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.625 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 71.7 mt -63.17 -37.71 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.208 0.528 . . . . 0.0 110.004 175.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -68.96 -24.52 64.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.074 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.82 58.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.8 130.89 46.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.203 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.05 -67.05 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.858 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.37 -24.58 9.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.09 157.93 43.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.793 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.5 p -130.05 143.36 41.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 14' ' ' LEU . 9.9 mtm180 -98.74 128.51 45.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 53' ' ' LEU . 94.4 mt -122.12 110.57 15.92 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 11.9 tp -93.62 126.46 38.79 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.3 m -130.97 165.36 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 96' ' ' ASP . 8.7 p -148.14 140.1 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.569 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.5 p30 -75.1 145.12 80.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 50.4 Cg_exo -55.21 -31.52 76.47 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.017 3.145 . . . . 0.0 114.512 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.93 -47.89 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.777 0.323 . . . . 0.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.1 m -64.19 -44.78 90.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.622 0.725 . . . . 0.0 109.879 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 17.6 t70 -59.24 -39.64 83.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.507 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.48 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 1.9 tm-20 -57.41 -49.81 75.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.136 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.597 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 6.0 pt20 -73.96 -47.34 38.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 104' ' ' VAL . 2.7 mm? -58.76 -38.9 79.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 7.4 pt20 -64.53 -40.64 95.98 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.212 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 97' ' ' GLU . 44.1 mtmt -75.52 -34.98 60.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.878 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 90.6 mt -63.16 -27.3 69.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.606 -177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.61 73.92 0.9 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 99' ' ' LEU . 57.4 t -121.37 153.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.566 0.222 . . . . 0.0 110.605 -173.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 11.5 pt20 -71.22 57.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.36 0.6 . . . . 0.0 111.171 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.506 HG13 ' HG3' ' A' ' 12' ' ' PRO . 47.8 t -63.66 -27.57 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.775 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.549 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 39.4 ptt180 -60.61 -23.04 64.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -169.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 17.8 tt0 171.18 -41.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.418 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.0 mt-10 -54.47 -32.5 57.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.206 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 61.7 tp -70.28 -41.97 72.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 0.0 111.245 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.257 0.551 . . . . 0.0 111.135 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 CA--C 1.518 -0.313 0 CA-C-O 121.528 0.554 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -144.75 142.83 30.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.609 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 179.7 132.11 0.09 Allowed 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.496 0.498 . . . . 0.0 110.39 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.8 mtt 44.06 47.06 7.31 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.74 0.65 . . . . 0.0 111.622 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.75 135.74 96.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.363 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 54.4 Cg_endo -68.1 155.43 69.54 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.132 2.555 . . . . 0.0 113.518 -174.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -116.81 154.09 31.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.315 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.4 tp -82.06 115.48 21.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.8 m -93.41 115.85 28.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -104.38 112.21 25.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.727 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.66 155.68 34.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.182 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -104.34 145.77 29.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.512 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 26.0 ttpt -77.74 119.53 21.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.373 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.16 -158.36 25.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.701 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.12 -27.45 65.12 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.77 2.313 . . . . 0.0 112.457 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -110.25 26.1 11.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.274 0.559 . . . . 0.0 110.208 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 80.91 -100.58 1.99 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.5 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 87.1 m-85 -133.72 -22.63 1.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.302 0.551 . . . . 0.0 111.804 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.05 28.96 24.23 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.76 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -127.31 140.6 52.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 41' ' ' LEU . 93.6 m-70 -109.85 138.77 45.75 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.54 132.18 56.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.739 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.415 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 5.0 p80 -122.78 146.74 47.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.977 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.89 113.0 1.95 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.563 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 8.8 mm-40 -61.57 133.71 55.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.612 0.244 . . . . 0.0 110.833 -175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.12 98.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.276 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.01 -13.16 9.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.229 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 27.8 mmmt -91.54 155.66 18.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.2 pp -102.57 19.28 19.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.31 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.39 152.47 20.64 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.666 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -103.71 137.52 41.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.907 0.384 . . . . 0.0 110.578 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m-85 -125.08 155.41 39.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.013 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.33 127.83 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 3.9 tmm_? -101.14 -45.15 5.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.807 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -146.68 141.22 26.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.53 -172.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 41' ' ' LEU . 55.1 t -121.67 113.79 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.9 mm-40 -73.59 130.14 84.28 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.16 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.3 Cg_exo -70.13 124.04 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.367 2.044 . . . . 0.0 111.815 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.9 16.93 29.34 Favored Glycine 0 C--N 1.317 -0.496 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.899 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 95.9 p -101.71 159.54 29.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 0.0 110.829 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.96 -20.25 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.83 172.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -64.19 -42.13 96.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.21 -42.0 89.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.307 0.575 . . . . 0.0 110.362 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.65 -22.93 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.11 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -87.28 -17.83 31.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.901 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.67 29.96 5.71 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.202 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.13 133.51 36.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 tt -139.97 141.06 36.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.86 100.03 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.382 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.04 -31.23 1.74 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.9 m-20 -60.28 140.9 56.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.519 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -89.04 132.35 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.861 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 90' ' ' VAL . 32.7 tp -75.2 114.06 13.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.758 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG11 HG12 ' A' ' 106' ' ' VAL . 46.3 t -101.7 -36.45 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.07 150.25 35.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.003 -178.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.618 HG23 HG21 ' A' ' 67' ' ' VAL . 93.0 t -136.17 107.24 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.123 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.5 m120 62.99 22.4 13.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.346 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' A' ' 61' ' ' GLU . . . 106.67 4.22 36.94 Favored Glycine 0 C--N 1.321 -0.285 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.218 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.642 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.1 tp10 -109.09 128.7 55.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.725 0.298 . . . . 0.0 110.356 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.36 93.29 1.91 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.422 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 62' ' ' VAL . 35.7 m -95.41 35.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -173.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.48 -18.69 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.1 19.2 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.673 -177.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mp0 -93.93 141.12 28.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.99 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . 82.2 p -81.01 175.14 10.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.908 -174.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 21.9 t60 -53.84 -47.04 71.34 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.029 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.95 -40.97 91.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 84.1 mm-40 -62.86 -44.03 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.958 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 71' ' ' THR . 12.6 m -71.71 -44.96 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.7 t -59.22 -35.88 60.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.027 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 t -57.53 -40.95 79.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.317 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.642 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 68.2 mtt-85 -70.0 -37.68 75.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.44 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.8 mt -64.61 -37.92 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.353 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.776 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.48 -22.33 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 127.68 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.8 mp -78.06 -62.29 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.755 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -128.33 -12.58 5.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.379 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.55 31.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.628 0.251 . . . . 0.0 110.81 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.1 p -126.21 146.99 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.504 ' HB3' HD11 ' A' ' 14' ' ' LEU . 8.4 mtm180 -98.61 120.83 39.71 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 17' ' ' LEU . 92.6 mt -122.33 116.07 23.41 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.65 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 29.3 tp -101.54 117.37 34.77 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 25.8 m -131.04 153.77 39.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.943 0.402 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 96' ' ' ASP . 11.3 p -142.65 149.04 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.185 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.39 129.35 68.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.31 -34.11 88.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.61 2.873 . . . . 0.0 113.576 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.35 -43.34 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 17.3 m -66.39 -41.4 89.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HB2' HG13 ' A' ' 91' ' ' VAL . 14.0 t70 -58.84 -42.75 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.75 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.22 -47.03 84.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.019 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 13.6 pt20 -73.27 -38.67 65.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.0 111.001 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.97 -40.3 91.12 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -175.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.81 -37.18 85.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -71.67 -17.9 62.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.526 . . . . 0.0 110.655 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 77.0 mt -79.51 -3.85 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.906 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.84 41.71 72.26 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.104 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.91 137.64 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.859 0.361 . . . . 0.0 111.668 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 109' ' ' GLU . 17.3 mm-40 -79.33 54.64 1.73 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.475 HG12 HG11 ' A' ' 60' ' ' VAL . 1.5 t -60.57 -26.61 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.946 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.715 ' HD2' ' H ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -65.72 -5.44 8.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 33.3 tt0 168.55 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.934 0.397 . . . . 0.0 110.634 171.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 31.7 tt0 -55.54 -37.68 68.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.412 -172.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 110' ' ' LEU . 2.2 tm? -65.73 -26.79 67.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.97 -177.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.555 -177.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.856 0.274 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HD2' HD11 ' A' ' 11' ' ' LEU . 16.2 m-85 -144.81 151.87 39.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 -174.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.482 ' O ' HG21 ' A' ' 95' ' ' THR . 10.1 t 175.96 142.74 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -169.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 95' ' ' THR . 86.1 mtp 48.44 47.4 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.807 0.692 . . . . 0.0 111.651 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 2.0 mm? -72.8 157.61 88.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.515 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 37.7 Cg_endo -64.45 178.88 1.44 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.438 2.759 . . . . 0.0 113.709 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -143.3 149.37 37.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.626 -178.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 13.4 mt -84.22 108.01 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.6 m -94.38 108.41 20.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.044 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -95.1 111.85 23.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.915 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -122.04 150.79 41.61 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.42 147.83 29.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.558 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -69.43 97.53 1.0 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.653 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 -167.09 14.56 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.836 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.23 -34.2 98.15 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.928 2.418 . . . . 0.0 112.261 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -102.34 24.37 10.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.547 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.63 64.27 3.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.37 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.7 m-85 78.74 -38.57 0.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.215 1.006 . . . . 0.0 111.374 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.617 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.51 12.45 53.83 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -123.35 149.76 44.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.126 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.492 ' CD2' HD23 ' A' ' 41' ' ' LEU . 39.6 m-70 -124.3 131.94 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.806 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -104.71 142.05 35.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.42 -172.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -133.42 134.93 44.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.149 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.39 104.04 2.15 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.585 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.5 mt-10 -60.39 146.37 44.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.095 0.474 . . . . 0.0 111.635 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.78 117.98 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.636 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.0 -38.3 3.36 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.851 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.585 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 70.7 mmtt -66.85 157.18 33.71 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.503 HD13 ' HG2' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -113.0 5.08 17.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.88 165.69 16.65 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.676 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 75' ' ' VAL . 3.1 mp0 -103.66 148.56 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.804 0.335 . . . . 0.0 110.411 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.449 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 32.6 m-85 -131.44 154.47 48.65 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.91 113.41 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 ttp180 -85.48 -47.51 9.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.491 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 27' ' ' HIS . 26.7 tp -145.7 142.49 29.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.704 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 54' ' ' LEU . 1.7 p -135.66 112.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -78.87 135.43 59.25 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.68 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' CD ' ' A' ' 49' ' ' GLU . 27.8 Cg_exo -61.67 129.17 26.82 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.609 2.206 . . . . 0.0 112.057 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.79 1.38 45.99 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.942 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.617 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 96.0 p -93.76 152.14 40.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.156 0.503 . . . . 0.0 110.947 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.24 -13.7 41.04 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.86 2.373 . . . . 0.0 112.17 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.98 -39.96 95.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.001 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' CD ' ' HA ' ' A' ' 44' ' ' PRO . 30.1 mt-10 -62.92 -39.46 94.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.963 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -65.6 -29.84 70.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.934 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.12 -19.42 51.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.331 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.63 49.98 1.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -124.68 121.13 33.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.17 171.24 10.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.729 173.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.55 78.62 6.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.39 0.614 . . . . 0.0 111.191 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.33 -21.2 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.957 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 67.3 m-20 -63.97 141.75 58.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.686 0.279 . . . . 0.0 111.114 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.18 124.92 34.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.78 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.578 ' HA ' HG12 ' A' ' 90' ' ' VAL . 51.8 tp -78.4 119.48 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 106' ' ' VAL . 60.2 t -103.78 -34.97 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.388 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 16.6 tt0 -150.55 151.18 32.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.761 0.315 . . . . 0.0 111.17 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.47 HG23 HG21 ' A' ' 67' ' ' VAL . 65.6 t -132.4 119.92 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.469 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 72.9 -26.1 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.027 0.931 . . . . 0.0 111.729 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 145.16 10.68 0.28 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.604 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.3 tp10 -125.81 128.97 48.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.44 132.41 53.64 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.456 0.472 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 HG12 ' A' ' 75' ' ' VAL . 33.0 m -128.16 29.55 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.8 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.72 -24.28 66.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.503 ' HG2' HD13 ' A' ' 35' ' ' LEU . 98.3 mttt -129.95 29.83 4.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.813 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 15.9 mm-40 -95.19 179.93 5.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.934 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.65 ' OG1' ' HB2' ' A' ' 74' ' ' GLN . 25.1 p -107.63 167.62 9.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.695 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.2 t60 -62.69 -44.13 97.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -64.83 -36.75 85.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 0.0 109.973 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.65 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -62.96 -45.4 92.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.819 -177.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG12 HG11 ' A' ' 67' ' ' VAL . 4.7 m -71.32 -40.14 73.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.348 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' HIS . 45.1 t -57.55 -36.92 55.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.6 t -57.96 -41.53 83.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -69.09 -36.69 77.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -64.22 -32.8 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 109.906 176.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -21.34 62.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.847 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.09 -18.35 46.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.424 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.18 119.07 26.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.832 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.96 -62.85 1.43 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.295 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -107.15 -27.52 10.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.306 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.63 155.06 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.994 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 24' ' ' TYR . 9.8 p -131.5 153.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.802 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -106.7 125.19 50.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 99.5 mt -120.37 127.68 52.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.2 tp -103.37 116.73 32.98 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.7 m -130.54 153.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -131.9 148.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.296 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.0 m-20 -68.24 123.14 86.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 33.0 Cg_exo -57.62 -31.74 92.61 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.541 2.827 . . . . 0.0 113.318 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.77 -48.46 81.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 109.897 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 9' ' ' THR . 2.6 m -73.67 -36.04 65.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.261 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.07 -40.42 76.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 43.7 mt-10 -61.04 -43.51 98.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.775 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -74.41 -39.89 62.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.076 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 mt -64.94 -34.18 77.8 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 18.1 pt20 -60.17 -34.33 73.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.42 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -71.71 -37.77 70.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.321 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 99' ' ' LEU . 27.2 mt -76.89 -44.51 31.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.458 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.58 94.19 0.16 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.05 95.54 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.14 0.971 . . . . 0.0 112.072 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -113.08 28.33 8.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.418 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.807 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 21.8 m -66.35 -14.19 17.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.551 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.29 -37.76 75.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -166.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HD23 ' A' ' 111' ' ' LEU . 39.0 tt0 -162.13 -19.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.175 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.26 -36.2 65.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.722 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 3.9 mm? -77.92 -28.64 49.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.087 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.6 mm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.235 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.62 ' HA ' HD13 ' A' ' 102' ' ' LEU . 30.0 Cg_endo . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 113.298 0.461 . . . . 0.0 113.298 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.525 ' HD1' HD21 ' A' ' 11' ' ' LEU . 16.2 m-85 -146.01 150.05 35.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.066 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -173.71 126.58 0.39 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.453 -171.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt 72.8 -71.0 0.14 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.884 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.525 HD21 ' HD1' ' A' ' 8' ' ' PHE . 2.8 mm? 65.74 156.89 0.13 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.778 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 72.4 Cg_endo -74.01 158.99 45.35 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.774 2.316 . . . . 0.0 112.553 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -115.33 143.98 44.45 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.737 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HB2' HD13 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -83.19 106.3 14.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.3 m -96.24 108.52 21.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.671 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 22.0 m -91.82 111.75 23.4 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 48' ' ' ALA . 21.1 mt -88.27 163.65 15.99 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 41.6 mt-10 -115.34 121.85 44.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.19 101.75 2.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.932 0.396 . . . . 0.0 110.666 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.59 -157.87 33.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.709 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 -26.82 73.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.59 14.8 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 -124.44 6.47 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.155 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 86' ' ' VAL . 91.4 m-85 -108.47 -22.55 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.896 0.379 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.06 33.94 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.112 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.17 149.9 52.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.458 0.629 . . . . 0.0 110.182 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -105.78 134.53 48.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.3 tp -119.87 124.25 45.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.1 p80 -123.88 146.0 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.074 -175.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.62 105.01 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.941 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.613 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 41.8 mt-10 -74.78 -178.33 3.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.655 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -99.2 138.68 35.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.64 -1.46 60.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.957 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -104.65 -173.95 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.612 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.4 pt? -127.99 -12.67 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.588 174.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.12 -173.41 13.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.898 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.66 149.78 26.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.661 0.267 . . . . 0.0 110.658 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -125.91 152.17 45.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.532 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.3 mm -70.57 122.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.691 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.585 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -91.7 -48.52 6.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.973 -177.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.548 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 2.8 tp -154.93 152.09 29.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 54.8 t -119.52 115.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.19 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 69.4 mm-40 -62.94 127.66 91.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 7.6 Cg_exo -69.77 109.72 2.38 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.215 1.943 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.91 28.76 4.88 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.507 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 96.7 p -115.18 161.38 29.85 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.712 0.291 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 50' ' ' LYS . 38.6 Cg_endo -66.86 -13.41 39.83 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.132 2.555 . . . . 0.0 112.501 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.55 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -65.67 -39.94 91.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.359 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.41 -46.98 74.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 47' ' ' PRO . 21.2 ptmt -61.12 -34.77 75.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.951 -174.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.04 -17.68 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 58.92 0.71 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.494 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.7 mp -120.11 126.31 50.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 54' ' ' LEU . 2.9 mm? -127.84 166.6 17.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.3 0.571 . . . . 0.0 110.826 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.9 105.48 6.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.263 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.92 -24.73 2.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.175 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.586 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 27.8 m-20 -63.87 144.4 57.09 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -95.75 133.05 40.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 90' ' ' VAL . 28.9 tp -73.33 110.37 7.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.004 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -95.33 -45.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.073 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -143.59 149.78 37.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.602 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 67' ' ' VAL . 82.3 t -137.04 119.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.965 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.29 37.79 13.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.2 5.86 82.3 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.526 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' VAL . 32.9 tt0 -126.09 128.75 47.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.17 0.485 . . . . 0.0 111.07 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -58.86 119.95 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.702 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 62' ' ' VAL . 36.0 m -116.96 21.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.411 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.0 -14.89 61.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.86 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -122.69 19.01 10.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.964 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 21.6 mm-40 -92.0 -176.82 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.039 0.447 . . . . 0.0 111.202 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 75' ' ' VAL . 55.5 p -115.19 169.34 9.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.853 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.4 t60 -55.1 -47.0 75.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.741 0.305 . . . . 0.0 110.263 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -65.6 -46.35 79.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.444 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -62.57 -40.64 97.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.45 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 71' ' ' THR . 15.9 m -70.18 -42.98 79.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.668 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 72' ' ' HIS . 71.3 t -58.64 -36.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.731 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.8 m -59.52 -40.15 86.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 110.184 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.21 -36.85 82.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.34 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 76' ' ' VAL . 74.0 mt -63.53 -38.04 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.659 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.2 mmt180 -71.82 -22.71 61.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.666 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.23 -19.28 63.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.374 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -82.06 127.89 33.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.85 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.62 -71.15 0.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.465 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -108.45 -17.66 13.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.353 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.514 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.276 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 ' CE1' ' A' ' 24' ' ' TYR . 7.5 p -131.4 146.64 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.612 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 98.6 mtt180 -98.68 119.88 38.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.205 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.7 mt -121.67 121.96 38.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.396 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.9 tp -102.42 118.27 36.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.231 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 23.8 m -128.59 153.49 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.612 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 150.17 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.483 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 5.1 m-20 -71.8 116.16 45.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.446 174.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 43.1 Cg_exo -58.07 -24.89 68.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.897 2.398 . . . . 0.0 112.277 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 7.1 pt-20 -65.31 -47.79 75.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.059 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 m -73.75 -38.83 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.488 . . . . 0.0 110.909 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 11.8 t70 -58.48 -32.16 68.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.78 -48.28 80.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.397 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -74.28 -40.14 62.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.015 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.84 -38.3 85.04 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 46.8 mt-30 -58.07 -35.9 72.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.417 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -72.66 -19.43 61.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 7' ' ' PRO . 16.2 mt -101.55 -35.09 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.3 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.79 86.21 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.956 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 106' ' ' VAL . 3.0 p -85.45 102.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.772 0.796 . . . . 0.0 111.942 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -126.71 49.18 2.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.109 0.957 . . . . 0.0 108.504 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 30.7 m -67.17 -13.42 16.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.063 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.59 -35.43 72.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -163.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' HD12 ' A' ' 111' ' ' LEU . 22.5 tt0 -164.66 -22.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.191 0.52 . . . . 0.0 110.986 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -55.39 -45.57 76.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.526 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 110' ' ' LEU . 3.5 mm? -78.16 -18.54 55.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 89' ' ' LEU . 73.3 mt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.228 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 CA--C 1.522 -0.095 0 CA-C-O 120.776 0.24 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.33 156.2 36.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.897 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.491 HG21 ' NE2' ' A' ' 98' ' ' GLN . 5.1 t -170.42 127.52 0.8 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.151 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.554 ' HB3' HG21 ' A' ' 95' ' ' THR . 26.1 ttt 43.9 64.03 1.41 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.902 0.751 . . . . 0.0 111.302 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.84 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -75.81 146.85 80.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 -176.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.114 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 55.2 Cg_endo -67.15 140.14 52.91 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 123.342 2.695 . . . . 0.0 112.274 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -113.71 140.68 48.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.967 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.53 105.01 12.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.626 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 56.3 m -96.09 113.07 24.65 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.891 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.32 115.98 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.151 0.501 . . . . 0.0 109.851 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 24' ' ' TYR . 15.1 mt -98.59 147.55 24.69 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.396 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -100.17 122.43 42.99 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -65.75 111.31 3.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.85 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.44 -160.5 36.54 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.889 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.44 -29.65 71.63 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.777 2.318 . . . . 0.0 112.417 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -113.19 31.99 6.05 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -116.0 4.13 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.215 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 17' ' ' LEU . 45.8 m-85 -125.16 -25.67 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.985 0.393 . . . . 0.0 111.274 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.58 30.44 11.85 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.562 -0.828 . . . . 0.0 114.026 172.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -125.46 152.2 45.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.577 0.688 . . . . 0.0 110.051 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 51.1 m-70 -117.52 139.3 51.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.391 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.35 127.84 49.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.064 -169.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.0 p80 -116.55 133.54 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.34 6.79 42.66 Favored Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.989 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.818 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 11.7 mm-40 64.16 172.3 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.816 0.817 . . . . 0.0 112.708 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -125.14 101.26 6.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.296 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.69 -19.19 10.53 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -98.44 -177.24 3.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 35' ' ' LEU . 2.0 pt? -141.22 35.72 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.858 0.361 . . . . 0.0 110.952 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.94 155.72 24.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.833 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.542 ' HG3' HG21 ' A' ' 75' ' ' VAL . 68.2 mm-40 -104.0 137.22 42.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.553 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 7.2 m-85 -134.07 152.9 52.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.729 0.3 . . . . 0.0 110.633 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.46 120.37 18.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -99.12 -26.81 14.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.598 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.6 tp -163.93 150.15 11.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.7 t -125.24 118.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.395 173.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 40.5 mm-40 -64.17 129.87 94.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.0 Cg_exo -69.3 123.11 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.075 1.85 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.44 20.58 26.85 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.593 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 90.7 p -104.17 159.3 29.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.87 -21.31 56.73 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.695 2.263 . . . . 0.0 111.887 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -61.73 -38.78 89.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.151 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.426 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 21.3 mt-10 -71.08 -33.1 69.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.31 -36.69 77.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.41 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -80.44 -17.98 50.14 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.115 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 38.32 4.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.525 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.62 127.79 34.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 tp -121.02 141.48 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.67 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.62 102.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.331 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.9 -28.3 2.01 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.394 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 31.7 m-20 -62.23 139.41 58.5 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.595 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 42.7 ttp180 -89.75 132.68 35.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.2 tp -74.72 112.5 10.99 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.729 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG13 ' CD ' ' A' ' 68' ' ' GLU . 57.3 t -95.7 -44.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.24 -175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -145.58 150.04 35.66 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.619 -175.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.588 HG21 HG13 ' A' ' 75' ' ' VAL . 92.3 t -137.13 116.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m120 62.2 30.38 17.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.471 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.52 7.01 58.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.553 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.5 tp10 -125.53 135.4 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.603 0.701 . . . . 0.0 111.684 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -67.25 117.16 8.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.822 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 62' ' ' VAL . 29.6 m -117.9 26.38 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CD ' HG13 ' A' ' 60' ' ' VAL . 53.8 mt-10 -73.53 -19.7 60.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.836 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -122.06 21.48 10.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.599 0.714 . . . . 0.0 109.84 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 2.5 mp0 -101.54 153.82 19.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.472 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.8 p -77.1 162.32 27.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.354 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -56.38 -42.31 77.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.85 0.357 . . . . 0.0 110.166 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.1 tt0 -66.66 -40.79 88.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.053 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 88.7 mt-30 -62.01 -39.97 94.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 0.0 110.669 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 62' ' ' VAL . 93.5 t -67.24 -50.44 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.324 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 73' ' ' GLN . 26.8 m -61.08 -35.34 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 111.631 -177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 t -57.99 -43.12 86.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 83.7 mtt-85 -64.55 -39.9 94.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.999 0.428 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.7 -33.13 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -73.13 -20.99 60.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.123 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.8 -17.57 55.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.809 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.76 30.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.9 -66.98 0.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.645 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -116.23 -19.43 10.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.452 . . . . 0.0 110.351 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 153.66 35.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.317 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -127.55 145.23 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -107.83 117.56 34.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.06 123.35 45.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.487 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 111' ' ' LEU . 37.8 tp -97.12 120.01 36.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 21.4 m -132.09 154.96 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.727 0.298 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.828 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.2 p -147.15 140.96 19.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.963 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.93 119.26 43.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.797 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.595 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 35.9 Cg_exo -59.33 -32.36 96.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.52 2.813 . . . . 0.0 113.018 -172.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.94 -37.46 69.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.848 0.356 . . . . 0.0 110.189 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.8 m -72.14 -38.61 69.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 173.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.92 -35.66 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.245 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 43.9 tt0 -58.23 -37.6 75.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 27.6 mt-30 -72.07 -48.82 41.35 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.3 mt -62.69 -35.79 80.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.511 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.731 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -64.1 -36.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.604 178.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 65.0 mmtt -71.04 -25.1 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.518 . . . . 0.0 109.837 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 14.8 mt -82.61 -10.25 59.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.747 -177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.7 19.88 42.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.256 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -92.51 142.54 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.654 -0.321 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -116.91 98.16 6.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.114 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.3 m -65.7 -13.96 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.668 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 60.3 mtp180 -58.41 -29.53 66.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -167.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 9.2 tm-20 175.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -54.06 -38.36 65.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.244 0.545 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 11' ' ' LEU . 66.8 tp -77.38 -27.32 52.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.46 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.89 HD21 HD13 ' A' ' 89' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.465 0.316 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.706 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.471 0.192 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.64 146.19 6.86 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -163.29 136.59 5.67 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.711 ' HB2' HG21 ' A' ' 95' ' ' THR . 61.8 mtt 57.18 45.82 19.93 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.873 0.733 . . . . 0.0 109.676 176.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.25 145.62 89.93 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.643 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.012 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.6 Cg_endo -70.97 149.06 58.56 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.297 2.665 . . . . 0.0 112.647 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HD2' HH11 ' A' ' 13' ' ' ARG . 47.1 mtm180 -119.2 142.58 47.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.41 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 89' ' ' LEU . 58.9 tp -82.64 108.6 16.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.611 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.9 m -108.75 118.86 37.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.217 -169.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -95.04 133.86 38.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.016 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -133.91 153.46 51.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.721 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -100.34 151.4 21.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 0.0 110.349 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 34.6 ttpt -87.85 115.11 25.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.834 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.45 -154.12 29.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.303 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.9 -29.58 58.07 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.278 2.652 . . . . 0.0 111.96 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.67 28.47 8.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.294 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 82.1 -146.38 25.19 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.708 -177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 85.0 m-85 -93.29 -22.88 18.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.959 0.38 . . . . 0.0 111.234 -176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 30.1 22.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.216 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -131.03 157.45 42.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.212 0.506 . . . . 0.0 109.959 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' CD2' HD23 ' A' ' 41' ' ' LEU . 84.8 m-70 -127.26 145.11 50.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 37' ' ' GLN . 23.4 tp -122.92 137.18 55.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.773 0.321 . . . . 0.0 111.776 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 2.9 p80 -133.25 140.29 47.42 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.06 2.42 20.98 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 58.25 -169.3 0.12 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.709 0.403 . . . . 0.0 111.094 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -131.56 133.2 44.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.2 -21.13 46.96 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -86.32 173.61 9.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.4 pt? -130.98 16.52 5.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.24 161.94 25.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.711 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 34.9 mm-40 -103.3 145.36 30.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.404 . . . . 0.0 110.304 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.9 m-85 -128.73 150.94 50.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.722 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -70.7 125.16 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -91.7 -36.33 13.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 14.6 tp -164.08 148.33 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.469 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -125.01 118.72 53.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.169 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -63.9 128.34 92.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.462 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.78 127.73 22.37 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.302 2.001 . . . . 0.0 112.557 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.04 75.13 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.192 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.494 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 87.7 p -84.6 164.47 42.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.814 0.307 . . . . 0.0 110.583 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 12.3 Cg_endo -57.71 -26.32 72.48 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.555 2.17 . . . . 0.0 112.176 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.29 -31.8 73.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 3.7 mt-10 -69.74 -28.55 65.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.12 -37.07 84.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 110.119 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -78.96 -17.31 55.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.235 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.7 29.67 7.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.0 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.56 138.0 32.99 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.682 -0.305 . . . . 0.0 110.514 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.3 tt -145.59 143.13 29.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 41' ' ' LEU . . . -59.56 103.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.293 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -31.63 1.57 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.717 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 14.7 m-20 -61.54 141.49 57.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -89.36 124.99 34.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.394 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.555 ' HA ' HG12 ' A' ' 90' ' ' VAL . 48.2 tp -78.39 112.46 15.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.893 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.419 HG23 ' HG ' ' A' ' 89' ' ' LEU . 5.0 m -105.94 -26.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -146.41 150.64 36.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.778 0.323 . . . . 0.0 111.21 175.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG21 HG13 ' A' ' 75' ' ' VAL . 62.1 t -136.39 113.81 13.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 57.0 41.3 27.86 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.528 0.517 . . . . 0.0 112.344 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.85 -8.38 59.6 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.359 171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 78' ' ' ARG . 44.2 tt0 -126.36 128.62 47.35 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.127 0.963 . . . . 0.0 109.613 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 27.0 m120 -69.53 135.13 49.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.235 -174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 23.1 m -118.91 24.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.922 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 8.0 mt-10 -54.84 -33.15 61.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.508 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HE3' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -131.48 21.06 4.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.71 -175.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 1.4 mp0 -98.15 161.56 13.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.118 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.1 p -89.54 165.13 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.728 -172.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.3 t60 -58.62 -46.62 86.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.95 -41.48 96.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.843 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 98.2 mt-30 -63.57 -43.78 96.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG13 HG21 ' A' ' 62' ' ' VAL . 94.1 t -63.7 -46.2 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.419 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 72' ' ' HIS . 95.5 t -59.94 -39.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 0.0 110.991 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 m -58.45 -38.13 76.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 86.6 mtt-85 -61.73 -34.61 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.331 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.91 -31.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 -177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -69.88 -22.67 63.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 110.731 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.76 62.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.109 0.481 . . . . 0.0 110.07 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -72.32 121.09 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.837 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.78 -61.27 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.703 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.48 -7.26 4.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.23 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.78 154.48 36.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.513 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.2 p -130.65 144.59 37.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -101.55 117.63 35.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.486 HD12 HD21 ' A' ' 17' ' ' LEU . 98.5 mt -119.9 123.23 43.09 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 45.0 tp -101.9 118.32 36.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.587 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 59' ' ' LEU . 28.5 m -131.36 158.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.0 p -135.11 144.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.703 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.16 126.71 61.87 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.624 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' A' ' 57' ' ' ASP . 19.9 Cg_endo -58.7 -40.18 75.52 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.714 2.942 . . . . 0.0 113.929 -170.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 95' ' ' THR . 8.3 pt-20 -72.35 -39.86 67.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 10' ' ' MET . 1.8 m -71.76 -36.51 70.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 91' ' ' VAL . 6.7 t70 -56.88 -43.89 81.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.707 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 32.5 mt-10 -67.92 -36.42 80.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.686 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.22 -39.17 60.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.443 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 102' ' ' LEU . 53.6 mt -67.41 -31.95 72.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 23.6 pt20 -56.62 -36.71 69.77 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -172.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.44 -20.08 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.691 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 99' ' ' LEU . 55.7 mt -84.02 -40.11 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.242 0.544 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.56 0.52 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.412 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 107' ' ' ARG . 18.6 m -85.09 41.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.825 0.821 . . . . 0.0 110.427 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -83.44 5.31 24.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.197 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.012 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 2.5 m -65.12 -15.71 18.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.197 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.535 HH21 HG21 ' A' ' 104' ' ' VAL . 27.7 mtt180 -59.65 -32.19 70.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.027 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 51.0 tt0 171.65 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.703 0.627 . . . . 0.0 109.363 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -55.67 -51.84 65.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.629 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.8 tp -60.19 -30.14 69.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.773 0.321 . . . . 0.0 110.602 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.382 -176.478 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.464 -0.222 0 CA-C-O 121.262 0.442 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 110' ' ' LEU . 2.6 m-85 -150.95 147.0 26.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.544 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -157.26 122.67 4.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.981 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt 62.74 65.54 0.82 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.708 0.766 . . . . 0.0 109.991 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -81.59 138.09 47.7 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.807 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.008 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 66.5 Cg_endo -72.83 171.15 17.98 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.171 2.58 . . . . 0.0 113.653 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 156.56 46.82 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.694 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' HD23 ' A' ' 111' ' ' LEU . 32.8 tp -83.99 117.91 23.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 41.3 m -94.53 111.22 22.98 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.8 p -100.69 111.09 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 110.195 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -116.6 146.61 42.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.408 -177.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.14 141.6 44.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.1 -170.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.0 ttmt -68.07 119.57 12.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.926 0.393 . . . . 0.0 111.201 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.1 -149.32 25.34 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.267 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.62 -27.27 45.67 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.947 2.432 . . . . 0.0 112.468 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -132.86 53.03 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 0.0 110.497 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 79.14 -121.6 5.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.441 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.558 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.6 m-85 -123.15 -27.74 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.38 29.31 9.6 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.322 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -141.1 143.2 34.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.308 0.554 . . . . 0.0 110.328 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -129.68 143.46 50.83 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.91 150.05 32.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.978 -173.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -134.73 144.01 47.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.325 176.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.43 114.94 3.93 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.77 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 38.5 mt-10 -55.58 125.45 21.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 20.8 tptp -67.42 133.95 50.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.34 -15.41 63.02 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.722 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -100.91 178.33 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -129.93 25.29 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.46 166.61 25.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.857 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -104.24 136.91 42.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 0.0 110.594 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 89.3 m-85 -121.43 157.36 30.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.544 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.0 mm -71.35 114.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -85.19 -43.14 14.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.2 tp -149.37 141.95 24.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.415 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.84 114.51 46.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -70.73 112.93 14.84 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 14.0 Cg_endo -58.32 121.55 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 112.232 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.96 13.78 26.43 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.082 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.501 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 89.8 p -103.91 160.22 26.8 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 37.1 Cg_endo -66.46 -16.19 50.29 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.803 2.335 . . . . 0.0 112.106 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.117 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 42.2 mt-10 -63.06 -43.64 98.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.6 mttm -62.72 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.31 -19.66 31.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.269 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 44.36 1.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.551 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.0 mt -102.67 146.95 27.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 174.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tt -145.96 143.62 29.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.77 101.48 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.4 -25.41 1.85 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.97 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 71.0 m-20 -75.28 148.56 39.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -92.74 133.57 35.9 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.445 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 40.7 tp -75.91 107.12 7.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.648 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.872 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 47.2 t -95.31 -33.96 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -175.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -147.09 150.55 35.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 0.0 111.008 -178.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 81.3 t -136.58 113.83 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.096 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.46 33.27 20.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.077 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.65 16.13 60.55 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.859 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -123.87 135.23 53.61 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.591 -0.358 . . . . 0.0 110.617 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.404 ' CG ' HH12 ' A' ' 107' ' ' ARG . 3.4 t-20 -73.55 114.75 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.663 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 62' ' ' VAL . 17.4 m -128.47 11.53 2.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -172.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.872 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -72.34 -21.7 61.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.768 -174.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 33.8 mtmm -110.23 18.21 20.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.215 174.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 36.9 mm-40 -97.3 175.57 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.314 0.578 . . . . 0.0 111.97 -176.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.4 p -89.58 173.98 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.073 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 76' ' ' VAL . 61.8 t60 -65.31 -44.43 87.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 175.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.79 -39.29 90.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.71 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 11.1 mm-40 -61.39 -45.82 92.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.05 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 79' ' ' ILE . 18.6 m -68.68 -45.15 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.369 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 80.2 t -54.7 -43.77 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.994 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -60.27 -41.26 92.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 75.1 mtt-85 -69.18 -36.23 77.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.189 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 86' ' ' VAL . 89.1 mt -62.26 -42.19 94.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 7.8 mpt_? -64.89 -20.79 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.16 64.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.65 0.262 . . . . 0.0 111.507 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.641 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -69.27 142.29 54.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.308 0.575 . . . . 0.0 110.746 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 -56.55 4.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.884 -175.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.87 -28.75 3.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.8 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -146.18 143.42 29.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.359 -172.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -109.56 158.4 9.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.142 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.26 119.21 38.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 88.2 mt -119.7 128.54 53.9 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.902 0.382 . . . . 0.0 110.831 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 15.6 tp -106.46 121.8 45.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.978 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.7 m -131.69 155.29 41.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.05 0.452 . . . . 0.0 110.983 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.79 150.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.074 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 18.3 t70 -64.5 120.51 66.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 32.9 Cg_exo -60.89 -29.46 88.15 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.448 2.765 . . . . 0.0 113.208 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.8 -47.87 50.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 20.3 m -66.24 -37.18 84.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 22.0 t70 -58.5 -36.14 73.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.61 -48.16 81.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.8 pt20 -71.63 -38.79 70.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.47 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.83 -33.87 73.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.749 0.309 . . . . 0.0 110.926 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 67.3 mt-30 -57.86 -41.61 82.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.927 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -71.12 -21.26 62.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.982 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.38 -43.03 8.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.369 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.2 84.69 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -66.85 90.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 122.228 1.013 . . . . 0.0 111.834 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 23.7 mt-30 -103.14 22.1 14.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.16 177.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.008 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.9 m -66.0 -18.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.582 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 66' ' ' ASN . 5.8 ptp180 -63.38 -33.73 76.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -170.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -179.68 -27.83 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.104 0.478 . . . . 0.0 109.995 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 5.0 mm-40 -55.74 -40.95 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.312 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 8' ' ' PHE . 52.8 mt -78.72 -17.48 55.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 111.898 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.571 HD21 HD13 ' A' ' 89' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.32 -0.709 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 121.346 0.477 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.611 ' CZ ' ' HB ' ' A' ' 104' ' ' VAL . 7.3 m-85 -149.01 150.88 33.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 9' ' ' THR . 7.3 t -172.16 101.98 0.17 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.875 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.1 tpt 69.42 64.06 0.27 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -172.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.7 pt? -80.15 160.1 69.03 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.933 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.88 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 73.7 Cg_endo -73.35 165.76 31.71 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.768 2.312 . . . . 0.0 113.049 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -143.16 146.19 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 111' ' ' LEU . 47.0 tp -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -93.66 115.89 28.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.45 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 m -103.97 111.24 23.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.808 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -117.21 154.63 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.845 -177.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -111.59 136.51 50.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.565 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 38.9 ttmt -67.27 131.09 45.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.341 0.591 . . . . 0.0 111.928 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.86 -148.74 10.45 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.618 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.27 -2.67 12.72 Favored 'Trans proline' 0 N--CA 1.472 0.209 0 C-N-CA 123.157 2.572 . . . . 0.0 112.444 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -128.08 22.22 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.235 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 77.28 -106.11 2.17 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 -172.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.0 m-85 -127.79 -15.93 4.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.1 0.45 . . . . 0.0 111.332 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.19 32.57 43.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.102 -0.57 . . . . 0.0 114.078 173.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.26 151.79 50.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.618 0.709 . . . . 0.0 110.225 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.475 ' CD2' HD23 ' A' ' 41' ' ' LEU . 26.1 m-70 -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 37' ' ' GLN . 14.1 mt -118.45 151.36 37.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.106 0.479 . . . . 0.0 111.809 -177.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.6 p80 -130.86 144.84 51.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.67 108.65 3.04 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 33.4 mm-40 -71.51 125.0 25.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.073 0.464 . . . . 0.0 110.176 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.05 133.75 52.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.107 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.6 -28.22 11.82 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.819 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 12.1 mptt -93.13 -32.75 14.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.837 0.351 . . . . 0.0 111.383 -177.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt 74.65 -50.32 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.578 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.61 157.95 8.14 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.683 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.461 ' HB3' HD22 ' A' ' 28' ' ' LEU . 35.8 mm-40 -102.09 144.64 30.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.033 0.445 . . . . 0.0 110.11 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.572 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 19.5 m-85 -122.53 152.15 40.65 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mm -70.83 108.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -81.12 -42.9 20.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 27' ' ' HIS . 22.9 tp -147.31 145.27 29.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.162 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -135.76 120.96 28.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -63.99 126.07 89.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.59 -172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.52 109.06 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.316 2.011 . . . . 0.0 111.721 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.84 12.91 21.46 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.987 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 88.1 p -91.57 159.4 38.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.7 Cg_endo -69.07 -13.66 36.83 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.555 2.17 . . . . 0.0 112.355 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.616 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -67.51 -45.45 75.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.726 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.71 -39.14 83.64 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.39 0.614 . . . . 0.0 110.207 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -75.96 -11.17 59.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.399 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.07 -17.61 25.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.105 0.479 . . . . 0.0 110.237 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.75 53.05 0.72 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.2 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.31 114.74 16.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.466 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.8 tp -118.0 162.12 18.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.06 43.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.961 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.22 5.6 0.32 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.416 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.9 m-20 -91.1 146.6 23.71 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.622 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 41.0 ttp180 -99.78 130.33 45.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 41.7 tp -77.71 109.16 11.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.216 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.68 -42.84 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.11 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -144.21 150.84 38.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 0.0 110.427 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 75' ' ' VAL . 61.3 t -135.78 107.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.238 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 58.74 39.06 24.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.129 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.68 35.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.718 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.89 136.68 54.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.298 1.049 . . . . 0.0 111.826 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -67.95 115.72 7.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.535 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 29.0 m -102.57 18.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -67.3 -16.7 64.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.336 0.588 . . . . 0.0 111.211 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -122.5 22.29 9.98 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.947 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 33.9 mm-40 -105.07 -173.62 2.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.1 p -117.16 173.93 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.1 t60 -60.49 -47.06 87.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.872 0.368 . . . . 0.0 110.153 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.71 -44.76 89.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.823 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 51.3 mt-30 -63.89 -41.32 97.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 HG21 ' A' ' 62' ' ' VAL . 55.1 t -62.79 -44.99 99.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.133 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 72' ' ' HIS . 96.9 t -61.15 -38.68 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -60.13 -38.21 82.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 110.402 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 77.0 mtt-85 -68.48 -36.04 78.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.697 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.6 -35.82 75.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.163 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 40.0 mmt180 -68.6 -21.96 64.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.98 95.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.619 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -77.2 132.79 38.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.299 0.571 . . . . 0.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.47 -68.05 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.41 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -110.87 -16.66 13.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -150.43 134.98 17.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -110.68 158.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HD3' HD21 ' A' ' 14' ' ' LEU . 62.5 mtt180 -112.58 114.63 27.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.561 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 71.2 mt -118.72 119.33 34.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.831 0.348 . . . . 0.0 110.773 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.708 HD13 HD11 ' A' ' 111' ' ' LEU . 21.7 tp -94.53 124.11 38.36 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.2 m -132.58 155.16 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.928 0.394 . . . . 0.0 111.412 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.0 p -139.24 144.32 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.345 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.11 116.97 28.67 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 34.5 Cg_exo -58.17 -24.95 69.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.959 2.44 . . . . 0.0 112.243 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.21 -47.06 68.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.01 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 90.3 m -72.02 -38.39 69.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.87 -31.19 66.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.187 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -57.38 -45.68 84.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.699 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 1.9 mp0 -72.42 -48.1 43.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 110.394 175.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.618 ' HB3' HG21 ' A' ' 104' ' ' VAL . 22.7 mt -59.72 -40.87 89.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.482 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -59.5 -38.64 81.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -75.13 -19.91 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.124 0.488 . . . . 0.0 110.337 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 99' ' ' LEU . 50.0 mt -83.48 -6.57 59.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.72 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.14 41.45 39.3 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.662 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 99' ' ' LEU . 14.9 m -90.23 169.16 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 111.504 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -125.17 83.23 2.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.077 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.88 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 8.5 m -67.5 -17.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.9 ttm180 -60.63 -44.68 96.06 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -168.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 111' ' ' LEU . 31.2 tt0 -161.25 -18.75 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.985 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.84 -47.37 74.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 111.603 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.79 -18.18 56.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.708 HD11 HD13 ' A' ' 89' ' ' LEU . 38.0 mt . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 121.802 0.81 . . . . 0.0 108.969 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.5 mm -97.97 139.71 19.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -91.04 117.8 68.13 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.63 -22.05 38.43 Favored 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 123.039 2.492 . . . . 0.0 112.065 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.463 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 9.0 m-85 -148.04 151.94 36.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.241 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 t -170.38 126.37 0.77 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.994 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt 47.86 60.98 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.714 0.634 . . . . 0.0 110.572 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.849 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.55 164.61 59.67 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.29 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HG3' HG13 ' A' ' 106' ' ' VAL . 18.1 Cg_endo -56.63 161.48 9.84 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.754 2.97 . . . . 0.0 113.099 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -144.27 127.27 16.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.127 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 tp -84.08 106.34 15.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.595 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 30.7 m -96.47 114.7 26.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.54 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.8 m -98.97 111.78 24.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.328 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -121.38 153.49 37.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.467 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.59 147.45 30.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.139 -173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.82 117.92 20.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.382 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.41 -151.43 20.29 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.041 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.08 -17.3 36.21 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.987 2.458 . . . . 0.0 113.238 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -119.88 30.21 7.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.202 0.525 . . . . 0.0 110.626 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.89 -122.0 5.73 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.5 m-85 -110.73 -13.79 14.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.431 0.616 . . . . 0.0 111.18 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 80.32 32.89 33.51 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.438 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.52 152.05 46.63 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.419 -0.46 . . . . 0.0 109.976 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.8 m-70 -112.18 125.36 54.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.77 131.52 54.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.45 151.19 47.2 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.015 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.83 120.21 6.16 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.17 133.14 44.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.873 0.368 . . . . 0.0 111.523 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.96 138.51 55.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.511 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.31 -44.23 2.48 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.638 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.76 173.15 11.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -129.9 35.81 4.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.299 0.571 . . . . 0.0 110.456 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.94 167.51 25.62 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.844 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.631 ' HG3' HG21 ' A' ' 75' ' ' VAL . 36.4 mm-40 -103.66 146.03 29.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.705 0.288 . . . . 0.0 110.379 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.43 152.35 51.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.495 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.6 mm -70.76 113.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' O ' ' HD2' ' A' ' 40' ' ' ARG . 3.6 tmm_? -86.94 -39.91 15.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 110.086 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . 46.2 tp -153.39 143.97 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.69 116.23 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -73.32 111.13 10.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.66 119.46 6.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 112.346 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.71 30.32 Favored Glycine 0 C--N 1.316 -0.561 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.165 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 79.9 p -95.76 160.22 30.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.985 0.421 . . . . 0.0 111.281 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.27 -17.56 58.6 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.841 2.361 . . . . 0.0 112.138 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.19 -38.34 90.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.75 -38.97 92.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.046 0.45 . . . . 0.0 110.007 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -64.36 -32.51 74.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.652 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.21 -18.16 53.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.126 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.97 37.8 4.82 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.989 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 48' ' ' ALA . 98.3 mt -91.04 130.14 36.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.89 0.345 . . . . 0.0 110.162 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 tt -126.84 141.63 51.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.06 95.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 111.225 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.12 -26.65 1.13 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.485 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 70.2 m-20 -63.71 139.07 58.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.714 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -85.1 132.23 34.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.303 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 54.9 tp -76.26 117.12 17.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.554 ' HB ' HD12 ' A' ' 89' ' ' LEU . 57.9 t -103.47 -36.2 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.274 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 8.7 tt0 -152.01 151.49 31.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 111.142 -177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG12 HD22 ' A' ' 63' ' ' ASN . 51.5 t -127.66 116.85 44.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.453 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 60.6 m-80 68.61 -60.9 0.42 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.281 1.033 . . . . 0.0 111.059 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.26 26.89 0.07 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -125.79 129.01 48.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -68.34 125.25 25.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.272 0.358 . . . . 0.0 111.044 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' HG12 ' A' ' 75' ' ' VAL . 29.8 m -127.7 24.67 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.461 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' HG2' HG13 ' A' ' 60' ' ' VAL . 53.5 mt-10 -53.08 -47.52 68.46 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.951 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -111.0 9.47 22.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.223 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.27 157.73 19.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.457 0.646 . . . . 0.0 112.088 -171.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -85.56 169.06 13.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.909 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 64.3 t60 -56.74 -45.55 81.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.928 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.85 -38.61 89.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 111.057 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -67.07 -38.79 86.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.489 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG21 ' HG3' ' A' ' 37' ' ' GLN . 29.3 m -70.26 -43.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.442 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.9 t -54.69 -42.4 61.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.884 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.4 m -60.07 -40.65 90.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -68.52 -35.85 78.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.458 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 75' ' ' VAL . 83.7 mt -62.77 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.7 mmt180 -61.53 -23.22 65.8 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.86 -6.99 53.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.428 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.16 117.16 17.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.96 -60.13 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.985 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -129.61 -20.04 3.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -143.75 145.96 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.042 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 24' ' ' TYR . 14.5 p -116.82 141.81 33.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.128 0.49 . . . . 0.0 110.407 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 95.8 mtt180 -101.92 117.02 33.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.807 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.493 HD12 HD11 ' A' ' 53' ' ' LEU . 92.6 mt -112.75 118.96 36.43 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 1.6 tm? -93.48 116.55 29.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 35.4 m -134.02 154.15 37.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.158 0.504 . . . . 0.0 111.338 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.4 p -148.73 150.02 14.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.181 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.08 125.46 74.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 109.973 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.67 -38.36 94.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.921 3.081 . . . . 0.0 113.905 -169.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -68.75 -39.15 80.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.098 0.475 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 17.4 m -71.33 -36.52 71.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.303 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 8.9 t70 -56.97 -45.87 82.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 57.2 mt-10 -65.85 -39.36 90.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.386 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 95' ' ' THR . 21.0 pt20 -72.38 -39.85 67.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.535 HD13 HD11 ' A' ' 110' ' ' LEU . 53.4 mt -70.43 -34.04 72.02 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.72 0.295 . . . . 0.0 110.746 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 49.0 mt-30 -66.05 -34.46 78.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.619 0.247 . . . . 0.0 110.825 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 61.5 mttp -61.92 -19.07 62.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.078 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.01 -9.81 57.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.71 11.48 63.77 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.175 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.463 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -92.91 138.22 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 0.0 111.102 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -77.95 98.45 5.67 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.407 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.574 HG13 ' HG3' ' A' ' 12' ' ' PRO . 67.0 t -66.18 -22.38 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.08 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -59.89 -35.36 74.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -173.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 111' ' ' LEU . 65.4 tt0 -165.86 -40.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.94 0.4 . . . . 0.0 110.989 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.805 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 30.4 mm-40 -55.74 -30.83 61.87 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.62 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.535 HD11 HD13 ' A' ' 99' ' ' LEU . 2.1 tt -65.44 -40.26 93.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.137 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 108' ' ' GLU . 6.0 mp -69.41 -31.21 69.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 0.0 110.387 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -76.4 -54.63 6.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.063 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB1' ' H ' ' A' ' 118' ' ' GLY . . . -74.27 46.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.749 -175.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -85.72 -7.85 58.53 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 170.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.13 104.63 13.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.587 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 62.1 94.56 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.669 0.605 . . . . 0.0 110.429 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -51.67 101.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.589 2.86 . . . . 0.0 113.654 -174.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.496 ' H ' ' HB1' ' A' ' 113' ' ' ALA . . . 144.39 -174.26 24.7 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.07 -19.18 58.81 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.076 179.605 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.07 144.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.6 118.16 70.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.988 0.423 . . . . 0.0 110.172 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' HD13 ' A' ' 102' ' ' LEU . 18.3 Cg_endo -66.51 -29.08 45.05 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.848 2.365 . . . . 0.0 111.825 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.464 ' HZ ' HG11 ' A' ' 104' ' ' VAL . 38.0 m-85 -152.59 149.21 28.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.475 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -160.37 -43.51 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.201 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.425 ' HB3' HG21 ' A' ' 95' ' ' THR . 15.0 tpt -139.82 90.89 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.807 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.69 157.84 83.61 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.819 -177.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.048 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 57.9 Cg_endo -67.72 149.56 78.85 Favored 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 122.835 2.357 . . . . 0.0 112.067 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.492 HH21 ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.93 128.25 48.33 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.187 178.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.78 107.27 16.87 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 67.5 m -94.02 111.47 23.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HB2' HH11 ' A' ' 87' ' ' ARG . 4.3 p -98.62 110.79 23.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.069 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.4 156.37 32.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.393 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.74 138.7 49.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.399 -172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 35.2 ttpt -71.55 124.64 25.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.914 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.15 -162.2 35.41 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.31 -28.84 87.62 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.989 2.459 . . . . 0.0 112.711 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -122.41 40.89 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.902 0.382 . . . . 0.0 110.681 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 84.21 -144.2 21.56 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.363 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.8 m-85 -101.66 -25.62 13.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.92 0.391 . . . . 0.0 110.982 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.84 32.82 12.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.739 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -127.46 141.26 51.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.457 0.629 . . . . 0.0 110.339 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.47 ' C ' ' HB3' ' A' ' 40' ' ' ARG . 30.4 m-70 -100.94 144.69 29.58 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 37' ' ' GLN . 21.0 tp -124.82 137.25 54.32 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.118 0.261 . . . . 0.0 110.541 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -138.47 149.35 45.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.65 117.31 3.47 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.9 137.61 43.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -173.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.03 100.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.827 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.11 -38.27 1.62 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -84.5 -179.24 7.11 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.509 -0.845 . . . . 0.0 109.043 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.58 21.27 2.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 110.449 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.1 176.38 18.44 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' A' ' 75' ' ' VAL . 35.0 mm-40 -104.14 143.51 32.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.076 0.465 . . . . 0.0 110.89 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.91 156.72 41.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.884 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 55' ' ' ALA . 31.7 mm -70.39 120.51 18.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.979 0.418 . . . . 0.0 110.267 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB3' ' C ' ' A' ' 27' ' ' HIS . 0.5 OUTLIER -93.52 -47.96 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.266 -173.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.5 tm? -158.57 140.12 13.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' N ' HD13 ' A' ' 41' ' ' LEU . 48.2 t -117.63 115.74 49.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -60.21 130.99 89.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.2 127.46 18.4 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.008 1.806 . . . . 0.0 111.892 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.92 28.69 40.96 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.58 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.8 p -102.36 162.3 20.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 122.674 -0.31 . . . . 0.0 110.811 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 18.6 Cg_endo -62.31 -23.5 75.28 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.467 2.112 . . . . 0.0 112.23 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.45 -41.73 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.305 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -59.92 -43.58 94.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.756 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -59.6 -37.35 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.7 -11.79 59.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.056 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.11 31.89 15.87 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.146 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -81.34 104.54 11.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.0 140.97 35.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.366 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 39' ' ' ILE . . . -70.79 106.88 3.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.806 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.43 -16.5 3.83 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.553 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -73.73 146.39 44.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 0.0 110.859 176.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -91.26 127.39 36.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.8 tp -77.8 109.84 12.16 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.727 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG13 HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -99.11 -32.87 3.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.468 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -147.71 149.72 32.96 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.407 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.459 HG21 HG13 ' A' ' 75' ' ' VAL . 96.8 t -136.67 116.55 16.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.325 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 64.53 26.28 13.32 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.649 0.738 . . . . 0.0 110.683 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.36 16.03 59.52 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.366 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.547 ' HG2' ' NH1' ' A' ' 78' ' ' ARG . 8.9 tp10 -124.74 133.08 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.16 128.45 36.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.675 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 75' ' ' VAL . 35.7 m -123.63 26.83 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.56 -27.31 64.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.661 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -118.12 14.0 13.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.386 0.612 . . . . 0.0 109.583 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -96.47 146.51 24.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.19 -173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.1 p -81.28 178.04 8.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 57.3 t60 -58.02 -46.35 85.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.148 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -65.61 -42.88 91.1 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 57.9 mt-30 -61.49 -41.14 96.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.516 HG22 ' HB ' ' A' ' 67' ' ' VAL . 94.5 t -71.42 -44.61 71.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 25.4 t -54.57 -45.26 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.66 0.267 . . . . 0.0 111.611 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 p -59.93 -37.02 78.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.944 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.2 mtt-85 -68.3 -37.03 80.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.598 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 75' ' ' VAL . 68.7 mt -64.77 -35.47 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.194 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mpt_? -73.34 -20.57 60.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.28 64.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.096 0.474 . . . . 0.0 110.299 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 134.79 40.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.286 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.63 -70.74 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.579 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -112.57 -19.73 11.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.847 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.16 145.08 26.08 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.44 149.41 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.955 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.469 HH11 ' HB2' ' A' ' 16' ' ' CYS . 22.1 mmt180 -108.88 113.19 25.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.445 HD12 HD21 ' A' ' 17' ' ' LEU . 74.9 mt -109.38 118.62 37.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.683 0.278 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.1 tp -93.82 122.22 36.07 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.6 m -133.34 154.6 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.416 0.627 . . . . 0.0 111.431 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.4 p -148.09 145.14 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.327 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.01 122.06 45.03 Favored Pre-proline 0 C--O 1.225 -0.237 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.2 -39.87 88.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.666 2.911 . . . . 0.0 113.579 -172.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.97 -38.97 66.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.528 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 19.4 m -70.03 -37.87 75.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.27 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.76 -39.29 77.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.33 -49.2 78.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.445 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.668 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 14.4 pt20 -72.97 -46.69 50.92 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.653 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 95' ' ' THR . 29.6 mt -62.33 -43.77 98.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 111.537 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -67.75 -36.6 80.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.874 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -70.24 -23.04 62.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.263 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 96.3 mt -71.79 -22.28 61.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 110.655 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.38 19.94 8.11 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.464 HG11 ' HZ ' ' A' ' 8' ' ' PHE . 21.7 t -107.07 134.76 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.82 102.66 13.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.827 0.822 . . . . 0.0 110.925 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.048 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 14.8 m -65.2 -13.33 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.608 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -58.36 -31.36 67.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -167.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -171.14 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.415 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -54.4 -42.07 69.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.889 HD23 ' HG2' ' A' ' 114' ' ' GLN . 1.8 tm? -60.09 -29.18 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.434 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.49 -12.28 59.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.545 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -83.78 -81.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.311 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -174.96 109.88 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.648 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.889 ' HG2' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -97.06 76.33 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.92 0.39 . . . . 0.0 110.057 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -107.41 133.75 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.029 0.442 . . . . 0.0 110.929 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.38 130.84 10.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.878 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.73 76.89 1.47 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.27 73.9 1.08 Allowed Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.94 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -95.09 126.32 40.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.237 -179.36 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -86.04 132.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.51 125.61 53.25 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.961 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -71.05 -25.64 22.47 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.861 2.374 . . . . 0.0 111.758 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.574 ' HB3' HD12 ' A' ' 11' ' ' LEU . 29.3 m-85 -148.61 154.04 39.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.326 -176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -172.52 123.58 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.687 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.57 61.09 2.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.89 ' H ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -67.0 140.43 96.05 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.578 -169.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 19.4 Cg_endo -61.62 159.28 33.06 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.024 2.483 . . . . 0.0 111.524 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -143.07 156.64 44.86 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.133 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.1 tp -84.21 114.17 21.62 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.717 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.9 m -93.55 107.76 19.56 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.09 111.71 23.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.971 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.7 148.68 39.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 85' ' ' ALA . 32.8 mt-10 -122.92 129.31 51.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.161 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.9 ttmt -54.94 126.42 24.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.625 -170.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.7 12.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.378 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.32 -19.56 13.24 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.545 2.163 . . . . 0.0 112.701 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.23 27.15 7.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.261 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 89.72 -114.6 4.38 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.562 -175.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.7 m-85 -123.89 -22.9 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.238 0.519 . . . . 0.0 111.642 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.73 33.83 23.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.966 171.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -132.66 142.63 49.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.396 0.598 . . . . 0.0 110.086 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 41' ' ' LEU . 29.3 m-70 -111.32 131.69 54.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.5 tp -101.96 144.4 30.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.299 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.435 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 3.1 p80 -141.69 153.05 44.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.916 0.388 . . . . 0.0 111.259 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.74 125.87 4.9 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.522 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -74.21 -175.77 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.896 0.379 . . . . 0.0 110.431 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -109.5 135.62 50.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.987 0.422 . . . . 0.0 110.133 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.83 15.49 57.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.5 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 -174.38 2.51 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.741 0.305 . . . . 0.0 110.365 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.1 pt? -125.4 -33.53 2.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.621 172.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.9 177.8 21.24 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.587 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -104.99 155.13 19.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -130.73 153.21 49.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 0.0 110.577 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 mm -71.58 123.54 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.633 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HG2' ' CG ' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.6 -45.91 8.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 42' ' ' VAL . 3.0 tm? -150.67 140.88 22.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.601 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 41' ' ' LEU . 96.6 t -122.14 116.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.487 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -58.8 126.78 81.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -63.4 115.44 3.02 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.035 1.824 . . . . 0.0 111.972 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . 84.76 41.76 7.55 Favored Glycine 0 C--N 1.317 -0.517 0 CA-C-N 114.975 -1.012 . . . . 0.0 112.536 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 77.3 p -112.23 168.06 8.23 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' A' ' 24' ' ' TYR . 10.2 Cg_endo -56.07 -30.38 78.5 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.241 1.961 . . . . 0.0 112.313 172.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -61.7 -38.66 88.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 0.0 110.332 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 45' ' ' GLY . 6.9 mm-40 -62.03 -39.35 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.462 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.2 mttm -64.61 -29.39 70.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.044 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -88.24 -17.88 29.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.32 35.79 5.37 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.926 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.1 mt -92.67 138.95 31.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.6 tp -145.87 153.2 40.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.874 0.369 . . . . 0.0 110.716 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.54 104.58 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.035 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.31 -30.01 2.46 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.902 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 14.1 m-20 -63.23 136.15 57.54 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.004 0.43 . . . . 0.0 110.664 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -87.79 128.71 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.361 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 90' ' ' VAL . 58.5 tp -80.23 121.31 25.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.123 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 89' ' ' LEU . 50.0 t -105.53 -42.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.585 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.1 tt0 -144.75 151.63 39.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.836 0.35 . . . . 0.0 111.181 -177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 66.0 t -132.31 114.82 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.323 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.08 36.29 27.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.418 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.09 1.83 59.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.134 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 8.6 tp10 -125.52 136.61 53.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.855 0.828 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -68.17 125.71 27.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.064 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 62' ' ' VAL . 34.3 m -122.78 31.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.895 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -66.51 -21.0 66.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 34.8 mtmm -127.5 5.43 6.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.464 . . . . 0.0 111.046 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.8 mp0 -79.01 164.97 23.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 -175.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.2 p -99.87 170.39 8.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -54.51 -47.93 72.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.537 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.53 -45.24 93.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.294 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -64.62 -39.2 93.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.77 -40.18 76.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.019 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 19.1 t -58.39 -39.33 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.487 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.4 m -57.74 -40.66 80.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 0.0 110.596 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -68.83 -37.19 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.699 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -65.12 -36.23 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 6.3 mpt_? -73.7 -22.82 59.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.267 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.16 59.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 110.19 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 113.58 12.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -84.71 -66.01 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.38 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -97.39 -33.12 11.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.023 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 18' ' ' GLU . . . -151.77 156.56 40.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.403 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.24 141.36 46.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.453 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -105.98 112.95 26.22 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.81 122.55 45.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 16.9 tp -94.88 118.77 32.34 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.5 m -129.89 161.08 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.991 0.424 . . . . 0.0 110.707 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 96' ' ' ASP . 7.5 p -131.93 138.65 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.163 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.65 125.63 54.34 Favored Pre-proline 0 C--O 1.224 -0.285 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.567 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -44.83 45.82 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.966 2.444 . . . . 0.0 115.117 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 41.0 mt-10 -73.53 -31.18 63.53 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.258 0.551 . . . . 0.0 110.584 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.441 HG22 ' HG ' ' A' ' 99' ' ' LEU . 40.4 m -71.95 -36.28 69.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.63 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HB2' HG13 ' A' ' 91' ' ' VAL . 11.3 t70 -56.16 -43.73 78.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.378 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 40.2 mt-10 -59.3 -41.13 88.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.495 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 29.8 mm-40 -73.07 -50.01 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.548 HD23 HD12 ' A' ' 102' ' ' LEU . 23.6 mt -68.56 -31.64 71.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.185 -170.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.618 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 pt20 -57.93 -41.9 83.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 28.5 mtpp -77.47 -37.12 52.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.258 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 99' ' ' LEU . 70.5 mt -69.43 -39.92 77.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.3 -176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.31 90.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 100' ' ' GLN . 6.1 p -80.64 80.62 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.271 1.034 . . . . 0.0 112.087 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -112.61 34.79 4.15 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 170.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 13.3 m -67.23 -14.65 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.753 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.575 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 78.8 ttt180 -58.91 -45.31 90.64 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -167.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 34.5 tt0 -167.26 -24.1 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.414 . . . . 0.0 110.474 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -56.18 -47.07 79.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.32 0.581 . . . . 0.0 110.281 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 11' ' ' LEU . 57.5 tp -67.46 -19.98 65.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.349 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.538 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 10.9 mp -71.92 -36.92 70.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.49 ' HD3' ' N ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -81.32 -20.5 40.58 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.402 0.62 . . . . 0.0 109.682 176.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.53 -22.04 51.7 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.905 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 2.3 pt20 -96.55 3.3 52.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.891 0.376 . . . . 0.0 110.828 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -135.14 174.88 10.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.06 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.68 107.05 5.46 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.458 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.17 64.43 5.25 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.153 2.568 . . . . 0.0 112.351 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.37 103.94 0.2 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.226 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -158.42 97.03 1.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.01 0.433 . . . . 0.0 110.149 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.256 -179.259 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG21 HD21 ' A' ' 102' ' ' LEU . 60.3 mt -101.45 143.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.09 134.45 30.02 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.8 -28.2 75.81 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.465 2.777 . . . . 0.0 113.534 -170.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.584 ' CZ ' ' HG ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -156.15 163.16 39.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.933 0.397 . . . . 0.0 110.956 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 95' ' ' THR . 4.5 t -173.13 128.42 0.46 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.092 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.708 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 22.2 ttt 73.54 -51.51 0.7 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.672 0.789 . . . . 0.0 112.313 175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.1 OUTLIER 55.8 133.53 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.801 1.241 . . . . 0.0 113.131 -174.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 75.7 Cg_endo -75.22 167.99 25.65 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.465 2.777 . . . . 0.0 113.24 -174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.52 144.63 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.652 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.18 109.04 19.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 167.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 51.0 m -94.17 116.45 28.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.852 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 p -104.12 112.3 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.01 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -120.72 154.48 35.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.2 142.49 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.578 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 38.4 ttmt -74.07 115.83 14.0 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.735 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.63 -150.95 18.17 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.727 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.83 -29.25 42.25 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.732 2.288 . . . . 0.0 112.556 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -130.69 43.99 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.164 0.507 . . . . 0.0 111.351 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 93.59 -108.76 3.71 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.992 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.648 ' HB3' HD12 ' A' ' 17' ' ' LEU . 99.5 m-85 -135.88 -21.98 1.44 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 112.774 -172.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 27.61 20.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.378 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -123.96 142.93 50.72 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 10.2 m170 -101.27 119.71 39.16 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.8 tp -102.46 133.15 47.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.769 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.5 p80 -123.57 143.69 50.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.469 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.9 93.95 0.52 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 45.2 mt-10 -55.99 130.36 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.853 0.384 . . . . 0.0 111.45 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -66.52 119.1 11.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.68 -37.31 3.34 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 37.2 mmtm -77.57 160.38 28.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.8 0.333 . . . . 0.0 110.163 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.4 pp -113.1 19.87 16.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.724 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.67 167.01 28.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.913 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG3' HG21 ' A' ' 75' ' ' VAL . 25.6 mm-40 -105.93 151.84 24.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 m-85 -138.54 153.77 48.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.58 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.456 HG12 ' OD1' ' A' ' 57' ' ' ASP . 9.7 mm -71.07 121.87 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -98.27 -25.69 14.78 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 42' ' ' VAL . 9.9 tt -164.85 147.1 8.22 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.67 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' N ' HD23 ' A' ' 41' ' ' LEU . 1.8 p -131.96 122.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.044 0.449 . . . . 0.0 109.806 173.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 37.2 mm-40 -60.22 130.1 89.15 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.987 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 18.1 Cg_exo -65.27 119.4 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.429 2.086 . . . . 0.0 111.451 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 13.92 52.41 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.334 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 98.4 p -91.82 160.4 36.2 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.809 0.338 . . . . 0.0 110.287 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 32.1 Cg_endo -65.23 -17.41 58.41 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 111.39 173.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.638 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.74 -43.04 90.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 42' ' ' VAL . 26.4 mt-10 -65.61 -37.01 85.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.108 0.48 . . . . 0.0 109.961 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -67.76 -26.04 65.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.045 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -81.8 -18.8 42.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.145 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.29 29.59 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.939 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.1 mt -86.38 147.94 25.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.95 0.375 . . . . 0.0 110.262 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 tt -146.13 140.3 26.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.24 81.18 1.0 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.463 0.649 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 93' ' ' PRO . . . 157.06 39.03 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 8.6 p-10 -105.76 -169.97 1.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.47 0.652 . . . . 0.0 111.165 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 96' ' ' ASP . 25.1 ttm-85 -132.76 124.1 27.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 156.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.439 HD11 HD22 ' A' ' 88' ' ' LEU . 34.6 tp -71.39 102.33 2.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.092 0.472 . . . . 0.0 109.775 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.27 -41.11 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.491 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 18.0 tt0 -148.55 151.06 34.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.705 0.288 . . . . 0.0 111.188 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG23 HG21 ' A' ' 67' ' ' VAL . 69.9 t -132.16 117.23 32.0 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.311 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.412 HD21 ' HB2' ' A' ' 82' ' ' ALA . 95.0 m-20 61.46 21.73 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.532 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.29 7.38 46.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.923 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.8 tp10 -124.41 133.03 53.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 110.696 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.78 126.97 30.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.098 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.619 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 33.6 m -126.52 27.73 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.431 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.19 -28.18 66.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.33 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 13.7 ptmm? -128.64 39.32 3.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.289 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 50.9 mm-40 -103.67 168.85 8.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 0.0 112.086 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 75' ' ' VAL . 66.9 p -97.78 178.61 5.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.366 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -65.45 -46.6 79.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.488 ' HA ' HG12 ' A' ' 76' ' ' VAL . 30.4 tt0 -66.46 -32.83 74.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.439 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 16.3 mm100 -70.42 -46.1 64.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.976 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 71' ' ' THR . 14.5 m -72.51 -41.2 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.545 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.6 p -57.74 -36.36 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.072 0.463 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -64.11 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.937 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 79.6 mtt-85 -66.52 -36.05 81.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.567 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.0 mt -63.01 -38.12 81.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.262 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 22.2 mmt85 -73.36 -25.01 60.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.323 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.73 55.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HB2' HD21 ' A' ' 63' ' ' ASN . . . -71.64 122.65 20.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.145 176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.17 -83.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.515 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.01 -11.96 13.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.96 25.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.462 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.82 144.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -109.9 112.88 25.18 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.439 HD22 HD11 ' A' ' 59' ' ' LEU . 78.9 mt -115.61 122.75 46.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.634 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 18.6 tp -95.27 116.41 28.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 35.5 m -129.97 154.65 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.692 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.9 p -144.73 145.93 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.255 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -65.95 133.16 94.8 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.676 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 38.8 Cg_exo -59.87 -28.24 86.75 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.7 2.934 . . . . 0.0 113.736 -171.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.5 -48.25 67.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 109.86 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.661 HG23 HG23 ' A' ' 9' ' ' THR . 15.0 m -71.78 -37.32 70.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.269 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.651 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 2.6 t70 -57.21 -47.13 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.607 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.753 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 28.5 tt0 -72.48 -39.37 67.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.041 -176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 95' ' ' THR . 20.0 pt20 -69.47 -38.72 77.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.572 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 95' ' ' THR . 43.7 mt -68.83 -39.13 80.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 10.6 pt20 -66.32 -33.16 75.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.16 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.753 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 34.4 mmtp -57.22 -35.33 69.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.414 0.626 . . . . 0.0 109.34 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 5' ' ' ILE . 15.8 mt -80.39 -55.57 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.22 -108.09 0.48 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.1 t 68.74 125.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.532 0.682 . . . . 0.0 112.572 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.82 71.86 10.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.487 0.66 . . . . 0.0 109.924 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.504 HG13 ' HG3' ' A' ' 12' ' ' PRO . 2.4 t -56.12 -24.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.421 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.634 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 14.7 ptm180 -60.6 -26.71 67.18 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -165.62 -26.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -44.3 67.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.762 0.315 . . . . 0.0 111.406 -167.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 3.0 mm? -68.66 -31.09 69.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.521 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' H ' HD12 ' A' ' 111' ' ' LEU . 4.4 mp -85.62 -31.46 22.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.105 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 2.9 tpm_? -58.1 -60.96 2.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.771 -178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.8 -4.63 50.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -100.88 12.74 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 112' ' ' ARG . 8.0 pt-20 -87.04 57.73 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.572 0.701 . . . . 0.0 110.481 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.25 100.22 1.13 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.804 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -84.54 172.71 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.739 2.292 . . . . 0.0 112.077 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 119' ' ' GLN . . . 130.09 -17.16 5.43 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.784 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 118' ' ' GLY . 27.6 tt0 74.26 -42.14 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 111.604 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.327 177.299 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.73 136.99 46.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.88 0.371 . . . . 0.0 110.085 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -98.05 129.16 31.6 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.33 -25.08 79.78 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.975 2.45 . . . . 0.0 112.722 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -154.0 137.65 16.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.516 0.674 . . . . 0.0 111.272 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -141.33 111.71 6.9 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.859 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.4 mtm 48.93 54.98 9.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.071 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -59.04 144.56 82.29 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.878 -175.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.932 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 28.9 Cg_endo -63.85 159.93 39.52 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.447 2.765 . . . . 0.0 112.762 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -143.16 155.1 44.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.971 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 87' ' ' ARG . 45.9 tp -84.9 109.55 18.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.54 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -93.79 108.09 19.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -96.92 114.84 26.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.509 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -121.81 154.13 37.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.471 -179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.24 146.7 28.03 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.226 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -74.99 118.16 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.946 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -149.12 17.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.477 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.91 -20.06 20.03 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.98 2.454 . . . . 0.0 112.78 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -124.48 39.07 4.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.076 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.65 -122.99 7.96 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.41 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.3 m-85 -112.26 -30.18 7.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.17 0.485 . . . . 0.0 110.658 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.96 27.83 8.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.243 173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -128.9 142.26 51.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 117.238 0.519 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -107.3 144.36 34.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.406 HD21 HG21 ' A' ' 75' ' ' VAL . 27.0 tp -119.49 129.84 54.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.497 0.189 . . . . 0.0 110.967 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -127.19 150.42 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 110.56 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.71 129.09 9.37 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.4 mm-40 -70.37 128.26 35.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.009 0.433 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.01 110.24 5.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.341 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.51 -12.18 33.11 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.466 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 4.2 mptp? -96.17 178.96 5.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.5 pp -122.27 16.46 10.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.608 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.67 168.58 25.19 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.909 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -104.54 146.35 29.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 110.204 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -133.11 157.12 46.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.244 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.417 HD11 HD11 ' A' ' 53' ' ' LEU . 16.2 mm -70.75 122.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.034 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 40' ' ' ARG . 0.7 OUTLIER -85.15 -47.65 9.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.171 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -164.05 140.88 6.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.509 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.459 HG11 ' HG2' ' A' ' 49' ' ' GLU . 18.3 t -110.7 124.42 67.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.737 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.07 124.15 87.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.46 126.64 18.08 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.845 1.697 . . . . 0.0 112.074 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.81 17.69 37.37 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.254 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 81.1 p -97.89 158.94 32.04 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.855 0.36 . . . . 0.0 110.871 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.9 -20.03 67.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.651 2.234 . . . . 0.0 111.994 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.26 -45.7 92.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.669 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HG2' HG11 ' A' ' 42' ' ' VAL . 30.8 mt-10 -63.09 -37.24 86.42 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.148 0.499 . . . . 0.0 110.011 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -70.23 -23.51 62.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.923 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -84.06 -17.84 38.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.21 22.65 10.38 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.26 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 39' ' ' ILE . 15.5 tp -93.46 113.06 25.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' LEU . 2.7 mm? -117.83 166.55 12.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.344 0.592 . . . . 0.0 111.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.56 122.16 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.133 -177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.59 -20.44 12.13 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.022 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 6.0 m-20 -59.47 141.86 53.75 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.288 0.566 . . . . 0.0 111.597 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 93' ' ' PRO . 30.1 ttt180 -85.73 121.78 28.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.822 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HA ' HG12 ' A' ' 90' ' ' VAL . 27.1 tp -78.95 109.43 13.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.118 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.29 -37.86 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.409 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 25.6 tt0 -144.95 151.76 39.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.642 0.258 . . . . 0.0 110.673 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.68 HG23 HG21 ' A' ' 67' ' ' VAL . 74.0 t -134.5 119.75 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.694 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.59 -43.65 0.56 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.86 3.86 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.622 -0.799 . . . . 0.0 114.125 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -126.69 146.97 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.193 0.996 . . . . 0.0 111.251 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -63.48 123.16 18.06 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.843 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.68 HG21 HG23 ' A' ' 62' ' ' VAL . 32.6 m -118.39 17.98 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.214 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.19 -22.54 63.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.834 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 6.6 ptpp? -131.42 28.88 4.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.588 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 7.5 mm-40 -103.5 -174.55 2.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.327 -176.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 28.4 p -112.71 169.79 8.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.072 -177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.3 t60 -58.58 -48.68 80.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.511 0.196 . . . . 0.0 110.914 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.97 -38.66 86.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.794 0.807 . . . . 0.0 110.334 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.481 ' HG3' ' NH1' ' A' ' 78' ' ' ARG . 5.3 tp-100 -61.18 -44.64 96.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.133 -176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' THR . 15.6 m -72.77 -42.69 61.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.498 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 43.5 t -54.88 -40.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.402 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 m -58.24 -38.06 76.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 0.0 110.655 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' NH1' ' HG3' ' A' ' 74' ' ' GLN . 61.2 mtt85 -68.62 -35.89 77.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.852 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 76' ' ' VAL . 69.0 mt -62.61 -33.65 60.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.492 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 4.3 mpt_? -66.92 -21.79 65.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.1 -2.11 57.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.23 128.53 36.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.242 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.4 mt -66.55 -73.39 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.546 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -131.83 -4.88 3.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.19 158.5 44.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.856 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.7 p -127.83 146.4 33.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.541 ' HB3' HD11 ' A' ' 14' ' ' LEU . 14.8 mtm180 -97.7 122.84 41.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 17' ' ' LEU . 89.4 mt -121.46 113.63 20.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.962 177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.75 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 26.9 tp -94.1 116.08 28.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.2 m -133.01 157.41 42.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.221 0.534 . . . . 0.0 111.765 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 11.7 p -147.98 148.43 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.866 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.82 118.26 33.36 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' ARG . 34.6 Cg_endo -63.53 -31.88 70.77 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.239 2.626 . . . . 0.0 113.169 -172.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.26 -37.04 69.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.025 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.5 m -71.79 -40.3 69.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.369 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.99 -30.84 66.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.194 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.31 -50.77 70.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.85 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.641 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 11.4 pt20 -74.87 -39.48 61.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.021 0.439 . . . . 0.0 110.839 174.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 102' ' ' LEU . 27.6 tp -66.13 -43.07 88.15 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.981 -164.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -68.19 -36.23 79.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.309 0.576 . . . . 0.0 110.245 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.27 -18.29 62.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.277 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 92.9 mt -70.15 -15.06 62.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.36 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 62.15 0.93 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.537 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.4 t -138.28 131.66 41.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.548 0.213 . . . . 0.0 110.773 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 10.7 mt-30 -83.15 85.89 7.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.572 0.701 . . . . 0.0 109.754 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.651 HG13 ' HG3' ' A' ' 12' ' ' PRO . 3.8 t -59.99 -27.82 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.734 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -60.71 -25.52 66.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -175.18 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.122 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 33.7 tt0 -55.79 -41.02 73.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.108 0.48 . . . . 0.0 110.961 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 11' ' ' LEU . 49.0 tp -64.39 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.396 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.701 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 9.8 mp -73.99 -26.24 60.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -63.06 -25.99 68.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.743 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.89 -10.31 55.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.701 ' HG2' ' HA ' ' A' ' 111' ' ' LEU . 12.2 pt20 -118.99 24.89 10.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.874 0.369 . . . . 0.0 111.074 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -134.6 138.52 44.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.13 0.49 . . . . 0.0 111.307 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.78 82.64 55.3 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.76 176.07 8.77 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.584 2.189 . . . . 0.0 113.653 -171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 179.5 -98.23 0.11 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -159.03 104.83 1.73 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.228 -178.62 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 mp -99.61 132.47 45.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.047 0.451 . . . . 0.0 109.924 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' HB ' ' A' ' 9' ' ' THR . 21.5 t70 -81.2 129.43 66.85 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.91 -34.69 95.18 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.254 2.636 . . . . 0.0 113.012 -171.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -157.03 120.09 4.07 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.407 0.622 . . . . 0.0 110.557 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' ' OD2' ' A' ' 6' ' ' ASP . 10.2 t -159.4 126.53 4.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.79 -168.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.7 mtm 54.21 30.92 13.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.91 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.878 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -58.31 139.77 84.17 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.024 -176.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' CG ' ' HB ' ' A' ' 106' ' ' VAL . 40.5 Cg_endo -65.66 158.39 53.61 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.598 2.865 . . . . 0.0 113.588 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -143.69 169.96 16.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 111' ' ' LEU . 17.5 mt -84.34 122.5 29.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.756 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.1 m -94.37 108.28 20.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.357 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -95.62 111.82 23.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.115 0.483 . . . . 0.0 110.585 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -115.49 147.8 40.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.516 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -112.59 135.32 53.45 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.376 -170.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 33.2 ttpt -71.05 120.53 16.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.284 -173.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.35 -170.13 44.64 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.52 -29.91 91.15 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.651 2.234 . . . . 0.0 112.747 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -99.36 -0.56 40.8 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.166 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.37 -141.82 16.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.134 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 46' ' ' SER . 84.4 m-85 -105.72 -36.34 7.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.981 0.39 . . . . 0.0 111.33 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.15 40.59 4.81 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.928 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -135.56 152.96 51.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.504 0.652 . . . . 0.0 110.405 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -124.36 144.51 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.467 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.4 mt -120.96 154.59 35.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 0.0 111.17 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' HB3' ' HG3' ' A' ' 40' ' ' ARG . 2.1 p80 -144.13 151.65 39.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.296 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.44 141.42 15.27 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.499 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.0 mt-10 -107.69 152.14 24.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.799 0.333 . . . . 0.0 111.169 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.81 141.78 38.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.25 -43.6 2.81 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 27.0 mmtp -78.07 175.32 10.23 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 173.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 pt? -144.0 29.05 1.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.943 0.401 . . . . 0.0 110.836 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.38 -163.79 9.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.106 -0.568 . . . . 0.0 111.96 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HG3' HG21 ' A' ' 75' ' ' VAL . 31.1 mm-40 -112.27 148.03 35.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -134.39 160.83 36.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.426 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.491 HG12 ' CG ' ' A' ' 57' ' ' ASP . 31.8 mm -68.59 119.59 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.203 0.525 . . . . 0.0 110.86 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -91.25 -36.95 13.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.499 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.1 tp -161.94 143.31 10.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.8 117.3 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.823 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.4 mm-40 -68.8 129.54 92.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.835 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.5 Cg_exo -70.02 121.38 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.044 1.829 . . . . 0.0 111.355 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.94 17.24 21.39 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.549 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 91.4 p -105.41 154.97 38.66 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.77 -15.24 49.22 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.747 2.298 . . . . 0.0 111.813 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 53' ' ' LEU . . . -66.38 -35.88 81.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.602 178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.23 -38.65 91.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.0 110.091 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.42 -20.12 62.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.165 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.55 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.92 -18.0 33.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.21 28.11 7.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.172 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 48' ' ' ALA . 11.2 mp -79.2 136.36 37.06 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.582 -0.363 . . . . 0.0 110.489 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 tt -146.46 142.2 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.2 109.09 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.122 0.487 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.71 6.85 2.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.88 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' HG12 ' A' ' 39' ' ' ILE . 6.8 p-10 -72.16 -173.11 1.0 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.923 0.868 . . . . 0.0 111.787 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -135.96 115.37 12.66 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.661 165.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.2 tp -78.31 106.65 10.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.053 0.454 . . . . 0.0 109.809 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -97.5 -38.06 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.873 -175.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 25.2 tt0 -149.77 151.8 34.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.709 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.492 HG23 HG21 ' A' ' 67' ' ' VAL . 90.4 t -134.62 117.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.217 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 56.46 29.82 15.99 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.22 5.73 57.03 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.563 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 9.2 tp10 -124.41 130.32 52.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.432 0.616 . . . . 0.0 110.656 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -66.97 127.08 31.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.011 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 35.3 m -123.79 24.21 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 52.1 mt-10 -68.26 -25.35 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.633 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 1.3 ptpt -126.44 29.93 5.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.193 -177.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 44.4 mm-40 -93.17 -171.36 2.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 74' ' ' GLN . 33.6 p -113.16 -179.79 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.683 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 75.1 t60 -64.38 -47.0 80.9 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -67.55 -37.83 83.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.764 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' HG2' ' OG1' ' A' ' 71' ' ' THR . 14.5 mm100 -60.51 -43.23 97.32 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.735 0.303 . . . . 0.0 110.908 -176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG21 ' HG3' ' A' ' 37' ' ' GLN . 13.4 m -71.58 -40.21 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.835 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 72' ' ' HIS . 72.5 t -54.09 -37.91 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.451 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -57.14 -44.51 83.47 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.284 0.564 . . . . 0.0 110.122 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -69.23 -36.19 76.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.121 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 75' ' ' VAL . 72.6 mt -64.21 -40.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.486 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 41.6 mmt180 -69.78 -22.55 63.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.98 55.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.896 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.8 116.83 15.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.92 -66.5 0.78 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.55 -172.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.75 -17.84 10.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.002 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.65 150.07 29.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.0 111.19 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -123.79 141.09 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.594 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -105.84 111.16 23.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 109.969 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.56 129.87 53.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.028 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 14.7 tp -102.01 118.81 37.69 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.7 m -132.4 154.92 40.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.114 0.483 . . . . 0.0 110.686 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 7.6 p -140.64 145.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.73 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.3 138.18 68.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.1 -25.63 64.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.701 2.934 . . . . 0.0 113.995 -172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -72.96 -50.39 23.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 0.0 110.532 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -42.6 83.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.658 0.742 . . . . 0.0 110.158 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -58.14 -45.71 86.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.66 -43.25 89.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.567 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.2 pt20 -72.21 -44.35 63.08 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.038 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 12.7 mt -67.16 -40.17 86.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.415 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 1.3 pt20 -64.67 -36.08 83.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.757 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 99.1 mttt -70.58 -19.7 62.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.872 0.367 . . . . 0.0 110.883 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 74.5 mt -81.76 -8.24 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.266 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.97 24.19 30.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.08 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.439 HG13 HD21 ' A' ' 110' ' ' LEU . 98.6 t -89.55 128.42 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.815 0.34 . . . . 0.0 111.141 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 109' ' ' GLU . 37.0 mt-30 -96.51 83.85 3.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.032 0.444 . . . . 0.0 109.884 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CG ' ' A' ' 12' ' ' PRO . 19.7 m -59.23 -14.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.97 -25.75 63.83 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.19 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.809 0.337 . . . . 0.0 110.938 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 105' ' ' GLN . 44.9 tt0 -54.98 -38.03 67.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 57.3 mt -79.21 -40.26 31.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.455 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.489 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 7.3 mp -66.54 -26.76 67.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -68.23 -49.49 60.36 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.136 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.73 -31.94 68.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.561 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 63.4 mt-30 -77.99 62.46 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.133 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.34 159.84 38.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.965 0.412 . . . . 0.0 111.242 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.54 121.88 3.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.041 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 99.13 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.119 2.546 . . . . 0.0 112.481 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.86 -128.55 47.78 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.587 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 71.11 -11.38 0.68 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.384 0.674 . . . . 0.0 112.183 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.759 -0.639 . . . . 0.0 109.993 178.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.9 mt -122.32 143.56 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.1 126.72 90.18 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 -28.92 69.91 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.075 2.517 . . . . 0.0 113.285 -172.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.498 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 7.2 m-85 -156.61 118.36 3.87 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.216 1.008 . . . . 0.0 112.172 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 95' ' ' THR . 4.6 t -153.49 125.66 7.96 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.181 -1.827 . . . . 0.0 108.434 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.6 mtt 53.77 48.79 20.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.039 0.447 . . . . 0.0 110.434 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -74.04 152.92 88.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.641 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.943 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.0 Cg_endo -68.79 151.45 74.31 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.943 2.429 . . . . 0.0 112.694 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.545 ' HA ' HD11 ' A' ' 111' ' ' LEU . 69.6 mtp180 -126.05 153.72 44.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.618 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.635 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 40.9 tp -89.64 106.07 18.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.682 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 68.8 m -93.22 108.03 19.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 p -95.31 120.78 36.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.96 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -125.51 151.52 46.22 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.37 135.14 42.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.479 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 29.5 ttmt -68.47 119.33 12.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.06 -144.03 14.21 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.069 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.36 -14.2 25.35 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.072 2.514 . . . . 0.0 113.398 -175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -137.85 35.94 2.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.945 0.402 . . . . 0.0 111.015 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 84.1 -104.72 2.71 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.544 -175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.655 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.2 m-85 -132.53 -22.13 2.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.411 0.605 . . . . 0.0 112.255 -175.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.47 28.38 24.82 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.497 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -123.94 155.72 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 91.1 m-70 -122.06 134.19 54.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.404 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.3 tp -108.45 135.66 49.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.8 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -128.85 152.1 48.88 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.77 119.92 3.15 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.811 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -67.46 118.85 11.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.657 0.265 . . . . 0.0 110.448 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -63.36 125.36 23.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.045 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.3 -36.33 3.66 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -106.3 165.95 10.88 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -112.22 10.06 20.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.681 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.9 143.1 16.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.564 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -105.04 143.88 32.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.409 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 53.0 m-85 -129.02 151.5 49.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.92 0.391 . . . . 0.0 110.794 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 mm -71.11 121.89 21.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.879 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 -26.25 14.13 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.68 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 8.1 tp -162.45 151.56 15.35 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.073 0.463 . . . . 0.0 111.311 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.532 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.6 t -128.8 119.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.614 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.07 125.75 90.65 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.64 111.63 2.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.038 1.825 . . . . 0.0 111.386 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.59 10.97 20.59 Favored Glycine 0 C--N 1.311 -0.852 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.948 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 89.3 p -99.1 159.75 29.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.728 0.299 . . . . 0.0 110.231 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 36.1 Cg_endo -65.91 -14.41 44.43 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.99 2.46 . . . . 0.0 112.409 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.656 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.05 -40.43 94.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.779 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -62.64 -33.09 74.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.309 0.576 . . . . 0.0 110.242 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -71.69 -13.27 61.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.067 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -100.24 -17.66 17.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.26 28.24 7.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.863 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.5 mp -84.83 134.15 34.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.715 0.258 . . . . 0.0 110.324 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -137.84 152.22 48.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 110.577 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.7 107.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.533 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.88 -21.27 3.75 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.944 -176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 42.8 m-20 -66.68 142.58 57.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 111.443 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.581 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 71.1 ttt180 -91.43 121.66 33.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HA ' HG12 ' A' ' 90' ' ' VAL . 53.6 tp -79.03 104.76 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 0.0 110.22 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.438 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 41.5 t -91.39 -40.93 12.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.135 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 10.7 tt0 -144.74 150.98 38.18 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.168 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.527 HG21 HG13 ' A' ' 75' ' ' VAL . 90.0 t -130.24 117.57 40.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 9.9 t-20 70.92 -61.2 0.49 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.151 0.98 . . . . 0.0 110.631 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.0 20.65 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.027 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -125.85 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.715 0.257 . . . . 0.0 110.506 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -71.9 99.65 2.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.452 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.552 ' HB ' HG22 ' A' ' 75' ' ' VAL . 27.0 m -82.75 0.93 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.233 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 60' ' ' VAL . 24.2 mm-40 -70.79 -3.99 21.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 171.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -113.53 6.89 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.025 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 13.5 mm-40 -110.75 -165.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.298 -172.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 75' ' ' VAL . 65.3 p -132.29 176.34 8.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.119 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 76' ' ' VAL . 13.4 t60 -54.16 -48.05 71.31 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 176.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -65.34 -43.01 92.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.185 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 54.9 mt-30 -66.88 -44.07 81.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 67' ' ' VAL . 91.4 t -62.29 -42.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.963 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' HIS . 52.3 t -57.95 -45.03 87.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 110.27 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.7 m -58.4 -39.33 79.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 84.0 mtt-85 -65.92 -34.53 78.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.24 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 75' ' ' VAL . 67.6 mt -62.5 -33.92 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 110.642 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -71.9 -22.98 61.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.686 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.32 60.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.77 115.03 10.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.851 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.95 -74.49 0.24 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.304 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -101.32 -28.84 12.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.417 0.627 . . . . 0.0 109.902 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.77 159.01 44.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.761 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.48 142.27 41.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.857 0.36 . . . . 0.0 110.37 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.546 ' HD3' HD21 ' A' ' 14' ' ' LEU . 96.2 mtt180 -98.74 112.87 24.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.888 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 HD21 ' A' ' 53' ' ' LEU . 91.9 mt -114.06 113.67 25.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 28.2 tp -94.11 116.78 29.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 30.4 m -130.84 153.67 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.053 0.454 . . . . 0.0 111.459 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.774 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.1 p -142.54 142.15 27.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.8 114.63 10.85 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 32.4 Cg_exo -57.75 -29.39 85.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.095 2.53 . . . . 0.0 112.767 -174.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.7 -47.58 68.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.955 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 7.5 m -72.46 -35.23 68.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.898 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -56.33 -39.79 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.741 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 10.2 tp10 -58.73 -48.35 81.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.545 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.9 pt20 -72.92 -40.13 65.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.361 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.4 mt -67.79 -43.18 80.33 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 104' ' ' VAL . 29.6 pt20 -60.44 -34.38 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.735 0.302 . . . . 0.0 111.318 -175.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLU . 55.7 mttm -67.56 -18.94 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.964 0.412 . . . . 0.0 111.077 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 mt -84.34 -3.73 58.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.558 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.19 42.86 8.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.815 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 100' ' ' GLN . 19.7 m -90.72 171.75 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 111.666 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 109' ' ' GLU . 57.6 mt-30 -133.97 83.4 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.658 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.943 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.7 m -66.34 -16.47 20.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 41.1 ttm180 -59.29 -43.96 92.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.643 ' HA ' HD23 ' A' ' 111' ' ' LEU . 35.3 tt0 -169.77 -11.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.975 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -55.48 -39.91 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.058 0.456 . . . . 0.0 110.141 -177.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 46.8 mt -73.61 -39.48 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.485 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.0 mm? -70.09 -34.24 72.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.087 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -76.91 -17.78 58.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.04 0.448 . . . . 0.0 110.686 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.5 -10.54 31.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.871 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 78.6 mt-30 -87.5 85.98 7.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.036 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -76.64 163.3 26.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.674 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.8 99.3 15.42 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.35 -166.32 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.337 2.691 . . . . 0.0 111.829 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.5 67.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.977 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.977 0.418 . . . . 0.0 111.311 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.934 178.481 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.8 mt -75.26 140.12 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -84.99 130.71 51.3 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.023 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.68 -24.23 48.02 Favored 'Trans proline' 0 CA--C 1.518 -0.294 0 C-N-CA 122.896 2.397 . . . . 0.0 111.656 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.525 ' CE1' HD22 ' A' ' 110' ' ' LEU . 2.6 m-85 -148.77 146.79 28.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.791 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -171.03 134.72 0.96 Allowed 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 95' ' ' THR . 13.7 tpt 53.36 63.98 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.843 0.83 . . . . 0.0 109.538 -174.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.574 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -65.56 140.47 97.55 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.624 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 77.0 Cg_endo -72.76 169.23 22.5 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.298 2.665 . . . . 0.0 112.147 -176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -130.02 136.1 49.01 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.838 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 87' ' ' ARG . 57.2 tp -83.9 104.83 14.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.4 m -94.87 115.78 27.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.697 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.0 110.37 22.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.826 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -110.21 152.69 25.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.434 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -103.69 143.03 33.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.553 -170.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -72.83 104.95 4.17 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.8 -151.01 21.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.543 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 -22.57 23.61 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.876 2.384 . . . . 0.0 112.478 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -124.38 39.02 4.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.473 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.2 -125.61 8.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.44 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' HB3' HD12 ' A' ' 17' ' ' LEU . 88.3 m-85 -111.29 -28.04 8.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.145 0.472 . . . . 0.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.51 36.58 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.28 170.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -123.9 146.41 48.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.472 0.636 . . . . 0.0 110.458 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . 11.5 m-70 -106.8 125.16 50.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.247 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.31 127.29 54.95 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.494 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 4.4 p80 -113.18 132.12 55.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.341 0.591 . . . . 0.0 109.983 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.63 112.23 2.95 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 11.8 mm-40 -57.1 132.02 51.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.189 0.518 . . . . 0.0 111.126 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.41 119.7 14.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.564 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.65 -36.41 3.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.652 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 31' ' ' GLU . 58.4 mmtt -76.01 160.8 29.47 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -100.77 16.14 26.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.017 0.436 . . . . 0.0 111.615 -177.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.41 132.06 10.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.53 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.06 137.88 40.65 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.0 m-85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.618 0.247 . . . . 0.0 110.424 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 mm -70.79 119.61 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -100.56 -25.79 14.06 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 -175.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.2 tm? -164.62 145.91 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.529 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -132.6 132.98 59.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 34.9 mm-40 -78.73 98.39 0.32 Allowed Pre-proline 0 N--CA 1.465 0.325 0 O-C-N 123.355 0.409 . . . . 0.0 110.734 -174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' VAL . 14.5 Cg_exo -34.67 94.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.469 3.446 . . . . 0.0 114.301 -168.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.04 25.16 1.91 Allowed Glycine 0 C--N 1.314 -0.653 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.742 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -96.03 163.01 21.99 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 117.228 0.514 . . . . 0.0 110.193 178.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 29.7 Cg_endo -64.22 -17.38 59.51 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.324 2.016 . . . . 0.0 111.686 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.51 -48.73 76.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.197 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 46' ' ' SER . 1.9 mp0 -66.12 -38.74 88.93 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 29.5 mtpp -62.41 -32.16 72.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.35 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.19 -19.19 51.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.03 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.27 39.94 1.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.823 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.56 134.3 47.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 tt -137.4 138.08 39.49 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.19 99.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.418 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.06 -24.88 1.91 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.119 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 68.0 m-20 -70.73 141.68 51.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.653 0.263 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -88.47 134.56 33.82 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.225 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.519 ' HA ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -75.49 124.83 27.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.785 177.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.4 -43.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -145.14 150.32 36.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.864 0.364 . . . . 0.0 110.802 -178.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG21 HG13 ' A' ' 75' ' ' VAL . 63.6 t -133.65 111.67 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.051 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 60.71 38.64 18.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.868 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.0 9.73 80.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.952 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG2' ' NE ' ' A' ' 78' ' ' ARG . 7.2 tp10 -120.81 127.05 51.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -69.7 129.14 38.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.75 -0.204 . . . . 0.0 110.751 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.559 HG12 ' NH1' ' A' ' 78' ' ' ARG . 20.4 m -120.94 31.21 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.262 0.553 . . . . 0.0 111.418 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 35' ' ' LEU . 58.0 mt-10 -71.33 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.398 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.918 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.3 mtmp? -130.02 16.76 5.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.451 0.644 . . . . 0.0 110.106 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.403 ' CG ' HH12 ' A' ' 78' ' ' ARG . 1.0 OUTLIER -95.78 -174.45 3.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.302 -169.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.491 ' H ' ' HB3' ' A' ' 74' ' ' GLN . 32.5 p -119.68 166.98 12.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.863 -176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 76' ' ' VAL . 49.5 t60 -58.11 -48.4 80.31 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.899 0.124 . . . . 0.0 110.684 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.08 -41.35 99.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.801 0.81 . . . . 0.0 110.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 71' ' ' THR . 6.6 tp60 -60.87 -39.25 88.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.811 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.72 HG13 HG21 ' A' ' 62' ' ' VAL . 74.4 t -71.69 -41.34 71.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.406 175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 72' ' ' HIS . 69.6 t -55.69 -41.15 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.673 0.273 . . . . 0.0 111.729 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -57.86 -40.0 79.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.208 0.527 . . . . 0.0 110.442 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.559 ' NH1' HG12 ' A' ' 67' ' ' VAL . 59.6 mtt180 -69.98 -36.05 74.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.123 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.57 -36.33 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.057 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -72.94 -22.59 60.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.842 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.25 -15.52 59.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.981 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.72 128.55 36.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.747 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.48 -67.66 0.78 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.36 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -111.18 -26.93 8.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.349 0.595 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.2 155.42 38.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.37 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.09 144.56 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HD3' HD21 ' A' ' 14' ' ' LEU . 84.9 mtt180 -98.82 118.49 35.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.94 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.546 HD12 HD21 ' A' ' 17' ' ' LEU . 88.9 mt -121.86 115.51 22.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.245 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 18.4 tp -95.09 123.34 38.53 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.8 m -133.3 155.74 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.291 0.567 . . . . 0.0 112.349 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.7 p -146.7 146.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.1 p30 -73.23 134.29 80.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.93 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 58.3 Cg_exo -53.4 -34.1 69.69 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.064 3.176 . . . . 0.0 114.301 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.58 -46.7 78.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.835 0.35 . . . . 0.0 110.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 10' ' ' MET . 24.9 m -69.78 -37.18 76.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 3.9 t70 -57.51 -45.1 85.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.429 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 39.8 mt-10 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.927 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 9.5 pt20 -74.8 -42.53 57.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.079 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 102' ' ' LEU . 25.7 mt -62.43 -34.15 76.21 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 9.6 pt20 -64.7 -35.6 81.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.383 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -74.56 -24.98 59.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.072 0.463 . . . . 0.0 110.32 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 99' ' ' LEU . 37.1 mt -84.8 -46.47 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.422 0.629 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.99 96.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.01 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -76.67 86.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 122.309 1.052 . . . . 0.0 111.85 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 77.9 mt-30 -104.7 17.49 24.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.43 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m -66.66 -16.33 20.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.441 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.45 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 96.3 mtt180 -60.73 -43.77 97.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.9 -172.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.497 ' HA ' HD13 ' A' ' 111' ' ' LEU . 30.0 tt0 -172.66 -21.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 110.348 171.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 2.5 mp0 -55.15 -46.33 75.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.322 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.525 HD22 ' CE1' ' A' ' 8' ' ' PHE . 52.0 tp -65.39 -35.54 81.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 108' ' ' GLU . 7.0 mp -68.6 -18.0 64.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.307 -176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -73.24 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.533 0.682 . . . . 0.0 109.813 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.01 102.81 11.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.669 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.944 ' HA ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -88.23 8.32 27.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.62 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.93 -81.63 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.681 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.4 108.85 2.41 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.715 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.7 156.56 63.18 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.575 2.183 . . . . 0.0 112.474 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 112.73 173.93 19.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.019 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.3 37.86 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.071 0.462 . . . . 0.0 110.833 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.985 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.4 mt -123.16 143.19 37.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 7' ' ' PRO . 35.2 t0 -87.22 118.9 70.58 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 6' ' ' ASP . 24.6 Cg_endo -63.69 -27.97 68.83 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 123.014 2.476 . . . . 0.0 112.283 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.449 ' CD1' HD22 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -159.81 138.73 10.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.406 176.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -136.95 113.64 10.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.491 -167.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 77.3 mtp 54.32 57.04 6.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.566 0.698 . . . . 0.0 109.663 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.767 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -64.26 161.59 39.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.392 -173.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HG3' HG13 ' A' ' 106' ' ' VAL . 22.1 Cg_endo -59.52 164.24 11.52 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.546 2.831 . . . . 0.0 112.419 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' HD11 ' A' ' 111' ' ' LEU . 28.2 mmm180 -136.96 139.72 41.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.945 -172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' HA ' HD22 ' A' ' 89' ' ' LEU . 48.6 tp -84.63 105.02 15.12 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 29.9 m -95.17 108.35 20.47 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.09 -173.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m -92.9 110.9 22.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -114.67 148.98 37.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.765 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -119.54 128.08 53.6 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.008 -168.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 24' ' ' TYR . 30.9 ttpt -65.4 114.75 5.03 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.291 -172.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.04 -166.24 37.01 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.27 -12.54 33.32 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.578 2.185 . . . . 0.0 112.39 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -103.78 1.6 31.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.97 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.36 -133.75 11.89 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.132 -172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.6 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.9 m-85 -106.71 -28.83 9.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.263 0.532 . . . . 0.0 111.133 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.85 39.59 9.37 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 115.826 -0.624 . . . . 0.0 114.267 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -138.4 157.83 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.586 0.693 . . . . 0.0 109.999 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.548 ' CD2' HD23 ' A' ' 41' ' ' LEU . 52.9 m-70 -125.55 139.07 53.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -110.35 141.86 42.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.721 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 1.4 p80 -136.2 151.85 50.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.47 112.12 1.01 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.978 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 46.0 mt-10 -65.8 176.81 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 0.0 110.881 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -103.29 137.82 40.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.85 15.22 63.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.177 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -100.37 -171.33 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD12 ' HD3' ' A' ' 69' ' ' LYS . 1.8 pt? -124.38 -34.29 2.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.172 172.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.0 -177.94 15.32 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.247 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -104.66 150.24 24.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.589 0.356 . . . . 0.0 110.106 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 15.8 m-85 -126.69 151.43 48.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.66 0.266 . . . . 0.0 110.422 -175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.93 122.59 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.054 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.608 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 5.6 tmm_? -92.43 -42.14 9.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.989 0.423 . . . . 0.0 110.051 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 27' ' ' HIS . 23.7 tp -149.22 150.22 32.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.451 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -125.7 118.84 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.22 121.53 76.98 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.985 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.64 121.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.222 1.948 . . . . 0.0 111.808 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.04 43.81 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.368 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 99.3 p -83.28 164.81 44.0 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.561 -0.376 . . . . 0.0 111.054 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.2 Cg_endo -67.81 -18.38 47.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.48 2.12 . . . . 0.0 112.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.65 -43.15 99.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.625 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.05 -38.7 89.73 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.338 0.59 . . . . 0.0 110.035 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 60.1 mttp -68.88 -25.05 64.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.86 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -84.61 -18.55 35.15 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.87 10.46 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.506 HD21 HD12 ' A' ' 88' ' ' LEU . 10.2 mp -81.48 131.7 35.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.999 0.4 . . . . 0.0 110.45 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.6 tp -133.64 152.65 51.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.05 92.87 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.32 -26.73 0.78 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.649 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 9.7 m-20 -64.26 140.78 58.9 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 111.12 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -90.47 132.33 35.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 90' ' ' VAL . 33.5 tp -80.73 112.7 18.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.833 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.04 -38.6 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.296 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.577 ' OE1' ' HD2' ' A' ' 107' ' ' ARG . 3.0 tt0 -148.88 150.59 33.24 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.275 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 67' ' ' VAL . 86.5 t -132.21 111.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.176 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 53.44 37.06 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.798 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.06 9.6 58.11 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.674 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.6 tp10 -120.23 130.83 54.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.439 0.619 . . . . 0.0 111.039 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -72.53 101.44 2.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 62' ' ' VAL . 32.7 m -102.74 5.96 10.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.253 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -8.92 41.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD3' HD12 ' A' ' 35' ' ' LEU . 30.4 mmtp -125.0 17.02 8.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.799 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 39.9 mt-10 -107.12 -172.2 2.03 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.324 0.583 . . . . 0.0 112.483 -174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 p -107.63 170.47 7.96 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.049 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 76' ' ' VAL . 10.0 t60 -57.36 -47.55 81.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.023 177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -63.8 -47.59 80.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.278 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 28.1 mt-30 -61.71 -43.6 98.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.567 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' ILE . 70.3 t -66.73 -44.02 89.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.572 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 72' ' ' HIS . 50.1 t -57.8 -37.49 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.777 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 t -62.79 -39.34 93.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mtt-85 -68.91 -36.39 77.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' VAL . 78.3 mt -63.26 -42.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.76 -23.29 63.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -12.71 61.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.212 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.57 123.26 30.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.952 0.406 . . . . 0.0 109.942 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.47 -64.54 1.14 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.319 -174.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -104.0 -28.81 11.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.57 32.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.777 0.322 . . . . 0.0 111.488 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.98 146.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.627 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -112.29 114.25 26.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.506 HD12 HD21 ' A' ' 53' ' ' LEU . 84.1 mt -114.63 126.02 54.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -175.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -95.15 119.57 33.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 28.9 m -132.8 160.03 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.886 0.374 . . . . 0.0 111.41 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.9 p -147.77 143.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.372 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.3 t70 -67.26 126.78 93.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.298 175.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 31.6 Cg_exo -59.46 -32.82 97.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.625 2.883 . . . . 0.0 113.971 -174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -72.1 -41.31 67.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.663 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 30.5 m -69.52 -39.59 77.45 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.272 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.48 -33.41 69.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.93 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 10.7 tp10 -57.49 -40.56 78.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.76 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 96.8 mt-30 -72.78 -49.15 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 173.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 95' ' ' THR . 30.1 mt -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.401 -166.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -64.15 -35.73 81.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 47.9 mmtm -71.46 -36.04 71.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 66.7 mt -63.32 -59.53 4.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.193 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 146.11 -154.45 25.96 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' A' ' 110' ' ' LEU . 91.7 t 67.0 146.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.861 0.864 . . . . 0.0 112.491 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 14.6 mm100 -81.3 91.69 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 0.0 109.857 175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -55.35 -25.07 16.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.643 -1.162 . . . . 0.0 114.013 -171.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 17.8 ptt180 -66.4 -17.67 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -170.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 111' ' ' LEU . 33.2 tt0 179.99 -13.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.2 tt0 -55.56 -37.42 67.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.058 0.456 . . . . 0.0 110.976 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.631 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 52.4 mt -73.09 -39.68 65.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.071 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.5 mm? -67.02 -35.85 80.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.928 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -76.91 -30.15 56.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.47 -41.79 54.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.518 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 11.5 pt20 -120.86 45.06 2.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.974 0.416 . . . . 0.0 111.391 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -63.01 149.62 44.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.043 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . . . -156.36 120.67 2.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.708 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 116' ' ' ALA . 25.7 Cg_exo -62.95 110.59 1.17 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.838 2.359 . . . . 0.0 111.777 178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 148.45 -28.18 1.35 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.774 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 69.39 -72.44 0.1 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.438 0.695 . . . . 0.0 111.852 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.329 -178.605 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 111.904 -0.479 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -130.55 139.88 50.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.762 0.315 . . . . 0.0 110.17 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -103.85 135.8 19.3 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.152 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.81 -28.13 36.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.045 2.497 . . . . 0.0 112.356 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -150.58 149.54 30.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.251 0.548 . . . . 0.0 111.733 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG21 ' A' ' 95' ' ' THR . 5.1 t -170.63 123.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.603 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.5 ttt 53.54 54.21 10.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.571 0.7 . . . . 0.0 110.338 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.3 pt? -80.36 162.25 61.91 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' CG ' HG13 ' A' ' 106' ' ' VAL . 81.1 Cg_endo -88.52 172.66 4.77 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.718 2.279 . . . . 0.0 113.833 -166.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -138.11 154.09 49.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.853 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.9 111.5 19.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 64.0 m -92.55 109.72 21.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.472 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -95.48 110.7 22.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.381 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -113.98 149.57 35.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.956 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -112.9 134.89 54.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.472 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 33.1 ttpt -68.99 112.66 5.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.007 -174.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.27 -156.02 30.19 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.129 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.18 -8.95 24.58 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.014 2.476 . . . . 0.0 113.81 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -126.45 10.77 7.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 104.22 -139.14 14.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.311 -173.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.5 m-85 -103.17 -32.43 9.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.551 0.675 . . . . 0.0 112.072 -174.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.25 32.17 7.18 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.069 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -138.85 150.69 46.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -123.11 130.28 52.57 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.6 tp -100.71 139.23 36.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.703 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -142.18 152.74 43.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.23 155.89 19.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.376 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HG3' ' CE2' ' A' ' 38' ' ' TYR . 51.3 mt-10 -78.22 -172.37 2.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -75.45 92.42 2.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.117 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.33 -83.98 0.75 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 37.83 -154.35 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.288 -0.956 . . . . 0.0 112.378 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 1.8 pp -145.0 5.0 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.008 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.52 154.05 21.29 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.041 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -105.38 148.59 26.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.747 0.308 . . . . 0.0 110.191 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 31' ' ' GLU . 8.4 m-85 -126.93 153.29 45.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 110.538 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.69 121.35 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.187 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 tmm_? -88.99 -46.69 8.68 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 40' ' ' ARG . 34.7 tp -147.39 144.29 28.59 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.083 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 49' ' ' GLU . 2.2 p -129.97 113.72 27.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG3' ' CA ' ' A' ' 25' ' ' GLY . 1.7 mt-10 -70.34 132.76 87.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.195 -166.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.19 118.14 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.407 2.071 . . . . 0.0 111.89 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.85 -1.43 33.85 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.382 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.483 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 99.3 p -85.45 158.95 56.83 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.181 -177.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -17.86 49.02 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 111.339 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.53 -43.39 97.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.721 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 42' ' ' VAL . 44.6 mt-10 -60.15 -44.16 95.18 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.279 0.561 . . . . 0.0 110.004 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -70.41 -17.67 63.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.511 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -83.27 -18.83 37.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 0.0 110.286 175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.41 26.41 6.56 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.07 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.68 136.23 33.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.76 0.315 . . . . 0.0 110.634 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 55' ' ' ALA . 3.8 tt -137.41 143.37 41.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 54' ' ' LEU . . . -58.03 117.65 4.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.305 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.55 -26.51 6.27 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.126 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 94.3 m-20 -58.17 141.73 49.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.025 0.441 . . . . 0.0 111.792 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 46.8 ttt180 -85.31 122.68 29.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.436 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.74 118.8 21.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.908 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.55 -41.13 7.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.576 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 11.6 tt0 -149.96 150.94 32.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.729 0.3 . . . . 0.0 110.731 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 75' ' ' VAL . 48.8 t -128.81 116.11 39.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 62.8 m-80 68.39 -58.25 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.427 1.091 . . . . 0.0 111.171 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.11 28.21 0.06 OUTLIER Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.189 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 7.7 tp10 -125.54 127.26 46.14 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -69.92 115.72 9.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.771 0.32 . . . . 0.0 110.489 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.454 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 31.4 m -111.52 29.95 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.13 0.49 . . . . 0.0 111.486 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 35' ' ' LEU . 4.4 mm-40 -73.14 -8.72 57.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.732 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 99.8 mttt -138.43 32.45 2.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 111.169 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 61.4 mm-40 -107.11 -172.17 2.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.363 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 74' ' ' GLN . 65.1 p -123.48 174.1 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.56 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.421 ' O ' HG23 ' A' ' 76' ' ' VAL . 9.5 t60 -55.3 -47.9 74.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.001 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -65.73 -43.36 89.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.151 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 14.0 mm-40 -60.76 -42.9 98.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.298 0.571 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.721 HG13 HG21 ' A' ' 62' ' ' VAL . 90.1 t -70.79 -38.9 74.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.504 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 72' ' ' HIS . 25.4 t -58.88 -39.85 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -59.13 -41.78 89.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.277 0.561 . . . . 0.0 109.856 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.506 ' NE ' ' HG2' ' A' ' 65' ' ' GLU . 53.1 mtt180 -69.34 -35.88 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.417 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.9 mt -65.18 -32.59 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.202 0.525 . . . . 0.0 109.898 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -21.84 60.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.91 -17.3 61.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 109.997 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.53 114.29 20.83 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.562 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.53 -63.7 1.01 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.575 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -135.38 -0.12 2.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.149 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.98 141.65 20.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.9 p -126.62 144.15 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.839 0.352 . . . . 0.0 110.246 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . 59.6 mtm-85 -103.31 113.23 26.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.969 0.414 . . . . 0.0 110.152 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 17' ' ' LEU . 99.0 mt -112.37 118.47 35.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.014 0.435 . . . . 0.0 110.968 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 107' ' ' ARG . 32.8 tp -95.1 116.32 28.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 31.8 m -130.02 154.08 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.842 0.353 . . . . 0.0 110.6 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.83 147.57 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.154 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 13.5 t70 -62.54 121.75 69.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.604 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 37.0 Cg_exo -60.43 -31.1 92.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.526 2.817 . . . . 0.0 113.508 -173.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.84 -44.74 63.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.003 0.43 . . . . 0.0 110.241 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 9' ' ' THR . 23.7 m -71.13 -36.74 72.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.735 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 9.1 t70 -56.92 -33.28 66.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.872 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 101' ' ' LYS . 8.7 mm-40 -59.03 -49.66 77.04 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -72.74 -39.77 66.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.931 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.84 -33.9 76.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.988 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.59 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 1.3 tt0 -57.23 -49.14 76.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.495 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 14.0 mptt -68.94 -18.32 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.515 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.06 -10.81 59.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 111.225 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.84 46.3 38.43 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.614 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 106' ' ' VAL . 24.0 m -91.72 160.86 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.278 0.561 . . . . 0.0 111.96 -176.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -104.32 69.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.9 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.625 HG23 HG23 ' A' ' 104' ' ' VAL . 16.8 t -56.72 -27.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.6 ptm180 -59.9 -29.22 68.2 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -165.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -174.59 -27.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.177 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.22 -32.28 70.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -78.81 -19.73 51.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.035 0.445 . . . . 0.0 111.197 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.97 -38.0 46.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.426 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -81.3 -18.83 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.216 0.531 . . . . 0.0 110.055 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.04 -171.74 3.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.964 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.558 ' NE2' HD11 ' A' ' 11' ' ' LEU . 37.7 mt-30 54.08 37.29 26.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.347 0.594 . . . . 0.0 110.473 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.66 16.2 5.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.98 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 59.25 79.78 0.29 Allowed Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.301 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 95.73 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.833 2.356 . . . . 0.0 111.815 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -146.76 18.76 1.63 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.309 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -71.25 -46.97 59.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.153 0.501 . . . . 0.0 110.168 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.833 177.634 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -85.06 140.96 15.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.422 ' OD1' ' HD2' ' A' ' 7' ' ' PRO . 16.7 t0 -78.36 115.49 51.65 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HD2' ' OD1' ' A' ' 6' ' ' ASP . 37.2 Cg_endo -68.05 -21.62 42.71 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.893 2.395 . . . . 0.0 112.034 -175.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HD11 ' A' ' 110' ' ' LEU . 17.4 m-85 -146.78 147.32 30.79 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.519 0.676 . . . . 0.0 112.255 -174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 10' ' ' MET . 4.0 t -172.0 133.74 0.73 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.794 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 16.4 tpt 75.2 -60.58 0.51 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.708 0.803 . . . . 0.0 110.493 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 51.91 132.91 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.296 1.438 . . . . 0.0 114.178 -179.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.025 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 84.9 Cg_endo -76.8 173.43 14.49 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.577 2.851 . . . . 0.0 113.514 -176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -143.04 157.69 44.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.124 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' A' ' 89' ' ' LEU . 29.6 mt -84.54 115.98 22.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.2 m -94.49 108.31 20.25 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.517 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -94.62 111.62 23.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.659 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.7 OUTLIER -121.88 150.31 42.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 178.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 36.3 mt-10 -112.97 134.76 54.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.786 -171.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.87 117.58 4.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -172.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.63 -161.67 32.16 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.489 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.74 -33.15 93.35 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.42 2.747 . . . . 0.0 113.046 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -136.98 24.01 3.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 111.544 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.43 -153.26 18.08 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.155 -1.022 . . . . 0.0 111.758 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.694 ' HB3' HD12 ' A' ' 17' ' ' LEU . 92.4 m-85 -104.08 -29.91 10.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.967 0.383 . . . . 0.0 111.985 -173.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.14 29.65 6.69 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.79 172.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -134.0 141.07 47.11 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.429 -0.454 . . . . 0.0 110.32 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -101.6 144.17 30.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.53 128.32 49.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.493 0.187 . . . . 0.0 111.311 -172.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.5 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.4 p80 -123.94 140.27 53.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 34' ' ' LYS . . . -118.1 6.48 15.17 Favored Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 64.16 -173.7 0.17 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.978 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -107.61 122.09 45.98 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.58 -8.46 61.98 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.68 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 4.2 mptp? -96.44 167.71 11.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 110.718 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.883 HD12 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -130.51 20.48 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.061 175.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 144.05 15.8 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG3' HG21 ' A' ' 75' ' ' VAL . 12.5 mm100 -103.86 146.22 28.97 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 117.007 0.404 . . . . 0.0 110.299 -173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -128.22 152.69 47.77 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 55' ' ' ALA . 28.5 mm -70.09 118.3 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 109.952 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.5 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 1.2 tpt180 -93.96 -49.67 5.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.521 -173.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 42' ' ' VAL . 2.7 tm? -152.5 141.37 21.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.561 ' N ' HD13 ' A' ' 41' ' ' LEU . 25.0 t -118.82 127.29 75.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.1 mm-40 -80.88 120.05 77.79 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 11.7 Cg_exo -70.92 101.94 1.14 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.511 2.14 . . . . 0.0 112.386 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.2 22.11 1.26 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.99 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -118.49 173.84 3.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.77 0.319 . . . . 0.0 110.196 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 56.1 Cg_endo -70.34 -13.46 33.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.405 2.07 . . . . 0.0 112.922 174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -47.9 81.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.945 0.402 . . . . 0.0 110.891 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.7 mp0 -67.34 -32.97 74.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.406 0.622 . . . . 0.0 109.791 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 27.3 mtpp -69.56 -21.02 63.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.908 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.67 -17.81 24.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.37 38.11 4.1 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.52 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 88' ' ' LEU . 94.6 mt -92.9 130.86 38.35 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.9 tt -129.09 138.74 52.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HG22 ' A' ' 39' ' ' ILE . . . -63.4 103.89 0.56 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.183 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.99 -26.89 2.58 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.654 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.647 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.7 m-20 -65.25 149.39 50.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.33 0.586 . . . . 0.0 111.549 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 58.8 ttt180 -92.13 125.51 36.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.285 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 37' ' ' GLN . 48.2 tp -80.42 100.71 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.032 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -86.32 -39.51 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.161 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 4.1 tt0 -146.73 151.42 37.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 111.534 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.767 HG21 HG13 ' A' ' 75' ' ' VAL . 83.9 t -131.3 111.3 19.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.617 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.99 -24.0 0.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.844 0.858 . . . . 0.0 112.03 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 148.0 13.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.454 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -126.0 135.39 51.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.393 0.597 . . . . 0.0 110.185 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.22 102.49 4.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.916 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG21 HG23 ' A' ' 62' ' ' VAL . 29.9 m -92.61 12.7 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -170.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -71.5 -3.22 19.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.096 0.474 . . . . 0.0 111.185 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 35' ' ' LEU . 97.9 mttt -132.64 31.16 4.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.172 0.51 . . . . 0.0 110.086 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -116.9 -164.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.261 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 59.6 p -133.29 167.1 21.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.102 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.567 ' O ' HG23 ' A' ' 76' ' ' VAL . 20.4 t60 -53.88 -47.34 71.18 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.16 -46.81 88.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.2 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.552 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 48.6 mt-30 -65.32 -38.12 89.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.767 HG13 HG21 ' A' ' 62' ' ' VAL . 75.7 t -66.05 -39.55 84.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.924 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 72' ' ' HIS . 62.0 t -57.54 -46.1 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.614 0.245 . . . . 0.0 111.069 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -37.33 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.674 0.273 . . . . 0.0 110.989 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 85.9 mtt-85 -66.57 -36.38 82.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.974 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 75' ' ' VAL . 89.2 mt -65.52 -39.87 86.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.0 110.173 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 35.4 mmt180 -71.21 -20.87 62.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.687 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.87 -21.63 62.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.963 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 131.01 45.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.77 -52.27 10.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.216 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -132.87 -22.19 2.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.3 153.28 34.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.705 0.288 . . . . 0.0 110.937 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.0 141.71 44.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.12 114.51 27.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 53' ' ' LEU . 94.3 mt -109.62 119.46 39.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.485 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.423 ' HB2' HD23 ' A' ' 14' ' ' LEU . 26.8 tp -94.33 116.01 28.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 29.3 m -127.89 153.09 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.12 0.486 . . . . 0.0 111.041 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 10.6 p -148.26 153.51 11.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.326 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.89 118.69 16.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.41 -40.96 77.3 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.542 2.828 . . . . 0.0 113.597 -170.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.34 -37.47 66.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -66.21 -38.28 87.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.913 0.387 . . . . 0.0 110.271 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 33.7 t70 -61.68 -36.7 81.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.88 -48.33 80.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.296 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 17.0 pt20 -72.43 -42.87 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.998 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 28.5 mt -59.44 -43.98 93.02 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.639 0.257 . . . . 0.0 111.203 -177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 96' ' ' ASP . 77.5 mm-40 -61.9 -38.16 87.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.796 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 98' ' ' GLN . 12.5 pttp -75.55 -19.79 59.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.366 . . . . 0.0 110.453 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 86.4 mt -76.89 -3.65 39.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.488 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.82 30.48 26.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.737 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 99' ' ' LEU . 39.8 t -89.35 131.28 37.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.027 0.441 . . . . 0.0 111.869 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -95.18 85.29 4.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.336 174.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.557 HG13 ' HG3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -65.47 -17.47 22.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.222 -175.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -59.39 -45.91 90.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -167.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.545 ' HA ' HD13 ' A' ' 111' ' ' LEU . 21.3 tt0 -166.79 -10.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.137 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 42.1 mm-40 -55.69 -40.79 72.83 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 110.6 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 8' ' ' PHE . 45.1 mt -65.23 -40.22 93.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.392 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 108' ' ' GLU . 4.9 mp -83.91 -13.93 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.052 -170.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -78.61 -49.2 13.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.829 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.24 84.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.771 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -98.29 98.31 9.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.888 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.74 102.64 2.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.483 0.658 . . . . 0.0 110.311 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.08 129.61 77.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.985 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.73 84.79 1.96 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.597 2.198 . . . . 0.0 112.383 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 -43.49 36.95 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -149.13 47.77 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.41 -179.651 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.159 -0.376 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.0 mt -107.15 150.6 9.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -93.29 104.43 12.21 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.78 -30.55 78.05 Favored 'Trans proline' 0 CA--C 1.513 -0.56 0 C-N-CA 122.848 2.365 . . . . 0.0 111.498 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -149.53 139.67 22.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.317 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -148.56 -45.52 0.15 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.974 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.558 ' HB3' HG21 ' A' ' 95' ' ' THR . 51.0 tpp -138.9 78.57 1.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.924 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.54 155.8 85.35 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 -179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.715 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 55.3 Cg_endo -93.75 160.01 2.3 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.166 2.578 . . . . 0.0 112.775 -173.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -136.38 150.01 48.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.377 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD21 ' HD3' ' A' ' 87' ' ' ARG . 33.1 tp -82.21 106.79 14.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -92.49 111.66 23.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.051 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.632 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 42.6 m -97.31 110.9 23.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.256 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -110.97 154.98 23.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.339 176.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.96 130.41 55.69 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.211 -167.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -65.19 126.34 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.18 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.6 -169.18 21.82 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.24 -16.73 56.64 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.443 2.095 . . . . 0.0 112.135 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -97.81 0.74 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.132 0.492 . . . . 0.0 110.087 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.49 -119.76 5.81 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' HB3' HD12 ' A' ' 17' ' ' LEU . 91.7 m-85 -119.26 -24.55 6.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.114 0.457 . . . . 0.0 110.661 176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.0 31.18 29.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.576 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -128.7 156.6 43.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.361 0.581 . . . . 0.0 110.056 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.441 ' CD2' HD23 ' A' ' 41' ' ' LEU . 69.5 m-70 -126.16 144.61 50.69 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -120.15 143.18 48.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -139.48 147.35 41.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.706 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.36 108.81 2.29 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.733 ' O ' ' HD2' ' A' ' 34' ' ' LYS . 9.1 mm-40 -70.53 147.01 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -67.4 116.93 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 50.81 2.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.784 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -134.76 -171.87 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.906 0.384 . . . . 0.0 110.55 -177.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 pt? -129.4 -29.27 2.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.752 171.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.06 -163.95 12.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.04 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -111.93 155.69 23.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.892 0.377 . . . . 0.0 110.622 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.567 ' HE1' ' HE ' ' A' ' 58' ' ' ARG . 83.2 m-85 -131.16 151.9 50.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.534 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.1 mm -72.53 124.91 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.806 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' O ' ' HD2' ' A' ' 40' ' ' ARG . 2.4 tmm_? -89.06 -40.73 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 7.7 tp -161.9 150.07 14.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.751 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.487 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 65.0 t -129.29 129.9 67.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -76.94 115.97 53.04 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.31 114.2 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.207 1.938 . . . . 0.0 111.051 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.09 40.81 2.75 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.842 -174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.775 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 34.3 p -119.64 -164.16 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 74.5 Cg_endo -90.31 -13.36 2.42 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.245 1.296 . . . . 0.0 112.919 163.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -73.81 -41.62 62.1 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -74.73 -35.14 62.66 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.392 1.091 . . . . 0.0 108.14 -174.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -57.29 -34.66 68.9 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.797 -2.001 . . . . 0.0 110.938 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -78.87 -17.32 55.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.24 24.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.618 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.69 130.44 37.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.765 0.317 . . . . 0.0 110.495 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.3 tp -137.31 150.83 48.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.999 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.44 94.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.272 0.558 . . . . 0.0 111.179 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.71 -25.25 1.05 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.1 m-20 -62.26 140.81 58.48 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.137 0.494 . . . . 0.0 111.231 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 38' ' ' TYR . 42.1 ttm180 -88.9 126.7 35.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.907 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 46.3 tp -80.46 117.36 21.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.02 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HB ' HD23 ' A' ' 89' ' ' LEU . 52.6 t -102.21 -37.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.463 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -146.65 149.73 34.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.632 -178.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 75' ' ' VAL . 86.8 t -137.05 117.68 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.617 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 60.44 37.42 19.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.386 0.613 . . . . 0.0 110.147 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.52 16.24 76.25 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.705 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 7.3 tp10 -125.16 135.15 52.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.519 -0.401 . . . . 0.0 110.957 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.755 HD22 ' HD3' ' A' ' 107' ' ' ARG . 23.1 t-20 -70.02 113.96 7.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.375 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' HG3' ' A' ' 70' ' ' GLU . 32.9 m -111.99 26.61 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 0.0 111.327 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.462 ' CD ' HD21 ' A' ' 66' ' ' ASN . 81.2 mt-10 -61.24 -25.4 67.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.424 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 5.7 ptpp? -141.94 34.98 1.56 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.037 0.446 . . . . 0.0 111.543 -170.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mt-10 -110.56 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.019 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.3 p -113.48 167.62 10.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 76' ' ' VAL . 16.6 t60 -56.71 -44.52 81.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.853 175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.62 -46.01 90.24 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.607 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 56.8 mt-30 -61.38 -42.4 98.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 62' ' ' VAL . 74.3 t -64.97 -41.14 91.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.506 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 72' ' ' HIS . 73.1 t -58.01 -44.21 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.625 0.25 . . . . 0.0 111.425 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 p -64.0 -36.48 84.11 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.534 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 44.6 mtt-85 -64.94 -37.67 88.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 75' ' ' VAL . 77.2 mt -63.22 -32.8 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 110.268 176.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.6 mmt180 -70.34 -21.06 62.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.883 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -6.69 51.02 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.175 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -90.14 125.23 35.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.707 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.55 -75.86 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.144 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -118.64 -1.92 11.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.506 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.98 149.58 29.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 174.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.23 142.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.632 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 94.1 mtt180 -98.68 117.37 33.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.98 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.463 HD12 HD21 ' A' ' 17' ' ' LEU . 89.3 mt -121.75 125.92 47.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 10.4 tp -100.25 115.94 31.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.3 m -127.93 155.79 39.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.067 0.461 . . . . 0.0 110.375 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.715 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 14.3 p -148.0 154.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.039 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.62 123.37 56.93 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.95 -35.34 98.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.55 2.833 . . . . 0.0 113.246 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -72.22 -43.58 64.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.6 m -66.38 -37.43 85.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.689 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.51 ' HB2' HG13 ' A' ' 91' ' ' VAL . 30.5 t70 -57.92 -39.74 78.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.347 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -58.51 -49.05 78.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.281 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.546 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 15.3 pt20 -72.64 -39.59 67.08 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.765 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 102' ' ' LEU . 38.8 mt -70.48 -42.78 70.93 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -47.93 82.49 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -67.7 -18.92 65.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.685 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 95.8 mt -69.49 -20.84 63.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.54 33.09 4.59 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.058 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.26 132.1 56.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.049 0.452 . . . . 0.0 111.139 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -87.08 88.58 7.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.91 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 12' ' ' PRO . 2.3 t -65.64 -29.62 47.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.121 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.755 ' HD3' HD22 ' A' ' 66' ' ' ASN . 15.1 ttp85 -60.69 -44.02 97.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -168.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -158.81 -34.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.965 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.848 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 8.4 tp10 -55.52 -39.51 70.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.618 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 38.6 tp -68.86 -20.86 64.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.385 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.73 -32.55 16.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.968 0.414 . . . . 0.0 110.857 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.501 ' HD3' ' HA ' ' A' ' 109' ' ' GLU . 10.3 ptm180 -83.07 -30.69 27.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.938 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.98 98.01 3.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.636 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 2.9 mt-30 -98.41 16.12 22.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.48 0.657 . . . . 0.0 109.292 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.38 81.08 8.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.287 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.78 113.81 40.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.229 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.87 157.31 57.27 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.021 2.481 . . . . 0.0 112.406 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.49 -101.03 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.171 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -113.03 7.17 17.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.864 -178.573 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.7 138.36 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.718 ' HB2' HE22 ' A' ' 98' ' ' GLN . 63.7 m-20 -104.3 128.1 27.75 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -77.04 -30.58 4.31 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.445 2.097 . . . . 0.0 110.776 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 11' ' ' LEU . 37.2 m-85 -153.97 145.11 22.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.74 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 10' ' ' MET . 1.5 t -142.68 -98.49 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.135 -169.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.47 ' H ' HG23 ' A' ' 9' ' ' THR . 82.6 mtp -97.41 -28.05 14.18 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 28.1 mt 76.36 160.09 0.15 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.083 167.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 58.5 Cg_endo -69.03 157.32 62.27 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.103 2.536 . . . . 0.0 112.732 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -129.75 126.27 37.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.153 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.8 tp -90.9 106.62 18.64 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.511 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.427 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 55.8 m -99.74 107.96 20.16 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.8 p -100.27 111.62 23.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.26 0.552 . . . . 0.0 110.126 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -114.89 165.43 12.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.386 -178.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.1 147.38 44.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.859 -170.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -72.03 107.52 4.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.781 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.41 -163.76 39.28 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.55 -26.72 81.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.74 2.293 . . . . 0.0 112.71 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -112.63 25.67 11.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.253 0.549 . . . . 0.0 110.475 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -105.05 2.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.958 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 46' ' ' SER . 90.3 m-85 -131.7 -42.07 1.04 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.488 -0.419 . . . . 0.0 111.662 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.66 42.72 4.4 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 114.397 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.82 158.3 43.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.491 0.646 . . . . 0.0 110.171 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.48 ' CD2' HD23 ' A' ' 41' ' ' LEU . 60.8 m-70 -128.27 143.83 51.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.166 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.4 mt -124.68 155.91 38.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.212 0.529 . . . . 0.0 111.748 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -140.17 139.1 35.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.61 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.43 117.57 5.57 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -74.75 134.87 41.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 111.38 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -59.82 108.33 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.945 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.6 -31.46 3.96 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 12.0 mptt -110.25 159.51 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 109.864 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 1.5 pp -106.51 -4.05 20.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.076 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.06 147.99 24.08 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 75' ' ' VAL . 33.8 mm-40 -103.33 152.4 21.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.953 0.406 . . . . 0.0 110.061 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -126.39 144.75 50.72 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.1 120.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.27 -47.2 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.9 tp -146.66 149.41 33.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -123.67 120.04 58.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.163 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 53.0 mm-40 -64.29 131.91 95.18 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.5 Cg_exo -70.89 123.85 10.1 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.887 1.725 . . . . 0.0 111.786 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.7 22.07 24.67 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.055 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 89.9 p -104.24 158.08 32.69 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.746 0.308 . . . . 0.0 110.564 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.75 -14.82 46.99 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.601 2.201 . . . . 0.0 111.7 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -66.47 -40.69 89.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.347 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HG2' HG11 ' A' ' 42' ' ' VAL . 28.8 mt-10 -64.94 -37.68 88.46 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.874 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -68.67 -29.11 67.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.006 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -79.16 -18.89 52.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.34 33.66 5.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 88' ' ' LEU . 83.4 mt -86.89 134.74 33.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.691 0.281 . . . . 0.0 110.444 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.71 153.33 51.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 128.1 34.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.468 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.71 -15.73 21.61 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.149 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 1.7 m-20 -78.29 147.18 34.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.925 0.393 . . . . 0.0 110.761 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 90' ' ' VAL . 61.0 ttt180 -92.48 126.9 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.4 tp -77.58 112.79 14.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.163 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' HB ' HD23 ' A' ' 89' ' ' LEU . 40.8 t -104.88 -31.37 2.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.428 -176.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -143.13 149.96 38.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.055 -0.403 . . . . 0.0 110.78 -178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.2 t -136.59 113.59 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.315 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.82 35.28 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.837 0.827 . . . . 0.0 110.844 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.66 10.96 69.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.147 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.7 tp10 -124.79 132.05 53.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.112 0.456 . . . . 0.0 110.868 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.26 108.95 3.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.598 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.7 16.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.698 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -76.39 7.54 4.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.46 23.48 2.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.668 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -109.25 -172.61 2.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.811 -174.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 69.5 p -128.19 175.22 8.61 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.551 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 t60 -61.57 -46.56 89.37 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.217 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -66.51 -41.46 88.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.846 0.355 . . . . 0.0 110.716 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.55 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 15.8 mt-30 -67.17 -38.71 85.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' A' ' 37' ' ' GLN . 17.8 m -68.64 -41.18 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.08 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 72' ' ' HIS . 76.3 t -56.31 -39.13 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 m -61.94 -38.64 89.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.387 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 63.2 mtt-85 -67.37 -36.57 81.62 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.625 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 71.7 mt -63.17 -37.71 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.208 0.528 . . . . 0.0 110.004 175.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -68.96 -24.52 64.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.074 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.82 58.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.8 130.89 46.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.203 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.05 -67.05 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.858 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.37 -24.58 9.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.08 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.09 157.93 43.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.793 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.5 p -130.05 143.36 41.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 14' ' ' LEU . 9.9 mtm180 -98.74 128.51 45.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 53' ' ' LEU . 94.4 mt -122.12 110.57 15.92 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.812 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 11.9 tp -93.62 126.46 38.79 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.3 m -130.97 165.36 31.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 96' ' ' ASP . 8.7 p -148.14 140.1 18.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.569 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 1.5 p30 -75.1 145.12 80.18 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 50.4 Cg_exo -55.21 -31.52 76.47 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.017 3.145 . . . . 0.0 114.512 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -71.93 -47.89 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.777 0.323 . . . . 0.0 110.327 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.1 m -64.19 -44.78 90.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.622 0.725 . . . . 0.0 109.879 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' HG13 ' A' ' 91' ' ' VAL . 17.6 t70 -59.24 -39.64 83.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.507 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.48 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 1.9 tm-20 -57.41 -49.81 75.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.136 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.718 HE22 ' HB2' ' A' ' 6' ' ' ASP . 6.0 pt20 -73.96 -47.34 38.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 104' ' ' VAL . 2.7 mm? -58.76 -38.9 79.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -171.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' LYS . 7.4 pt20 -64.53 -40.64 95.98 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.212 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 97' ' ' GLU . 44.1 mtmt -75.52 -34.98 60.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.39 . . . . 0.0 110.878 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 90.6 mt -63.16 -27.3 69.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.606 -177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.61 73.92 0.9 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 99' ' ' LEU . 57.4 t -121.37 153.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.566 0.222 . . . . 0.0 110.605 -173.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.827 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 11.5 pt20 -71.22 57.16 0.23 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.36 0.6 . . . . 0.0 111.171 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.506 HG13 ' HG3' ' A' ' 12' ' ' PRO . 47.8 t -63.66 -27.57 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.775 -177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.549 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 39.4 ptt180 -60.61 -23.04 64.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -169.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 112' ' ' ARG . 17.8 tt0 171.18 -41.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.418 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 105' ' ' GLN . 34.0 mt-10 -54.47 -32.5 57.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.206 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.411 ' O ' ' HG3' ' A' ' 114' ' ' GLN . 61.7 tp -70.28 -41.97 72.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 0.0 111.245 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -90.37 -12.65 36.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.257 0.551 . . . . 0.0 111.135 -176.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.2 ttp180 -78.88 -46.94 17.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.663 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.24 39.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.345 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -120.0 112.09 18.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.261 0.553 . . . . 0.0 111.072 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.53 6.63 10.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.41 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 61.77 80.19 0.26 Allowed Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.905 -175.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.44 87.71 1.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.662 2.241 . . . . 0.0 111.854 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 161.74 60.26 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -70.68 148.67 47.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.8 0.333 . . . . 0.0 110.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.205 178.642 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.6 mt -73.85 135.9 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.91 0.355 . . . . 0.0 110.226 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.03 110.18 48.55 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.358 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.82 -16.36 18.49 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.747 2.298 . . . . 0.0 111.581 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -144.75 142.83 30.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.609 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t 179.7 132.11 0.09 Allowed 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 123.496 0.498 . . . . 0.0 110.39 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.8 mtt 44.06 47.06 7.31 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.74 0.65 . . . . 0.0 111.622 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.75 135.74 96.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.363 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 54.4 Cg_endo -68.1 155.43 69.54 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.132 2.555 . . . . 0.0 113.518 -174.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -116.81 154.09 31.33 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.315 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 87' ' ' ARG . 58.4 tp -82.06 115.48 21.22 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 70.8 m -93.41 115.85 28.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -104.38 112.21 25.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.727 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.66 155.68 34.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.182 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -104.34 145.77 29.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.512 -172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 26.0 ttpt -77.74 119.53 21.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.373 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.16 -158.36 25.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.701 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.12 -27.45 65.12 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.77 2.313 . . . . 0.0 112.457 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -110.25 26.1 11.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.274 0.559 . . . . 0.0 110.208 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' LYS . . . 80.91 -100.58 1.99 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.5 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 87.1 m-85 -133.72 -22.63 1.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.302 0.551 . . . . 0.0 111.804 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.05 28.96 24.23 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.76 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -127.31 140.6 52.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.401 ' CD2' ' HB3' ' A' ' 41' ' ' LEU . 93.6 m-70 -109.85 138.77 45.75 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.54 132.18 56.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.739 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.415 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 5.0 p80 -122.78 146.74 47.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.977 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.89 113.0 1.95 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.563 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 8.8 mm-40 -61.57 133.71 55.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.612 0.244 . . . . 0.0 110.833 -175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.12 98.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.276 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.01 -13.16 9.14 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.229 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HG3' ' HB2' ' A' ' 31' ' ' GLU . 27.8 mmmt -91.54 155.66 18.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.2 pp -102.57 19.28 19.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.31 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.39 152.47 20.64 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.666 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -103.71 137.52 41.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.907 0.384 . . . . 0.0 110.578 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 31.1 m-85 -125.08 155.41 39.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.013 -178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -71.33 127.83 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG3' ' HB3' ' A' ' 29' ' ' HIS . 3.9 tmm_? -101.14 -45.15 5.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.807 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -146.68 141.22 26.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.53 -172.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 41' ' ' LEU . 55.1 t -121.67 113.79 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.34 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.9 mm-40 -73.59 130.14 84.28 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.16 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.3 Cg_exo -70.13 124.04 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.367 2.044 . . . . 0.0 111.815 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.9 16.93 29.34 Favored Glycine 0 C--N 1.317 -0.496 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.899 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 95.9 p -101.71 159.54 29.13 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 0.0 110.829 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -65.96 -20.25 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.83 172.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -64.19 -42.13 96.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.21 -42.0 89.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.307 0.575 . . . . 0.0 110.362 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.65 -22.93 62.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.11 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -87.28 -17.83 31.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.901 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.67 29.96 5.71 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.202 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.13 133.51 36.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.2 tt -139.97 141.06 36.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.86 100.03 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.382 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.04 -31.23 1.74 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 2.9 m-20 -60.28 140.9 56.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 111.519 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -89.04 132.35 34.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.861 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.552 ' HA ' HG12 ' A' ' 90' ' ' VAL . 32.7 tp -75.2 114.06 13.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.758 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG11 HG12 ' A' ' 106' ' ' VAL . 46.3 t -101.7 -36.45 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.07 150.25 35.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.003 -178.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.618 HG23 HG21 ' A' ' 67' ' ' VAL . 93.0 t -136.17 107.24 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.123 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 87' ' ' ARG . 22.5 m120 62.99 22.4 13.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.346 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' A' ' 61' ' ' GLU . . . 106.67 4.22 36.94 Favored Glycine 0 C--N 1.321 -0.285 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.218 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.642 ' HG2' ' CZ ' ' A' ' 78' ' ' ARG . 9.1 tp10 -109.09 128.7 55.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.725 0.298 . . . . 0.0 110.356 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.36 93.29 1.91 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.422 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 62' ' ' VAL . 35.7 m -95.41 35.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -173.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.48 -18.69 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.1 19.2 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.673 -177.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 16.6 mp0 -93.93 141.12 28.88 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.99 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . 82.2 p -81.01 175.14 10.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.908 -174.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 21.9 t60 -53.84 -47.04 71.34 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.029 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.95 -40.97 91.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 84.1 mm-40 -62.86 -44.03 97.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.958 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 71' ' ' THR . 12.6 m -71.71 -44.96 68.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 72' ' ' HIS . 77.7 t -59.22 -35.88 60.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.027 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 t -57.53 -40.95 79.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.077 0.465 . . . . 0.0 110.317 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.642 ' CZ ' ' HG2' ' A' ' 65' ' ' GLU . 68.2 mtt-85 -70.0 -37.68 75.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.44 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.8 mt -64.61 -37.92 81.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.353 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.776 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.48 -22.33 51.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 127.68 32.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.234 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.8 mp -78.06 -62.29 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.755 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -128.33 -12.58 5.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.379 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -152.61 152.55 31.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.628 0.251 . . . . 0.0 110.81 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 24' ' ' TYR . 12.1 p -126.21 146.99 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.504 ' HB3' HD11 ' A' ' 14' ' ' LEU . 8.4 mtm180 -98.61 120.83 39.71 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 174.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 17' ' ' LEU . 92.6 mt -122.33 116.07 23.41 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.65 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 29.3 tp -101.54 117.37 34.77 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 25.8 m -131.04 153.77 39.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.943 0.402 . . . . 0.0 111.191 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 96' ' ' ASP . 11.3 p -142.65 149.04 19.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.185 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.39 129.35 68.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.31 -34.11 88.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.61 2.873 . . . . 0.0 113.576 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -71.35 -43.34 67.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 17.3 m -66.39 -41.4 89.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.709 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.539 ' HB2' HG13 ' A' ' 91' ' ' VAL . 14.0 t70 -58.84 -42.75 90.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.75 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -58.22 -47.03 84.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.019 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 13.6 pt20 -73.27 -38.67 65.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.0 111.001 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.97 -40.3 91.12 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -175.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.81 -37.18 85.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -71.67 -17.9 62.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.206 0.526 . . . . 0.0 110.655 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 77.0 mt -79.51 -3.85 48.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.906 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.84 41.71 72.26 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.104 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.91 137.64 22.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.859 0.361 . . . . 0.0 111.668 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 109' ' ' GLU . 17.3 mm-40 -79.33 54.64 1.73 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.464 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.475 HG12 HG11 ' A' ' 60' ' ' VAL . 1.5 t -60.57 -26.61 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.946 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.715 ' HD2' ' H ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -65.72 -5.44 8.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 33.3 tt0 168.55 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.934 0.397 . . . . 0.0 110.634 171.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 31.7 tt0 -55.54 -37.68 68.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.412 -172.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 110' ' ' LEU . 2.2 tm? -65.73 -26.79 67.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.668 0.27 . . . . 0.0 110.97 -177.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.39 -11.99 54.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.555 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -63.33 -72.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.3 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -177.58 -70.03 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.351 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 110' ' ' LEU . 2.2 mp0 52.64 40.78 30.75 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.791 -173.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.54 100.2 9.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 65.49 92.17 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.21 0 O-C-N 124.067 0.854 . . . . 0.0 109.705 -168.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 104.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.213 2.609 . . . . 0.0 112.684 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -125.17 38.6 2.26 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.926 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -127.81 95.47 4.22 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.78 178.153 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -133.41 133.6 57.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.863 0.364 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -112.75 125.44 29.89 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.566 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.41 -28.87 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.711 2.274 . . . . 0.0 112.588 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HD2' HD11 ' A' ' 11' ' ' LEU . 16.2 m-85 -144.81 151.87 39.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 -174.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.482 ' O ' HG21 ' A' ' 95' ' ' THR . 10.1 t 175.96 142.74 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -169.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.48 ' HB2' HG21 ' A' ' 95' ' ' THR . 86.1 mtp 48.44 47.4 20.14 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.807 0.692 . . . . 0.0 111.651 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 2.0 mm? -72.8 157.61 88.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.515 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 37.7 Cg_endo -64.45 178.88 1.44 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.438 2.759 . . . . 0.0 113.709 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -143.3 149.37 37.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.626 -178.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 13.4 mt -84.22 108.01 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.247 0.546 . . . . 0.0 109.688 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.6 m -94.38 108.41 20.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.044 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -95.1 111.85 23.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.915 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -122.04 150.79 41.61 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.183 0.516 . . . . 0.0 110.304 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.42 147.83 29.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.558 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -69.43 97.53 1.0 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.653 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 -167.09 14.56 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.836 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.23 -34.2 98.15 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.928 2.418 . . . . 0.0 112.261 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -102.34 24.37 10.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.547 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.63 64.27 3.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.37 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 17' ' ' LEU . 98.7 m-85 78.74 -38.57 0.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.215 1.006 . . . . 0.0 111.374 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.617 ' HA3' ' HB2' ' A' ' 46' ' ' SER . . . 95.51 12.45 53.83 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -123.35 149.76 44.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.126 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.492 ' CD2' HD23 ' A' ' 41' ' ' LEU . 39.6 m-70 -124.3 131.94 53.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.806 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -104.71 142.05 35.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.42 -172.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -133.42 134.93 44.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.149 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.39 104.04 2.15 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.585 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 39.5 mt-10 -60.39 146.37 44.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.095 0.474 . . . . 0.0 111.635 -173.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.78 117.98 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.636 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.0 -38.3 3.36 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.851 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' CG ' ' HB2' ' A' ' 31' ' ' GLU . 70.7 mmtt -66.85 157.18 33.71 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.503 HD13 ' HG2' ' A' ' 69' ' ' LYS . 1.0 OUTLIER -113.0 5.08 17.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.425 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.88 165.69 16.65 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.676 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 75' ' ' VAL . 3.1 mp0 -103.66 148.56 25.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.804 0.335 . . . . 0.0 110.411 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.449 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 32.6 m-85 -131.44 154.47 48.65 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.91 113.41 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 29' ' ' HIS . 2.9 ttp180 -85.48 -47.51 9.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.491 -177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 27' ' ' HIS . 26.7 tp -145.7 142.49 29.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.704 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 54' ' ' LEU . 1.7 p -135.66 112.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -78.87 135.43 59.25 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.68 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HA ' ' CD ' ' A' ' 49' ' ' GLU . 27.8 Cg_exo -61.67 129.17 26.82 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.609 2.206 . . . . 0.0 112.057 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.79 1.38 45.99 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.942 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.617 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 96.0 p -93.76 152.14 40.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.156 0.503 . . . . 0.0 110.947 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.24 -13.7 41.04 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.86 2.373 . . . . 0.0 112.17 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -63.98 -39.96 95.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.001 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' CD ' ' HA ' ' A' ' 44' ' ' PRO . 30.1 mt-10 -62.92 -39.46 94.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.963 176.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -65.6 -29.84 70.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.934 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -79.12 -19.42 51.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.331 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.63 49.98 1.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.4 mt -124.68 121.13 33.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.17 171.24 10.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.729 173.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.55 78.62 6.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.39 0.614 . . . . 0.0 111.191 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.33 -21.2 0.08 OUTLIER Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.957 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 67.3 m-20 -63.97 141.75 58.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.686 0.279 . . . . 0.0 111.114 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.18 124.92 34.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.78 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.578 ' HA ' HG12 ' A' ' 90' ' ' VAL . 51.8 tp -78.4 119.48 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG11 HG23 ' A' ' 106' ' ' VAL . 60.2 t -103.78 -34.97 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.388 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 16.6 tt0 -150.55 151.18 32.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.761 0.315 . . . . 0.0 111.17 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.47 HG23 HG21 ' A' ' 67' ' ' VAL . 65.6 t -132.4 119.92 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.469 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 72.9 -26.1 0.19 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.027 0.931 . . . . 0.0 111.729 175.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 145.16 10.68 0.28 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.604 -177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.3 tp10 -125.81 128.97 48.5 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.44 132.41 53.64 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.456 0.472 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 HG12 ' A' ' 75' ' ' VAL . 33.0 m -128.16 29.55 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.8 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.72 -24.28 66.94 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.503 ' HG2' HD13 ' A' ' 35' ' ' LEU . 98.3 mttt -129.95 29.83 4.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.813 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 15.9 mm-40 -95.19 179.93 5.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.934 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.65 ' OG1' ' HB2' ' A' ' 74' ' ' GLN . 25.1 p -107.63 167.62 9.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.695 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.2 t60 -62.69 -44.13 97.03 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -64.83 -36.75 85.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 0.0 109.973 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.65 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -62.96 -45.4 92.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.819 -177.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG12 HG11 ' A' ' 67' ' ' VAL . 4.7 m -71.32 -40.14 73.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.348 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' HIS . 45.1 t -57.55 -36.92 55.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.6 t -57.96 -41.53 83.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -69.09 -36.69 77.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 75' ' ' VAL . 70.0 mt -64.22 -32.8 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.049 0.452 . . . . 0.0 109.906 176.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -21.34 62.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.847 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.09 -18.35 46.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.424 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.18 119.07 26.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.832 173.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.96 -62.85 1.43 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.295 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -107.15 -27.52 10.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.306 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.63 155.06 37.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.994 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 24' ' ' TYR . 9.8 p -131.5 153.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.802 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -106.7 125.19 50.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 99.5 mt -120.37 127.68 52.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.2 tp -103.37 116.73 32.98 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 27.7 m -130.54 153.84 39.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.823 0.344 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -131.9 148.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.296 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 8.0 m-20 -68.24 123.14 86.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 33.0 Cg_exo -57.62 -31.74 92.61 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.541 2.827 . . . . 0.0 113.318 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.77 -48.46 81.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.656 0.741 . . . . 0.0 109.897 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 9' ' ' THR . 2.6 m -73.67 -36.04 65.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.261 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.07 -40.42 76.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 -176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 43.7 mt-10 -61.04 -43.51 98.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.775 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -74.41 -39.89 62.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.076 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 mt -64.94 -34.18 77.8 Favored 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 18.1 pt20 -60.17 -34.33 73.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.42 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -71.71 -37.77 70.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.321 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 99' ' ' LEU . 27.2 mt -76.89 -44.51 31.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.458 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.58 94.19 0.16 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.4 p -83.05 95.54 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.14 0.971 . . . . 0.0 112.072 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -113.08 28.33 8.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.418 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.807 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 21.8 m -66.35 -14.19 17.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.551 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.29 -37.76 75.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -166.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.616 ' HA ' HD23 ' A' ' 111' ' ' LEU . 39.0 tt0 -162.13 -19.86 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.175 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.26 -36.2 65.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.098 0.475 . . . . 0.0 110.722 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.686 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 3.9 mm? -77.92 -28.64 49.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.087 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 108' ' ' GLU . 3.6 mm? -74.94 -22.09 58.8 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.03 0.443 . . . . 0.0 110.235 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -60.4 -35.56 76.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.505 170.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 69.88 112.84 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.262 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.492 HE22 ' HA ' ' A' ' 110' ' ' LEU . 0.7 OUTLIER -84.28 92.11 7.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.951 -174.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.55 131.24 41.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.871 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.684 ' HB1' ' HG3' ' A' ' 119' ' ' GLN . . . -98.88 110.97 59.48 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.203 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.19 104.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 123.193 2.595 . . . . 0.0 112.871 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.7 31.45 67.66 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.219 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.684 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 9.2 pt20 -171.4 -173.26 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.851 0.325 . . . . 0.0 110.336 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.591 173.485 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.46 136.83 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -71.59 137.22 83.24 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.73 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.62 ' HA ' HD13 ' A' ' 102' ' ' LEU . 30.0 Cg_endo -64.79 -24.33 61.72 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.639 2.893 . . . . 0.0 113.298 -173.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.525 ' HD1' HD21 ' A' ' 11' ' ' LEU . 16.2 m-85 -146.01 150.05 35.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.066 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -173.71 126.58 0.39 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.453 -171.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 65.3 mtt 72.8 -71.0 0.14 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.884 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.525 HD21 ' HD1' ' A' ' 8' ' ' PHE . 2.8 mm? 65.74 156.89 0.13 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.778 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 72.4 Cg_endo -74.01 158.99 45.35 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.774 2.316 . . . . 0.0 112.553 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -115.33 143.98 44.45 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.737 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HB2' HD13 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -83.19 106.3 14.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.3 m -96.24 108.52 21.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.671 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HG2' ' A' ' 87' ' ' ARG . 22.0 m -91.82 111.75 23.4 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 48' ' ' ALA . 21.1 mt -88.27 163.65 15.99 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 41.6 mt-10 -115.34 121.85 44.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.19 101.75 2.89 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.932 0.396 . . . . 0.0 110.666 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.59 -157.87 33.04 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.709 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.0 -26.82 73.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.855 2.37 . . . . 0.0 112.556 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.59 14.8 30.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 -124.44 6.47 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.992 -1.099 . . . . 0.0 111.155 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CE1' HG12 ' A' ' 86' ' ' VAL . 91.4 m-85 -108.47 -22.55 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.896 0.379 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.06 33.94 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.005 -0.617 . . . . 0.0 114.112 171.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -132.17 149.9 52.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.458 0.629 . . . . 0.0 110.182 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -105.78 134.53 48.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.3 tp -119.87 124.25 45.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 40' ' ' ARG . 3.1 p80 -123.88 146.0 48.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.074 -175.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.62 105.01 1.29 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.941 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.613 ' O ' ' HE2' ' A' ' 34' ' ' LYS . 41.8 mt-10 -74.78 -178.33 3.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.655 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -99.2 138.68 35.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.64 -1.46 60.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.957 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HE2' ' O ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -104.65 -173.95 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.612 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.4 pt? -127.99 -12.67 5.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.588 174.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.12 -173.41 13.16 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.898 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.66 149.78 26.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.661 0.267 . . . . 0.0 110.658 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -125.91 152.17 45.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.532 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.3 mm -70.57 122.64 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.691 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.585 ' HB2' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -91.7 -48.52 6.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.973 -177.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.548 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 2.8 tp -154.93 152.09 29.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 54.8 t -119.52 115.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.19 174.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 69.4 mm-40 -62.94 127.66 91.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 7.6 Cg_exo -69.77 109.72 2.38 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.215 1.943 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.91 28.76 4.88 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.507 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 96.7 p -115.18 161.38 29.85 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.712 0.291 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 50' ' ' LYS . 38.6 Cg_endo -66.86 -13.41 39.83 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.132 2.555 . . . . 0.0 112.501 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.55 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -65.67 -39.94 91.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.359 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.41 -46.98 74.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 47' ' ' PRO . 21.2 ptmt -61.12 -34.77 75.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.951 -174.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.04 -17.68 36.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 58.92 0.71 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.494 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' O ' HG21 ' A' ' 42' ' ' VAL . 10.7 mp -120.11 126.31 50.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 54' ' ' LEU . 2.9 mm? -127.84 166.6 17.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.3 0.571 . . . . 0.0 110.826 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.9 105.48 6.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.263 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.92 -24.73 2.71 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.175 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.586 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 27.8 m-20 -63.87 144.4 57.09 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -95.75 133.05 40.3 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 90' ' ' VAL . 28.9 tp -73.33 110.37 7.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.004 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -95.33 -45.73 13.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.073 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -143.59 149.78 37.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.602 -176.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.663 HG23 HG21 ' A' ' 67' ' ' VAL . 82.3 t -137.04 119.31 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.965 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 62.29 37.79 13.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.2 5.86 82.3 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.526 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' VAL . 32.9 tt0 -126.09 128.75 47.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.17 0.485 . . . . 0.0 111.07 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -58.86 119.95 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.702 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG21 HG23 ' A' ' 62' ' ' VAL . 36.0 m -116.96 21.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.411 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.0 -14.89 61.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.86 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -122.69 19.01 10.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.964 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 21.6 mm-40 -92.0 -176.82 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.039 0.447 . . . . 0.0 111.202 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.571 ' O ' HG22 ' A' ' 75' ' ' VAL . 55.5 p -115.19 169.34 9.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.853 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.4 t60 -55.1 -47.0 75.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.741 0.305 . . . . 0.0 110.263 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -65.6 -46.35 79.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.444 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -62.57 -40.64 97.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.45 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 71' ' ' THR . 15.9 m -70.18 -42.98 79.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.668 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 72' ' ' HIS . 71.3 t -58.64 -36.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 110.731 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.8 m -59.52 -40.15 86.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 110.184 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.4 mtp85 -67.21 -36.85 82.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.34 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 76' ' ' VAL . 74.0 mt -63.53 -38.04 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.659 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 32.2 mmt180 -71.82 -22.71 61.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.666 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.23 -19.28 63.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.374 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -82.06 127.89 33.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.85 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.62 -71.15 0.48 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.465 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -108.45 -17.66 13.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.353 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.514 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -152.68 152.01 31.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.276 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG12 ' CE1' ' A' ' 24' ' ' TYR . 7.5 p -131.4 146.64 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.612 ' HG2' ' SG ' ' A' ' 16' ' ' CYS . 98.6 mtt180 -98.68 119.88 38.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.205 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.7 mt -121.67 121.96 38.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.396 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 14.9 tp -102.42 118.27 36.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.231 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 23.8 m -128.59 153.49 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.612 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 150.17 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.483 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 5.1 m-20 -71.8 116.16 45.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.446 174.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 96' ' ' ASP . 43.1 Cg_exo -58.07 -24.89 68.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.897 2.398 . . . . 0.0 112.277 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 7.1 pt-20 -65.31 -47.79 75.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.059 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 m -73.75 -38.83 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.488 . . . . 0.0 110.909 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 11.8 t70 -58.48 -32.16 68.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.78 -48.28 80.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.397 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -74.28 -40.14 62.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.015 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.8 mt -60.84 -38.3 85.04 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 46.8 mt-30 -58.07 -35.9 72.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.417 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -72.66 -19.43 61.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 7' ' ' PRO . 16.2 mt -101.55 -35.09 9.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.3 -174.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.79 86.21 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.956 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 106' ' ' VAL . 3.0 p -85.45 102.26 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.772 0.796 . . . . 0.0 111.942 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -126.71 49.18 2.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.109 0.957 . . . . 0.0 108.504 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 30.7 m -67.17 -13.42 16.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.063 -173.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -58.59 -35.43 72.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -163.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' HA ' HD12 ' A' ' 111' ' ' LEU . 22.5 tt0 -164.66 -22.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.191 0.52 . . . . 0.0 110.986 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -55.39 -45.57 76.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.526 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 110' ' ' LEU . 3.5 mm? -78.16 -18.54 55.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 111.408 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 89' ' ' LEU . 73.3 mt -76.01 -30.64 58.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.228 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 112' ' ' ARG . 9.2 ptp85 -88.89 -31.49 18.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.834 0.35 . . . . 0.0 110.864 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -161.93 143.57 11.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -123.81 126.4 46.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.86 130.49 43.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.098 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 61.51 70.11 0.93 Allowed Pre-proline 0 C--O 1.233 0.229 0 O-C-N 124.231 0.957 . . . . 0.0 110.218 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.27 115.89 2.95 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.894 2.396 . . . . 0.0 112.585 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.37 40.73 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.008 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -107.71 -87.57 0.48 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.187 178.283 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.4 mt -124.55 132.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 0.0 110.89 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -95.47 141.71 23.58 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.845 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.04 -21.88 68.12 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.109 2.539 . . . . 0.0 112.642 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.33 156.2 36.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.897 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.491 HG21 ' NE2' ' A' ' 98' ' ' GLN . 5.1 t -170.42 127.52 0.8 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.151 -177.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.554 ' HB3' HG21 ' A' ' 95' ' ' THR . 26.1 ttt 43.9 64.03 1.41 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.902 0.751 . . . . 0.0 111.302 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.84 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -75.81 146.85 80.3 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.03 -176.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.114 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 55.2 Cg_endo -67.15 140.14 52.91 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 123.342 2.695 . . . . 0.0 112.274 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -113.71 140.68 48.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.967 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.9 tp -81.53 105.01 12.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.626 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 56.3 m -96.09 113.07 24.65 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.891 -170.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.32 115.98 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.151 0.501 . . . . 0.0 109.851 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 24' ' ' TYR . 15.1 mt -98.59 147.55 24.69 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.396 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -100.17 122.43 42.99 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -65.75 111.31 3.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.85 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.44 -160.5 36.54 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.889 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.44 -29.65 71.63 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.777 2.318 . . . . 0.0 112.417 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -113.19 31.99 6.05 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.834 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.38 -116.0 4.13 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.215 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 17' ' ' LEU . 45.8 m-85 -125.16 -25.67 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.985 0.393 . . . . 0.0 111.274 -175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.58 30.44 11.85 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.562 -0.828 . . . . 0.0 114.026 172.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -125.46 152.2 45.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.577 0.688 . . . . 0.0 110.051 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 51.1 m-70 -117.52 139.3 51.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.391 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.35 127.84 49.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.064 -169.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.0 p80 -116.55 133.54 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.34 6.79 42.66 Favored Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.989 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.818 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 11.7 mm-40 64.16 172.3 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.816 0.817 . . . . 0.0 112.708 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -125.14 101.26 6.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.296 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.69 -19.19 10.53 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -98.44 -177.24 3.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 35' ' ' LEU . 2.0 pt? -141.22 35.72 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.858 0.361 . . . . 0.0 110.952 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.94 155.72 24.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.833 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.542 ' HG3' HG21 ' A' ' 75' ' ' VAL . 68.2 mm-40 -104.0 137.22 42.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.553 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 7.2 m-85 -134.07 152.9 52.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.729 0.3 . . . . 0.0 110.633 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -70.46 120.37 18.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -99.12 -26.81 14.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.598 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 42' ' ' VAL . 4.6 tp -163.93 150.15 11.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.7 t -125.24 118.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.395 173.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 40.5 mm-40 -64.17 129.87 94.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 8.0 Cg_exo -69.3 123.11 9.92 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.075 1.85 . . . . 0.0 111.807 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.44 20.58 26.85 Favored Glycine 0 C--N 1.317 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.593 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TYR . 90.7 p -104.17 159.3 29.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.87 -21.31 56.73 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.695 2.263 . . . . 0.0 111.887 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HA ' HD22 ' A' ' 17' ' ' LEU . . . -61.73 -38.78 89.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.151 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 21.3 mt-10 -71.08 -33.1 69.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.31 -36.69 77.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.41 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -80.44 -17.98 50.14 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.115 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 38.32 4.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.525 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.62 127.79 34.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 tp -121.02 141.48 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.67 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.62 102.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.331 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.9 -28.3 2.01 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.394 -175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 31.7 m-20 -62.23 139.41 58.5 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.595 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 42.7 ttp180 -89.75 132.68 35.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HA ' HG12 ' A' ' 90' ' ' VAL . 38.2 tp -74.72 112.5 10.99 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.729 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG13 ' CD ' ' A' ' 68' ' ' GLU . 57.3 t -95.7 -44.39 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.24 -175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -145.58 150.04 35.66 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.619 -175.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.588 HG21 HG13 ' A' ' 75' ' ' VAL . 92.3 t -137.13 116.17 15.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.9 m120 62.2 30.38 17.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.471 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.52 7.01 58.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.553 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 6.5 tp10 -125.53 135.4 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.603 0.701 . . . . 0.0 111.684 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -67.25 117.16 8.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.822 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 62' ' ' VAL . 29.6 m -117.9 26.38 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CD ' HG13 ' A' ' 60' ' ' VAL . 53.8 mt-10 -73.53 -19.7 60.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.836 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -122.06 21.48 10.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.599 0.714 . . . . 0.0 109.84 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 2.5 mp0 -101.54 153.82 19.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.472 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.8 p -77.1 162.32 27.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.354 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -56.38 -42.31 77.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.85 0.357 . . . . 0.0 110.166 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 7.1 tt0 -66.66 -40.79 88.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.053 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 88.7 mt-30 -62.01 -39.97 94.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.028 0.442 . . . . 0.0 110.669 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 62' ' ' VAL . 93.5 t -67.24 -50.44 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.324 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 73' ' ' GLN . 26.8 m -61.08 -35.34 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.614 0.245 . . . . 0.0 111.631 -177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 t -57.99 -43.12 86.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 83.7 mtt-85 -64.55 -39.9 94.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.999 0.428 . . . . 0.0 110.782 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.7 -33.13 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 2.9 mpt_? -73.13 -20.99 60.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.123 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.8 -17.57 55.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.809 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.69 126.76 30.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.9 -66.98 0.82 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.645 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -116.23 -19.43 10.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.05 0.452 . . . . 0.0 110.351 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.95 153.66 35.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.317 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -127.55 145.23 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -107.83 117.56 34.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -118.06 123.35 45.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.487 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 111' ' ' LEU . 37.8 tp -97.12 120.01 36.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 21.4 m -132.09 154.96 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.727 0.298 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.828 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.2 p -147.15 140.96 19.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.963 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.93 119.26 43.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.797 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.595 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 35.9 Cg_exo -59.33 -32.36 96.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.52 2.813 . . . . 0.0 113.018 -172.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.94 -37.46 69.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.848 0.356 . . . . 0.0 110.189 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 10' ' ' MET . 27.8 m -72.14 -38.61 69.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 173.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.92 -35.66 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.245 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 43.9 tt0 -58.23 -37.6 75.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 27.6 mt-30 -72.07 -48.82 41.35 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.3 mt -62.69 -35.79 80.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.511 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.731 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -64.1 -36.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.604 178.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 65.0 mmtt -71.04 -25.1 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.518 . . . . 0.0 109.837 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 98' ' ' GLN . 14.8 mt -82.61 -10.25 59.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.747 -177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.7 19.88 42.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.256 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.1 t -92.51 142.54 12.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.654 -0.321 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -116.91 98.16 6.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.114 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 15.3 m -65.7 -13.96 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.668 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 60.3 mtp180 -58.41 -29.53 66.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -167.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 9.2 tm-20 175.07 -23.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -54.06 -38.36 65.18 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.244 0.545 . . . . 0.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 11' ' ' LEU . 66.8 tp -77.38 -27.32 52.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.46 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.89 HD21 HD13 ' A' ' 89' ' ' LEU . 11.0 mp -71.76 -12.38 61.28 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.706 -175.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -73.18 -51.23 18.59 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.543 . . . . 0.0 110.284 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.24 69.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.475 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 110' ' ' LEU . 26.9 pt20 -86.82 127.9 35.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.056 0.455 . . . . 0.0 110.712 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -96.88 159.03 15.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.09 0.471 . . . . 0.0 110.975 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.9 115.13 27.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.004 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.22 112.01 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.982 2.454 . . . . 0.0 111.83 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -99.91 103.17 2.62 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.404 -174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -96.3 52.3 1.25 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.626 0.727 . . . . 0.0 109.758 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.029 -179.462 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.3 mt -117.15 134.47 60.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' OD2' ' HB ' ' A' ' 9' ' ' THR . 14.6 t0 -92.94 117.42 67.53 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.46 -28.41 86.66 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.327 2.685 . . . . 0.0 112.859 -171.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.64 146.19 6.86 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.644 ' HB ' ' OD2' ' A' ' 6' ' ' ASP . 2.5 t -163.29 136.59 5.67 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -172.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.711 ' HB2' HG21 ' A' ' 95' ' ' THR . 61.8 mtt 57.18 45.82 19.93 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.873 0.733 . . . . 0.0 109.676 176.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.25 145.62 89.93 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.643 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.012 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 58.6 Cg_endo -70.97 149.06 58.56 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.297 2.665 . . . . 0.0 112.647 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HD2' HH11 ' A' ' 13' ' ' ARG . 47.1 mtm180 -119.2 142.58 47.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.41 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 89' ' ' LEU . 58.9 tp -82.64 108.6 16.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.611 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.9 m -108.75 118.86 37.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.217 -169.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -95.04 133.86 38.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.016 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.587 HD13 ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -133.91 153.46 51.74 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.721 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -100.34 151.4 21.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.961 0.41 . . . . 0.0 110.349 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 34.6 ttpt -87.85 115.11 25.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.834 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.45 -154.12 29.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.303 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -64.9 -29.58 58.07 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.278 2.652 . . . . 0.0 111.96 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -116.67 28.47 8.53 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.294 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 82.1 -146.38 25.19 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.708 -177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB3' HD12 ' A' ' 17' ' ' LEU . 85.0 m-85 -93.29 -22.88 18.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.959 0.38 . . . . 0.0 111.234 -176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 30.1 22.87 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.216 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -131.03 157.45 42.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.212 0.506 . . . . 0.0 109.959 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' CD2' HD23 ' A' ' 41' ' ' LEU . 84.8 m-70 -127.26 145.11 50.89 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 37' ' ' GLN . 23.4 tp -122.92 137.18 55.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.773 0.321 . . . . 0.0 111.776 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 2.9 p80 -133.25 140.29 47.42 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.06 2.42 20.98 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 58.25 -169.3 0.12 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.709 0.403 . . . . 0.0 111.094 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -131.56 133.2 44.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.2 -21.13 46.96 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -86.32 173.61 9.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 2.4 pt? -130.98 16.52 5.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.85 0.357 . . . . 0.0 110.75 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.24 161.94 25.65 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.711 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 34.9 mm-40 -103.3 145.36 30.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.404 . . . . 0.0 110.304 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 8.9 m-85 -128.73 150.94 50.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.722 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -70.7 125.16 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -91.7 -36.33 13.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.902 0.382 . . . . 0.0 110.103 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 14.6 tp -164.08 148.33 9.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.766 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.469 ' N ' ' HG ' ' A' ' 41' ' ' LEU . 58.1 t -125.01 118.72 53.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.169 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -63.9 128.34 92.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.462 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.78 127.73 22.37 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.302 2.001 . . . . 0.0 112.557 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.85 9.04 75.13 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.192 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.494 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 87.7 p -84.6 164.47 42.5 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.814 0.307 . . . . 0.0 110.583 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 12.3 Cg_endo -57.71 -26.32 72.48 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.555 2.17 . . . . 0.0 112.176 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -65.29 -31.8 73.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' CG1' ' A' ' 42' ' ' VAL . 3.7 mt-10 -69.74 -28.55 65.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -66.12 -37.07 84.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 110.119 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -78.96 -17.31 55.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.235 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.7 29.67 7.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.0 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.56 138.0 32.99 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.682 -0.305 . . . . 0.0 110.514 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 55' ' ' ALA . 6.3 tt -145.59 143.13 29.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 41' ' ' LEU . . . -59.56 103.2 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.293 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -31.63 1.57 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.717 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 14.7 m-20 -61.54 141.49 57.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.898 0.38 . . . . 0.0 111.06 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -89.36 124.99 34.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.394 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.555 ' HA ' HG12 ' A' ' 90' ' ' VAL . 48.2 tp -78.39 112.46 15.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.893 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG23 ' HG ' ' A' ' 89' ' ' LEU . 5.0 m -105.94 -26.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -146.41 150.64 36.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.778 0.323 . . . . 0.0 111.21 175.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG21 HG13 ' A' ' 75' ' ' VAL . 62.1 t -136.39 113.81 13.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.118 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 57.0 41.3 27.86 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.528 0.517 . . . . 0.0 112.344 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.85 -8.38 59.6 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.359 171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 78' ' ' ARG . 44.2 tt0 -126.36 128.62 47.35 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.127 0.963 . . . . 0.0 109.613 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 27.0 m120 -69.53 135.13 49.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.235 -174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 23.1 m -118.91 24.18 4.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.922 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.551 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 8.0 mt-10 -54.84 -33.15 61.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.508 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.551 ' HE3' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -131.48 21.06 4.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.71 -175.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 1.4 mp0 -98.15 161.56 13.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.118 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.1 p -89.54 165.13 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.728 -172.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.3 t60 -58.62 -46.62 86.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.95 -41.48 96.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.843 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 98.2 mt-30 -63.57 -43.78 96.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG13 HG21 ' A' ' 62' ' ' VAL . 94.1 t -63.7 -46.2 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.419 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 72' ' ' HIS . 95.5 t -59.94 -39.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 0.0 110.991 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 m -58.45 -38.13 76.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 86.6 mtt-85 -61.73 -34.61 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.331 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.91 -31.97 52.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 -177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -69.88 -22.67 63.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 110.731 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.76 62.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.109 0.481 . . . . 0.0 110.07 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 85' ' ' ALA . . . -72.32 121.09 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.837 175.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.78 -61.27 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.703 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -129.48 -7.26 4.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.23 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -151.78 154.48 36.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.513 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 24' ' ' TYR . 11.2 p -130.65 144.59 37.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -101.55 117.63 35.31 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.486 HD12 HD21 ' A' ' 17' ' ' LEU . 98.5 mt -119.9 123.23 43.09 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.099 0.476 . . . . 0.0 111.093 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.819 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 45.0 tp -101.9 118.32 36.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.587 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 59' ' ' LEU . 28.5 m -131.36 158.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 12.0 p -135.11 144.43 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.703 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.16 126.71 61.87 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.624 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' A' ' 57' ' ' ASP . 19.9 Cg_endo -58.7 -40.18 75.52 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.714 2.942 . . . . 0.0 113.929 -170.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 95' ' ' THR . 8.3 pt-20 -72.35 -39.86 67.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 10' ' ' MET . 1.8 m -71.76 -36.51 70.4 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -176.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.461 ' HB2' HG13 ' A' ' 91' ' ' VAL . 6.7 t70 -56.88 -43.89 81.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.707 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 32.5 mt-10 -67.92 -36.42 80.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.686 -176.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.22 -39.17 60.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.443 174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 102' ' ' LEU . 53.6 mt -67.41 -31.95 72.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 97' ' ' GLU . 23.6 pt20 -56.62 -36.71 69.77 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -172.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -75.44 -20.08 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.691 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 99' ' ' LEU . 55.7 mt -84.02 -40.11 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.242 0.544 . . . . 0.0 109.87 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.94 120.56 0.52 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.412 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.535 HG21 HH21 ' A' ' 107' ' ' ARG . 18.6 m -85.09 41.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.825 0.821 . . . . 0.0 110.427 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -83.44 5.31 24.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.197 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.012 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 2.5 m -65.12 -15.71 18.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.197 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.535 HH21 HG21 ' A' ' 104' ' ' VAL . 27.7 mtt180 -59.65 -32.19 70.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.027 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 107' ' ' ARG . 51.0 tt0 171.65 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.703 0.627 . . . . 0.0 109.363 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -55.67 -51.84 65.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.629 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.8 tp -60.19 -30.14 69.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.773 0.321 . . . . 0.0 110.602 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.46 -26.29 62.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.382 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -63.05 -32.5 73.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.544 0.688 . . . . 0.0 109.849 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 67.73 44.54 1.61 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.444 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.644 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.5 OUTLIER -71.52 0.74 7.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.406 -177.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -105.81 150.0 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.553 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 60.22 74.48 0.55 Allowed Pre-proline 0 C--O 1.235 0.332 0 O-C-N 123.962 0.789 . . . . 0.0 111.344 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.31 111.64 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.941 2.427 . . . . 0.0 111.762 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.93 -29.51 58.93 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.456 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.26 -86.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.587 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.0 mm -83.72 137.14 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.18 127.65 93.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.28 -20.03 32.89 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 123.101 2.534 . . . . 0.0 111.653 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.409 ' CE1' HD11 ' A' ' 110' ' ' LEU . 2.6 m-85 -150.95 147.0 26.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.544 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -157.26 122.67 4.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.981 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 tpt 62.74 65.54 0.82 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.708 0.766 . . . . 0.0 109.991 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -81.59 138.09 47.7 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.807 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.008 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 66.5 Cg_endo -72.83 171.15 17.98 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.171 2.58 . . . . 0.0 113.653 -173.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 156.56 46.82 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.694 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' HD23 ' A' ' 111' ' ' LEU . 32.8 tp -83.99 117.91 23.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 41.3 m -94.53 111.22 22.98 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.8 p -100.69 111.09 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 110.195 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -116.6 146.61 42.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.408 -177.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.14 141.6 44.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.1 -170.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 40.0 ttmt -68.07 119.57 12.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.926 0.393 . . . . 0.0 111.201 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.1 -149.32 25.34 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.267 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.62 -27.27 45.67 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.947 2.432 . . . . 0.0 112.468 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -132.86 53.03 2.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 0.0 110.497 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 79.14 -121.6 5.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.441 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.558 ' HB3' HD12 ' A' ' 17' ' ' LEU . 97.6 m-85 -123.15 -27.74 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.38 29.31 9.6 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.322 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -141.1 143.2 34.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.308 0.554 . . . . 0.0 110.328 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -129.68 143.46 50.83 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.4 mt -112.91 150.05 32.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.978 -173.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 38' ' ' TYR . 0.4 OUTLIER -134.73 144.01 47.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.325 176.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.43 114.94 3.93 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.77 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 38.5 mt-10 -55.58 125.45 21.12 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 20.8 tptp -67.42 133.95 50.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.34 -15.41 63.02 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.722 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -100.91 178.33 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -129.93 25.29 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.46 166.61 25.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.857 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -104.24 136.91 42.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.994 0.426 . . . . 0.0 110.594 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 89.3 m-85 -121.43 157.36 30.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.544 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.0 mm -71.35 114.8 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -85.19 -43.14 14.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.2 tp -149.37 141.95 24.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.415 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.84 114.51 46.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -70.73 112.93 14.84 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 14.0 Cg_endo -58.32 121.55 10.17 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.545 2.163 . . . . 0.0 112.232 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.96 13.78 26.43 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.082 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.501 ' CB ' ' HA3' ' A' ' 25' ' ' GLY . 89.8 p -103.91 160.22 26.8 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 37.1 Cg_endo -66.46 -16.19 50.29 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.803 2.335 . . . . 0.0 112.106 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -63.04 -41.72 99.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.117 177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 44' ' ' PRO . 42.2 mt-10 -63.06 -43.64 98.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 176.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 65.6 mttm -62.72 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.25 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 15' ' ' CYS . . . -85.31 -19.66 31.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.269 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.68 44.36 1.68 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.551 HD12 ' HB1' ' A' ' 48' ' ' ALA . 85.0 mt -102.67 146.95 27.43 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 174.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tt -145.96 143.62 29.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.77 101.48 0.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.4 -25.41 1.85 Allowed Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.97 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 71.0 m-20 -75.28 148.56 39.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.84 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -92.74 133.57 35.9 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.445 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 90' ' ' VAL . 40.7 tp -75.91 107.12 7.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.648 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.872 ' HA ' ' HB3' ' A' ' 68' ' ' GLU . 47.2 t -95.31 -33.96 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -175.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -147.09 150.55 35.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.861 0.362 . . . . 0.0 111.008 -178.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.765 HG23 HG21 ' A' ' 67' ' ' VAL . 81.3 t -136.58 113.83 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.096 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.46 33.27 20.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.077 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.65 16.13 60.55 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.859 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -123.87 135.23 53.61 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.591 -0.358 . . . . 0.0 110.617 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.404 ' CG ' HH12 ' A' ' 107' ' ' ARG . 3.4 t-20 -73.55 114.75 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.663 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.765 HG21 HG23 ' A' ' 62' ' ' VAL . 17.4 m -128.47 11.53 2.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -172.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.872 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -72.34 -21.7 61.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.768 -174.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 69' ' ' LYS . 33.8 mtmm -110.23 18.21 20.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.215 174.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 67' ' ' VAL . 36.9 mm-40 -97.3 175.57 6.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.314 0.578 . . . . 0.0 111.97 -176.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.4 p -89.58 173.98 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.073 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 76' ' ' VAL . 61.8 t60 -65.31 -44.43 87.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 175.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.79 -39.29 90.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.71 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 11.1 mm-40 -61.39 -45.82 92.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.05 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 79' ' ' ILE . 18.6 m -68.68 -45.15 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.369 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 80' ' ' ARG . 80.2 t -54.7 -43.77 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.994 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -60.27 -41.26 92.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 75.1 mtt-85 -69.18 -36.23 77.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.189 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.562 HG23 HG11 ' A' ' 86' ' ' VAL . 89.1 mt -62.26 -42.19 94.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 7.8 mpt_? -64.89 -20.79 66.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.16 64.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.65 0.262 . . . . 0.0 111.507 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.641 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -69.27 142.29 54.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.308 0.575 . . . . 0.0 110.746 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 -56.55 4.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.884 -175.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -123.87 -28.75 3.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.8 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -146.18 143.42 29.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.359 -172.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.641 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -109.56 158.4 9.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.142 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -110.26 119.21 38.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 88.2 mt -119.7 128.54 53.9 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.902 0.382 . . . . 0.0 110.831 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 15.6 tp -106.46 121.8 45.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.978 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 57' ' ' ASP . 26.7 m -131.69 155.29 41.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.05 0.452 . . . . 0.0 110.983 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.79 150.29 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.074 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 18.3 t70 -64.5 120.51 66.02 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.459 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 32.9 Cg_exo -60.89 -29.46 88.15 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.448 2.765 . . . . 0.0 113.208 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.8 -47.87 50.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 20.3 m -66.24 -37.18 84.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 22.0 t70 -58.5 -36.14 73.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.184 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.61 -48.16 81.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 95' ' ' THR . 20.8 pt20 -71.63 -38.79 70.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.47 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.83 -33.87 73.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.749 0.309 . . . . 0.0 110.926 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 67.3 mt-30 -57.86 -41.61 82.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.927 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -71.12 -21.26 62.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.982 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.38 -43.03 8.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.369 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.2 84.69 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -66.85 90.06 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 122.228 1.013 . . . . 0.0 111.834 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 23.7 mt-30 -103.14 22.1 14.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.16 177.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.008 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 3.9 m -66.0 -18.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.582 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 66' ' ' ASN . 5.8 ptp180 -63.38 -33.73 76.18 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -170.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -179.68 -27.83 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.104 0.478 . . . . 0.0 109.995 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 105' ' ' GLN . 5.0 mm-40 -55.74 -40.95 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.312 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 8' ' ' PHE . 52.8 mt -78.72 -17.48 55.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 111.898 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.571 HD21 HD13 ' A' ' 89' ' ' LEU . 7.9 mp -79.9 -12.61 59.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -96.83 -60.85 1.51 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.334 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.0 143.84 23.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.098 0.475 . . . . 0.0 111.714 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -84.58 99.33 10.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.938 172.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.81 80.58 2.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.926 0.869 . . . . 0.0 111.382 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -177.96 72.38 0.22 Allowed Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 113.611 -1.631 . . . . 0.0 109.83 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.4 71.8 1.81 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.063 2.509 . . . . 0.0 112.385 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.47 -45.41 4.34 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.04 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -64.22 -35.73 81.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.011 179.371 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.93 133.73 60.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.18 122.9 42.55 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.433 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.57 -26.97 11.31 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.582 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.611 ' CZ ' ' HB ' ' A' ' 104' ' ' VAL . 7.3 m-85 -149.01 150.88 33.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 9' ' ' THR . 7.3 t -172.16 101.98 0.17 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.875 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.1 tpt 69.42 64.06 0.27 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -172.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.7 pt? -80.15 160.1 69.03 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.933 -171.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.88 ' HG3' ' HB ' ' A' ' 106' ' ' VAL . 73.7 Cg_endo -73.35 165.76 31.71 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.768 2.312 . . . . 0.0 113.049 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -143.16 146.19 33.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.904 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 111' ' ' LEU . 47.0 tp -84.43 111.29 19.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -93.66 115.89 28.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.45 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 m -103.97 111.24 23.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.808 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -117.21 154.63 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.845 -177.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -111.59 136.51 50.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.346 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.565 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 38.9 ttmt -67.27 131.09 45.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.341 0.591 . . . . 0.0 111.928 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.86 -148.74 10.45 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.618 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.27 -2.67 12.72 Favored 'Trans proline' 0 N--CA 1.472 0.209 0 C-N-CA 123.157 2.572 . . . . 0.0 112.444 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -128.08 22.22 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.235 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA2' ' HG3' ' A' ' 19' ' ' LYS . . . 77.28 -106.11 2.17 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 110.581 -1.007 . . . . 0.0 110.581 -172.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' HD12 ' A' ' 17' ' ' LEU . 84.0 m-85 -127.79 -15.93 4.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.1 0.45 . . . . 0.0 111.332 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.19 32.57 43.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.102 -0.57 . . . . 0.0 114.078 173.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.26 151.79 50.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.618 0.709 . . . . 0.0 110.225 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.475 ' CD2' HD23 ' A' ' 41' ' ' LEU . 26.1 m-70 -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 37' ' ' GLN . 14.1 mt -118.45 151.36 37.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.106 0.479 . . . . 0.0 111.809 -177.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.572 ' NE2' ' HB2' ' A' ' 38' ' ' TYR . 3.6 p80 -130.86 144.84 51.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.67 108.65 3.04 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 33.4 mm-40 -71.51 125.0 25.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.073 0.464 . . . . 0.0 110.176 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.05 133.75 52.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.107 -175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.6 -28.22 11.82 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.819 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 31' ' ' GLU . 12.1 mptt -93.13 -32.75 14.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.837 0.351 . . . . 0.0 111.383 -177.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.6 mt 74.65 -50.32 0.67 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.578 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.61 157.95 8.14 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.683 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.461 ' HB3' HD22 ' A' ' 28' ' ' LEU . 35.8 mm-40 -102.09 144.64 30.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.033 0.445 . . . . 0.0 110.11 -175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.572 ' HB2' ' NE2' ' A' ' 29' ' ' HIS . 19.5 m-85 -122.53 152.15 40.65 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mm -70.83 108.21 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -81.12 -42.9 20.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 27' ' ' HIS . 22.9 tp -147.31 145.27 29.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.162 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -135.76 120.96 28.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -63.99 126.07 89.29 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.59 -172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.52 109.06 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.316 2.011 . . . . 0.0 111.721 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.84 12.91 21.46 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.987 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 88.1 p -91.57 159.4 38.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 37.7 Cg_endo -69.07 -13.66 36.83 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.555 2.17 . . . . 0.0 112.355 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.616 ' HA ' HD13 ' A' ' 17' ' ' LEU . . . -67.51 -45.45 75.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.726 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -59.71 -39.14 83.64 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.39 0.614 . . . . 0.0 110.207 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -75.96 -11.17 59.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.399 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -91.07 -17.61 25.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.105 0.479 . . . . 0.0 110.237 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.75 53.05 0.72 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.2 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.31 114.74 16.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.775 0.321 . . . . 0.0 110.466 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.8 tp -118.0 162.12 18.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.06 43.95 0.22 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.961 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.22 5.6 0.32 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.416 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 90' ' ' VAL . 3.9 m-20 -91.1 146.6 23.71 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.622 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . 41.0 ttp180 -99.78 130.33 45.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 41.7 tp -77.71 109.16 11.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.216 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.68 -42.84 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.11 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 1.3 tm-20 -144.21 150.84 38.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.737 0.303 . . . . 0.0 110.427 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 75' ' ' VAL . 61.3 t -135.78 107.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.238 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 58.74 39.06 24.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.129 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.68 35.71 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.718 170.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.89 136.68 54.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 118.298 1.049 . . . . 0.0 111.826 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -67.95 115.72 7.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.535 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' HA ' ' HG2' ' A' ' 70' ' ' GLU . 29.0 m -102.57 18.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -67.3 -16.7 64.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.336 0.588 . . . . 0.0 111.211 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -122.5 22.29 9.98 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.947 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 67' ' ' VAL . 33.9 mm-40 -105.07 -173.62 2.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.93 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.1 p -117.16 173.93 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.572 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.1 t60 -60.49 -47.06 87.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.872 0.368 . . . . 0.0 110.153 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.71 -44.76 89.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.823 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 51.3 mt-30 -63.89 -41.32 97.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.02 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 HG21 ' A' ' 62' ' ' VAL . 55.1 t -62.79 -44.99 99.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.133 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 72' ' ' HIS . 96.9 t -61.15 -38.68 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.9 0.381 . . . . 0.0 110.733 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -60.13 -38.21 82.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 110.402 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 74' ' ' GLN . 77.0 mtt-85 -68.48 -36.04 78.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.697 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.6 -35.82 75.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.163 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 40.0 mmt180 -68.6 -21.96 64.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.007 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.98 95.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.619 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.755 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -77.2 132.79 38.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.299 0.571 . . . . 0.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.47 -68.05 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.41 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -110.87 -16.66 13.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -150.43 134.98 17.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 82' ' ' ALA . 3.2 m -110.68 158.38 11.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HD3' HD21 ' A' ' 14' ' ' LEU . 62.5 mtt180 -112.58 114.63 27.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.561 173.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' A' ' 86' ' ' VAL . 71.2 mt -118.72 119.33 34.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.831 0.348 . . . . 0.0 110.773 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.708 HD13 HD11 ' A' ' 111' ' ' LEU . 21.7 tp -94.53 124.11 38.36 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 59' ' ' LEU . 29.2 m -132.58 155.16 41.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.928 0.394 . . . . 0.0 111.412 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 12' ' ' PRO . 13.0 p -139.24 144.32 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.345 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.11 116.97 28.67 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 58' ' ' ARG . 34.5 Cg_exo -58.17 -24.95 69.4 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.959 2.44 . . . . 0.0 112.243 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.21 -47.06 68.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.01 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 90.3 m -72.02 -38.39 69.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.179 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.87 -31.19 66.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.187 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -57.38 -45.68 84.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.699 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 1.9 mp0 -72.42 -48.1 43.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 110.394 175.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.618 ' HB3' HG21 ' A' ' 104' ' ' VAL . 22.7 mt -59.72 -40.87 89.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.482 -169.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -59.5 -38.64 81.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -75.13 -19.91 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.124 0.488 . . . . 0.0 110.337 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 99' ' ' LEU . 50.0 mt -83.48 -6.57 59.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.72 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.14 41.45 39.3 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.662 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 99' ' ' LEU . 14.9 m -90.23 169.16 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 111.504 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -125.17 83.23 2.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.077 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.88 ' HB ' ' HG3' ' A' ' 12' ' ' PRO . 8.5 m -67.5 -17.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 7.9 ttm180 -60.63 -44.68 96.06 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -168.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 111' ' ' LEU . 31.2 tt0 -161.25 -18.75 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.985 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -54.84 -47.37 74.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.838 0.351 . . . . 0.0 111.603 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.79 -18.18 56.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.708 HD11 HD13 ' A' ' 89' ' ' LEU . 38.0 mt -81.61 -22.42 37.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.802 0.81 . . . . 0.0 108.969 175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -86.73 -51.97 5.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.296 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -95.88 86.62 4.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.805 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -120.5 57.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -111.21 156.25 21.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.608 -169.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.01 109.04 45.33 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.551 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.71 90.69 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.67 2.246 . . . . 0.0 112.544 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -167.6 179.07 41.26 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.566 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 63.08 20.72 12.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 112.248 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.745 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.158 179.07 . . . . . . . . 0 0 . 1 stop_ save_